data_1zkh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zkh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 28.9 Cg_endo . . . . . 0 N--CA 1.478 0.584 0 N-CA-C 110.601 -0.577 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.97 157.13 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -90.65 117.83 29.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 110.449 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.618 HG21 ' HB1' ' A' ' 76' ' ' ALA . 6.8 pt -121.0 143.53 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.739 -176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -126.25 150.51 48.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.804 0.335 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 49.0 t -124.77 107.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.852 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.485 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -70.08 105.75 3.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.496 HG12 HD23 ' A' ' 19' ' ' LEU . 60.3 t -76.41 131.83 73.97 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.1 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.739 ' HG2' HD13 ' A' ' 19' ' ' LEU . 41.4 Cg_endo -68.0 149.58 77.33 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.223 1.949 . . . . 0.0 111.781 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.528 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -76.32 86.98 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.54 ' HB3' HG21 ' A' ' 15' ' ' THR . 47.5 mtm -135.55 76.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.679 . . . . 0.0 110.175 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 10.8 mp0 -79.9 -45.38 18.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.572 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.68 -5.59 10.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.006 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 34.7 mmtt -75.71 -8.13 56.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.662 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 11' ' ' MET . 13.3 t -163.81 -172.68 2.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -105.97 0.36 25.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.664 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m0 -85.38 168.61 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.753 ' HZ3' HG23 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.01 28.8 0.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.661 . . . . 0.0 111.407 -177.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.739 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -81.1 122.0 26.8 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.79 -0.569 . . . . 0.0 109.832 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.629 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 15.9 m-80 -138.06 16.66 2.82 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.943 -0.473 . . . . 0.0 110.665 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.19 -2.46 85.27 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.29 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.629 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -73.81 179.36 4.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.274 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.56 128.61 76.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.293 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD12 ' HZ2' ' A' ' 18' ' ' LYS . 86.2 mt -87.77 144.94 26.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.92 111.12 19.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.051 0.453 . . . . 0.0 109.856 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 92.6 m-85 -120.92 162.6 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.353 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 1' ' ' PRO . 6.7 m -127.67 119.01 24.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.755 0.312 . . . . 0.0 110.175 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -137.66 149.0 63.41 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.137 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 23.5 Cg_endo -64.99 148.62 89.78 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.302 2.001 . . . . 0.0 111.47 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.6 tp -60.54 -14.51 20.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.961 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -76.99 -21.57 54.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.776 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 29' ' ' PRO . 3.0 m-20 -74.18 -174.81 2.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.608 . . . . 0.0 110.71 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.97 174.75 10.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.72 -171.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' CG1' HG13 ' A' ' 61' ' ' ILE . 44.5 t -58.98 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.847 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 8.5 t -52.56 -34.29 49.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.134 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.05 -32.7 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 22.5 mm -72.0 -50.77 35.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 6.3 ptmt -58.0 -41.88 84.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.473 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 14.2 p -70.8 -41.26 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.009 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.604 ' HB3' ' HZ3' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -64.65 -35.66 81.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.957 -178.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -69.81 -41.89 79.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.05 0.452 . . . . 0.0 110.362 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -58.73 -31.45 68.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.93 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 5.7 mm-40 -81.69 -36.63 28.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 110.573 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.46 -49.26 17.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.64 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.753 HG23 ' HZ3' ' A' ' 18' ' ' LYS . 3.5 p -96.07 -45.28 6.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.969 0.414 . . . . 0.0 110.51 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.13 -20.14 6.34 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.68 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.567 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 15.7 ptm -77.81 119.33 76.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.547 . . . . 0.0 111.341 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.483 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 19.8 Cg_endo -68.03 157.98 59.39 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.329 2.019 . . . . 0.0 111.831 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -64.22 -9.57 18.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.419 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.05 -26.53 61.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.886 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.483 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -134.05 -5.67 2.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.926 0.394 . . . . 0.0 110.316 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -94.65 116.03 28.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.9 mmpt? -105.79 140.23 39.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.53 116.82 28.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.338 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 60' ' ' PHE . 30.3 tt0 -108.03 112.12 24.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' HB2' HD12 ' A' ' 78' ' ' ILE . 26.5 t80 -102.61 114.43 28.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.767 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 31.1 mm-40 56.56 29.54 15.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.459 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.52 8.77 57.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.733 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 9.5 mt -115.17 118.51 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.4 m-30 -68.49 94.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 0.0 109.953 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.558 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.45 152.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.428 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -122.43 167.3 13.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 6.2 t70 -59.36 -27.93 66.39 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.149 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -75.02 -11.06 60.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.382 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.9 170.01 8.15 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.932 0.396 . . . . 0.0 110.141 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.6 p -130.36 175.01 9.3 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.202 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.38 -43.34 73.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.26 -35.11 76.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.452 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -57.18 -42.15 80.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.641 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.477 ' CZ ' HG21 ' A' ' 61' ' ' ILE . 73.5 m-85 -95.08 0.34 54.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.96 47.28 12.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.786 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtt -69.96 87.46 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.25 -173.28 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.348 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -63.37 115.69 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 110.035 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.82 2.85 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.041 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -82.65 114.93 21.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.016 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.27 104.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.041 0.448 . . . . 0.0 110.719 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.13 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.59 114.66 23.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.16 133.58 34.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.92 148.27 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 51' ' ' LYS . 21.6 tp . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.479 0.633 0 N-CA-C 109.48 -1.008 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 15.8 m -126.56 153.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.395 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -84.2 124.6 31.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 76' ' ' ALA . 2.7 pt -124.48 137.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.249 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 mttm -117.85 146.36 43.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.088 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.0 105.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.06 104.24 3.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.654 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 69.9 t -75.26 128.09 85.2 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.364 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.718 ' HG2' HD13 ' A' ' 19' ' ' LEU . 33.4 Cg_endo -64.87 150.81 87.6 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.152 1.901 . . . . 0.0 111.907 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.552 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 12.8 m120 -77.54 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.713 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.565 ' HE1' HD11 ' A' ' 19' ' ' LEU . 41.0 mtm -142.53 75.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.707 0.289 . . . . 0.0 110.251 174.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 7.4 mp0 -78.92 -44.22 23.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 110.134 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.53 -2.54 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.029 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -87.79 -6.92 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.423 -172.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 11' ' ' MET . 15.0 t -161.38 -179.91 7.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.07 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.72 3.0 41.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.548 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.548 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 6.0 m0 -85.94 171.91 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.756 ' HZ3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -87.9 26.83 1.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 0.0 110.886 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.718 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.9 mt -80.19 128.16 33.19 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.655 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.3 m-80 -140.78 9.13 2.17 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.063 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.552 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.23 7.99 72.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.265 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.655 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -80.8 175.86 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.54 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.96 124.19 67.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.73 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.45 HD13 ' HZ2' ' A' ' 18' ' ' LYS . 81.0 mt -87.62 136.07 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.73 107.51 19.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -122.55 166.2 15.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.717 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 m -126.8 122.02 33.58 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.853 0.359 . . . . 0.0 110.775 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 4' ' ' ILE . 68.9 mt -138.57 152.36 70.8 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.513 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 43.5 Cg_endo -69.86 152.1 68.69 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.215 1.943 . . . . 0.0 111.748 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.49 -11.97 19.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -73.97 -23.98 59.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -76.28 -172.95 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.276 0.56 . . . . 0.0 110.72 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.85 171.97 13.68 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.625 -171.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.614 HG12 HG13 ' A' ' 61' ' ' ILE . 26.1 t -63.05 -26.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.338 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.43 -31.83 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.75 -30.65 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.11 0.481 . . . . 0.0 110.247 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.3 mm -71.16 -51.99 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.2 ptmt -58.03 -43.72 86.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.68 -38.58 79.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.583 0.23 . . . . 0.0 111.004 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.9 ptmt -68.87 -35.29 76.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.498 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.75 -41.88 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 47' ' ' MET . 8.1 t-80 -56.71 -35.2 68.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.022 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.53 -20.86 21.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.44 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.55 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.756 HG22 ' HZ3' ' A' ' 18' ' ' LYS . 6.0 p -107.88 -42.94 4.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.047 0.451 . . . . 0.0 110.721 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.08 -8.42 10.52 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.012 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.527 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 17.5 ptm -90.32 119.95 69.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.134 0.492 . . . . 0.0 111.699 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.91 156.89 63.95 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.547 2.164 . . . . 0.0 112.266 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.69 -16.87 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.4 -30.61 33.69 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.281 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.35 -6.0 3.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.441 . . . . 0.0 110.005 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.527 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.67 112.04 23.84 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.1 mmpt? -103.43 141.03 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.392 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.44 121.61 45.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.448 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.5 tt0 -113.64 115.77 28.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.8 t80 -101.81 107.53 18.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.225 0.536 . . . . 0.0 110.029 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 57.15 30.47 18.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.831 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.5 38.62 Favored Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.49 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.1 mt -118.74 116.02 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.0 m-85 -72.04 91.9 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.167 0.508 . . . . 0.0 110.114 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.614 HG13 HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -78.12 150.32 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.3 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HE3' HD22 ' A' ' 65' ' ' ASN . 0.6 OUTLIER -109.57 156.27 20.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.806 0.336 . . . . 0.0 110.827 177.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 5.7 p-10 -71.37 -2.93 18.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.996 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t -86.12 -5.34 59.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.748 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.433 HD22 ' HE3' ' A' ' 62' ' ' LYS . 95.7 m-20 -104.15 178.44 4.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.524 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 76.6 p -133.38 173.16 11.77 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.44 -33.46 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.231 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -56.47 -45.9 80.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -91.68 -0.62 57.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.744 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 m120 63.82 41.41 6.84 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.365 0.415 . . . . 0.0 110.888 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -64.27 93.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.316 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 177.98 4.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.918 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.623 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 36.0 t-20 -64.45 115.37 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.144 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.21 28.14 5.04 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.195 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.572 ' HB3' HG23 ' A' ' 4' ' ' ILE . . . -71.98 115.11 10.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.449 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG23 ' HD2' ' A' ' 5' ' ' LYS . 15.3 t -95.08 103.54 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.793 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.51 146.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -116.41 111.57 20.22 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -76.78 132.41 39.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.407 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 147.24 32.12 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.699 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.518 ' HB2' HG23 ' A' ' 27' ' ' THR . 9.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.06 152.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.945 0.403 . . . . 0.0 110.298 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -88.73 114.99 25.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.244 0.545 . . . . 0.0 110.355 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 76' ' ' ALA . 2.1 pt -114.81 136.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.481 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HD2' HG22 ' A' ' 77' ' ' VAL . 13.5 mttm -118.63 147.33 43.86 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.122 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.43 105.27 14.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 104.52 2.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 25.9 t -76.53 126.84 85.64 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.798 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.787 ' HG2' HD13 ' A' ' 19' ' ' LEU . 27.5 Cg_endo -63.97 147.26 91.92 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.399 2.066 . . . . 0.0 111.875 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.667 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -73.85 88.5 1.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.771 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.539 ' HE1' HD11 ' A' ' 19' ' ' LEU . 49.1 mtm -138.53 75.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.12 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 3.8 mp0 -79.49 -44.87 20.42 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.311 -173.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -116.44 2.14 13.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.908 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -90.81 -4.87 56.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.493 -171.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' MET . 13.1 t -164.25 -174.21 3.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.887 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -99.02 -3.66 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.407 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.595 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.9 m0 -85.78 169.98 12.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.094 0.473 . . . . 0.0 111.176 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.664 ' HZ1' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -82.09 22.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.001 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.787 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -77.52 133.32 38.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.611 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 21.1 m-80 -146.96 10.1 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.667 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 86.31 16.08 63.17 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.291 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.611 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -87.96 175.69 7.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.55 127.73 75.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.971 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.578 HD11 ' HZ3' ' A' ' 18' ' ' LYS . 85.7 mt -87.91 141.71 28.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.39 107.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.418 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 24.1 m-85 -121.01 164.83 16.15 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.518 HG23 ' HB2' ' A' ' 1' ' ' PRO . 4.9 m -126.44 122.26 34.78 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.218 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.467 HD11 HD12 ' A' ' 4' ' ' ILE . 78.6 mt -137.41 149.81 66.65 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.652 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 33.5 Cg_endo -66.27 152.2 81.61 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.273 1.982 . . . . 0.0 111.471 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HG ' ' HB1' ' A' ' 68' ' ' ALA . 21.7 tp -62.82 -8.07 6.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -80.11 -20.71 44.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -74.84 -176.2 2.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.138 0.494 . . . . 0.0 110.217 177.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.97 174.65 10.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.901 0.381 . . . . 0.0 111.563 -173.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG11 HG13 ' A' ' 61' ' ' ILE . 39.8 t -60.68 -30.33 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 m -51.69 -36.1 45.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.024 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -72.05 -32.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.641 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 23.9 mm -72.5 -51.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.452 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.583 ' HD3' ' OD2' ' A' ' 63' ' ' ASP . 3.3 ptmt -59.2 -42.56 91.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.498 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.3 p -69.83 -37.45 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.164 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 11.3 ptmt -69.31 -36.67 77.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.745 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.03 -41.35 81.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -58.73 -32.78 69.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.305 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 15.1 mm-40 -85.44 -30.89 23.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.902 0.382 . . . . 0.0 110.798 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.88 -46.62 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.956 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.664 HG22 ' HZ1' ' A' ' 18' ' ' LYS . 5.8 p -97.53 -40.56 8.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.477 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.11 -15.92 10.11 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.931 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.549 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.14 117.0 66.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.385 0.612 . . . . 0.0 111.464 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 22.1 Cg_endo -67.25 159.01 54.24 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.595 2.197 . . . . 0.0 111.882 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -65.4 -13.58 58.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.45 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -29.25 54.76 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.968 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -132.45 -2.63 3.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 0.0 110.63 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -95.24 117.65 30.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.114 0.483 . . . . 0.0 109.887 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.7 mmpt? -104.27 139.96 38.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -120.04 118.87 31.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.634 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -112.96 117.32 31.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 -175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 78' ' ' ILE . 12.2 t80 -102.73 107.98 19.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.947 0.403 . . . . 0.0 110.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 57.18 30.57 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.355 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.58 23.73 25.43 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.064 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 mt -126.38 116.21 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -72.15 95.9 1.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.474 0.654 . . . . 0.0 110.29 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.537 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -80.28 150.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.567 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.97 162.54 18.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.583 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 5.5 t70 -54.06 -27.7 34.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.218 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.15 -1.94 16.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.789 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.462 HD21 ' HE2' ' A' ' 70' ' ' TYR . 77.4 m-20 -115.69 168.76 9.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.394 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 91.9 p -125.73 173.15 9.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.33 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.12 -42.86 79.57 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB1' ' HG ' ' A' ' 30' ' ' LEU . . . -60.51 -33.92 73.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.222 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.09 -44.87 91.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.19 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.462 ' HE2' HD21 ' A' ' 65' ' ' ASN . 27.9 m-85 -94.66 5.52 51.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.654 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 43.28 13.19 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 110.866 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.468 ' HE1' HD12 ' A' ' 61' ' ' ILE . 58.7 mtt -69.18 84.89 0.37 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.026 0.441 . . . . 0.0 110.76 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.48 -176.58 2.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.702 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -58.69 115.5 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.56 36.11 3.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.654 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -81.35 114.9 20.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.51 HG22 ' HD2' ' A' ' 5' ' ' LYS . 14.7 t -97.66 105.57 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.101 0.477 . . . . 0.0 110.94 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.628 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -95.53 148.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -118.24 117.04 28.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -84.55 133.97 34.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.61 151.8 35.64 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 51' ' ' LYS . 24.3 tp . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.441 ' HB2' HG23 ' A' ' 27' ' ' THR . 19.6 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.92 154.43 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -90.81 120.83 32.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.332 0.586 . . . . 0.0 109.851 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.594 HG21 ' HB2' ' A' ' 76' ' ' ALA . 9.5 pt -120.46 143.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.402 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.527 ' HD2' HG22 ' A' ' 77' ' ' VAL . 4.5 mttm -119.26 150.14 40.59 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.889 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.12 105.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -71.43 106.2 3.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.68 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 79.2 t -77.18 130.0 76.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.751 ' HG2' HD12 ' A' ' 19' ' ' LEU . 37.8 Cg_endo -65.82 156.56 63.55 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.636 2.224 . . . . 0.0 111.829 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.638 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 13.3 m120 -85.32 85.82 7.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 19' ' ' LEU . 49.0 mtm -137.95 76.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.725 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.579 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -77.76 -48.03 17.6 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.657 0.742 . . . . 0.0 110.334 -171.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 10.9 10.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.311 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -90.66 -4.89 56.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.678 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -158.24 -172.94 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.796 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -101.17 -5.07 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.54 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.65 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.2 m0 -91.6 171.87 8.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.879 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HZ2' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -86.52 28.22 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 110.996 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.751 HD12 ' HG2' ' A' ' 9' ' ' PRO . 15.5 mt -78.26 127.74 32.68 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.642 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -138.74 16.53 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.462 -0.774 . . . . 0.0 111.022 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.638 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.91 7.86 86.64 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.642 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -80.28 175.1 10.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.394 0.616 . . . . 0.0 110.61 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.401 HG21 ' HG2' ' A' ' 7' ' ' GLN . 49.3 t -120.6 123.01 69.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.603 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.564 HD13 ' HZ2' ' A' ' 18' ' ' LYS . 72.7 mt -87.59 142.11 28.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HG2' ' A' ' 5' ' ' LYS . 57.8 t -132.39 107.78 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.529 0.681 . . . . 0.0 109.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.45 164.28 13.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.825 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -126.79 118.7 25.19 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.99 174.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 4' ' ' ILE . 89.9 mt -134.9 152.66 77.77 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.851 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.11 150.08 82.23 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.389 2.059 . . . . 0.0 111.246 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -61.8 -10.59 9.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.538 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -79.09 -18.94 52.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.867 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.02 -175.44 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.44 177.32 8.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.145 0.498 . . . . 0.0 111.567 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.492 ' CG1' HG13 ' A' ' 61' ' ' ILE . 60.3 t -56.14 -33.07 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.742 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m -54.9 -30.76 59.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.22 -27.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 110.532 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.715 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.1 mm -72.4 -54.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 9.0 ptmt -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.13 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.889 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.59 -35.22 78.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.5 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.433 HD11 HD11 ' A' ' 54' ' ' LEU . 67.4 mt -72.65 -43.08 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.526 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -59.04 -33.4 70.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.536 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -89.24 -20.41 24.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.064 0.459 . . . . 0.0 110.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.75 -54.48 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.153 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.7 p -91.15 -43.01 10.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.3 7.23 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.929 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.4 118.07 70.63 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.395 0.617 . . . . 0.0 111.602 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.36 157.33 62.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.433 2.088 . . . . 0.0 111.9 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.04 -8.02 20.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.384 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.76 -28.9 66.33 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.281 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.6 -2.75 3.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 110.449 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.553 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.64 117.26 32.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 mmpt? -110.92 140.33 45.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.391 -176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -111.0 124.21 51.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.436 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.45 117.9 31.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.739 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' HB2' HD13 ' A' ' 78' ' ' ILE . 14.2 t80 -103.33 108.25 19.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.092 0.473 . . . . 0.0 110.073 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.59 30.95 16.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.031 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.59 45.08 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.203 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mt -120.57 113.04 38.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -73.49 92.96 1.93 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.607 0.717 . . . . 0.0 110.409 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.492 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -72.57 158.11 6.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.425 -174.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -130.48 163.65 26.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.322 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m-20 -50.58 -32.19 17.98 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.814 0.696 . . . . 0.0 112.236 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -82.45 2.42 32.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.103 0.477 . . . . 0.0 110.95 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -110.47 163.74 13.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.5 p -129.76 165.94 20.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.87 -44.04 97.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.767 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.14 82.74 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.368 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -59.34 -42.75 92.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -89.11 1.28 55.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.665 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.72 44.22 17.52 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.641 0.588 . . . . 0.0 110.864 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.9 mtt -67.24 89.45 0.2 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.06 -169.65 1.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.712 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -61.74 115.53 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.26 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.29 38.75 3.92 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.768 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.594 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -75.59 115.02 14.83 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.786 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.527 HG22 ' HD2' ' A' ' 5' ' ' LYS . 21.7 t -94.94 102.26 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.192 0.52 . . . . 0.0 110.946 -176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.618 HD13 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -93.9 146.41 6.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -114.78 113.97 24.96 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.69 133.32 35.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.39 146.07 30.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.156 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.4 tp . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.473 0.31 0 N-CA-C 109.974 -0.818 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.0 m -121.05 153.87 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -89.94 116.18 27.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.035 0.445 . . . . 0.0 110.266 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -118.28 138.52 48.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.752 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HD2' HG23 ' A' ' 77' ' ' VAL . 8.6 mttm -118.66 146.97 44.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.903 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -123.31 105.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.38 106.68 4.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.646 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.506 HG13 HD22 ' A' ' 19' ' ' LEU . 84.4 t -78.18 130.63 71.64 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.33 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.709 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.5 Cg_endo -66.09 150.0 85.47 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.37 2.047 . . . . 0.0 111.995 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.596 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.6 m120 -76.53 88.54 3.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.52 ' HE1' HD11 ' A' ' 19' ' ' LEU . 47.0 mtm -139.49 75.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.549 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.82 -45.1 19.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.77 0.795 . . . . 0.0 110.226 -175.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -0.6 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.682 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -92.48 -1.52 56.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.623 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 11' ' ' MET . 13.0 t -166.7 -177.5 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.321 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.69 -7.09 38.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.445 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.641 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -86.02 167.24 15.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.76 ' HZ3' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.17 29.09 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.229 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.709 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.9 mt -79.27 130.69 35.72 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.667 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 20.5 m-80 -143.41 11.84 1.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.849 -0.532 . . . . 0.0 110.826 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.596 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.86 2.43 78.42 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.758 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.667 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.4 pm0 -76.21 174.08 10.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.4 124.36 72.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.08 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.583 HD12 ' HZ2' ' A' ' 18' ' ' LYS . 86.3 mt -87.97 147.53 24.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -133.19 109.11 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 89.4 m-85 -115.93 159.47 21.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.214 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -126.78 112.96 15.99 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.02 0.438 . . . . 0.0 110.038 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.6 mt -133.47 149.68 72.96 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.819 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.69 151.36 85.43 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.354 2.036 . . . . 0.0 111.429 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 26.1 tp -63.17 -12.41 27.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.299 0.571 . . . . 0.0 110.567 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.0 p -80.72 -18.39 47.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.824 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.33 -173.27 2.01 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.153 0.502 . . . . 0.0 110.795 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.9 175.97 9.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 112.039 -173.041 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 26.1 t -64.95 -26.56 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.646 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 9.8 m -52.22 -33.88 43.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 t -73.54 -33.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.403 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 25.0 mm -70.23 -48.59 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.692 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.96 -39.34 89.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.69 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -74.15 -38.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.046 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.736 ' HB3' ' HZ3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.52 -36.23 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.971 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.435 ' CD1' HD13 ' A' ' 54' ' ' LEU . 78.8 mt -70.47 -42.69 78.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 110.571 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -57.87 -32.38 67.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.232 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.47 -25.17 22.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.03 0.443 . . . . 0.0 111.102 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.33 -47.86 11.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.605 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.76 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 3.1 p -98.77 -45.12 6.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.656 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.42 -20.49 5.54 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.878 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.689 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 ptm -77.97 119.94 79.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 0.0 111.615 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.6 Cg_endo -67.24 159.29 52.92 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 111.8 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.46 -11.38 51.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.542 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.5 -30.33 61.84 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.523 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.2 -0.98 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.988 0.423 . . . . 0.0 110.399 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.689 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -100.56 125.27 46.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -116.19 142.82 46.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.002 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.8 mm? -112.46 117.59 32.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.574 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.4 tt0 -107.04 113.93 27.69 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.008 0.433 . . . . 0.0 111.041 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.62 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.4 t80 -103.6 109.52 21.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.212 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 58.09 30.15 18.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.462 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.08 14.15 46.67 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.34 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 24.2 mt -117.23 118.62 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -75.04 90.36 2.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.194 0.521 . . . . 0.0 109.998 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -79.25 148.48 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.093 -174.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.66 162.69 13.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.977 176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.55 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.06 -21.73 66.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 -177.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -74.31 5.68 4.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.78 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.475 ' ND2' ' HE2' ' A' ' 70' ' ' TYR . 58.6 m-20 -111.03 166.81 10.74 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 52.8 p -126.15 165.34 19.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.88 -45.01 91.33 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.214 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.3 -33.67 73.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.213 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 66' ' ' SER . 77.9 t80 -57.44 -42.43 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.259 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.475 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 34.5 m-85 -98.85 8.17 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.268 177.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.8 OUTLIER 61.45 40.26 14.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.43 176.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -63.75 90.29 0.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.483 . . . . 0.0 111.443 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 178.34 6.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.248 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.32 115.36 2.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.27 29.59 4.76 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.038 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.05 114.3 15.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG23 ' HD2' ' A' ' 5' ' ' LYS . 27.5 t -95.1 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.543 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -94.31 145.69 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 11.3 m-70 -113.27 114.41 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.44 134.48 35.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.42 145.58 29.28 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.29 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 51' ' ' LYS . 33.1 tp . . . . . 0 C--N 1.316 -0.85 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.465 ' HB2' HG23 ' A' ' 27' ' ' THR . 31.4 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 18.3 m -124.76 154.29 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.0 110.326 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -87.19 114.44 23.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 110.084 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.571 HG22 ' HB1' ' A' ' 76' ' ' ALA . 1.4 pt -113.33 135.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 13.5 mttt -122.11 146.48 47.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.572 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -124.11 105.98 16.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.738 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.5 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -69.22 103.82 2.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG12 HD23 ' A' ' 19' ' ' LEU . 91.0 t -74.0 133.15 79.04 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.563 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.5 Cg_endo -66.48 147.48 82.46 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.766 1.644 . . . . 0.0 111.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.562 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -74.37 88.29 2.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.709 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.527 ' HE1' HD11 ' A' ' 19' ' ' LEU . 52.6 mtm -140.61 76.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.577 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.09 -46.42 18.09 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.448 0.642 . . . . 0.0 110.137 -171.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.64 6.91 9.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.517 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -80.6 -15.98 55.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 109.576 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 11' ' ' MET . 10.8 t -153.0 -178.78 7.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.991 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.31 -3.91 56.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.231 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.576 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -86.87 172.81 9.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HZ3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.32 29.72 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.872 -177.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.3 mt -81.05 130.14 34.88 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.6 m-80 -138.29 15.54 2.79 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.103 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.562 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.26 -0.95 88.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.377 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.551 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -73.18 177.56 5.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.323 0.583 . . . . 0.0 111.136 -177.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.53 124.65 73.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.567 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.661 HD22 ' HZ3' ' A' ' 18' ' ' LYS . 84.9 mt -86.91 142.67 27.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 110.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.047 0.451 . . . . 0.0 109.806 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -122.71 158.58 29.79 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.895 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -126.22 112.91 16.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.106 0.479 . . . . 0.0 109.938 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB2' HD11 ' A' ' 4' ' ' ILE . 85.3 mt -131.32 153.08 81.55 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.74 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.23 150.39 87.52 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.906 1.737 . . . . 0.0 111.277 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.34 -12.21 8.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.725 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.2 p -78.83 -20.28 50.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.833 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -72.66 -176.25 1.91 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.258 0.552 . . . . 0.0 110.268 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.42 173.3 11.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.888 0.375 . . . . 0.0 111.684 -172.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 61' ' ' ILE . 40.8 t -61.96 -26.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.479 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -53.94 -32.77 54.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.181 176.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.7 t -78.22 -27.7 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.451 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.405 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 33.6 mm -73.04 -48.21 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.952 0.406 . . . . 0.0 110.553 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 7.2 ptmt -61.33 -39.66 91.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.456 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.4 p -72.61 -39.96 61.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.038 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -64.4 -39.23 93.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.802 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.58 -43.29 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.739 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -57.74 -32.54 67.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.544 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 49.3 mt-10 -82.07 -38.18 25.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 110.141 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.09 -51.16 19.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.431 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.542 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 3.1 p -96.57 -43.07 7.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.0 110.303 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.3 -19.49 6.76 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.81 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 15.6 ptm -79.05 119.96 79.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.672 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.6 Cg_endo -68.28 156.43 65.74 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.566 2.177 . . . . 0.0 112.037 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -63.12 -15.99 58.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.66 -33.6 34.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.863 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.42 -3.91 4.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.554 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.593 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.72 121.41 38.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 110.009 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.788 ' HZ2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -113.06 144.05 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.02 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.431 ' HB3' HG23 ' A' ' 78' ' ' ILE . 1.3 mm? -112.83 120.04 40.09 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -108.05 110.33 22.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.101 0.477 . . . . 0.0 111.585 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.624 ' HB2' HD11 ' A' ' 78' ' ' ILE . 21.1 t80 -102.52 112.54 25.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.834 0.349 . . . . 0.0 110.136 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 16.2 mm-40 57.3 30.32 18.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.95 11.53 57.59 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.47 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 22.2 mt -113.97 119.08 60.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 6.7 m-30 -70.74 91.12 0.81 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.292 0.568 . . . . 0.0 109.905 174.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.657 HG13 HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -77.76 153.25 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.272 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -121.82 161.85 21.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.746 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.78 -2.55 17.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.292 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 m -84.22 -2.89 57.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.035 0.445 . . . . 0.0 110.386 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -119.3 175.11 5.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 80.7 p -129.78 170.38 13.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.172 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.65 -44.0 78.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.74 -37.03 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.318 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -58.82 -46.84 86.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.91 -4.23 58.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.752 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.4 41.23 4.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.504 0.503 . . . . 0.0 110.854 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtt -68.01 86.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.47 . . . . 0.0 111.408 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.46 -174.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.889 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.6 t-20 -65.71 115.3 5.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.71 29.16 4.79 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.439 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.571 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -72.67 114.44 10.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.97 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.38 150.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 7.6 m-70 -118.54 117.76 29.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.44 134.13 34.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.58 147.08 31.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.874 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.0 tp . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.579 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.49 ' HB2' HG21 ' A' ' 27' ' ' THR . 7.7 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 12.3 m -123.39 151.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 110.296 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 109.02 20.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.71 0.767 . . . . 0.0 110.778 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.527 HG22 ' HB1' ' A' ' 76' ' ' ALA . 1.4 pt -107.38 143.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.414 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HG2' HG21 ' A' ' 25' ' ' VAL . 10.5 mtmm -126.89 152.03 47.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.656 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t -131.3 105.87 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.606 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 107.13 4.06 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.002 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 53.8 t -79.37 133.29 60.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.834 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HG2' HD13 ' A' ' 19' ' ' LEU . 57.5 Cg_endo -70.42 151.99 65.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.464 2.109 . . . . 0.0 112.091 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.523 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -78.88 100.95 7.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.542 ' HB3' HG21 ' A' ' 15' ' ' THR . 27.6 mtm -147.21 76.8 1.43 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.455 0.169 . . . . 0.0 110.598 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.2 -48.4 15.93 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.014 0.435 . . . . 0.0 110.912 -169.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -121.42 9.33 10.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.965 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -84.52 -5.5 59.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.542 HG21 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -162.15 -178.84 6.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.239 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.34 1.55 47.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.418 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -88.15 175.57 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.684 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -94.88 30.79 1.99 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.605 -177.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.555 HD13 ' HG2' ' A' ' 9' ' ' PRO . 22.0 mt -86.38 115.33 23.83 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.941 -0.475 . . . . 0.0 110.401 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.608 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 23.6 m-80 -130.32 21.65 5.21 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.555 -0.716 . . . . 0.0 110.863 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.523 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.55 1.63 87.58 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.046 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.608 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.6 pm0 -75.13 179.45 5.03 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 111.117 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.83 132.71 69.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.728 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 67.0 mt -87.51 144.26 26.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 5' ' ' LYS . 96.1 t -131.93 114.62 24.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 110.058 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 99.2 m-85 -128.85 160.16 33.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 1' ' ' PRO . 6.8 m -126.55 119.09 26.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.82 151.32 70.23 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.83 149.66 89.28 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.006 1.804 . . . . 0.0 111.192 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.5 -14.16 11.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.66 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -76.67 -19.39 57.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.125 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.31 -174.06 2.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.421 0.629 . . . . 0.0 111.029 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.11 172.88 12.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 0.0 112.266 -172.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.566 HG11 HG13 ' A' ' 61' ' ' ILE . 45.0 t -60.83 -26.42 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.623 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.29 -33.32 52.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.049 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -76.96 -29.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.446 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 21.4 mm -73.0 -45.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.573 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.69 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.4 ptmt -62.68 -42.94 99.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.48 -37.48 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.651 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.56 -35.34 80.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.578 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.88 -42.26 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -59.54 -35.87 75.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.355 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -83.85 -31.35 25.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.819 0.342 . . . . 0.0 111.463 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.47 -38.41 26.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.8 p -106.15 -47.91 3.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.043 0.449 . . . . 0.0 110.628 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.87 -6.55 10.33 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.115 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.512 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 22.0 ptm -87.19 115.7 63.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.406 0.622 . . . . 0.0 110.978 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.4 157.56 61.29 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.626 2.217 . . . . 0.0 112.127 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.75 -17.15 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.209 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.55 -31.15 52.01 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.859 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.504 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.84 -5.37 4.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.49 . . . . 0.0 110.535 -178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.69 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -87.52 113.48 23.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mmpt? -104.94 138.72 40.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.7 mt -118.88 122.4 42.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.975 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -112.3 120.27 41.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.191 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.607 ' HB2' HD13 ' A' ' 78' ' ' ILE . 17.6 t80 -108.84 110.32 21.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.42 30.79 20.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.05 49.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.16 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 mt -121.94 113.58 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -74.63 95.27 2.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.752 0.787 . . . . 0.0 110.287 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.566 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.73 168.9 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.098 -176.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.46 166.04 21.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.365 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.36 -2.78 20.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.898 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.6 t -94.32 13.23 24.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.191 0.519 . . . . 0.0 110.237 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.64 165.69 16.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 71.6 m -126.15 166.38 17.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.02 -46.53 84.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.767 0.318 . . . . 0.0 110.397 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.99 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.455 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 66' ' ' SER . 56.7 t80 -62.81 -40.99 99.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -97.86 5.17 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.28 46.55 23.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.332 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 mtt -66.05 82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 110.806 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 171.79 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.551 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 48.0 t-20 -55.36 115.95 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.73 27.38 4.66 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.058 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -78.11 115.06 17.56 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.57 104.33 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 56' ' ' TYR . 6.3 mm -94.27 150.62 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -116.78 119.71 36.28 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.75 134.27 33.96 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.715 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.9 142.66 27.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.933 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 C--N 1.316 -0.877 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.142 178.228 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.535 ' HB2' HG23 ' A' ' 27' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.476 0.499 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.15 152.03 24.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.933 0.397 . . . . 0.0 110.389 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -89.02 114.19 25.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.058 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 28' ' ' LEU . 1.3 pt -117.64 138.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.696 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -121.53 145.14 48.26 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.233 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.04 105.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.427 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.48 104.61 2.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.567 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 95.8 t -75.75 127.32 85.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.425 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.813 ' HG2' HD11 ' A' ' 19' ' ' LEU . 26.1 Cg_endo -61.92 151.13 83.14 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.515 2.143 . . . . 0.0 112.2 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.676 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -79.71 83.22 5.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.78 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.583 ' HE1' HD12 ' A' ' 19' ' ' LEU . 55.4 mtm -135.81 75.57 1.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.594 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -77.22 -45.8 25.32 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.363 0.601 . . . . 0.0 110.229 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.96 8.86 10.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.984 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -90.39 -4.81 56.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.046 -173.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.4 t -161.2 -172.71 3.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.942 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.3 4.67 36.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.57 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -96.44 171.65 8.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.81 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.717 ' HZ3' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -84.58 27.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 110.944 -178.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD11 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -78.85 129.63 34.78 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.615 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.5 m-80 -142.27 15.67 2.04 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.935 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.676 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.03 5.03 90.42 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.919 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.615 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.04 179.38 6.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.34 136.59 60.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.184 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.91 142.76 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.28 109.9 19.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -123.19 163.66 20.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.581 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 1' ' ' PRO . 7.2 m -127.06 117.34 22.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 110.236 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 4' ' ' ILE . 89.9 mt -134.33 149.76 72.11 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.617 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.9 151.8 81.57 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.167 1.912 . . . . 0.0 111.256 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 72' ' ' MET . 29.7 tp -61.89 -10.18 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -80.19 -19.05 47.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.848 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.58 -173.05 2.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.69 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.67 175.4 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.485 -173.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 61' ' ' ILE . 42.3 t -60.0 -28.49 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.527 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -51.28 -31.61 21.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.86 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.89 -33.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 0.0 110.408 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 19.4 mm -72.12 -49.61 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.572 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.583 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 8.4 ptmt -60.01 -40.67 90.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 p -72.05 -38.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.756 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -66.87 -36.12 81.59 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.843 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.77 -41.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.499 . . . . 0.0 110.202 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 20.1 t-80 -58.3 -32.12 68.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.45 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 8.7 mm-40 -87.81 -30.29 20.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.118 0.485 . . . . 0.0 110.724 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.75 -46.39 14.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.784 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.717 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 7.1 p -98.23 -43.4 7.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.348 . . . . 0.0 110.721 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.21 -2.33 18.93 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.401 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 17.5 ptm -92.0 118.04 68.02 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.353 0.597 . . . . 0.0 111.281 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.41 155.88 67.61 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.434 2.089 . . . . 0.0 112.119 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -62.66 -16.88 59.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.668 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.52 -29.67 40.14 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.292 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.87 -1.82 4.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.237 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.75 113.37 24.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.557 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -105.22 139.15 40.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.095 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.64 121.3 41.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 109.889 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.3 tt0 -113.46 113.99 25.93 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.333 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.1 t80 -103.05 110.89 22.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.933 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 57.39 29.78 17.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.432 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.23 7.34 57.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.524 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.3 mt -112.34 119.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -72.52 91.8 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.141 0.496 . . . . 0.0 110.196 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -77.3 154.25 5.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.608 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 28.9 pttt -123.16 162.08 23.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.448 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.583 ' OD1' ' HD3' ' A' ' 38' ' ' LYS . 6.5 t70 -54.48 -30.35 52.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.806 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.454 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 16.0 m -69.47 -13.88 62.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.919 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -105.43 177.91 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 110.657 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 78.5 p -134.59 171.12 14.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.408 -175.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.7 -44.03 78.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.937 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.82 70.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.493 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -62.37 -45.29 93.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -89.19 1.6 55.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.79 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 m120 64.56 31.27 12.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.416 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.435 ' O ' HD12 ' A' ' 30' ' ' LEU . 58.5 mtt -59.72 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.214 0.531 . . . . 0.0 112.113 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 -172.08 3.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -64.4 116.19 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.905 0.383 . . . . 0.0 110.664 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.08 19.23 7.76 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.552 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 114.45 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.136 0.468 . . . . 0.0 110.102 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.12 104.85 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.0 mm -94.36 148.01 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -115.09 115.42 26.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.04 131.51 35.79 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.01 32.99 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.127 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 51' ' ' LYS . 31.7 tp . . . . . 0 C--N 1.316 -0.89 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.514 ' HB2' HG23 ' A' ' 27' ' ' THR . 2.2 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.09 155.41 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.685 0.279 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -87.91 117.01 26.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.138 0.494 . . . . 0.0 110.234 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 28' ' ' LEU . 3.3 pt -124.01 142.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.999 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -123.99 146.84 48.24 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.566 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.37 105.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 104.17 3.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.9 t -75.89 126.71 86.67 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.316 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.81 ' HG2' HD11 ' A' ' 19' ' ' LEU . 38.4 Cg_endo -65.74 147.5 85.76 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.3 2.0 . . . . 0.0 112.114 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.566 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -72.61 90.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.518 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.558 ' HB3' HG23 ' A' ' 15' ' ' THR . 42.3 mtm -141.43 76.56 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.871 0.367 . . . . 0.0 110.367 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.92 -45.54 20.31 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.57 0.7 . . . . 0.0 110.201 -172.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -120.51 7.79 10.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.161 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -94.81 3.53 54.9 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.807 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -168.28 -174.45 2.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.452 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.29 3.65 27.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.289 -171.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.717 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.4 m0 -102.28 170.64 7.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.757 ' HZ1' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -78.84 26.82 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.629 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.81 HD11 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -78.5 126.45 30.78 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.0 m-80 -140.99 15.74 2.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 110.667 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.566 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.53 1.0 89.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.196 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.589 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 1.1 pm0 -75.66 173.66 10.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 110.779 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.04 124.67 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.878 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.55 134.35 33.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -121.43 107.36 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -122.0 162.24 21.49 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.543 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 1' ' ' PRO . 3.4 m -125.77 116.78 22.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.996 0.426 . . . . 0.0 110.44 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.645 ' HB2' HD12 ' A' ' 4' ' ' ILE . 81.0 mt -133.68 151.31 76.87 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.035 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.04 147.96 80.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.292 1.995 . . . . 0.0 111.687 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.05 -10.66 10.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 110.601 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.9 p -81.98 -15.0 55.22 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.725 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.5 -173.39 4.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.115 0.483 . . . . 0.0 110.573 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.56 173.59 11.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.889 0.376 . . . . 0.0 111.666 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.675 HG13 HG13 ' A' ' 61' ' ' ILE . 41.8 t -61.43 -27.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.012 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -53.11 -33.28 51.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.399 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.63 -34.01 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.222 0.534 . . . . 0.0 110.264 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.0 mm -70.48 -52.07 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.859 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.2 ptmt -58.19 -42.71 86.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.518 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 11.1 p -71.32 -38.98 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.678 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.2 ptmt -66.07 -35.26 80.04 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.39 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.2 mt -72.71 -41.13 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 110.196 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.478 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 23.5 t-80 -58.04 -32.4 67.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.339 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 56.8 mm-40 -85.94 -34.52 20.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.992 0.425 . . . . 0.0 110.047 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.06 -46.53 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.637 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.757 HG21 ' HZ1' ' A' ' 18' ' ' LYS . 6.9 p -97.78 -43.6 7.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.067 0.46 . . . . 0.0 110.626 -176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 -7.19 11.24 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.131 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.561 ' HE3' ' HB2' ' A' ' 52' ' ' GLN . 13.2 ptm -89.7 119.64 69.48 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 111.827 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.2 Cg_endo -67.65 157.41 61.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.541 2.161 . . . . 0.0 112.057 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -65.99 -12.07 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.597 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.5 -33.76 62.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.647 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.548 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -126.54 -5.12 6.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.337 0.589 . . . . 0.0 109.979 -177.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB2' ' HE3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -99.83 113.55 26.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 12.0 mmpt? -107.66 135.3 49.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.544 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.38 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.09 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 tt0 -108.5 116.52 32.12 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.582 ' HB2' HD12 ' A' ' 78' ' ' ILE . 7.5 t80 -101.04 102.83 13.9 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.457 0.646 . . . . 0.0 109.685 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 6.4 mm-40 57.42 31.01 19.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.076 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.49 23.59 Favored Glycine 0 CA--C 1.511 -0.167 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.829 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.99 112.06 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 55' ' ' GLN . 5.0 m-85 -72.0 95.4 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.59 0.71 . . . . 0.0 110.002 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.675 HG13 HG13 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.2 162.12 3.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.27 -178.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HE2' HD22 ' A' ' 65' ' ' ASN . 0.0 OUTLIER -135.46 165.17 26.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -72.73 -4.85 33.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.622 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -79.97 -7.7 58.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 109.905 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.404 HD22 ' HE2' ' A' ' 62' ' ' LYS . 86.0 m-20 -114.82 178.91 4.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.303 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 53.5 p -136.93 173.43 11.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.336 -175.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.16 -45.08 70.93 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.26 72.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.259 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 66' ' ' SER . 46.2 t80 -56.74 -46.19 81.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.657 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -90.62 1.11 57.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.9 OUTLIER 58.98 42.25 19.64 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.557 0.536 . . . . 0.0 110.395 -178.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.6 mtt -65.27 88.14 0.08 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.9 -178.07 5.28 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.85 116.28 3.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.287 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.75 29.3 5.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.364 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -79.11 114.67 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.91 106.35 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.14 0.495 . . . . 0.0 110.58 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.582 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.2 mm -94.46 145.47 7.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -116.25 111.69 20.52 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.56 132.37 35.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 144.11 30.56 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.479 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 51' ' ' LYS . 32.1 tp . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 Cg_endo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 110.258 -0.708 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.73 154.9 37.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 m -86.77 125.15 33.74 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.598 HG23 ' HB3' ' A' ' 76' ' ' ALA . 12.9 pt -128.71 145.37 35.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.968 0.413 . . . . 0.0 111.045 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -126.5 146.53 50.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.2 t -123.18 105.79 16.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.615 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.53 103.86 3.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG13 HD22 ' A' ' 19' ' ' LEU . 94.3 t -77.03 131.68 72.43 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.843 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.614 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.9 Cg_endo -66.16 155.76 68.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.567 2.178 . . . . 0.0 111.851 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.723 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -84.66 84.16 7.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.587 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 15' ' ' THR . 47.8 mtm -133.44 75.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.9 mp0 -78.43 -46.3 20.15 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 110.383 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 0.63 10.32 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.046 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HE2' ' OE1' ' A' ' 12' ' ' GLN . 20.6 mmtt -86.14 0.98 52.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.369 0.605 . . . . 0.0 109.63 -173.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.508 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -160.38 -173.53 4.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.45 -5.8 24.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 111.508 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.508 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.1 m0 -85.37 173.87 9.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.567 ' HZ3' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -90.4 29.38 1.28 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.359 -176.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.0 mt -81.53 124.97 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.552 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 4.8 m-80 -132.33 19.6 4.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.899 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.723 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.66 12.96 83.44 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.302 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -83.22 179.12 7.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.137 0.494 . . . . 0.0 110.754 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.97 126.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.567 HD21 ' HZ3' ' A' ' 18' ' ' LYS . 72.5 mt -87.3 139.49 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.16 109.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -124.2 166.02 16.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.394 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 1' ' ' PRO . 9.9 m -126.87 121.98 33.36 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.099 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.437 HD13 HD11 ' A' ' 4' ' ' ILE . 77.4 mt -136.15 149.28 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.774 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.4 Cg_endo -65.25 150.13 87.8 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.182 1.921 . . . . 0.0 110.947 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HG ' ' HB1' ' A' ' 68' ' ' ALA . 20.0 tp -62.33 -8.82 6.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.652 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -82.52 -18.85 40.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.9 -175.26 2.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 110.063 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.93 174.68 10.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.93 0.395 . . . . 0.0 111.546 -174.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.566 HG11 HG13 ' A' ' 61' ' ' ILE . 35.0 t -62.87 -25.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.632 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 1.6 t -53.13 -33.81 54.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.66 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -72.43 -33.36 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.155 0.502 . . . . 0.0 110.553 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -70.54 -47.16 66.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.4 ptmt -63.15 -41.89 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.273 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -68.85 -39.38 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.695 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.45 ' HZ2' ' HB3' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.42 -39.74 85.5 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.199 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.73 -40.51 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 110.421 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -61.1 -32.8 72.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.566 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.55 -30.23 18.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.586 0.231 . . . . 0.0 111.133 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.11 -39.02 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.595 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 9.3 p -105.69 -45.28 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.548 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.65 -11.81 8.9 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.286 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.567 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 23.4 ptm -84.21 117.76 69.51 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.349 0.595 . . . . 0.0 111.116 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.437 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 29.3 Cg_endo -68.94 157.1 63.21 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.579 2.186 . . . . 0.0 112.161 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -63.71 -15.55 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.69 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.71 -30.03 50.79 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.981 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.59 -0.41 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.117 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.13 113.86 25.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 178.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.3 mmpt? -106.73 141.84 37.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 mm? -114.42 118.19 33.13 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -107.2 115.14 29.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.413 . . . . 0.0 110.668 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.5 t80 -103.91 111.38 23.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 57.88 29.74 18.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.191 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.41 24.52 26.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.071 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.78 110.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -71.69 94.92 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.761 0.791 . . . . 0.0 110.648 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.566 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -80.73 154.61 4.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.159 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.49 162.73 13.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -70.89 -15.71 62.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 111.335 -174.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 m -78.24 7.22 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.801 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 80.9 m-20 -109.99 166.66 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 87.3 p -123.75 164.5 19.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.15 -43.24 92.46 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.192 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB1' ' HG ' ' A' ' 30' ' ' LEU . . . -60.34 -38.03 82.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.231 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -55.66 -43.64 76.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.233 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.99 5.06 53.0 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.709 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.43 46.98 14.36 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.376 0.423 . . . . 0.0 111.399 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.24 84.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 110.775 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.31 -176.64 1.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.074 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -61.37 116.51 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.309 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.41 33.64 4.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.962 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.598 ' HB3' HG23 ' A' ' 4' ' ' ILE . . . -74.32 114.63 12.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.043 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.58 103.45 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.116 0.484 . . . . 0.0 110.58 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.37 143.39 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -113.19 113.05 24.8 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.11 132.19 36.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.59 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.96 143.96 26.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.628 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 ' HE3' ' A' ' 11' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.146 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.078 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.506 ' HB2' HG21 ' A' ' 27' ' ' THR . 37.0 Cg_endo . . . . . 0 N--CA 1.478 0.577 0 N-CA-C 109.839 -0.869 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 25.8 m -126.27 156.7 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.707 0.289 . . . . 0.0 110.354 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -86.63 121.33 29.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.029 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' A' ' 76' ' ' ALA . 2.2 pt -122.5 137.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.568 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HD3' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -120.25 151.96 38.43 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.474 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.04 106.21 15.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.492 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.464 ' HG2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.52 106.73 3.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.461 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 19' ' ' LEU . 59.0 t -77.35 127.62 82.54 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.751 ' HG2' HD11 ' A' ' 19' ' ' LEU . 31.9 Cg_endo -64.31 148.59 90.98 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.122 1.882 . . . . 0.0 112.081 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.555 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -74.83 93.85 2.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.775 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.579 ' HB3' HG23 ' A' ' 15' ' ' THR . 35.9 mtm -146.45 75.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.584 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -78.53 -49.01 14.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.384 0.611 . . . . 0.0 110.543 -169.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.4 17.49 9.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.19 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -91.33 -7.91 49.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 11' ' ' MET . 15.4 t -158.76 -172.5 3.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.685 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.55 -0.44 25.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.913 0.387 . . . . 0.0 111.58 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.664 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.8 m0 -85.95 168.66 13.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.63 ' HZ1' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -84.93 31.64 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.427 0.632 . . . . 0.0 111.045 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' A' ' 9' ' ' PRO . 13.5 mt -84.77 112.98 20.99 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.814 -0.554 . . . . 0.0 110.096 -175.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.62 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -126.46 16.26 7.65 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.33 -0.856 . . . . 0.0 111.209 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.555 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.24 5.96 86.76 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -79.6 175.18 10.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.651 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 7' ' ' GLN . 43.9 t -124.84 124.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.099 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.92 142.54 27.72 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.47 111.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.152 0.501 . . . . 0.0 110.261 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.44 166.25 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.5 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.506 HG21 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -125.99 116.86 22.11 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.314 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.506 ' HB2' HD12 ' A' ' 4' ' ' ILE . 82.3 mt -131.98 153.74 81.48 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.679 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.9 Cg_endo -64.85 149.32 89.75 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.274 1.983 . . . . 0.0 111.533 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -62.67 -12.05 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.726 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -80.93 -16.24 54.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.512 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.93 -174.87 2.35 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.23 173.4 11.98 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 HG13 ' A' ' 61' ' ' ILE . 39.9 t -62.47 -25.14 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.598 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.33 -34.34 57.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.246 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.52 -30.29 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.533 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.418 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 26.1 mm -72.31 -47.57 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.831 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 4.1 ptmt -61.92 -40.12 94.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -71.12 -39.7 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.013 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.49 -38.44 89.75 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.92 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.506 ' CD1' HD12 ' A' ' 54' ' ' LEU . 79.4 mt -71.59 -42.16 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 0.0 110.552 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' MET . 32.7 t60 -57.64 -32.77 67.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.434 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.45 -29.21 18.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.804 0.335 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.8 -31.1 28.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.053 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.63 HG22 ' HZ1' ' A' ' 18' ' ' LYS . 6.8 p -112.18 -43.4 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.468 . . . . 0.0 110.548 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.97 -7.06 10.93 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.597 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 15.6 ptm -89.97 119.24 69.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.347 0.594 . . . . 0.0 111.586 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 25.9 Cg_endo -67.81 161.36 44.26 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 111.86 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.56 -10.67 57.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -176.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -28.69 62.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.69 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.83 -3.05 3.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 110.329 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.597 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.12 122.19 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.3 mmpt? -114.0 142.56 46.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.506 HD12 ' CD1' ' A' ' 41' ' ' ILE . 1.8 mm? -111.49 119.38 38.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.582 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.1 tt0 -108.55 112.66 25.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.936 0.398 . . . . 0.0 111.026 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.598 ' HB2' HD11 ' A' ' 78' ' ' ILE . 11.0 t80 -103.23 109.97 21.76 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 57.34 30.18 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.549 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.93 17.16 38.84 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.35 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 17.6 mt -120.65 116.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 16.2 m-85 -72.75 91.38 1.47 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 110.096 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.56 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.67 157.04 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 -175.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HE3' HD22 ' A' ' 65' ' ' ASN . 3.1 pttp -121.44 160.22 24.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.758 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.14 -8.3 52.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 -174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 m -85.24 -1.58 57.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 0.0 110.261 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.409 HD22 ' HE3' ' A' ' 62' ' ' LYS . 94.2 m-20 -109.6 170.67 7.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.449 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.0 p -126.33 170.94 11.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.88 -43.65 82.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.18 -35.27 73.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.298 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.14 -46.58 85.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.91 5.58 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.503 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 m120 59.37 43.36 16.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -67.16 92.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.93 -176.46 2.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.755 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.525 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.5 t30 -66.08 115.39 6.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.14 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.69 28.68 5.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.358 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -73.18 114.76 11.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.039 0.447 . . . . 0.0 110.188 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.431 HG22 ' HD3' ' A' ' 5' ' ' LYS . 38.9 t -95.68 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.696 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.89 148.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.36 118.37 32.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -80.43 133.67 35.9 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.48 146.43 31.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 51' ' ' LYS . 26.6 tp . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 110.187 -0.736 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 28' ' ' LEU . 18.6 m -125.94 155.77 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.267 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -90.72 109.84 21.03 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.444 0.64 . . . . 0.0 110.71 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.573 HG23 ' HB1' ' A' ' 76' ' ' ALA . 2.8 pt -111.26 147.56 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.591 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HZ2' ' HA2' ' A' ' 75' ' ' GLY . 10.1 mtmm -130.47 150.43 51.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.801 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -127.08 105.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.96 108.64 4.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.598 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG12 HD23 ' A' ' 19' ' ' LEU . 86.0 t -80.46 129.02 70.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.31 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.715 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.3 Cg_endo -65.71 150.52 86.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.375 2.05 . . . . 0.0 111.912 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.66 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -76.76 91.63 3.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.761 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.534 ' HE1' HD11 ' A' ' 19' ' ' LEU . 46.1 mtm -141.95 74.48 1.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.762 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.557 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -44.66 17.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.819 0.819 . . . . 0.0 110.163 -176.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.9 -12.63 14.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.781 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 39.2 mmtt -75.33 -20.34 59.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.757 -172.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -152.24 -174.47 4.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.41 -175.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.06 -2.04 28.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.351 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.536 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -85.4 174.21 9.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.278 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -88.82 30.46 0.92 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.34 0.591 . . . . 0.0 111.453 -176.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 9' ' ' PRO . 11.3 mt -85.02 124.52 31.81 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.679 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.3 m-80 -136.19 17.7 3.2 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.857 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.66 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.2 11.11 82.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.915 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.679 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -82.36 -179.77 7.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.903 0.383 . . . . 0.0 110.301 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.91 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.494 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 85.0 mt -89.86 143.4 26.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.088 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 5' ' ' LYS . 48.5 t -127.99 111.16 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -126.04 162.65 24.81 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -125.97 115.68 20.28 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.249 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' O ' HG21 ' A' ' 2' ' ' VAL . 86.9 mt -134.73 150.9 74.73 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.88 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.54 152.22 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.459 2.106 . . . . 0.0 111.707 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.0 tp -63.99 -9.06 13.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -80.69 -21.42 41.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.82 -174.79 2.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.293 0.568 . . . . 0.0 110.373 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.74 175.79 10.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.017 0.437 . . . . 0.0 111.495 -174.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 61' ' ' ILE . 46.0 t -59.74 -27.03 36.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.237 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.5 m -54.63 -34.16 61.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.1 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -74.62 -28.45 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.946 0.403 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 31.7 mm -72.87 -52.64 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 8.5 ptmt -57.78 -43.14 85.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.663 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.93 -37.87 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.719 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.7 -35.52 78.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.894 -177.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.84 -42.48 77.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.53 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -57.57 -32.85 67.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.088 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.4 -20.76 23.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.93 0.395 . . . . 0.0 111.271 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.94 -37.22 13.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 5.2 p -108.57 -46.11 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.192 0.52 . . . . 0.0 110.318 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.49 -17.45 5.84 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.596 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 16.6 ptm -81.13 117.49 68.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.454 0.645 . . . . 0.0 111.35 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.4 Cg_endo -67.29 159.76 50.77 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 111.948 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.75 -6.71 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.948 0.404 . . . . 0.0 111.87 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.37 -27.05 67.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.501 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.54 -3.48 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.102 0.477 . . . . 0.0 110.409 -177.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.596 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.58 116.99 32.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.674 -177.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.0 mmpt? -104.68 141.34 36.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.62 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.19 122.13 45.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -112.11 117.84 33.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.102 0.477 . . . . 0.0 111.448 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HB2' HD12 ' A' ' 78' ' ' ILE . 25.6 t80 -106.79 112.06 24.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.117 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 8.3 mm-40 57.54 29.82 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.308 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.39 10.23 57.18 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.381 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.01 116.58 52.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -76.85 93.34 3.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.676 0.75 . . . . 0.0 110.071 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.427 HG13 HG13 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.18 165.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.283 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -139.1 171.93 13.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.439 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.39 -5.45 36.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.7 p -81.37 -4.11 54.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -113.5 172.81 6.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.67 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' A' ' 33' ' ' GLN . 71.1 p -132.87 167.75 19.64 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.27 -45.11 89.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.33 75.49 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -57.37 -44.48 84.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.036 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.42 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 47.4 m-85 -89.46 -0.2 57.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.582 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 42.15 14.73 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.461 0.475 . . . . 0.0 110.619 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 mtt -65.09 85.4 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.988 0.423 . . . . 0.0 110.907 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.29 -174.21 3.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -58.81 116.32 3.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.167 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.558 ' HA2' ' HZ2' ' A' ' 5' ' ' LYS . . . 102.85 36.5 3.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.369 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' HG23 ' A' ' 4' ' ' ILE . . . -83.11 114.76 21.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.38 103.69 15.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.788 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.6 mm -94.26 151.01 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.28 119.34 35.4 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -85.31 134.05 34.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.8 149.21 35.06 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.035 0.445 . . . . 0.0 110.527 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 51' ' ' LYS . 35.9 tp . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 N-CA-C 109.692 -0.926 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 17.3 m -125.67 154.58 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.362 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -86.26 123.94 32.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 28' ' ' LEU . 1.4 pt -126.73 138.05 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 110.984 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.504 ' HD2' HG22 ' A' ' 77' ' ' VAL . 12.5 mttm -120.15 147.73 44.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.311 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 59.5 t -123.75 105.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -73.98 103.06 4.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.862 -178.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.476 HG12 HD22 ' A' ' 19' ' ' LEU . 59.0 t -73.97 131.83 80.84 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.617 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.677 ' HG2' HD13 ' A' ' 19' ' ' LEU . 44.0 Cg_endo -68.25 153.23 74.95 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.145 1.897 . . . . 0.0 111.794 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.573 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.5 m120 -80.22 93.71 5.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.541 ' HE2' HD11 ' A' ' 19' ' ' LEU . 46.2 mtm -142.77 75.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.787 0.327 . . . . 0.0 110.286 174.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -79.52 -45.12 19.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.555 0.693 . . . . 0.0 110.71 -173.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -118.06 15.46 14.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.726 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -102.59 -3.39 26.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.485 HG22 ' HB3' ' A' ' 11' ' ' MET . 11.4 t -164.24 -171.68 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.592 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.74 4.04 37.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.452 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.606 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.5 m0 -94.84 173.77 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.078 0.466 . . . . 0.0 110.858 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.768 ' HZ1' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.22 29.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.883 -177.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.677 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.6 mt -81.44 119.22 23.44 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.95 -0.469 . . . . 0.0 109.928 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.64 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 10.6 m-80 -131.7 15.81 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 83.75 2.63 89.78 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.809 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.64 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -76.44 178.05 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 7' ' ' GLN . 48.5 t -121.69 126.64 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.1 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.598 HD12 ' HZ3' ' A' ' 18' ' ' LYS . 86.9 mt -87.35 142.8 27.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.9 t -131.17 108.65 15.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.55 161.37 19.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.03 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -127.1 113.94 17.08 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.031 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.553 ' HB2' HD12 ' A' ' 4' ' ' ILE . 87.6 mt -131.2 153.91 81.83 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.806 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.3 150.42 87.32 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.177 1.918 . . . . 0.0 111.226 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -62.88 -13.56 35.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -78.89 -15.22 58.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.425 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.95 -174.42 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -146.31 172.63 13.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -170.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 30.8 t -59.01 -28.28 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.44 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 2.7 t -54.27 -31.44 53.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.829 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.52 -29.66 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.8 mm -72.3 -51.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.451 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.4 ptmt -57.75 -43.75 85.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.601 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.78 -38.94 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.068 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.24 -35.47 77.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.531 -177.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -70.59 -43.44 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 110.297 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.03 -32.9 68.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.363 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.66 -22.92 22.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.039 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.87 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.653 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.768 HG21 ' HZ1' ' A' ' 18' ' ' LYS . 4.5 p -101.41 -44.74 5.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.839 0.352 . . . . 0.0 110.734 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.3 -6.39 10.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.102 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.601 ' HE3' ' HB2' ' A' ' 52' ' ' GLN . 18.3 ptm -91.16 120.02 68.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.316 0.579 . . . . 0.0 111.508 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.4 Cg_endo -68.72 157.57 61.32 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.467 2.111 . . . . 0.0 112.24 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.74 -8.67 15.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.761 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.69 66.35 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.445 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.47 -10.12 4.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.356 -177.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HB2' ' HE3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -90.58 113.77 25.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.5 mmpt? -102.57 142.12 34.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.51 130.19 56.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -121.76 120.81 35.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 78' ' ' ILE . 13.8 t80 -103.5 107.45 18.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.389 . . . . 0.0 110.592 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 55.59 30.49 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.735 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.62 19.17 30.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.186 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -123.65 109.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -72.0 95.03 1.54 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.797 0.808 . . . . 0.0 110.499 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 164.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.177 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HE2' HD22 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -135.25 163.78 29.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.191 0.519 . . . . 0.0 111.989 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -51.8 -32.4 31.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.348 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -75.77 2.46 12.15 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.412 HD22 ' HE2' ' A' ' 62' ' ' LYS . 89.5 m-20 -118.48 171.63 8.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.398 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 67.2 p -129.22 172.15 11.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.33 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.14 -45.26 74.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.997 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.22 71.65 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.343 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.79 -42.34 97.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -92.31 3.88 54.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.931 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.6 m120 57.29 39.38 28.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.1 mtt -63.78 92.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.78 176.3 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.401 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 2' ' ' VAL . 33.0 m-80 -57.35 116.4 3.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.144 0.497 . . . . 0.0 110.783 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.36 26.19 5.24 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.694 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 4' ' ' ILE . . . -73.25 114.42 11.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.504 HG22 ' HD2' ' A' ' 5' ' ' LYS . 25.7 t -96.94 104.68 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.193 0.52 . . . . 0.0 110.75 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 56' ' ' TYR . 6.9 mm -94.33 143.33 11.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -110.44 112.02 23.67 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.16 134.12 36.71 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.46 142.2 24.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.534 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.422 HD11 ' O ' ' A' ' 51' ' ' LYS . 19.7 tp . . . . . 0 C--N 1.317 -0.815 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' HG21 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.477 0.524 0 N-CA-C 109.767 -0.897 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 20.9 m -129.14 155.52 41.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.043 0.449 . . . . 0.0 110.768 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -85.14 122.66 29.67 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.627 HG21 ' HB3' ' A' ' 76' ' ' ALA . 7.3 pt -123.8 144.22 34.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.095 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HE3' HG22 ' A' ' 77' ' ' VAL . 31.5 mtmt -125.67 151.21 46.87 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.119 0.485 . . . . 0.0 111.172 -175.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.2 105.45 13.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.139 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 104.41 3.36 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.2 t -76.81 128.41 81.68 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.758 ' HG2' HD13 ' A' ' 19' ' ' LEU . 30.6 Cg_endo -63.44 149.02 92.19 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 122.517 2.145 . . . . 0.0 112.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.677 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.8 m120 -75.69 93.89 3.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.555 ' HE3' HD11 ' A' ' 19' ' ' LEU . 43.6 mtm -143.78 73.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.438 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.584 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -78.84 -45.61 20.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.596 0.713 . . . . 0.0 110.074 -171.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.46 16.69 12.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.814 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -100.8 -6.13 25.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -160.53 -176.01 5.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.157 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.14 -4.0 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.424 -172.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.604 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.2 m-90 -95.75 169.94 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -175.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HZ1' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -82.27 24.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 111.578 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.758 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.7 mt -75.84 131.28 39.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.66 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.6 m-80 -142.43 14.38 1.99 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.677 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.91 0.12 89.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.015 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.66 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.6 pm0 -73.66 174.72 7.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 126.74 71.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.158 0.504 . . . . 0.0 109.814 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.68 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 HG23 ' HG2' ' A' ' 5' ' ' LYS . 45.8 t -124.02 106.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -119.79 164.38 16.07 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.523 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 1' ' ' PRO . 12.6 m -126.29 126.33 43.79 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.406 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.473 HD12 HD13 ' A' ' 4' ' ' ILE . 53.4 mt -140.9 152.75 66.31 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.263 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.3 152.38 79.32 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.862 1.708 . . . . 0.0 111.048 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.48 -10.79 19.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.8 p -77.39 -19.97 55.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.233 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.87 -173.8 3.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 111.251 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.09 176.8 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.017 0.437 . . . . 0.0 111.932 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.49 ' CG1' HG13 ' A' ' 61' ' ' ILE . 40.0 t -57.96 -31.74 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.403 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 29.0 t -55.66 -28.89 57.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.84 -30.74 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 120.989 0.423 . . . . 0.0 110.784 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mm -71.15 -52.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 9.6 ptmt -57.72 -43.14 85.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.8 p -69.29 -40.04 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 9.5 ptpt -67.05 -35.71 80.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.607 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.63 -43.54 77.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' MET . 12.1 t-160 -60.39 -33.35 72.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.423 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 18.7 mm-40 -88.6 -25.69 22.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.795 0.331 . . . . 0.0 110.635 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.96 -53.08 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.4 p -90.35 -42.98 10.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.95 -8.24 11.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.682 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 19.8 ptm -89.67 117.09 67.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.412 0.625 . . . . 0.0 111.346 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 Cg_endo -67.78 158.47 57.09 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.386 2.057 . . . . 0.0 112.132 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.99 -6.35 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.158 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.38 67.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.371 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.38 -11.67 4.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.248 0.547 . . . . 0.0 110.019 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.682 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.84 112.77 24.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.217 -179.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mmpt? -104.36 140.33 38.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.753 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.1 mm? -110.33 135.8 50.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -128.56 117.61 21.56 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.981 0.42 . . . . 0.0 111.464 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' ' 78' ' ' ILE . 12.2 t80 -104.45 111.27 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.943 0.401 . . . . 0.0 110.503 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 56.32 29.94 15.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.357 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.95 21.26 33.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.25 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -125.93 116.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -74.55 96.05 2.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.846 0.831 . . . . 0.0 110.663 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.49 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -76.84 153.88 5.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.81 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.2 166.36 14.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.381 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -32.82 21.83 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.83 0.852 . . . . 0.0 111.78 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -74.88 -14.27 60.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.325 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -97.0 165.16 12.21 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -130.67 167.4 18.86 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.66 -45.52 86.37 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.51 78.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.467 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -56.8 -46.3 81.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -85.8 -3.29 58.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.518 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.77 47.37 15.59 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 123.42 0.45 . . . . 0.0 110.031 -174.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.01 87.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.15 178.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.945 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.424 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 16.2 t-20 -60.52 114.87 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.935 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.21 40.38 2.1 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.404 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -83.61 114.55 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 110.249 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.484 HG22 ' HE3' ' A' ' 5' ' ' LYS . 15.3 t -94.74 104.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.976 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 56' ' ' TYR . 6.5 mm -94.81 146.55 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -113.02 116.42 29.9 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.1 tp -84.64 133.78 34.4 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.32 142.67 27.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.004 0.431 . . . . 0.0 111.071 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.233 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.51 157.9 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -88.93 125.84 35.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.301 0.572 . . . . 0.0 110.277 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -122.29 135.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.544 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -121.06 145.63 47.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.632 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.96 108.1 19.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.584 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 102.99 3.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.007 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 63.0 t -73.75 130.25 83.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.899 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.732 ' HG2' HD13 ' A' ' 19' ' ' LEU . 39.9 Cg_endo -66.44 155.19 71.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.963 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.645 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.2 m120 -82.37 90.81 6.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.555 ' HB3' HG23 ' A' ' 15' ' ' THR . 47.5 mtm -142.5 76.78 1.55 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.057 0.455 . . . . 0.0 110.523 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.5 mp0 -78.77 -47.5 16.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.943 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -120.98 2.97 10.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.423 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -76.96 -19.16 57.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.346 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 11' ' ' MET . 14.3 t -150.96 -174.02 4.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.442 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -95.41 -5.76 42.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 0.0 111.509 -173.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.573 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -87.74 174.21 8.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.452 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HE2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -89.35 30.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.058 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.732 HD13 ' HG2' ' A' ' 9' ' ' PRO . 16.8 mt -83.12 131.7 35.13 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.644 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.3 m-80 -143.12 15.84 1.89 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.123 0.487 . . . . 0.0 110.365 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.645 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.42 2.86 87.19 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.985 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.644 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.1 pm0 -74.35 177.11 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.11 0.481 . . . . 0.0 110.685 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.74 132.82 70.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.181 0.515 . . . . 0.0 110.101 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 HD22 ' HZ2' ' A' ' 18' ' ' LYS . 81.2 mt -93.75 143.98 25.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.145 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.1 107.68 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -115.47 159.41 21.21 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -126.27 114.31 18.12 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 4' ' ' ILE . 80.5 mt -132.59 154.74 81.62 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.446 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.15 152.96 78.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.038 1.825 . . . . 0.0 111.238 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.73 -8.2 9.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.2 p -82.4 -15.92 50.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.108 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.91 -172.95 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 110.928 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.94 174.97 10.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.727 -172.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.734 HG12 HG13 ' A' ' 61' ' ' ILE . 24.5 t -63.12 -25.24 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.899 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 23.0 t -52.42 -35.39 51.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.914 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.41 HG11 ' HZ2' ' A' ' 40' ' ' LYS . 19.0 t -75.05 -26.7 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.666 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -72.45 -49.85 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.952 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 7.0 ptmt -61.75 -42.13 98.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 13.9 p -67.2 -38.8 81.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 -177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.737 ' HB3' ' HZ3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -69.13 -35.07 76.0 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.132 -177.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.436 HD12 HD12 ' A' ' 54' ' ' LEU . 74.4 mt -74.18 -42.95 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.138 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -58.25 -32.91 68.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.477 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 61.5 mt-10 -85.93 -32.31 21.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.834 0.35 . . . . 0.0 110.64 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.33 -44.22 25.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.502 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.7 p -102.27 -45.62 5.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.044 0.449 . . . . 0.0 110.632 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.58 -19.34 5.93 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.948 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.488 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 18.6 ptm -78.38 117.64 67.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.351 0.596 . . . . 0.0 111.466 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 32.0 Cg_endo -68.88 159.03 55.54 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.306 2.004 . . . . 0.0 111.939 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.1 -17.47 63.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.027 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.94 -31.08 38.8 Favored Glycine 0 C--O 1.225 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.1 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.82 -3.47 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.239 0.542 . . . . 0.0 110.178 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.615 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -94.07 113.65 25.66 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.704 ' HZ2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -106.74 139.13 41.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 41' ' ' ILE . 1.4 mm? -110.21 125.03 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -115.89 114.93 25.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.118 0.485 . . . . 0.0 111.395 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.6 t80 -102.68 107.72 18.73 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.41 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 27.2 mm-40 56.92 30.93 18.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.546 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.91 57.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -107.79 115.17 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -68.62 92.75 0.48 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 109.894 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.734 HG13 HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.19 149.6 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.642 -177.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -109.44 160.79 15.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.722 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 35' ' ' SER . 4.3 p30 -66.81 -16.9 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -86.88 6.23 32.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.434 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 94.5 m-20 -106.28 167.06 10.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 82.6 p -124.43 166.33 16.17 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.242 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -66.0 -44.26 85.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.416 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.85 76.72 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.281 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.04 -47.82 83.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -89.58 5.24 46.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.208 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.88 45.66 21.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.075 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.96 88.03 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.597 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.3 -170.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.913 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.11 114.43 3.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.5 39.68 3.62 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.937 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -77.24 115.13 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 t -95.65 102.45 13.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 111.264 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.8 mm -94.55 147.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -114.09 115.42 27.53 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 52' ' ' GLN . 51.8 tp -81.52 133.82 35.44 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.01 143.69 29.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 51' ' ' LYS . 29.8 tp . . . . . 0 N--CA 1.444 -0.764 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.755 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 109.393 -1.041 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 17.9 m -127.26 152.69 35.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.877 0.37 . . . . 0.0 110.512 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -88.64 122.52 32.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' A' ' 76' ' ' ALA . 13.0 pt -126.38 145.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -127.04 147.8 50.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.009 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.51 105.68 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.591 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.1 104.96 3.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.894 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 37.9 t -76.17 130.66 77.18 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HG2' HD13 ' A' ' 19' ' ' LEU . 59.0 Cg_endo -70.06 152.25 67.67 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.073 1.848 . . . . 0.0 111.77 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.436 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 10.6 m120 -75.83 83.67 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.5 ' HE3' HD11 ' A' ' 19' ' ' LEU . 12.6 mtp -133.83 73.32 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 120.927 0.394 . . . . 0.0 110.484 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.6 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -80.98 -45.13 17.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.622 0.725 . . . . 0.0 110.599 -175.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -113.9 3.67 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.466 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -91.17 -6.89 52.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.061 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.4 HG23 ' HB3' ' A' ' 11' ' ' MET . 12.4 t -167.03 -176.03 3.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.935 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.71 7.37 28.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.022 0.439 . . . . 0.0 111.029 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 7.4 m0 -85.23 165.94 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.857 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HZ3' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.4 27.72 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 111.357 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.593 HD13 ' HG2' ' A' ' 9' ' ' PRO . 25.5 mt -81.72 123.62 28.91 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.937 -0.477 . . . . 0.0 109.747 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.0 m-80 -137.91 15.3 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.882 -0.511 . . . . 0.0 111.41 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 79.45 14.01 81.93 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.27 -0.966 . . . . 0.0 112.6 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.533 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -87.24 176.49 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 177.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.86 125.06 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.232 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' HZ2' ' A' ' 18' ' ' LYS . 82.6 mt -86.96 141.62 28.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.07 108.61 16.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.469 0.652 . . . . 0.0 109.906 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -116.64 162.98 16.8 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.95 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -126.6 119.19 26.46 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.475 HD13 HD13 ' A' ' 4' ' ' ILE . 87.4 mt -134.9 151.42 75.55 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.695 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.21 154.69 73.18 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.67 -6.77 12.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.6 p -82.83 -17.31 44.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.939 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.402 ' OD2' HG23 ' A' ' 36' ' ' VAL . 1.3 m-20 -75.69 -175.44 2.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 110.643 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.45 171.44 14.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.543 -172.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.597 HG12 HG13 ' A' ' 61' ' ' ILE . 40.2 t -63.41 -27.86 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -53.62 -31.44 47.14 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.091 175.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.2 t -78.61 -28.24 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.639 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 30.4 mm -73.44 -46.48 48.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.39 -41.99 94.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.443 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.84 -40.57 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.9 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -64.89 -38.55 91.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.886 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.85 -43.77 79.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.68 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' MET . 11.3 t-80 -57.52 -33.81 68.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.55 -25.43 20.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.073 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.43 -39.53 24.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.392 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 6.8 p -104.14 -47.86 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.565 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.58 7.89 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.47 ' HE3' ' HB2' ' A' ' 52' ' ' GLN . 16.0 ptm -86.99 119.73 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.26 0.553 . . . . 0.0 111.517 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.4 Cg_endo -68.82 158.73 56.66 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.397 2.065 . . . . 0.0 112.166 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.05 -9.45 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.889 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.6 -27.31 65.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.663 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.518 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.73 -2.53 3.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.037 0.446 . . . . 0.0 110.462 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.47 ' HB2' ' HE3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.69 114.47 26.45 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.238 0.542 . . . . 0.0 109.699 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.5 mmpt? -106.54 142.7 35.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.738 -176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.27 121.46 38.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.87 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -111.77 117.53 33.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.015 0.436 . . . . 0.0 111.605 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' HD11 ' A' ' 78' ' ' ILE . 16.7 t80 -105.28 109.67 21.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 56.88 30.59 18.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.803 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.47 56.15 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.308 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 20.2 mt -111.02 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -72.66 90.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.597 HG13 HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -76.99 158.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.892 -175.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.0 pttp -118.69 159.31 23.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.994 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.72 -2.68 21.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.1 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.533 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -91.37 -0.85 57.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.777 0.322 . . . . 0.0 111.23 177.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -112.4 -175.35 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.269 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 39.1 p -137.75 176.57 8.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.784 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.01 -45.73 59.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.764 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.42 -33.0 69.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.127 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.13 -48.64 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 61' ' ' ILE . 72.1 m-85 -88.95 1.75 54.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.292 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 60.91 45.85 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.38 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.0 mtt -70.5 85.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.774 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.25 -172.31 1.38 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.78 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 53.0 t30 -62.22 114.95 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.224 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 39.49 2.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.645 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' A' ' 4' ' ' ILE . . . -80.87 114.62 19.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.171 0.485 . . . . 0.0 110.312 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.75 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.07 0.462 . . . . 0.0 110.851 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.46 149.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -117.69 119.65 35.61 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -84.47 131.86 34.62 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.588 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.73 144.35 27.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 51' ' ' LYS . 23.1 tp . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.421 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.7 Cg_endo . . . . . 0 N--CA 1.478 0.592 0 N-CA-C 109.773 -0.895 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 28' ' ' LEU . 11.1 m -120.36 152.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 0.0 110.544 -177.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 m -87.54 119.23 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 76' ' ' ALA . 3.1 pt -120.0 142.36 35.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.275 0.559 . . . . 0.0 110.987 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -125.58 148.2 49.02 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.413 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.79 105.86 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.56 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HG2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -70.7 106.41 3.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.635 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 HG12 HD23 ' A' ' 19' ' ' LEU . 85.6 t -76.94 128.78 80.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.1 Cg_endo -65.32 149.75 88.0 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.29 1.993 . . . . 0.0 111.698 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.582 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.1 m120 -76.08 84.73 2.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.462 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.539 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 51.0 mtm -137.49 75.58 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.142 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.3 mp0 -79.03 -45.46 20.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.729 0.775 . . . . 0.0 109.747 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -119.61 -0.06 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.737 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 33.9 mmtt -81.17 -6.01 58.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.056 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -164.85 -175.84 3.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.647 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.4 -0.08 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.92 0.39 . . . . 0.0 111.665 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.677 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.6 m0 -85.01 168.87 14.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.67 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.668 ' HZ3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.9 28.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.454 0.645 . . . . 0.0 110.898 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.788 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.0 mt -79.88 128.8 33.89 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 20.7 m-80 -140.55 9.78 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.883 -0.511 . . . . 0.0 111.368 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.09 10.49 78.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.882 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -84.02 179.45 7.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.891 0.377 . . . . 0.0 110.426 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.445 HG21 ' HG2' ' A' ' 7' ' ' GLN . 62.2 t -125.46 126.83 71.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.514 HD12 ' HZ2' ' A' ' 18' ' ' LYS . 68.3 mt -87.64 141.87 28.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.16 114.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CD2' ' HE3' ' A' ' 40' ' ' LYS . 56.7 m-85 -130.13 166.46 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.75 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.8 m -126.81 123.38 37.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.775 0.321 . . . . 0.0 110.418 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 2' ' ' VAL . 73.2 mt -139.04 152.41 69.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.953 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.45 152.81 74.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.223 1.948 . . . . 0.0 111.689 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 68' ' ' ALA . 31.0 tp -64.3 -7.05 8.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -83.82 -17.26 41.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.491 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.26 -173.78 3.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.237 0.542 . . . . 0.0 110.716 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -146.07 175.22 10.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.419 -172.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.464 ' CG1' HG13 ' A' ' 61' ' ' ILE . 19.8 t -59.46 -29.74 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.702 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.585 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.4 m -53.38 -29.35 34.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.397 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.7 t -78.81 -32.61 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.601 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.68 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -70.59 -46.99 67.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.306 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.711 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.1 ptmt -62.29 -44.46 96.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.922 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.48 -35.39 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.703 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.34 -34.63 74.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.624 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 54' ' ' LEU . 82.6 mt -74.57 -42.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.361 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' MET . 19.3 t60 -57.41 -32.38 66.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.561 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.7 -29.13 21.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.45 -44.94 18.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.2 p -99.58 -45.04 5.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.649 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.79 -17.17 6.85 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.681 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.58 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.5 ptm -82.86 116.17 62.63 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.541 0.686 . . . . 0.0 111.451 -175.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.7 Cg_endo -68.07 162.9 38.04 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.522 2.148 . . . . 0.0 111.992 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -68.96 -8.46 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.847 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.39 66.64 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.399 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.564 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -128.07 -24.25 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 109.92 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.711 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.44 113.53 10.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.082 176.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 6.7 mmpt? -107.34 140.6 40.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 41' ' ' ILE . 1.9 mm? -112.27 123.98 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.829 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.0 tt0 -115.57 115.59 26.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.592 ' HB2' HD13 ' A' ' 78' ' ' ILE . 10.8 t80 -101.6 107.82 19.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.258 0.552 . . . . 0.0 110.108 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 5.2 mm-40 56.74 29.44 15.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.053 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.0 14.95 37.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.026 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 25.7 mt -117.51 116.0 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -72.36 95.65 1.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.464 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -84.52 154.09 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -132.51 174.84 9.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.839 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -28.79 20.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.568 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.447 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 4.6 m -86.16 10.52 14.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.174 -169.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 87.9 m-20 -114.71 172.66 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.4 p -130.08 166.58 19.88 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.05 -44.12 85.5 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' HA ' HD13 ' A' ' 30' ' ' LEU . . . -58.65 -38.88 79.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.628 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.14 -40.8 77.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -95.57 6.4 49.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.452 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.54 38.89 22.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.967 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.458 ' HE3' HD12 ' A' ' 61' ' ' ILE . 61.1 mtt -67.48 87.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.55 -168.64 2.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.302 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.51 115.12 2.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.121 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.7 3.25 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.648 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . -82.66 114.65 21.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.029 0.415 . . . . 0.0 109.978 177.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.85 102.2 13.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.57 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.592 HD13 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.24 150.52 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.16 116.47 27.88 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.529 HD13 ' HG3' ' A' ' 52' ' ' GLN . 38.0 tp -82.53 131.68 35.21 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.24 145.59 27.17 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 C--N 1.318 -0.784 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.817 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.487 ' HB2' HG21 ' A' ' 27' ' ' THR . 11.5 Cg_endo . . . . . 0 N--CA 1.479 0.643 0 N-CA-C 110.159 -0.747 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 16.1 m -122.49 156.21 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.813 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -82.52 127.24 33.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.021 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.598 HG22 ' HB1' ' A' ' 76' ' ' ALA . 6.5 pt -130.71 136.64 57.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.129 0.49 . . . . 0.0 110.826 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -123.35 145.47 48.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.764 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.8 108.44 24.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.527 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.03 104.01 4.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.649 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG12 HD23 ' A' ' 19' ' ' LEU . 62.1 t -76.71 131.19 74.38 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.455 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.821 ' HG2' HD12 ' A' ' 19' ' ' LEU . 36.1 Cg_endo -66.62 155.68 69.24 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.14 1.894 . . . . 0.0 112.214 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.0 m120 -82.54 84.2 7.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.568 ' HB3' HG22 ' A' ' 15' ' ' THR . 48.6 mtm -137.45 75.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.582 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 9.3 mp0 -79.91 -47.47 15.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.689 -171.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -120.89 10.78 10.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -93.27 -2.18 55.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.834 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.3 t -167.77 -176.73 3.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.86 -12.52 41.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.808 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.641 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.2 m0 -84.99 164.34 18.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.563 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HZ3' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -82.85 29.94 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.672 0.748 . . . . 0.0 110.86 -178.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.821 HD12 ' HG2' ' A' ' 9' ' ' PRO . 19.4 mt -78.94 127.25 31.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.556 -0.715 . . . . 0.0 109.269 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.582 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 17.2 m-80 -137.82 20.57 2.86 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.766 -0.584 . . . . 0.0 111.364 -175.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.14 1.39 63.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.085 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -76.58 176.51 8.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.26 0.552 . . . . 0.0 110.526 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 7' ' ' GLN . 58.2 t -125.31 123.48 65.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.904 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD12 ' HZ3' ' A' ' 18' ' ' LYS . 51.4 mt -88.05 136.92 32.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.35 110.38 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 120.971 0.415 . . . . 0.0 110.0 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.44 166.33 16.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.593 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 1' ' ' PRO . 6.6 m -126.49 122.59 35.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.806 HD11 ' HZ3' ' A' ' 40' ' ' LYS . 73.4 mt -136.09 154.04 77.2 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.72 152.52 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.87 1.713 . . . . 0.0 110.982 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.65 -8.7 10.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -79.61 -18.38 51.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.44 -175.13 2.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 110.648 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.1 172.83 12.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.342 -173.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.605 HG12 HG13 ' A' ' 61' ' ' ILE . 40.4 t -62.82 -26.81 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.564 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -54.16 -33.16 57.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.316 176.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -74.03 -32.05 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 mm -72.61 -48.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.751 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.7 ptmt -59.86 -40.95 90.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.744 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -72.97 -39.23 57.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.041 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HZ3' HD11 ' A' ' 28' ' ' LEU . 16.4 ptpt -63.5 -35.6 81.01 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.259 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.9 mt -72.35 -43.58 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.264 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -59.84 -34.71 73.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.36 -36.41 39.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.748 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.74 8.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.729 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.8 p -91.66 -43.49 9.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.11 -15.22 9.44 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.949 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.567 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 17.5 ptm -81.36 119.96 77.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.458 0.647 . . . . 0.0 111.565 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.0 Cg_endo -67.85 156.7 64.9 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.77 2.313 . . . . 0.0 112.056 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.97 -12.54 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.483 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.64 -32.58 58.56 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.557 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.68 -3.92 4.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.148 0.499 . . . . 0.0 110.495 -177.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.68 116.33 28.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.31 0.576 . . . . 0.0 109.547 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.945 ' HA ' ' HZ3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -104.92 140.92 37.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.74 118.69 32.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.146 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 25.9 tt0 -111.48 116.0 30.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.593 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.598 ' HB2' HD11 ' A' ' 78' ' ' ILE . 12.7 t80 -103.85 108.97 20.53 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 61.6 mm-40 57.35 30.23 18.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.741 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.46 10.36 53.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.316 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.8 mt -114.49 118.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 10.1 m-30 -74.11 89.41 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.605 HG13 HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -74.44 154.4 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.75 -175.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.9 pttp -117.14 160.02 21.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.945 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -72.19 -5.28 34.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -88.71 0.42 56.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.884 0.373 . . . . 0.0 110.748 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -112.47 176.89 4.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.3 p -130.43 170.03 14.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.318 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.52 -43.6 80.42 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.861 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.97 76.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.282 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -57.59 -44.73 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.958 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -88.9 3.38 51.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.264 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.466 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.9 OUTLIER 59.26 41.0 20.72 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.021 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -62.8 94.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.446 0.641 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.75 -177.9 2.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.523 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 33.3 t30 -61.83 116.76 5.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.22 39.29 3.79 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.364 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.598 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -77.53 114.91 16.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.345 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.28 105.11 16.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -93.87 148.82 4.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -117.0 116.9 28.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.05 133.31 34.66 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.0 148.91 31.24 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.392 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 51' ' ' LYS . 26.1 tp . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.564 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.401 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.4 Cg_endo . . . . . 0 C--O 1.231 0.145 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.96 154.66 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.385 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m -85.55 124.85 32.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.591 HG21 ' HB3' ' A' ' 76' ' ' ALA . 4.6 pt -128.38 148.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.491 ' HD2' HG21 ' A' ' 77' ' ' VAL . 10.1 mttm -128.13 147.53 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 105.81 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 104.72 5.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.979 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.494 HG11 HD21 ' A' ' 19' ' ' LEU . 57.6 t -73.67 133.02 80.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.367 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.831 ' HG2' HD11 ' A' ' 19' ' ' LEU . 38.0 Cg_endo -68.66 151.23 74.97 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.995 1.797 . . . . 0.0 111.772 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.589 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -79.89 88.45 5.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.557 ' HE1' HD12 ' A' ' 19' ' ' LEU . 51.0 mtm -138.84 75.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.6 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.9 mp0 -78.84 -45.95 19.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.86 -168.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -120.21 2.8 10.9 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.133 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -86.33 -4.83 59.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.157 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.522 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.6 t -161.47 -176.46 5.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.826 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.99 -0.33 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.106 0.479 . . . . 0.0 111.627 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.678 ' HZ2' ' HZ3' ' A' ' 51' ' ' LYS . 5.2 m0 -89.84 174.56 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.081 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.724 ' HZ2' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.15 28.51 1.4 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.193 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.831 HD11 ' HG2' ' A' ' 9' ' ' PRO . 15.7 mt -79.56 122.71 26.83 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.8 m-80 -136.49 20.13 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.255 0.55 . . . . 0.0 110.452 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.589 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.18 -7.85 59.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.976 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.566 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -65.79 176.02 1.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.522 0.677 . . . . 0.0 111.15 -178.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.91 126.69 74.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.919 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 mt -87.51 132.17 34.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.34 107.39 18.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -125.08 167.35 14.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.396 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.1 m -126.51 119.89 28.29 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 4' ' ' ILE . 67.4 mt -134.38 149.89 72.41 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 42.6 Cg_endo -70.01 149.23 65.02 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.387 2.058 . . . . 0.0 111.62 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.6 -12.16 21.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.872 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -72.65 -25.26 61.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -75.01 -173.62 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.136 0.493 . . . . 0.0 110.731 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.55 173.42 12.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.819 0.342 . . . . 0.0 111.714 -172.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.487 ' CG1' HG13 ' A' ' 61' ' ' ILE . 25.6 t -57.28 -31.35 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.74 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.521 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 15.3 m -50.64 -36.07 33.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.126 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 39.0 t -72.04 -33.97 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.615 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.7 -52.6 22.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.816 0.341 . . . . 0.0 110.479 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 10.7 ptmt -57.97 -44.59 87.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.513 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.63 -32.72 56.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.65 -46.52 78.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.856 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.47 -38.14 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.159 0.504 . . . . 0.0 110.264 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 47' ' ' MET . 7.6 t-80 -56.9 -34.57 68.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.481 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -90.91 -29.93 17.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.978 0.418 . . . . 0.0 111.024 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.62 -44.92 32.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.431 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.724 HG22 ' HZ2' ' A' ' 18' ' ' LYS . 5.8 p -102.03 -40.5 6.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.57 -8.77 10.91 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.962 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 15.0 ptm -90.99 117.89 68.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 111.811 -176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.2 Cg_endo -66.92 157.25 62.46 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.7 2.266 . . . . 0.0 111.873 175.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -62.65 -14.2 40.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.682 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.07 -34.12 52.12 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.44 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HZ3' ' HZ2' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -126.9 -7.82 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 110.252 -177.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.574 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.93 116.57 29.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.59 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.974 ' HA ' ' HZ3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -107.13 142.81 36.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.782 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.05 124.56 46.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -116.39 119.52 35.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.038 0.447 . . . . 0.0 111.44 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' ' 78' ' ' ILE . 8.8 t80 -103.65 104.78 14.86 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 57.24 29.69 17.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.849 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.44 14.51 37.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.916 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -120.69 114.35 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -76.67 92.74 3.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.855 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.487 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -74.89 150.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.42 -177.158 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -125.71 171.26 10.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.125 0.488 . . . . 0.0 111.869 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -18.88 45.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.188 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.409 ' HB2' ' CE ' ' A' ' 62' ' ' LYS . 3.9 m -86.97 10.12 17.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.065 0.459 . . . . 0.0 110.773 -175.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -122.4 171.19 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 79.4 p -129.56 169.93 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.94 -44.13 85.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.11 75.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.54 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.19 -39.96 84.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.439 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 49.1 m-85 -91.09 -2.33 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.285 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.71 46.47 20.04 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.638 0.586 . . . . 0.0 110.124 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.6 mtt -62.04 87.79 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.272 0.558 . . . . 0.0 110.747 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.58 179.58 3.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.712 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.18 115.8 4.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.344 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.97 33.61 3.7 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.135 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.591 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -79.22 114.79 18.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.118 0.485 . . . . 0.0 110.031 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.491 HG21 ' HD2' ' A' ' 5' ' ' LYS . 26.5 t -99.1 106.06 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.931 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -94.44 149.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -116.57 119.35 35.29 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 tp -85.74 133.3 34.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.63 34.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 51' ' ' LYS . 37.4 tp . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.109 0.48 . . . . 0.0 110.97 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.496 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 N-CA-C 110.307 -0.69 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.56 158.63 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 m -90.51 122.13 33.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.12 0.486 . . . . 0.0 110.595 -176.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 76' ' ' ALA . 1.8 pt -125.46 138.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.956 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -120.58 146.38 46.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.14 105.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.236 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 101.43 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.872 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 22.3 t -72.24 129.33 87.72 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.7 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.662 ' HG2' HD12 ' A' ' 19' ' ' LEU . 43.1 Cg_endo -66.15 149.19 85.72 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.517 2.145 . . . . 0.0 111.677 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.632 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -73.78 85.43 1.68 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.524 ' HE1' HD13 ' A' ' 19' ' ' LEU . 47.8 mtm -136.09 74.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.965 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 3.6 mp0 -78.99 -44.96 21.22 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.727 0.775 . . . . 0.0 109.557 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -119.79 3.59 11.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.212 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -88.87 -5.06 58.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.028 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.7 t -162.68 -175.74 4.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.675 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -105.19 3.26 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -90.43 169.52 10.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.126 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.572 ' HE2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -81.96 31.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.154 0.502 . . . . 0.0 111.631 -178.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.662 HD12 ' HG2' ' A' ' 9' ' ' PRO . 20.8 mt -83.74 132.97 34.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.683 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.6 m-80 -147.29 19.27 1.21 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 110.14 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.632 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.23 -3.26 87.49 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.683 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 3.5 pm0 -70.88 172.11 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.577 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.24 130.57 74.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.544 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 88.8 mt -91.01 147.34 23.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.53 109.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.68 160.68 19.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.241 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -127.1 115.9 19.87 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 4' ' ' ILE . 96.1 mt -134.19 151.88 77.28 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.557 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.27 151.89 80.18 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.207 1.938 . . . . 0.0 111.439 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.3 tp -64.72 -4.53 4.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -83.65 -20.68 33.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.444 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.458 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.6 m-20 -77.41 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.268 0.556 . . . . 0.0 110.622 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.81 174.01 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -172.203 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.779 HG13 HG13 ' A' ' 61' ' ' ILE . 39.5 t -61.91 -27.52 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.693 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 29.2 t -51.78 -33.31 34.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.44 175.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 HG21 ' OD2' ' A' ' 32' ' ' ASP . 19.8 t -77.44 -30.75 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.93 0.395 . . . . 0.0 110.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.2 mm -71.84 -49.28 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.368 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 2.9 ptmt -59.07 -40.6 85.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.48 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.601 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.6 p -71.24 -41.09 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.083 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -65.72 -35.58 81.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.893 -177.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.9 -41.57 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.281 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -57.84 -34.75 70.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.088 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 52.9 mt-10 -82.84 -33.02 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.952 0.406 . . . . 0.0 110.419 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.8 -44.14 23.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.769 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.1 p -102.18 -44.94 5.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.763 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.84 -5.84 10.49 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.116 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.555 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -89.57 116.88 67.45 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 111.366 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.12 159.36 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.518 2.145 . . . . 0.0 111.848 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -64.16 -14.85 57.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.822 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.16 -30.7 55.26 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.081 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -128.66 -3.96 5.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.167 0.508 . . . . 0.0 109.995 -177.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.555 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.23 115.52 28.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.734 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.7 mmpt? -108.14 141.61 39.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.0 mt -117.51 121.49 41.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.819 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.6 tt0 -113.54 117.36 31.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.238 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.597 ' HB2' HD13 ' A' ' 78' ' ' ILE . 9.9 t80 -103.54 109.45 21.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.027 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 56.4 29.59 15.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.747 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.67 13.05 45.37 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 19.6 mt -116.97 118.99 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -74.04 93.15 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.779 HG13 HG13 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -79.28 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.552 -178.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.22 166.83 12.12 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.59 -12.35 61.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 0.0 111.387 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -78.22 -10.3 59.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 72.7 m-20 -99.47 164.26 12.17 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.6 p -125.09 167.5 14.69 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.04 -43.41 87.63 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.911 0.386 . . . . 0.0 110.028 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.96 -34.85 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -55.64 -45.08 77.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.42 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 29.7 m-85 -97.53 9.48 42.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.631 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.25 45.84 19.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.248 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.3 mtt -69.08 90.09 0.45 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.085 0.469 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.81 -172.34 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.823 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -61.08 115.53 3.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.257 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 31.58 5.46 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.62 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -75.02 114.56 13.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.03 104.53 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 0.0 110.913 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.23 148.27 5.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -112.88 118.33 34.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -82.77 132.74 35.16 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.03 147.01 29.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 51' ' ' LYS . 27.3 tp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 28.9 Cg_endo . . . . . 0 N--CA 1.478 0.584 0 N-CA-C 110.601 -0.577 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.97 157.13 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -90.65 117.83 29.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 110.449 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.618 HG21 ' HB1' ' A' ' 76' ' ' ALA . 6.8 pt -121.0 143.53 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.739 -176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -126.25 150.51 48.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.804 0.335 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 49.0 t -124.77 107.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.852 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.485 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -70.08 105.75 3.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.496 HG12 HD23 ' A' ' 19' ' ' LEU . 60.3 t -76.41 131.83 73.97 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.1 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.739 ' HG2' HD13 ' A' ' 19' ' ' LEU . 41.4 Cg_endo -68.0 149.58 77.33 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.223 1.949 . . . . 0.0 111.781 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.528 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -76.32 86.98 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.54 ' HB3' HG21 ' A' ' 15' ' ' THR . 47.5 mtm -135.55 76.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.679 . . . . 0.0 110.175 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 10.8 mp0 -79.9 -45.38 18.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.572 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.68 -5.59 10.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.006 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 34.7 mmtt -75.71 -8.13 56.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.662 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 11' ' ' MET . 13.3 t -163.81 -172.68 2.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -105.97 0.36 25.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.664 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m0 -85.38 168.61 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.753 ' HZ3' HG23 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.01 28.8 0.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.661 . . . . 0.0 111.407 -177.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.739 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -81.1 122.0 26.8 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.79 -0.569 . . . . 0.0 109.832 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.629 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 15.9 m-80 -138.06 16.66 2.82 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.943 -0.473 . . . . 0.0 110.665 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.19 -2.46 85.27 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.29 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.629 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -73.81 179.36 4.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.274 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.56 128.61 76.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.293 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD12 ' HZ2' ' A' ' 18' ' ' LYS . 86.2 mt -87.77 144.94 26.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.92 111.12 19.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.051 0.453 . . . . 0.0 109.856 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 92.6 m-85 -120.92 162.6 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.353 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 1' ' ' PRO . 6.7 m -127.67 119.01 24.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.755 0.312 . . . . 0.0 110.175 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -137.66 149.0 63.41 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.137 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 23.5 Cg_endo -64.99 148.62 89.78 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.302 2.001 . . . . 0.0 111.47 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.6 tp -60.54 -14.51 20.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.961 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -76.99 -21.57 54.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.776 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 29' ' ' PRO . 3.0 m-20 -74.18 -174.81 2.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.608 . . . . 0.0 110.71 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.97 174.75 10.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.72 -171.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' CG1' HG13 ' A' ' 61' ' ' ILE . 44.5 t -58.98 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.847 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 8.5 t -52.56 -34.29 49.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.134 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.05 -32.7 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 22.5 mm -72.0 -50.77 35.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 6.3 ptmt -58.0 -41.88 84.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.473 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 14.2 p -70.8 -41.26 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.009 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.604 ' HB3' ' HZ3' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -64.65 -35.66 81.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.957 -178.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -69.81 -41.89 79.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.05 0.452 . . . . 0.0 110.362 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -58.73 -31.45 68.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.93 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 5.7 mm-40 -81.69 -36.63 28.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 110.573 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.46 -49.26 17.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.64 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.753 HG23 ' HZ3' ' A' ' 18' ' ' LYS . 3.5 p -96.07 -45.28 6.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.969 0.414 . . . . 0.0 110.51 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.13 -20.14 6.34 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.68 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.567 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 15.7 ptm -77.81 119.33 76.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.547 . . . . 0.0 111.341 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 19.8 Cg_endo -68.03 157.98 59.39 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.329 2.019 . . . . 0.0 111.831 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -64.22 -9.57 18.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.419 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.05 -26.53 61.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.886 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.05 -5.67 2.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.926 0.394 . . . . 0.0 110.316 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -94.65 116.03 28.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.9 mmpt? -105.79 140.23 39.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.53 116.82 28.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.338 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 60' ' ' PHE . 30.3 tt0 -108.03 112.12 24.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' HB2' HD12 ' A' ' 78' ' ' ILE . 26.5 t80 -102.61 114.43 28.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.767 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 31.1 mm-40 56.56 29.54 15.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.459 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.52 8.77 57.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.733 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 9.5 mt -115.17 118.51 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.4 m-30 -68.49 94.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 0.0 109.953 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.558 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.45 152.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.428 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -122.43 167.3 13.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 6.2 t70 -59.36 -27.93 66.39 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.149 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -75.02 -11.06 60.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.382 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.9 170.01 8.15 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.932 0.396 . . . . 0.0 110.141 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.6 p -130.36 175.01 9.3 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.202 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.38 -43.34 73.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.26 -35.11 76.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.452 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -57.18 -42.15 80.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.641 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.477 ' CZ ' HG21 ' A' ' 61' ' ' ILE . 73.5 m-85 -95.08 0.34 54.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.96 47.28 12.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.786 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtt -69.96 87.46 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.25 -173.28 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.348 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -63.37 115.69 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 110.035 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.82 2.85 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.041 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 4' ' ' ILE . . . -82.65 114.93 21.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.016 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.27 104.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.041 0.448 . . . . 0.0 110.719 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.13 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.59 114.66 23.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.16 133.58 34.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.92 148.27 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 51' ' ' LYS . 21.6 tp -76.72 129.07 35.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.606 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 25.2 ttpp -56.91 -51.1 70.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.408 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -148.23 110.63 4.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 -175.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HE ' ' N ' ' A' ' 86' ' ' GLY . 6.8 tpm_? -84.35 98.4 10.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.673 0.749 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.43 ' N ' ' HE ' ' A' ' 85' ' ' ARG . . . . . . . . 0 N--CA 1.438 -1.2 0 CA-C-O 117.87 -1.516 . . . . 0.0 110.181 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.479 0.633 0 N-CA-C 109.48 -1.008 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 15.8 m -126.56 153.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.395 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -84.2 124.6 31.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.572 HG23 ' HB3' ' A' ' 76' ' ' ALA . 2.7 pt -124.48 137.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.249 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 mttm -117.85 146.36 43.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.088 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.0 105.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.06 104.24 3.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.654 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 69.9 t -75.26 128.09 85.2 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.364 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.718 ' HG2' HD13 ' A' ' 19' ' ' LEU . 33.4 Cg_endo -64.87 150.81 87.6 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.152 1.901 . . . . 0.0 111.907 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.552 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 12.8 m120 -77.54 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.713 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.565 ' HE1' HD11 ' A' ' 19' ' ' LEU . 41.0 mtm -142.53 75.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.707 0.289 . . . . 0.0 110.251 174.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 7.4 mp0 -78.92 -44.22 23.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 110.134 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.53 -2.54 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.029 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -87.79 -6.92 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.423 -172.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 11' ' ' MET . 15.0 t -161.38 -179.91 7.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.07 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.72 3.0 41.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.548 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.548 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 6.0 m0 -85.94 171.91 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.756 ' HZ3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -87.9 26.83 1.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 0.0 110.886 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.718 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.9 mt -80.19 128.16 33.19 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.655 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.3 m-80 -140.78 9.13 2.17 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.063 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.552 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.23 7.99 72.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.265 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.655 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -80.8 175.86 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.54 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.96 124.19 67.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.73 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.45 HD13 ' HZ2' ' A' ' 18' ' ' LYS . 81.0 mt -87.62 136.07 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.73 107.51 19.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -122.55 166.2 15.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.717 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 m -126.8 122.02 33.58 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.853 0.359 . . . . 0.0 110.775 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 4' ' ' ILE . 68.9 mt -138.57 152.36 70.8 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.513 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 43.5 Cg_endo -69.86 152.1 68.69 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.215 1.943 . . . . 0.0 111.748 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.49 -11.97 19.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -73.97 -23.98 59.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -76.28 -172.95 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.276 0.56 . . . . 0.0 110.72 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.85 171.97 13.68 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.625 -171.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.614 HG12 HG13 ' A' ' 61' ' ' ILE . 26.1 t -63.05 -26.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.338 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.43 -31.83 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.75 -30.65 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.11 0.481 . . . . 0.0 110.247 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.3 mm -71.16 -51.99 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.2 ptmt -58.03 -43.72 86.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.68 -38.58 79.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.583 0.23 . . . . 0.0 111.004 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.9 ptmt -68.87 -35.29 76.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.498 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.75 -41.88 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 47' ' ' MET . 8.1 t-80 -56.71 -35.2 68.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.022 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.53 -20.86 21.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.44 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.55 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.756 HG22 ' HZ3' ' A' ' 18' ' ' LYS . 6.0 p -107.88 -42.94 4.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.047 0.451 . . . . 0.0 110.721 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.08 -8.42 10.52 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.012 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.527 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 17.5 ptm -90.32 119.95 69.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.134 0.492 . . . . 0.0 111.699 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.91 156.89 63.95 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.547 2.164 . . . . 0.0 112.266 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.69 -16.87 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.531 ' O ' ' HE2' ' A' ' 83' ' ' LYS . . . -52.4 -30.61 33.69 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.281 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -131.35 -6.0 3.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.441 . . . . 0.0 110.005 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.527 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.67 112.04 23.84 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.637 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.1 mmpt? -103.43 141.03 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.392 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.44 121.61 45.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.448 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.5 tt0 -113.64 115.77 28.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.8 t80 -101.81 107.53 18.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.225 0.536 . . . . 0.0 110.029 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 57.15 30.47 18.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.831 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.5 38.62 Favored Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.49 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.1 mt -118.74 116.02 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.0 m-85 -72.04 91.9 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.167 0.508 . . . . 0.0 110.114 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.614 HG13 HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -78.12 150.32 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.3 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HE3' HD22 ' A' ' 65' ' ' ASN . 0.6 OUTLIER -109.57 156.27 20.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.806 0.336 . . . . 0.0 110.827 177.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 5.7 p-10 -71.37 -2.93 18.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.996 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t -86.12 -5.34 59.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.748 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.433 HD22 ' HE3' ' A' ' 62' ' ' LYS . 95.7 m-20 -104.15 178.44 4.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.524 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 76.6 p -133.38 173.16 11.77 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.44 -33.46 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.231 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -56.47 -45.9 80.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -91.68 -0.62 57.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.744 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 m120 63.82 41.41 6.84 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.365 0.415 . . . . 0.0 110.888 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -64.27 93.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.316 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 177.98 4.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.918 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.623 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 36.0 t-20 -64.45 115.37 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.144 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.21 28.14 5.04 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.195 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.572 ' HB3' HG23 ' A' ' 4' ' ' ILE . . . -71.98 115.11 10.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.449 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG23 ' HD2' ' A' ' 5' ' ' LYS . 15.3 t -95.08 103.54 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.793 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.51 146.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -116.41 111.57 20.22 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -76.78 132.41 39.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.407 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 147.24 32.12 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.3 tp -78.15 135.39 37.64 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 17.8 ttpp -50.83 143.22 10.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.896 0.747 . . . . 0.0 111.506 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -46.43 127.68 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.798 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -56.25 -42.4 77.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.713 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.012 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.084 -179.509 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.518 ' HB2' HG23 ' A' ' 27' ' ' THR . 9.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.06 152.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.945 0.403 . . . . 0.0 110.298 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -88.73 114.99 25.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.244 0.545 . . . . 0.0 110.355 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 76' ' ' ALA . 2.1 pt -114.81 136.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.481 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HD2' HG22 ' A' ' 77' ' ' VAL . 13.5 mttm -118.63 147.33 43.86 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.122 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.43 105.27 14.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 104.52 2.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 25.9 t -76.53 126.84 85.64 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.798 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.787 ' HG2' HD13 ' A' ' 19' ' ' LEU . 27.5 Cg_endo -63.97 147.26 91.92 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.399 2.066 . . . . 0.0 111.875 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.667 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -73.85 88.5 1.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.771 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.539 ' HE1' HD11 ' A' ' 19' ' ' LEU . 49.1 mtm -138.53 75.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.12 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 3.8 mp0 -79.49 -44.87 20.42 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.311 -173.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -116.44 2.14 13.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.908 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -90.81 -4.87 56.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.493 -171.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' MET . 13.1 t -164.25 -174.21 3.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.887 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -99.02 -3.66 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.407 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.595 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.9 m0 -85.78 169.98 12.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.094 0.473 . . . . 0.0 111.176 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.664 ' HZ1' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -82.09 22.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.001 -178.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.787 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -77.52 133.32 38.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.611 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 21.1 m-80 -146.96 10.1 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.667 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 86.31 16.08 63.17 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.291 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.611 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -87.96 175.69 7.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.55 127.73 75.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.971 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.578 HD11 ' HZ3' ' A' ' 18' ' ' LYS . 85.7 mt -87.91 141.71 28.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.39 107.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.418 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 24.1 m-85 -121.01 164.83 16.15 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.518 HG23 ' HB2' ' A' ' 1' ' ' PRO . 4.9 m -126.44 122.26 34.78 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.218 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.467 HD11 HD12 ' A' ' 4' ' ' ILE . 78.6 mt -137.41 149.81 66.65 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.652 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 33.5 Cg_endo -66.27 152.2 81.61 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.273 1.982 . . . . 0.0 111.471 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HG ' ' HB1' ' A' ' 68' ' ' ALA . 21.7 tp -62.82 -8.07 6.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -80.11 -20.71 44.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -74.84 -176.2 2.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.138 0.494 . . . . 0.0 110.217 177.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.97 174.65 10.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.901 0.381 . . . . 0.0 111.563 -173.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG11 HG13 ' A' ' 61' ' ' ILE . 39.8 t -60.68 -30.33 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 m -51.69 -36.1 45.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.024 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -72.05 -32.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.641 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 23.9 mm -72.5 -51.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.452 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.583 ' HD3' ' OD2' ' A' ' 63' ' ' ASP . 3.3 ptmt -59.2 -42.56 91.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.498 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.3 p -69.83 -37.45 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.164 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 11.3 ptmt -69.31 -36.67 77.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.745 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.03 -41.35 81.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -58.73 -32.78 69.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.305 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 15.1 mm-40 -85.44 -30.89 23.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.902 0.382 . . . . 0.0 110.798 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.88 -46.62 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.956 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.664 HG22 ' HZ1' ' A' ' 18' ' ' LYS . 5.8 p -97.53 -40.56 8.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.477 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.11 -15.92 10.11 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.931 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.549 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.14 117.0 66.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.385 0.612 . . . . 0.0 111.464 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 22.1 Cg_endo -67.25 159.01 54.24 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.595 2.197 . . . . 0.0 111.882 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -65.4 -13.58 58.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.45 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -29.25 54.76 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.968 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -132.45 -2.63 3.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 0.0 110.63 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -95.24 117.65 30.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.114 0.483 . . . . 0.0 109.887 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.7 mmpt? -104.27 139.96 38.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -120.04 118.87 31.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.634 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -112.96 117.32 31.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 -175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.628 ' HB2' HD11 ' A' ' 78' ' ' ILE . 12.2 t80 -102.73 107.98 19.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.947 0.403 . . . . 0.0 110.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 57.18 30.57 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.355 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.58 23.73 25.43 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.064 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 mt -126.38 116.21 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -72.15 95.9 1.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.474 0.654 . . . . 0.0 110.29 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.537 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -80.28 150.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.567 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.97 162.54 18.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.583 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 5.5 t70 -54.06 -27.7 34.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.218 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.15 -1.94 16.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.789 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.462 HD21 ' HE2' ' A' ' 70' ' ' TYR . 77.4 m-20 -115.69 168.76 9.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.394 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 91.9 p -125.73 173.15 9.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.33 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.12 -42.86 79.57 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB1' ' HG ' ' A' ' 30' ' ' LEU . . . -60.51 -33.92 73.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.222 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.09 -44.87 91.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.19 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.462 ' HE2' HD21 ' A' ' 65' ' ' ASN . 27.9 m-85 -94.66 5.52 51.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.654 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 43.28 13.19 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 110.866 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.468 ' HE1' HD12 ' A' ' 61' ' ' ILE . 58.7 mtt -69.18 84.89 0.37 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.026 0.441 . . . . 0.0 110.76 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.48 -176.58 2.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.702 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -58.69 115.5 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.56 36.11 3.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.654 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -81.35 114.9 20.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.51 HG22 ' HD2' ' A' ' 5' ' ' LYS . 14.7 t -97.66 105.57 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.101 0.477 . . . . 0.0 110.94 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.628 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -95.53 148.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -118.24 117.04 28.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -84.55 133.97 34.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.61 151.8 35.64 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 51' ' ' LYS . 24.3 tp -81.87 143.45 31.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.78 -42.79 99.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.542 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -87.92 143.37 27.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -149.33 100.67 3.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.816 0.341 . . . . 0.0 111.14 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.828 -0.984 . . . . 0.0 111.625 176.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.441 ' HB2' HG23 ' A' ' 27' ' ' THR . 19.6 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.92 154.43 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -90.81 120.83 32.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.332 0.586 . . . . 0.0 109.851 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.594 HG21 ' HB2' ' A' ' 76' ' ' ALA . 9.5 pt -120.46 143.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.402 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' HD2' HG22 ' A' ' 77' ' ' VAL . 4.5 mttm -119.26 150.14 40.59 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.889 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.12 105.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -71.43 106.2 3.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.68 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 79.2 t -77.18 130.0 76.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.751 ' HG2' HD12 ' A' ' 19' ' ' LEU . 37.8 Cg_endo -65.82 156.56 63.55 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.636 2.224 . . . . 0.0 111.829 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.638 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 13.3 m120 -85.32 85.82 7.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.536 ' HE3' HD13 ' A' ' 19' ' ' LEU . 49.0 mtm -137.95 76.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.725 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.579 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -77.76 -48.03 17.6 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.657 0.742 . . . . 0.0 110.334 -171.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 10.9 10.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.311 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -90.66 -4.89 56.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.678 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -158.24 -172.94 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.796 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -101.17 -5.07 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.54 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.65 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.2 m0 -91.6 171.87 8.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.879 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HZ2' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -86.52 28.22 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 110.996 -178.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD12 ' HG2' ' A' ' 9' ' ' PRO . 15.5 mt -78.26 127.74 32.68 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.642 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -138.74 16.53 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.462 -0.774 . . . . 0.0 111.022 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.638 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.91 7.86 86.64 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.642 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -80.28 175.1 10.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.394 0.616 . . . . 0.0 110.61 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.401 HG21 ' HG2' ' A' ' 7' ' ' GLN . 49.3 t -120.6 123.01 69.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.603 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.564 HD13 ' HZ2' ' A' ' 18' ' ' LYS . 72.7 mt -87.59 142.11 28.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HG2' ' A' ' 5' ' ' LYS . 57.8 t -132.39 107.78 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.529 0.681 . . . . 0.0 109.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.45 164.28 13.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.825 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -126.79 118.7 25.19 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.99 174.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 4' ' ' ILE . 89.9 mt -134.9 152.66 77.77 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.851 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.11 150.08 82.23 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.389 2.059 . . . . 0.0 111.246 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -61.8 -10.59 9.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.538 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -79.09 -18.94 52.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.867 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.02 -175.44 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.44 177.32 8.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.145 0.498 . . . . 0.0 111.567 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 ' CG1' HG13 ' A' ' 61' ' ' ILE . 60.3 t -56.14 -33.07 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.742 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m -54.9 -30.76 59.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.22 -27.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 110.532 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.715 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.1 mm -72.4 -54.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 9.0 ptmt -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.13 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.889 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.59 -35.22 78.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.5 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.433 HD11 HD11 ' A' ' 54' ' ' LEU . 67.4 mt -72.65 -43.08 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.526 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -59.04 -33.4 70.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.536 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -89.24 -20.41 24.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.064 0.459 . . . . 0.0 110.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.75 -54.48 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.153 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.7 p -91.15 -43.01 10.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.3 7.23 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.929 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.4 118.07 70.63 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.395 0.617 . . . . 0.0 111.602 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.36 157.33 62.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.433 2.088 . . . . 0.0 111.9 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.04 -8.02 20.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.384 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.76 -28.9 66.33 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.281 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.6 -2.75 3.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 110.449 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.553 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.64 117.26 32.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 mmpt? -110.92 140.33 45.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.391 -176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -111.0 124.21 51.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.436 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.45 117.9 31.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.739 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' HB2' HD13 ' A' ' 78' ' ' ILE . 14.2 t80 -103.33 108.25 19.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.092 0.473 . . . . 0.0 110.073 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.59 30.95 16.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.031 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.59 45.08 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.203 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mt -120.57 113.04 38.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -73.49 92.96 1.93 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.607 0.717 . . . . 0.0 110.409 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.492 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -72.57 158.11 6.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.425 -174.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -130.48 163.65 26.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.322 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m-20 -50.58 -32.19 17.98 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.814 0.696 . . . . 0.0 112.236 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -82.45 2.42 32.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.103 0.477 . . . . 0.0 110.95 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -110.47 163.74 13.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.5 p -129.76 165.94 20.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.87 -44.04 97.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.767 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.14 82.74 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.368 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -59.34 -42.75 92.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -89.11 1.28 55.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.665 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.72 44.22 17.52 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.641 0.588 . . . . 0.0 110.864 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.9 mtt -67.24 89.45 0.2 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.06 -169.65 1.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.712 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -61.74 115.53 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.26 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.29 38.75 3.92 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.768 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.594 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -75.59 115.02 14.83 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.786 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.527 HG22 ' HD2' ' A' ' 5' ' ' LYS . 21.7 t -94.94 102.26 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.192 0.52 . . . . 0.0 110.946 -176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.618 HD13 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -93.9 146.41 6.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -114.78 113.97 24.96 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.69 133.32 35.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.39 146.07 30.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.156 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.4 tp -78.99 139.73 38.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -50.99 132.75 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.392 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -46.55 -57.74 4.46 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.984 0.802 . . . . 0.0 112.166 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -98.79 116.85 31.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.8 177.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.473 0.31 0 N-CA-C 109.974 -0.818 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.0 m -121.05 153.87 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -89.94 116.18 27.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.035 0.445 . . . . 0.0 110.266 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -118.28 138.52 48.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.752 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HD2' HG23 ' A' ' 77' ' ' VAL . 8.6 mttm -118.66 146.97 44.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.903 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -123.31 105.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.38 106.68 4.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.646 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.506 HG13 HD22 ' A' ' 19' ' ' LEU . 84.4 t -78.18 130.63 71.64 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.33 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.709 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.5 Cg_endo -66.09 150.0 85.47 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.37 2.047 . . . . 0.0 111.995 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.596 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.6 m120 -76.53 88.54 3.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.52 ' HE1' HD11 ' A' ' 19' ' ' LEU . 47.0 mtm -139.49 75.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.549 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.82 -45.1 19.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.77 0.795 . . . . 0.0 110.226 -175.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -0.6 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.682 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -92.48 -1.52 56.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.623 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 11' ' ' MET . 13.0 t -166.7 -177.5 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.321 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.69 -7.09 38.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.445 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.641 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -86.02 167.24 15.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.76 ' HZ3' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.17 29.09 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.229 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.709 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.9 mt -79.27 130.69 35.72 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.667 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 20.5 m-80 -143.41 11.84 1.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.849 -0.532 . . . . 0.0 110.826 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.596 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.86 2.43 78.42 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.758 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.667 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.4 pm0 -76.21 174.08 10.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.4 124.36 72.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.08 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.583 HD12 ' HZ2' ' A' ' 18' ' ' LYS . 86.3 mt -87.97 147.53 24.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -133.19 109.11 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 89.4 m-85 -115.93 159.47 21.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.214 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -126.78 112.96 15.99 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.02 0.438 . . . . 0.0 110.038 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.6 mt -133.47 149.68 72.96 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.819 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.69 151.36 85.43 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.354 2.036 . . . . 0.0 111.429 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 26.1 tp -63.17 -12.41 27.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.299 0.571 . . . . 0.0 110.567 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.0 p -80.72 -18.39 47.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.824 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.33 -173.27 2.01 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.153 0.502 . . . . 0.0 110.795 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.9 175.97 9.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 112.039 -173.041 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 26.1 t -64.95 -26.56 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.646 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 9.8 m -52.22 -33.88 43.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 t -73.54 -33.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 25.0 mm -70.23 -48.59 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.692 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.96 -39.34 89.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.69 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -74.15 -38.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.046 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.736 ' HB3' ' HZ3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.52 -36.23 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.971 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.435 ' CD1' HD13 ' A' ' 54' ' ' LEU . 78.8 mt -70.47 -42.69 78.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 110.571 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -57.87 -32.38 67.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.232 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.47 -25.17 22.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.03 0.443 . . . . 0.0 111.102 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.33 -47.86 11.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.605 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.76 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 3.1 p -98.77 -45.12 6.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.656 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.42 -20.49 5.54 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.878 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.689 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 16.1 ptm -77.97 119.94 79.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 0.0 111.615 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.6 Cg_endo -67.24 159.29 52.92 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 111.8 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.46 -11.38 51.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.542 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.5 -30.33 61.84 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.523 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -131.2 -0.98 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.988 0.423 . . . . 0.0 110.399 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.689 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -100.56 125.27 46.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -116.19 142.82 46.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.002 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.8 mm? -112.46 117.59 32.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.574 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.4 tt0 -107.04 113.93 27.69 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.008 0.433 . . . . 0.0 111.041 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.62 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.4 t80 -103.6 109.52 21.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.212 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 58.09 30.15 18.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.462 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.08 14.15 46.67 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.34 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 24.2 mt -117.23 118.62 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -75.04 90.36 2.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.194 0.521 . . . . 0.0 109.998 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -79.25 148.48 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.093 -174.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.66 162.69 13.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.977 176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.55 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.06 -21.73 66.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 -177.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -74.31 5.68 4.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.78 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.475 ' ND2' ' HE2' ' A' ' 70' ' ' TYR . 58.6 m-20 -111.03 166.81 10.74 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 52.8 p -126.15 165.34 19.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.88 -45.01 91.33 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.214 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.3 -33.67 73.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.213 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 66' ' ' SER . 77.9 t80 -57.44 -42.43 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.259 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 34.5 m-85 -98.85 8.17 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.268 177.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.8 OUTLIER 61.45 40.26 14.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.43 176.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -63.75 90.29 0.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.483 . . . . 0.0 111.443 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 178.34 6.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.248 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.32 115.36 2.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.27 29.59 4.76 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.038 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.05 114.3 15.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG23 ' HD2' ' A' ' 5' ' ' LYS . 27.5 t -95.1 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.543 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -94.31 145.69 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 11.3 m-70 -113.27 114.41 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.44 134.48 35.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.42 145.58 29.28 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.29 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 85' ' ' ARG . 33.1 tp -75.51 145.12 41.61 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 2.1 tppp? -44.62 -69.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.936 0.772 . . . . 0.0 109.991 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -142.31 122.88 14.14 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 170.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.548 ' HA ' HD21 ' A' ' 82' ' ' LEU . 19.5 ptp180 -65.95 -23.73 66.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.171 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.765 -1.019 . . . . 0.0 111.969 177.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.465 ' HB2' HG23 ' A' ' 27' ' ' THR . 31.4 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 18.3 m -124.76 154.29 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.0 110.326 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -87.19 114.44 23.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 110.084 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.571 HG22 ' HB1' ' A' ' 76' ' ' ALA . 1.4 pt -113.33 135.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 13.5 mttt -122.11 146.48 47.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.572 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -124.11 105.98 16.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.738 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.5 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -69.22 103.82 2.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG12 HD23 ' A' ' 19' ' ' LEU . 91.0 t -74.0 133.15 79.04 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.563 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.5 Cg_endo -66.48 147.48 82.46 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.766 1.644 . . . . 0.0 111.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.562 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -74.37 88.29 2.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.709 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.527 ' HE1' HD11 ' A' ' 19' ' ' LEU . 52.6 mtm -140.61 76.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.577 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.09 -46.42 18.09 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.448 0.642 . . . . 0.0 110.137 -171.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.64 6.91 9.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.517 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -80.6 -15.98 55.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 109.576 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 11' ' ' MET . 10.8 t -153.0 -178.78 7.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.991 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.31 -3.91 56.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.231 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.576 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -86.87 172.81 9.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HZ3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.32 29.72 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.872 -177.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.3 mt -81.05 130.14 34.88 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.577 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.6 m-80 -138.29 15.54 2.79 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.103 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.562 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.26 -0.95 88.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.377 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.551 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -73.18 177.56 5.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.323 0.583 . . . . 0.0 111.136 -177.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.53 124.65 73.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.567 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.661 HD22 ' HZ3' ' A' ' 18' ' ' LYS . 84.9 mt -86.91 142.67 27.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 110.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.047 0.451 . . . . 0.0 109.806 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -122.71 158.58 29.79 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.895 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -126.22 112.91 16.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.106 0.479 . . . . 0.0 109.938 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB2' HD11 ' A' ' 4' ' ' ILE . 85.3 mt -131.32 153.08 81.55 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.74 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.23 150.39 87.52 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.906 1.737 . . . . 0.0 111.277 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.7 tp -60.34 -12.21 8.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.725 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.2 p -78.83 -20.28 50.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.833 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' OD2' HG22 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -72.66 -176.25 1.91 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.258 0.552 . . . . 0.0 110.268 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.42 173.3 11.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.888 0.375 . . . . 0.0 111.684 -172.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 61' ' ' ILE . 40.8 t -61.96 -26.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.479 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -53.94 -32.77 54.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.181 176.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.7 t -78.22 -27.7 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.451 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.405 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 33.6 mm -73.04 -48.21 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.952 0.406 . . . . 0.0 110.553 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 7.2 ptmt -61.33 -39.66 91.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.456 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.4 p -72.61 -39.96 61.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.038 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -64.4 -39.23 93.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.802 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.4 mt -68.58 -43.29 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.739 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -57.74 -32.54 67.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.544 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 49.3 mt-10 -82.07 -38.18 25.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 110.141 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.09 -51.16 19.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.431 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.542 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 3.1 p -96.57 -43.07 7.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.0 110.303 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.3 -19.49 6.76 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.81 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.593 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 15.6 ptm -79.05 119.96 79.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.672 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.6 Cg_endo -68.28 156.43 65.74 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.566 2.177 . . . . 0.0 112.037 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -63.12 -15.99 58.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.66 -33.6 34.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.863 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.42 -3.91 4.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.554 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.593 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.72 121.41 38.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 110.009 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.788 ' HZ2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -113.06 144.05 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.02 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.431 ' HB3' HG23 ' A' ' 78' ' ' ILE . 1.3 mm? -112.83 120.04 40.09 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -108.05 110.33 22.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.101 0.477 . . . . 0.0 111.585 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.624 ' HB2' HD11 ' A' ' 78' ' ' ILE . 21.1 t80 -102.52 112.54 25.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.834 0.349 . . . . 0.0 110.136 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 16.2 mm-40 57.3 30.32 18.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.95 11.53 57.59 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.47 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 22.2 mt -113.97 119.08 60.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 6.7 m-30 -70.74 91.12 0.81 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.292 0.568 . . . . 0.0 109.905 174.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.657 HG13 HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -77.76 153.25 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.272 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -121.82 161.85 21.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.746 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.78 -2.55 17.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.292 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 m -84.22 -2.89 57.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.035 0.445 . . . . 0.0 110.386 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -119.3 175.11 5.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 80.7 p -129.78 170.38 13.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.172 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.65 -44.0 78.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.74 -37.03 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.318 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -58.82 -46.84 86.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.91 -4.23 58.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.752 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.4 41.23 4.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.504 0.503 . . . . 0.0 110.854 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtt -68.01 86.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.47 . . . . 0.0 111.408 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.46 -174.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.889 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.6 t-20 -65.71 115.3 5.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.71 29.16 4.79 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.439 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.571 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -72.67 114.44 10.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.97 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.38 150.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 7.6 m-70 -118.54 117.76 29.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.44 134.13 34.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.58 147.08 31.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.874 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.0 tp -84.87 127.25 34.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.579 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.82 -45.94 87.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.994 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.04 155.8 44.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.88 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -160.34 177.03 11.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.572 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.423 -1.209 . . . . 0.0 111.247 175.444 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.49 ' HB2' HG21 ' A' ' 27' ' ' THR . 7.7 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 12.3 m -123.39 151.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 110.296 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 109.02 20.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.71 0.767 . . . . 0.0 110.778 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.527 HG22 ' HB1' ' A' ' 76' ' ' ALA . 1.4 pt -107.38 143.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.414 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HG2' HG21 ' A' ' 25' ' ' VAL . 10.5 mtmm -126.89 152.03 47.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.656 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t -131.3 105.87 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.606 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 107.13 4.06 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.002 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 53.8 t -79.37 133.29 60.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.834 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HG2' HD13 ' A' ' 19' ' ' LEU . 57.5 Cg_endo -70.42 151.99 65.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.464 2.109 . . . . 0.0 112.091 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.523 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -78.88 100.95 7.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.542 ' HB3' HG21 ' A' ' 15' ' ' THR . 27.6 mtm -147.21 76.8 1.43 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.455 0.169 . . . . 0.0 110.598 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.2 -48.4 15.93 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.014 0.435 . . . . 0.0 110.912 -169.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -121.42 9.33 10.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.965 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -84.52 -5.5 59.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.542 HG21 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -162.15 -178.84 6.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.239 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.34 1.55 47.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.418 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -88.15 175.57 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.684 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -94.88 30.79 1.99 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.605 -177.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.555 HD13 ' HG2' ' A' ' 9' ' ' PRO . 22.0 mt -86.38 115.33 23.83 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.941 -0.475 . . . . 0.0 110.401 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.608 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 23.6 m-80 -130.32 21.65 5.21 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.555 -0.716 . . . . 0.0 110.863 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.523 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.55 1.63 87.58 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.046 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.608 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.6 pm0 -75.13 179.45 5.03 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 111.117 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.83 132.71 69.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.728 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 67.0 mt -87.51 144.26 26.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 5' ' ' LYS . 96.1 t -131.93 114.62 24.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 110.058 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 99.2 m-85 -128.85 160.16 33.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 1' ' ' PRO . 6.8 m -126.55 119.09 26.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.82 151.32 70.23 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.83 149.66 89.28 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.006 1.804 . . . . 0.0 111.192 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 tp -59.5 -14.16 11.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.66 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -76.67 -19.39 57.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.125 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.31 -174.06 2.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.421 0.629 . . . . 0.0 111.029 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.11 172.88 12.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 0.0 112.266 -172.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG11 HG13 ' A' ' 61' ' ' ILE . 45.0 t -60.83 -26.42 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.623 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.29 -33.32 52.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.049 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -76.96 -29.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.446 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 21.4 mm -73.0 -45.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.573 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.69 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.4 ptmt -62.68 -42.94 99.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.48 -37.48 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.651 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.56 -35.34 80.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.578 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.88 -42.26 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -59.54 -35.87 75.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.355 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -83.85 -31.35 25.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.819 0.342 . . . . 0.0 111.463 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.47 -38.41 26.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.8 p -106.15 -47.91 3.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.043 0.449 . . . . 0.0 110.628 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.87 -6.55 10.33 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.115 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.512 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 22.0 ptm -87.19 115.7 63.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.406 0.622 . . . . 0.0 110.978 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.4 157.56 61.29 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.626 2.217 . . . . 0.0 112.127 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.75 -17.15 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.209 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.55 -31.15 52.01 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.859 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.504 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.84 -5.37 4.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.49 . . . . 0.0 110.535 -178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.69 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -87.52 113.48 23.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mmpt? -104.94 138.72 40.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.7 mt -118.88 122.4 42.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.975 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -112.3 120.27 41.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.191 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.607 ' HB2' HD13 ' A' ' 78' ' ' ILE . 17.6 t80 -108.84 110.32 21.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.42 30.79 20.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.05 49.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.16 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 mt -121.94 113.58 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -74.63 95.27 2.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.752 0.787 . . . . 0.0 110.287 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.566 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.73 168.9 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.098 -176.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.46 166.04 21.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.365 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.36 -2.78 20.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.898 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.6 t -94.32 13.23 24.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.191 0.519 . . . . 0.0 110.237 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.64 165.69 16.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 71.6 m -126.15 166.38 17.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.02 -46.53 84.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.767 0.318 . . . . 0.0 110.397 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.99 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.455 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 66' ' ' SER . 56.7 t80 -62.81 -40.99 99.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -97.86 5.17 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.28 46.55 23.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.332 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 mtt -66.05 82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 110.806 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 171.79 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.551 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 48.0 t-20 -55.36 115.95 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.73 27.38 4.66 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.058 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -78.11 115.06 17.56 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.57 104.33 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 56' ' ' TYR . 6.3 mm -94.27 150.62 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -116.78 119.71 36.28 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.75 134.27 33.96 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.715 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.9 142.66 27.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.933 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 85' ' ' ARG . 40.2 tp -81.5 130.21 34.96 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.142 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.3 -55.58 31.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.058 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -174.05 151.12 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.735 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB2' HD21 ' A' ' 82' ' ' LEU . 34.8 ttt180 -121.69 100.1 6.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.472 -177.209 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.535 ' HB2' HG23 ' A' ' 27' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.476 0.499 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.15 152.03 24.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.933 0.397 . . . . 0.0 110.389 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -89.02 114.19 25.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.058 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 28' ' ' LEU . 1.3 pt -117.64 138.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.696 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -121.53 145.14 48.26 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.233 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.04 105.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.427 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.48 104.61 2.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.567 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 95.8 t -75.75 127.32 85.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.425 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.813 ' HG2' HD11 ' A' ' 19' ' ' LEU . 26.1 Cg_endo -61.92 151.13 83.14 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.515 2.143 . . . . 0.0 112.2 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.676 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -79.71 83.22 5.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.78 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.583 ' HE1' HD12 ' A' ' 19' ' ' LEU . 55.4 mtm -135.81 75.57 1.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.594 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -77.22 -45.8 25.32 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.363 0.601 . . . . 0.0 110.229 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.96 8.86 10.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.984 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -90.39 -4.81 56.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.046 -173.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.4 t -161.2 -172.71 3.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.942 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.3 4.67 36.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.57 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -96.44 171.65 8.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.81 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.717 ' HZ3' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -84.58 27.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 110.944 -178.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD11 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -78.85 129.63 34.78 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.615 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.5 m-80 -142.27 15.67 2.04 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.935 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.676 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.03 5.03 90.42 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.919 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.615 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.04 179.38 6.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.34 136.59 60.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.184 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.91 142.76 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.28 109.9 19.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -123.19 163.66 20.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.581 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 1' ' ' PRO . 7.2 m -127.06 117.34 22.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 110.236 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 4' ' ' ILE . 89.9 mt -134.33 149.76 72.11 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.617 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.9 151.8 81.57 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.167 1.912 . . . . 0.0 111.256 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 72' ' ' MET . 29.7 tp -61.89 -10.18 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -80.19 -19.05 47.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.848 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.58 -173.05 2.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.69 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.67 175.4 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.485 -173.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 61' ' ' ILE . 42.3 t -60.0 -28.49 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.527 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -51.28 -31.61 21.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.86 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.89 -33.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 0.0 110.408 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 19.4 mm -72.12 -49.61 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.572 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.583 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 8.4 ptmt -60.01 -40.67 90.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 p -72.05 -38.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.756 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -66.87 -36.12 81.59 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.843 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.77 -41.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.499 . . . . 0.0 110.202 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 20.1 t-80 -58.3 -32.12 68.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.45 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 8.7 mm-40 -87.81 -30.29 20.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.118 0.485 . . . . 0.0 110.724 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.75 -46.39 14.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.784 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.717 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 7.1 p -98.23 -43.4 7.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.348 . . . . 0.0 110.721 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.21 -2.33 18.93 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.401 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 17.5 ptm -92.0 118.04 68.02 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.353 0.597 . . . . 0.0 111.281 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.41 155.88 67.61 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.434 2.089 . . . . 0.0 112.119 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -62.66 -16.88 59.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.668 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.52 -29.67 40.14 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.292 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.87 -1.82 4.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.237 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.75 113.37 24.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.557 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -105.22 139.15 40.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.095 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.64 121.3 41.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 109.889 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.3 tt0 -113.46 113.99 25.93 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.333 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.1 t80 -103.05 110.89 22.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.933 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 57.39 29.78 17.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.432 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.23 7.34 57.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.524 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.3 mt -112.34 119.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -72.52 91.8 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.141 0.496 . . . . 0.0 110.196 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -77.3 154.25 5.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.608 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 28.9 pttt -123.16 162.08 23.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.448 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.583 ' OD1' ' HD3' ' A' ' 38' ' ' LYS . 6.5 t70 -54.48 -30.35 52.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.806 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.454 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 16.0 m -69.47 -13.88 62.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.919 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -105.43 177.91 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 110.657 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 78.5 p -134.59 171.12 14.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.408 -175.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.7 -44.03 78.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.937 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.82 70.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.493 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -62.37 -45.29 93.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -89.19 1.6 55.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.79 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 m120 64.56 31.27 12.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.416 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.435 ' O ' HD12 ' A' ' 30' ' ' LEU . 58.5 mtt -59.72 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.214 0.531 . . . . 0.0 112.113 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 -172.08 3.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -64.4 116.19 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.905 0.383 . . . . 0.0 110.664 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.08 19.23 7.76 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.552 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 114.45 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.136 0.468 . . . . 0.0 110.102 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.12 104.85 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.0 mm -94.36 148.01 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -115.09 115.42 26.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.04 131.51 35.79 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.01 32.99 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.127 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 51' ' ' LYS . 31.7 tp -83.56 138.01 33.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -51.11 -53.48 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.036 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -179.94 140.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.939 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.58 128.27 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.14 0.495 . . . . 0.0 110.788 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.813 -0.993 . . . . 0.0 111.155 174.557 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.514 ' HB2' HG23 ' A' ' 27' ' ' THR . 2.2 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.09 155.41 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.685 0.279 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -87.91 117.01 26.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.138 0.494 . . . . 0.0 110.234 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 28' ' ' LEU . 3.3 pt -124.01 142.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.999 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -123.99 146.84 48.24 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.566 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.37 105.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 104.17 3.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.9 t -75.89 126.71 86.67 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.316 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.81 ' HG2' HD11 ' A' ' 19' ' ' LEU . 38.4 Cg_endo -65.74 147.5 85.76 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.3 2.0 . . . . 0.0 112.114 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.566 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -72.61 90.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.518 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.558 ' HB3' HG23 ' A' ' 15' ' ' THR . 42.3 mtm -141.43 76.56 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.871 0.367 . . . . 0.0 110.367 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.92 -45.54 20.31 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.57 0.7 . . . . 0.0 110.201 -172.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -120.51 7.79 10.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.161 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -94.81 3.53 54.9 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.807 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -168.28 -174.45 2.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.452 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.29 3.65 27.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.289 -171.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.717 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.4 m0 -102.28 170.64 7.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.757 ' HZ1' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -78.84 26.82 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.629 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.81 HD11 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -78.5 126.45 30.78 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.0 m-80 -140.99 15.74 2.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 110.667 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.566 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.53 1.0 89.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.196 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.589 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 1.1 pm0 -75.66 173.66 10.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 110.779 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.04 124.67 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.878 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.55 134.35 33.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -121.43 107.36 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -122.0 162.24 21.49 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.543 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 1' ' ' PRO . 3.4 m -125.77 116.78 22.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.996 0.426 . . . . 0.0 110.44 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.645 ' HB2' HD12 ' A' ' 4' ' ' ILE . 81.0 mt -133.68 151.31 76.87 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.035 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.04 147.96 80.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.292 1.995 . . . . 0.0 111.687 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.05 -10.66 10.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 110.601 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.9 p -81.98 -15.0 55.22 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.725 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.5 -173.39 4.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.115 0.483 . . . . 0.0 110.573 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.56 173.59 11.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.889 0.376 . . . . 0.0 111.666 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.675 HG13 HG13 ' A' ' 61' ' ' ILE . 41.8 t -61.43 -27.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.012 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -53.11 -33.28 51.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.399 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.63 -34.01 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.222 0.534 . . . . 0.0 110.264 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.582 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.0 mm -70.48 -52.07 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.859 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.2 ptmt -58.19 -42.71 86.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.518 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 11.1 p -71.32 -38.98 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.678 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.2 ptmt -66.07 -35.26 80.04 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.39 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.2 mt -72.71 -41.13 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 110.196 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.478 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 23.5 t-80 -58.04 -32.4 67.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.339 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 56.8 mm-40 -85.94 -34.52 20.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.992 0.425 . . . . 0.0 110.047 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.06 -46.53 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.637 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.757 HG21 ' HZ1' ' A' ' 18' ' ' LYS . 6.9 p -97.78 -43.6 7.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.067 0.46 . . . . 0.0 110.626 -176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 -7.19 11.24 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.131 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.561 ' HE3' ' HB2' ' A' ' 52' ' ' GLN . 13.2 ptm -89.7 119.64 69.48 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 111.827 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.2 Cg_endo -67.65 157.41 61.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.541 2.161 . . . . 0.0 112.057 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -65.99 -12.07 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.597 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.5 -33.76 62.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.647 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.548 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -126.54 -5.12 6.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.337 0.589 . . . . 0.0 109.979 -177.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB2' ' HE3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -99.83 113.55 26.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 12.0 mmpt? -107.66 135.3 49.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.544 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.38 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.09 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 tt0 -108.5 116.52 32.12 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.582 ' HB2' HD12 ' A' ' 78' ' ' ILE . 7.5 t80 -101.04 102.83 13.9 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.457 0.646 . . . . 0.0 109.685 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 6.4 mm-40 57.42 31.01 19.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.076 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.49 23.59 Favored Glycine 0 CA--C 1.511 -0.167 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.829 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.99 112.06 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 55' ' ' GLN . 5.0 m-85 -72.0 95.4 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.59 0.71 . . . . 0.0 110.002 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.675 HG13 HG13 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.2 162.12 3.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.27 -178.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HE2' HD22 ' A' ' 65' ' ' ASN . 0.0 OUTLIER -135.46 165.17 26.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -72.73 -4.85 33.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.622 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -79.97 -7.7 58.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 109.905 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.404 HD22 ' HE2' ' A' ' 62' ' ' LYS . 86.0 m-20 -114.82 178.91 4.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.303 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 53.5 p -136.93 173.43 11.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.336 -175.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.16 -45.08 70.93 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.26 72.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.259 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 66' ' ' SER . 46.2 t80 -56.74 -46.19 81.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.657 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -90.62 1.11 57.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.9 OUTLIER 58.98 42.25 19.64 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.557 0.536 . . . . 0.0 110.395 -178.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.6 mtt -65.27 88.14 0.08 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.9 -178.07 5.28 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.85 116.28 3.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.287 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.75 29.3 5.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.364 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -79.11 114.67 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.91 106.35 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.14 0.495 . . . . 0.0 110.58 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.582 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.2 mm -94.46 145.47 7.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -116.25 111.69 20.52 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.56 132.37 35.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 144.11 30.56 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.479 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 51' ' ' LYS . 32.1 tp -76.6 137.5 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -46.2 -47.1 17.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.978 0.799 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -157.81 111.22 2.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -98.95 -34.13 10.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 CA-C-O 118.847 -0.974 . . . . 0.0 111.736 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 Cg_endo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 110.258 -0.708 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.73 154.9 37.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 m -86.77 125.15 33.74 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.598 HG23 ' HB3' ' A' ' 76' ' ' ALA . 12.9 pt -128.71 145.37 35.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.968 0.413 . . . . 0.0 111.045 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -126.5 146.53 50.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.2 t -123.18 105.79 16.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.615 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.53 103.86 3.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG13 HD22 ' A' ' 19' ' ' LEU . 94.3 t -77.03 131.68 72.43 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.843 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.614 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.9 Cg_endo -66.16 155.76 68.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.567 2.178 . . . . 0.0 111.851 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.723 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -84.66 84.16 7.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.587 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 15' ' ' THR . 47.8 mtm -133.44 75.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.9 mp0 -78.43 -46.3 20.15 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 110.383 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 0.63 10.32 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.046 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' HE2' ' OE1' ' A' ' 12' ' ' GLN . 20.6 mmtt -86.14 0.98 52.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.369 0.605 . . . . 0.0 109.63 -173.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.508 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -160.38 -173.53 4.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.45 -5.8 24.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 111.508 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.508 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.1 m0 -85.37 173.87 9.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.567 ' HZ3' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -90.4 29.38 1.28 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.359 -176.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.0 mt -81.53 124.97 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.552 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 4.8 m-80 -132.33 19.6 4.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.899 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.723 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.66 12.96 83.44 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.302 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -83.22 179.12 7.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.137 0.494 . . . . 0.0 110.754 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.97 126.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.567 HD21 ' HZ3' ' A' ' 18' ' ' LYS . 72.5 mt -87.3 139.49 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.16 109.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -124.2 166.02 16.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.394 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 1' ' ' PRO . 9.9 m -126.87 121.98 33.36 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.099 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.437 HD13 HD11 ' A' ' 4' ' ' ILE . 77.4 mt -136.15 149.28 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.774 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.4 Cg_endo -65.25 150.13 87.8 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.182 1.921 . . . . 0.0 110.947 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HG ' ' HB1' ' A' ' 68' ' ' ALA . 20.0 tp -62.33 -8.82 6.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.652 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -82.52 -18.85 40.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.9 -175.26 2.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 110.063 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.93 174.68 10.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.93 0.395 . . . . 0.0 111.546 -174.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG11 HG13 ' A' ' 61' ' ' ILE . 35.0 t -62.87 -25.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.632 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 1.6 t -53.13 -33.81 54.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.66 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -72.43 -33.36 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.155 0.502 . . . . 0.0 110.553 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -70.54 -47.16 66.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.4 ptmt -63.15 -41.89 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.273 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -68.85 -39.38 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.695 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.45 ' HZ2' ' HB3' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.42 -39.74 85.5 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.199 -177.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.73 -40.51 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 110.421 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -61.1 -32.8 72.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.566 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.55 -30.23 18.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.586 0.231 . . . . 0.0 111.133 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.11 -39.02 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.595 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 9.3 p -105.69 -45.28 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.548 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.65 -11.81 8.9 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.286 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.567 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 23.4 ptm -84.21 117.76 69.51 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.349 0.595 . . . . 0.0 111.116 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.437 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 29.3 Cg_endo -68.94 157.1 63.21 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.579 2.186 . . . . 0.0 112.161 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -63.71 -15.55 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.69 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.71 -30.03 50.79 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.981 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.59 -0.41 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.117 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.13 113.86 25.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 178.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.3 mmpt? -106.73 141.84 37.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 mm? -114.42 118.19 33.13 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -107.2 115.14 29.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.413 . . . . 0.0 110.668 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.5 t80 -103.91 111.38 23.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 57.88 29.74 18.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.191 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.41 24.52 26.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.071 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.78 110.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -71.69 94.92 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.761 0.791 . . . . 0.0 110.648 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.566 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -80.73 154.61 4.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.159 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.49 162.73 13.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -70.89 -15.71 62.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 111.335 -174.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 m -78.24 7.22 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.801 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 80.9 m-20 -109.99 166.66 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 87.3 p -123.75 164.5 19.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.15 -43.24 92.46 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.192 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB1' ' HG ' ' A' ' 30' ' ' LEU . . . -60.34 -38.03 82.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.231 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -55.66 -43.64 76.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.233 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.99 5.06 53.0 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.709 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.43 46.98 14.36 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.376 0.423 . . . . 0.0 111.399 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.24 84.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 110.775 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.31 -176.64 1.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.074 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -61.37 116.51 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.309 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.41 33.64 4.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.962 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.598 ' HB3' HG23 ' A' ' 4' ' ' ILE . . . -74.32 114.63 12.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.043 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.58 103.45 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.116 0.484 . . . . 0.0 110.58 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.37 143.39 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -113.19 113.05 24.8 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.11 132.19 36.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.59 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.96 143.96 26.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.628 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -82.34 136.88 34.92 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.078 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -62.03 -32.69 73.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.528 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.807 ' HG3' ' H ' ' A' ' 85' ' ' ARG . 9.7 tp10 -149.42 -153.09 0.47 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.807 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.41 -63.09 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.039 -1.423 . . . . 0.0 111.244 175.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.506 ' HB2' HG21 ' A' ' 27' ' ' THR . 37.0 Cg_endo . . . . . 0 N--CA 1.478 0.577 0 N-CA-C 109.839 -0.869 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 25.8 m -126.27 156.7 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.707 0.289 . . . . 0.0 110.354 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -86.63 121.33 29.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.029 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' A' ' 76' ' ' ALA . 2.2 pt -122.5 137.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.568 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HD3' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -120.25 151.96 38.43 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.474 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.04 106.21 15.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.492 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' HG2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.52 106.73 3.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.461 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 19' ' ' LEU . 59.0 t -77.35 127.62 82.54 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.751 ' HG2' HD11 ' A' ' 19' ' ' LEU . 31.9 Cg_endo -64.31 148.59 90.98 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.122 1.882 . . . . 0.0 112.081 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.555 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -74.83 93.85 2.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.775 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.579 ' HB3' HG23 ' A' ' 15' ' ' THR . 35.9 mtm -146.45 75.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.584 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -78.53 -49.01 14.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.384 0.611 . . . . 0.0 110.543 -169.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.4 17.49 9.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.19 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -91.33 -7.91 49.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 11' ' ' MET . 15.4 t -158.76 -172.5 3.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.685 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.55 -0.44 25.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.913 0.387 . . . . 0.0 111.58 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.664 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.8 m0 -85.95 168.66 13.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.63 ' HZ1' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -84.93 31.64 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.427 0.632 . . . . 0.0 111.045 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' A' ' 9' ' ' PRO . 13.5 mt -84.77 112.98 20.99 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.814 -0.554 . . . . 0.0 110.096 -175.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.62 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -126.46 16.26 7.65 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.33 -0.856 . . . . 0.0 111.209 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.555 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.24 5.96 86.76 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -79.6 175.18 10.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.651 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 7' ' ' GLN . 43.9 t -124.84 124.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.099 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.92 142.54 27.72 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.47 111.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.152 0.501 . . . . 0.0 110.261 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.44 166.25 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.5 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.506 HG21 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -125.99 116.86 22.11 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.314 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.506 ' HB2' HD12 ' A' ' 4' ' ' ILE . 82.3 mt -131.98 153.74 81.48 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.679 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.9 Cg_endo -64.85 149.32 89.75 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.274 1.983 . . . . 0.0 111.533 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -62.67 -12.05 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.726 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -80.93 -16.24 54.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.512 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.93 -174.87 2.35 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.23 173.4 11.98 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.56 HG11 HG13 ' A' ' 61' ' ' ILE . 39.9 t -62.47 -25.14 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.598 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.33 -34.34 57.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.246 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.52 -30.29 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.533 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.418 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 26.1 mm -72.31 -47.57 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.831 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 4.1 ptmt -61.92 -40.12 94.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -71.12 -39.7 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.013 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.49 -38.44 89.75 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.92 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.506 ' CD1' HD12 ' A' ' 54' ' ' LEU . 79.4 mt -71.59 -42.16 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 0.0 110.552 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' MET . 32.7 t60 -57.64 -32.77 67.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.434 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.45 -29.21 18.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.804 0.335 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.8 -31.1 28.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.053 -175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.63 HG22 ' HZ1' ' A' ' 18' ' ' LYS . 6.8 p -112.18 -43.4 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.468 . . . . 0.0 110.548 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.97 -7.06 10.93 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.597 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 15.6 ptm -89.97 119.24 69.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.347 0.594 . . . . 0.0 111.586 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 25.9 Cg_endo -67.81 161.36 44.26 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 111.86 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.56 -10.67 57.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -176.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -28.69 62.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.69 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.83 -3.05 3.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 110.329 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.597 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.12 122.19 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.3 mmpt? -114.0 142.56 46.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.506 HD12 ' CD1' ' A' ' 41' ' ' ILE . 1.8 mm? -111.49 119.38 38.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.582 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.1 tt0 -108.55 112.66 25.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.936 0.398 . . . . 0.0 111.026 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.598 ' HB2' HD11 ' A' ' 78' ' ' ILE . 11.0 t80 -103.23 109.97 21.76 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 57.34 30.18 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.549 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.93 17.16 38.84 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.35 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 17.6 mt -120.65 116.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 16.2 m-85 -72.75 91.38 1.47 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 110.096 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.56 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.67 157.04 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 -175.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HE3' HD22 ' A' ' 65' ' ' ASN . 3.1 pttp -121.44 160.22 24.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.758 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.14 -8.3 52.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 -174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 m -85.24 -1.58 57.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 0.0 110.261 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.409 HD22 ' HE3' ' A' ' 62' ' ' LYS . 94.2 m-20 -109.6 170.67 7.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.449 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.0 p -126.33 170.94 11.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.88 -43.65 82.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.18 -35.27 73.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.298 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.14 -46.58 85.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.91 5.58 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.503 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 m120 59.37 43.36 16.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -67.16 92.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.93 -176.46 2.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.755 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.525 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.5 t30 -66.08 115.39 6.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.14 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.69 28.68 5.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.358 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -73.18 114.76 11.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.039 0.447 . . . . 0.0 110.188 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.431 HG22 ' HD3' ' A' ' 5' ' ' LYS . 38.9 t -95.68 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.696 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.89 148.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.36 118.37 32.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -80.43 133.67 35.9 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.48 146.43 31.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.558 HD23 ' HG2' ' A' ' 85' ' ' ARG . 26.6 tp -79.76 138.48 37.29 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -50.62 -54.52 22.14 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.525 0.515 . . . . 0.0 110.217 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -173.05 138.17 0.74 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.894 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.558 ' HG2' HD23 ' A' ' 82' ' ' LEU . 49.5 mtp180 -83.96 -49.61 8.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.078 0.466 . . . . 0.0 110.523 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 CA-C-O 118.733 -1.037 . . . . 0.0 111.416 -177.34 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 110.187 -0.736 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 28' ' ' LEU . 18.6 m -125.94 155.77 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.267 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -90.72 109.84 21.03 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.444 0.64 . . . . 0.0 110.71 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.573 HG23 ' HB1' ' A' ' 76' ' ' ALA . 2.8 pt -111.26 147.56 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.591 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HZ2' ' HA2' ' A' ' 75' ' ' GLY . 10.1 mtmm -130.47 150.43 51.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.801 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -127.08 105.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.96 108.64 4.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.598 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG12 HD23 ' A' ' 19' ' ' LEU . 86.0 t -80.46 129.02 70.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.31 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.715 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.3 Cg_endo -65.71 150.52 86.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.375 2.05 . . . . 0.0 111.912 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.66 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -76.76 91.63 3.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.761 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.534 ' HE1' HD11 ' A' ' 19' ' ' LEU . 46.1 mtm -141.95 74.48 1.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.762 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.557 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -44.66 17.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.819 0.819 . . . . 0.0 110.163 -176.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.9 -12.63 14.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.781 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 39.2 mmtt -75.33 -20.34 59.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.757 -172.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -152.24 -174.47 4.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.41 -175.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.06 -2.04 28.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.351 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.536 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -85.4 174.21 9.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.278 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -88.82 30.46 0.92 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.34 0.591 . . . . 0.0 111.453 -176.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 9' ' ' PRO . 11.3 mt -85.02 124.52 31.81 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.679 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.3 m-80 -136.19 17.7 3.2 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.857 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.66 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.2 11.11 82.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.915 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.679 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -82.36 -179.77 7.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.903 0.383 . . . . 0.0 110.301 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.91 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.494 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 85.0 mt -89.86 143.4 26.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.088 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 5' ' ' LYS . 48.5 t -127.99 111.16 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -126.04 162.65 24.81 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -125.97 115.68 20.28 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.249 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' O ' HG21 ' A' ' 2' ' ' VAL . 86.9 mt -134.73 150.9 74.73 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.88 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.54 152.22 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.459 2.106 . . . . 0.0 111.707 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.0 tp -63.99 -9.06 13.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -80.69 -21.42 41.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.82 -174.79 2.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.293 0.568 . . . . 0.0 110.373 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.74 175.79 10.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.017 0.437 . . . . 0.0 111.495 -174.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 61' ' ' ILE . 46.0 t -59.74 -27.03 36.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.237 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.5 m -54.63 -34.16 61.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.1 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -74.62 -28.45 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.946 0.403 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 31.7 mm -72.87 -52.64 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 8.5 ptmt -57.78 -43.14 85.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.663 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.93 -37.87 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.719 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.7 -35.52 78.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.894 -177.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.84 -42.48 77.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.53 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -57.57 -32.85 67.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.088 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.4 -20.76 23.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.93 0.395 . . . . 0.0 111.271 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.94 -37.22 13.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.447 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 5.2 p -108.57 -46.11 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.192 0.52 . . . . 0.0 110.318 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.49 -17.45 5.84 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.596 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 16.6 ptm -81.13 117.49 68.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.454 0.645 . . . . 0.0 111.35 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.4 Cg_endo -67.29 159.76 50.77 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 111.948 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.75 -6.71 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.948 0.404 . . . . 0.0 111.87 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.37 -27.05 67.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.501 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -133.54 -3.48 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.102 0.477 . . . . 0.0 110.409 -177.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.596 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.58 116.99 32.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.674 -177.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.0 mmpt? -104.68 141.34 36.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.62 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.19 122.13 45.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -112.11 117.84 33.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.102 0.477 . . . . 0.0 111.448 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HB2' HD12 ' A' ' 78' ' ' ILE . 25.6 t80 -106.79 112.06 24.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.117 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 8.3 mm-40 57.54 29.82 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.308 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.39 10.23 57.18 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.381 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.01 116.58 52.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -76.85 93.34 3.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.676 0.75 . . . . 0.0 110.071 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.427 HG13 HG13 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.18 165.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.283 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -139.1 171.93 13.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.439 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.39 -5.45 36.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.7 p -81.37 -4.11 54.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -113.5 172.81 6.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.67 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' A' ' 33' ' ' GLN . 71.1 p -132.87 167.75 19.64 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.27 -45.11 89.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.33 75.49 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -57.37 -44.48 84.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.036 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.42 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 47.4 m-85 -89.46 -0.2 57.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.582 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 42.15 14.73 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.461 0.475 . . . . 0.0 110.619 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 mtt -65.09 85.4 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.988 0.423 . . . . 0.0 110.907 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.29 -174.21 3.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -58.81 116.32 3.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.167 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.558 ' HA2' ' HZ2' ' A' ' 5' ' ' LYS . . . 102.85 36.5 3.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.369 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' HG23 ' A' ' 4' ' ' ILE . . . -83.11 114.76 21.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.38 103.69 15.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.788 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.6 mm -94.26 151.01 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.28 119.34 35.4 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -85.31 134.05 34.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.8 149.21 35.06 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.035 0.445 . . . . 0.0 110.527 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 51' ' ' LYS . 35.9 tp -84.58 153.05 23.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 1.1 tppp? -50.38 -41.66 52.21 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.401 0.438 . . . . 0.0 111.07 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -128.26 137.57 52.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -154.94 -58.04 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.035 -176.049 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 N-CA-C 109.692 -0.926 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 17.3 m -125.67 154.58 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.362 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -86.26 123.94 32.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 28' ' ' LEU . 1.4 pt -126.73 138.05 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 110.984 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' HD2' HG22 ' A' ' 77' ' ' VAL . 12.5 mttm -120.15 147.73 44.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.311 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 59.5 t -123.75 105.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.493 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -73.98 103.06 4.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.862 -178.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.476 HG12 HD22 ' A' ' 19' ' ' LEU . 59.0 t -73.97 131.83 80.84 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.617 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.677 ' HG2' HD13 ' A' ' 19' ' ' LEU . 44.0 Cg_endo -68.25 153.23 74.95 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.145 1.897 . . . . 0.0 111.794 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.573 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.5 m120 -80.22 93.71 5.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.541 ' HE2' HD11 ' A' ' 19' ' ' LEU . 46.2 mtm -142.77 75.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.787 0.327 . . . . 0.0 110.286 174.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -79.52 -45.12 19.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.555 0.693 . . . . 0.0 110.71 -173.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -118.06 15.46 14.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.726 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -102.59 -3.39 26.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.485 HG22 ' HB3' ' A' ' 11' ' ' MET . 11.4 t -164.24 -171.68 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.592 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.74 4.04 37.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.452 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.606 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.5 m0 -94.84 173.77 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.078 0.466 . . . . 0.0 110.858 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.768 ' HZ1' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.22 29.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.883 -177.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.677 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.6 mt -81.44 119.22 23.44 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.95 -0.469 . . . . 0.0 109.928 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.64 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 10.6 m-80 -131.7 15.81 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.573 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 83.75 2.63 89.78 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.809 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.64 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -76.44 178.05 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 7' ' ' GLN . 48.5 t -121.69 126.64 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.1 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.598 HD12 ' HZ3' ' A' ' 18' ' ' LYS . 86.9 mt -87.35 142.8 27.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.9 t -131.17 108.65 15.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.55 161.37 19.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.03 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -127.1 113.94 17.08 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.031 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.553 ' HB2' HD12 ' A' ' 4' ' ' ILE . 87.6 mt -131.2 153.91 81.83 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.806 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.3 150.42 87.32 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.177 1.918 . . . . 0.0 111.226 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -62.88 -13.56 35.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -78.89 -15.22 58.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.425 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.95 -174.42 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -146.31 172.63 13.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -170.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 30.8 t -59.01 -28.28 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.44 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 2.7 t -54.27 -31.44 53.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.829 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.52 -29.66 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.8 mm -72.3 -51.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.451 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.4 ptmt -57.75 -43.75 85.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.601 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.78 -38.94 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.068 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.24 -35.47 77.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.531 -177.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -70.59 -43.44 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 110.297 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.03 -32.9 68.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.363 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.66 -22.92 22.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.039 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.87 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.653 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.768 HG21 ' HZ1' ' A' ' 18' ' ' LYS . 4.5 p -101.41 -44.74 5.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.839 0.352 . . . . 0.0 110.734 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.3 -6.39 10.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.102 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.601 ' HE3' ' HB2' ' A' ' 52' ' ' GLN . 18.3 ptm -91.16 120.02 68.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.316 0.579 . . . . 0.0 111.508 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.4 Cg_endo -68.72 157.57 61.32 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.467 2.111 . . . . 0.0 112.24 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.74 -8.67 15.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.761 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . -59.27 -29.69 66.35 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.445 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 1.008 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -129.47 -10.12 4.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.356 -177.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HB2' ' HE3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -90.58 113.77 25.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.961 -179.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.5 mmpt? -102.57 142.12 34.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.51 130.19 56.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -121.76 120.81 35.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 78' ' ' ILE . 13.8 t80 -103.5 107.45 18.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.389 . . . . 0.0 110.592 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 55.59 30.49 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.735 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.62 19.17 30.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.186 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -123.65 109.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -72.0 95.03 1.54 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.797 0.808 . . . . 0.0 110.499 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 164.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.177 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HE2' HD22 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -135.25 163.78 29.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.191 0.519 . . . . 0.0 111.989 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -51.8 -32.4 31.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.348 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -75.77 2.46 12.15 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.412 HD22 ' HE2' ' A' ' 62' ' ' LYS . 89.5 m-20 -118.48 171.63 8.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.398 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 67.2 p -129.22 172.15 11.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.33 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.14 -45.26 74.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.997 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.22 71.65 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.343 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.79 -42.34 97.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -92.31 3.88 54.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.931 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.6 m120 57.29 39.38 28.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.1 mtt -63.78 92.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.78 176.3 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.401 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 2' ' ' VAL . 33.0 m-80 -57.35 116.4 3.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.144 0.497 . . . . 0.0 110.783 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.36 26.19 5.24 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.694 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 4' ' ' ILE . . . -73.25 114.42 11.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.504 HG22 ' HD2' ' A' ' 5' ' ' LYS . 25.7 t -96.94 104.68 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.193 0.52 . . . . 0.0 110.75 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 56' ' ' TYR . 6.9 mm -94.33 143.33 11.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -110.44 112.02 23.67 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.16 134.12 36.71 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.46 142.2 24.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.534 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD23 ' HB2' ' A' ' 85' ' ' ARG . 19.7 tp -74.39 134.28 42.43 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 1.008 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 3.4 ptmm? -57.37 -22.47 42.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -165.01 119.96 1.34 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.176 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.568 ' HB2' HD23 ' A' ' 82' ' ' LEU . 2.9 tmm_? -167.02 93.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.253 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.584 177.206 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.44 ' HB2' HG21 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.477 0.524 0 N-CA-C 109.767 -0.897 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.424 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 20.9 m -129.14 155.52 41.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.043 0.449 . . . . 0.0 110.768 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -85.14 122.66 29.67 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.627 HG21 ' HB3' ' A' ' 76' ' ' ALA . 7.3 pt -123.8 144.22 34.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.095 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HE3' HG22 ' A' ' 77' ' ' VAL . 31.5 mtmt -125.67 151.21 46.87 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.119 0.485 . . . . 0.0 111.172 -175.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.2 105.45 13.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.139 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 104.41 3.36 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.2 t -76.81 128.41 81.68 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.758 ' HG2' HD13 ' A' ' 19' ' ' LEU . 30.6 Cg_endo -63.44 149.02 92.19 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 122.517 2.145 . . . . 0.0 112.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.677 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.8 m120 -75.69 93.89 3.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.555 ' HE3' HD11 ' A' ' 19' ' ' LEU . 43.6 mtm -143.78 73.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.438 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.584 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -78.84 -45.61 20.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.596 0.713 . . . . 0.0 110.074 -171.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.46 16.69 12.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.814 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -100.8 -6.13 25.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -160.53 -176.01 5.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.157 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.14 -4.0 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.424 -172.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.604 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.2 m-90 -95.75 169.94 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -175.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HZ1' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -82.27 24.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 111.578 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.758 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.7 mt -75.84 131.28 39.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.66 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.6 m-80 -142.43 14.38 1.99 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.677 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.91 0.12 89.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.015 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.66 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.6 pm0 -73.66 174.72 7.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 126.74 71.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.158 0.504 . . . . 0.0 109.814 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.68 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 HG23 ' HG2' ' A' ' 5' ' ' LYS . 45.8 t -124.02 106.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -119.79 164.38 16.07 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.523 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 1' ' ' PRO . 12.6 m -126.29 126.33 43.79 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.406 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.473 HD12 HD13 ' A' ' 4' ' ' ILE . 53.4 mt -140.9 152.75 66.31 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.263 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.3 152.38 79.32 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.862 1.708 . . . . 0.0 111.048 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.48 -10.79 19.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.8 p -77.39 -19.97 55.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.233 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.87 -173.8 3.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 111.251 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.09 176.8 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.017 0.437 . . . . 0.0 111.932 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.49 ' CG1' HG13 ' A' ' 61' ' ' ILE . 40.0 t -57.96 -31.74 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.403 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 29.0 t -55.66 -28.89 57.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.84 -30.74 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 120.989 0.423 . . . . 0.0 110.784 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mm -71.15 -52.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 9.6 ptmt -57.72 -43.14 85.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.8 p -69.29 -40.04 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 9.5 ptpt -67.05 -35.71 80.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.607 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.63 -43.54 77.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' MET . 12.1 t-160 -60.39 -33.35 72.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.423 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 18.7 mm-40 -88.6 -25.69 22.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.795 0.331 . . . . 0.0 110.635 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.96 -53.08 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.4 p -90.35 -42.98 10.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.95 -8.24 11.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.682 ' HE1' ' HB2' ' A' ' 52' ' ' GLN . 19.8 ptm -89.67 117.09 67.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.412 0.625 . . . . 0.0 111.346 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 Cg_endo -67.78 158.47 57.09 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.386 2.057 . . . . 0.0 112.132 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.99 -6.35 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.158 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.408 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . -60.68 -28.38 67.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.371 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 1.03 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -129.38 -11.67 4.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.248 0.547 . . . . 0.0 110.019 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.682 ' HB2' ' HE1' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.84 112.77 24.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.217 -179.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mmpt? -104.36 140.33 38.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.753 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.1 mm? -110.33 135.8 50.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -128.56 117.61 21.56 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.981 0.42 . . . . 0.0 111.464 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' ' 78' ' ' ILE . 12.2 t80 -104.45 111.27 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.943 0.401 . . . . 0.0 110.503 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 56.32 29.94 15.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.357 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.95 21.26 33.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.25 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -125.93 116.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -74.55 96.05 2.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.846 0.831 . . . . 0.0 110.663 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.49 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -76.84 153.88 5.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.81 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.2 166.36 14.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.381 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -32.82 21.83 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.83 0.852 . . . . 0.0 111.78 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -74.88 -14.27 60.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.325 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -97.0 165.16 12.21 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -130.67 167.4 18.86 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.66 -45.52 86.37 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.51 78.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.467 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -56.8 -46.3 81.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -85.8 -3.29 58.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.518 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.77 47.37 15.59 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 123.42 0.45 . . . . 0.0 110.031 -174.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.01 87.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.15 178.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.945 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.424 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 16.2 t-20 -60.52 114.87 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.935 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.21 40.38 2.1 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.404 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -83.61 114.55 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 110.249 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.484 HG22 ' HE3' ' A' ' 5' ' ' LYS . 15.3 t -94.74 104.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.976 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 56' ' ' TYR . 6.5 mm -94.81 146.55 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -113.02 116.42 29.9 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.1 tp -84.64 133.78 34.4 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.32 142.67 27.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.004 0.431 . . . . 0.0 111.071 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.14 130.04 37.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 1.03 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 6.0 ptmm? -52.26 -37.5 55.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -161.57 124.81 3.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 111.019 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 85' ' ' ARG . 2.5 ttp180 -113.04 -67.85 0.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.857 172.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.857 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.519 -178.238 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.51 157.9 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -88.93 125.84 35.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.301 0.572 . . . . 0.0 110.277 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -122.29 135.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.544 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -121.06 145.63 47.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.632 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.96 108.1 19.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.584 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 102.99 3.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.007 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 63.0 t -73.75 130.25 83.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.899 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.732 ' HG2' HD13 ' A' ' 19' ' ' LEU . 39.9 Cg_endo -66.44 155.19 71.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.963 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.645 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.2 m120 -82.37 90.81 6.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.555 ' HB3' HG23 ' A' ' 15' ' ' THR . 47.5 mtm -142.5 76.78 1.55 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.057 0.455 . . . . 0.0 110.523 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.5 mp0 -78.77 -47.5 16.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.943 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -120.98 2.97 10.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.423 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -76.96 -19.16 57.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.346 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 11' ' ' MET . 14.3 t -150.96 -174.02 4.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.442 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -95.41 -5.76 42.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 0.0 111.509 -173.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.573 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -87.74 174.21 8.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.452 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HE2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -89.35 30.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.058 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.732 HD13 ' HG2' ' A' ' 9' ' ' PRO . 16.8 mt -83.12 131.7 35.13 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.644 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.3 m-80 -143.12 15.84 1.89 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.123 0.487 . . . . 0.0 110.365 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.645 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.42 2.86 87.19 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.985 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.644 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.1 pm0 -74.35 177.11 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.11 0.481 . . . . 0.0 110.685 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.74 132.82 70.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.181 0.515 . . . . 0.0 110.101 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 HD22 ' HZ2' ' A' ' 18' ' ' LYS . 81.2 mt -93.75 143.98 25.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.145 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.1 107.68 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -115.47 159.41 21.21 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -126.27 114.31 18.12 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 4' ' ' ILE . 80.5 mt -132.59 154.74 81.62 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.446 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.15 152.96 78.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.038 1.825 . . . . 0.0 111.238 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.73 -8.2 9.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.2 p -82.4 -15.92 50.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.108 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.91 -172.95 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 110.928 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.94 174.97 10.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.727 -172.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.734 HG12 HG13 ' A' ' 61' ' ' ILE . 24.5 t -63.12 -25.24 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.899 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 23.0 t -52.42 -35.39 51.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.914 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.41 HG11 ' HZ2' ' A' ' 40' ' ' LYS . 19.0 t -75.05 -26.7 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.666 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -72.45 -49.85 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.952 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 7.0 ptmt -61.75 -42.13 98.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 13.9 p -67.2 -38.8 81.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 -177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.737 ' HB3' ' HZ3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -69.13 -35.07 76.0 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.132 -177.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.436 HD12 HD12 ' A' ' 54' ' ' LEU . 74.4 mt -74.18 -42.95 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.138 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -58.25 -32.91 68.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.477 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 61.5 mt-10 -85.93 -32.31 21.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.834 0.35 . . . . 0.0 110.64 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.33 -44.22 25.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.502 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.7 p -102.27 -45.62 5.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.044 0.449 . . . . 0.0 110.632 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.58 -19.34 5.93 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.948 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.488 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 18.6 ptm -78.38 117.64 67.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.351 0.596 . . . . 0.0 111.466 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 32.0 Cg_endo -68.88 159.03 55.54 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.306 2.004 . . . . 0.0 111.939 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.1 -17.47 63.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.027 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.94 -31.08 38.8 Favored Glycine 0 C--O 1.225 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.1 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.82 -3.47 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.239 0.542 . . . . 0.0 110.178 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.615 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -94.07 113.65 25.66 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.704 ' HZ2' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -106.74 139.13 41.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 41' ' ' ILE . 1.4 mm? -110.21 125.03 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -115.89 114.93 25.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.118 0.485 . . . . 0.0 111.395 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.6 t80 -102.68 107.72 18.73 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 27.2 mm-40 56.92 30.93 18.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.546 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.91 57.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -107.79 115.17 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -68.62 92.75 0.48 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 109.894 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.734 HG13 HG12 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.19 149.6 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.642 -177.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -109.44 160.79 15.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.722 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 35' ' ' SER . 4.3 p30 -66.81 -16.9 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -86.88 6.23 32.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.434 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 94.5 m-20 -106.28 167.06 10.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 82.6 p -124.43 166.33 16.17 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.242 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -66.0 -44.26 85.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.416 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.85 76.72 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.281 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.04 -47.82 83.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -89.58 5.24 46.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.208 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.88 45.66 21.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.075 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.96 88.03 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.597 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.3 -170.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.913 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.11 114.43 3.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.5 39.68 3.62 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.937 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -77.24 115.13 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 t -95.65 102.45 13.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 111.264 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.8 mm -94.55 147.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -114.09 115.42 27.53 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.404 HD13 ' HG3' ' A' ' 52' ' ' GLN . 51.8 tp -81.52 133.82 35.44 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.01 143.69 29.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 51' ' ' LYS . 29.8 tp -80.93 137.33 36.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.755 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -49.7 107.4 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.754 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 52.48 57.95 5.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.835 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 67.0 -73.72 0.07 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.21 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.326 -1.263 . . . . 0.0 111.246 -175.771 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 109.393 -1.041 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 17.9 m -127.26 152.69 35.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.877 0.37 . . . . 0.0 110.512 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -88.64 122.52 32.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.569 HG22 ' HB2' ' A' ' 76' ' ' ALA . 13.0 pt -126.38 145.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -127.04 147.8 50.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.009 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.51 105.68 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.591 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.1 104.96 3.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.894 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 37.9 t -76.17 130.66 77.18 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HG2' HD13 ' A' ' 19' ' ' LEU . 59.0 Cg_endo -70.06 152.25 67.67 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.073 1.848 . . . . 0.0 111.77 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.436 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 10.6 m120 -75.83 83.67 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.5 ' HE3' HD11 ' A' ' 19' ' ' LEU . 12.6 mtp -133.83 73.32 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 120.927 0.394 . . . . 0.0 110.484 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.6 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -80.98 -45.13 17.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.622 0.725 . . . . 0.0 110.599 -175.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -113.9 3.67 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.466 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -91.17 -6.89 52.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.061 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.4 HG23 ' HB3' ' A' ' 11' ' ' MET . 12.4 t -167.03 -176.03 3.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.935 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.71 7.37 28.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.022 0.439 . . . . 0.0 111.029 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 7.4 m0 -85.23 165.94 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.857 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HZ3' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.4 27.72 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 111.357 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.593 HD13 ' HG2' ' A' ' 9' ' ' PRO . 25.5 mt -81.72 123.62 28.91 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.937 -0.477 . . . . 0.0 109.747 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.0 m-80 -137.91 15.3 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.882 -0.511 . . . . 0.0 111.41 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 79.45 14.01 81.93 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.27 -0.966 . . . . 0.0 112.6 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.533 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -87.24 176.49 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 177.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.86 125.06 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.232 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' HZ2' ' A' ' 18' ' ' LYS . 82.6 mt -86.96 141.62 28.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.07 108.61 16.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.469 0.652 . . . . 0.0 109.906 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -116.64 162.98 16.8 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.95 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -126.6 119.19 26.46 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 HD13 HD13 ' A' ' 4' ' ' ILE . 87.4 mt -134.9 151.42 75.55 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.695 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.21 154.69 73.18 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.67 -6.77 12.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.6 p -82.83 -17.31 44.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.939 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.402 ' OD2' HG23 ' A' ' 36' ' ' VAL . 1.3 m-20 -75.69 -175.44 2.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 110.643 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.45 171.44 14.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.543 -172.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.597 HG12 HG13 ' A' ' 61' ' ' ILE . 40.2 t -63.41 -27.86 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -53.62 -31.44 47.14 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.091 175.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.2 t -78.61 -28.24 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.639 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 30.4 mm -73.44 -46.48 48.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.39 -41.99 94.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.443 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.84 -40.57 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.9 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -64.89 -38.55 91.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.886 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.85 -43.77 79.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.68 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' MET . 11.3 t-80 -57.52 -33.81 68.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.55 -25.43 20.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.073 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.43 -39.53 24.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.392 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' HZ3' ' A' ' 18' ' ' LYS . 6.8 p -104.14 -47.86 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.565 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.58 7.89 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.47 ' HE3' ' HB2' ' A' ' 52' ' ' GLN . 16.0 ptm -86.99 119.73 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.26 0.553 . . . . 0.0 111.517 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.4 Cg_endo -68.82 158.73 56.66 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.397 2.065 . . . . 0.0 112.166 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -66.05 -9.45 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.889 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.6 -27.31 65.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.663 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.518 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.73 -2.53 3.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.037 0.446 . . . . 0.0 110.462 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.47 ' HB2' ' HE3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.69 114.47 26.45 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.238 0.542 . . . . 0.0 109.699 -177.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.5 mmpt? -106.54 142.7 35.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.738 -176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.27 121.46 38.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.87 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -111.77 117.53 33.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.015 0.436 . . . . 0.0 111.605 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' HB2' HD11 ' A' ' 78' ' ' ILE . 16.7 t80 -105.28 109.67 21.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 56.88 30.59 18.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.803 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.47 56.15 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.308 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 20.2 mt -111.02 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -72.66 90.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.597 HG13 HG12 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -76.99 158.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.892 -175.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.0 pttp -118.69 159.31 23.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.994 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.72 -2.68 21.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.1 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.533 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -91.37 -0.85 57.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.777 0.322 . . . . 0.0 111.23 177.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -112.4 -175.35 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.269 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 39.1 p -137.75 176.57 8.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.784 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.01 -45.73 59.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.764 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.42 -33.0 69.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.127 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.13 -48.64 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.448 ' CE2' ' HB ' ' A' ' 61' ' ' ILE . 72.1 m-85 -88.95 1.75 54.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.292 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 60.91 45.85 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.38 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.0 mtt -70.5 85.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.774 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.25 -172.31 1.38 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.78 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 53.0 t30 -62.22 114.95 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.224 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 39.49 2.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.645 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' A' ' 4' ' ' ILE . . . -80.87 114.62 19.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.171 0.485 . . . . 0.0 110.312 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.75 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.07 0.462 . . . . 0.0 110.851 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.46 149.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -117.69 119.65 35.61 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -84.47 131.86 34.62 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.588 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.73 144.35 27.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 51' ' ' LYS . 23.1 tp -75.3 144.62 42.36 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -45.52 -53.01 9.57 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.835 0.709 . . . . 0.0 110.128 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -165.97 147.37 6.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 85' ' ' ARG . 5.3 ptp85 -77.67 101.27 6.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.386 0.613 . . . . 0.0 110.94 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.742 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.421 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.7 Cg_endo . . . . . 0 N--CA 1.478 0.592 0 N-CA-C 109.773 -0.895 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 28' ' ' LEU . 11.1 m -120.36 152.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 0.0 110.544 -177.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 m -87.54 119.23 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 76' ' ' ALA . 3.1 pt -120.0 142.36 35.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.275 0.559 . . . . 0.0 110.987 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -125.58 148.2 49.02 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.413 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.79 105.86 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.56 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HG2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -70.7 106.41 3.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.635 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 HG12 HD23 ' A' ' 19' ' ' LEU . 85.6 t -76.94 128.78 80.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.788 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.1 Cg_endo -65.32 149.75 88.0 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.29 1.993 . . . . 0.0 111.698 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.582 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.1 m120 -76.08 84.73 2.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.462 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.539 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 51.0 mtm -137.49 75.58 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.142 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.3 mp0 -79.03 -45.46 20.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.729 0.775 . . . . 0.0 109.747 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -119.61 -0.06 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.737 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 33.9 mmtt -81.17 -6.01 58.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.056 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -164.85 -175.84 3.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.647 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.4 -0.08 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.92 0.39 . . . . 0.0 111.665 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.677 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.6 m0 -85.01 168.87 14.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.67 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.668 ' HZ3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.9 28.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.454 0.645 . . . . 0.0 110.898 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.788 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.0 mt -79.88 128.8 33.89 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 20.7 m-80 -140.55 9.78 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.883 -0.511 . . . . 0.0 111.368 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.09 10.49 78.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.882 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -84.02 179.45 7.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.891 0.377 . . . . 0.0 110.426 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.445 HG21 ' HG2' ' A' ' 7' ' ' GLN . 62.2 t -125.46 126.83 71.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.514 HD12 ' HZ2' ' A' ' 18' ' ' LYS . 68.3 mt -87.64 141.87 28.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.16 114.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CD2' ' HE3' ' A' ' 40' ' ' LYS . 56.7 m-85 -130.13 166.46 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.75 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.8 m -126.81 123.38 37.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.775 0.321 . . . . 0.0 110.418 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 2' ' ' VAL . 73.2 mt -139.04 152.41 69.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.953 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.45 152.81 74.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.223 1.948 . . . . 0.0 111.689 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 68' ' ' ALA . 31.0 tp -64.3 -7.05 8.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -83.82 -17.26 41.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.491 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.26 -173.78 3.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.237 0.542 . . . . 0.0 110.716 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -146.07 175.22 10.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.419 -172.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.464 ' CG1' HG13 ' A' ' 61' ' ' ILE . 19.8 t -59.46 -29.74 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.702 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.585 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.4 m -53.38 -29.35 34.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.397 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.7 t -78.81 -32.61 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.601 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.68 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -70.59 -46.99 67.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.306 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.711 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.1 ptmt -62.29 -44.46 96.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.922 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.48 -35.39 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.703 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.34 -34.63 74.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.624 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 54' ' ' LEU . 82.6 mt -74.57 -42.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.361 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' MET . 19.3 t60 -57.41 -32.38 66.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.561 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -87.7 -29.13 21.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.45 -44.94 18.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.2 p -99.58 -45.04 5.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.649 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.79 -17.17 6.85 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.681 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.58 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.5 ptm -82.86 116.17 62.63 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.541 0.686 . . . . 0.0 111.451 -175.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.7 Cg_endo -68.07 162.9 38.04 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.522 2.148 . . . . 0.0 111.992 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -68.96 -8.46 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.847 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.39 66.64 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.399 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.57 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -128.07 -24.25 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 109.92 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.711 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.44 113.53 10.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.082 176.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 6.7 mmpt? -107.34 140.6 40.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 41' ' ' ILE . 1.9 mm? -112.27 123.98 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.829 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.0 tt0 -115.57 115.59 26.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.592 ' HB2' HD13 ' A' ' 78' ' ' ILE . 10.8 t80 -101.6 107.82 19.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.258 0.552 . . . . 0.0 110.108 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 5.2 mm-40 56.74 29.44 15.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.053 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.0 14.95 37.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.026 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 25.7 mt -117.51 116.0 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -72.36 95.65 1.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.464 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -84.52 154.09 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -132.51 174.84 9.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.839 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -28.79 20.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.568 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.447 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 4.6 m -86.16 10.52 14.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.174 -169.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 87.9 m-20 -114.71 172.66 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.4 p -130.08 166.58 19.88 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.05 -44.12 85.5 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' HA ' HD13 ' A' ' 30' ' ' LEU . . . -58.65 -38.88 79.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.628 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.14 -40.8 77.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -95.57 6.4 49.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.452 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.54 38.89 22.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.967 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.458 ' HE3' HD12 ' A' ' 61' ' ' ILE . 61.1 mtt -67.48 87.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.55 -168.64 2.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.302 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.51 115.12 2.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.121 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.7 3.25 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.648 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 4' ' ' ILE . . . -82.66 114.65 21.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.029 0.415 . . . . 0.0 109.978 177.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.85 102.2 13.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.57 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.592 HD13 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.24 150.52 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.16 116.47 27.88 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.529 HD13 ' HG3' ' A' ' 52' ' ' GLN . 38.0 tp -82.53 131.68 35.21 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.24 145.59 27.17 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.7 tp -76.0 144.63 40.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 11.2 ptpt -58.1 -179.75 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -47.85 -48.37 31.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.046 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 -96.64 130.6 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.286 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.627 -1.096 . . . . 0.0 111.891 -178.516 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.487 ' HB2' HG21 ' A' ' 27' ' ' THR . 11.5 Cg_endo . . . . . 0 N--CA 1.479 0.643 0 N-CA-C 110.159 -0.747 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 16.1 m -122.49 156.21 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.813 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -82.52 127.24 33.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.021 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.598 HG22 ' HB1' ' A' ' 76' ' ' ALA . 6.5 pt -130.71 136.64 57.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.129 0.49 . . . . 0.0 110.826 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -123.35 145.47 48.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.764 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.8 108.44 24.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.527 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.03 104.01 4.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.649 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG12 HD23 ' A' ' 19' ' ' LEU . 62.1 t -76.71 131.19 74.38 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.455 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.821 ' HG2' HD12 ' A' ' 19' ' ' LEU . 36.1 Cg_endo -66.62 155.68 69.24 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.14 1.894 . . . . 0.0 112.214 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.0 m120 -82.54 84.2 7.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.568 ' HB3' HG22 ' A' ' 15' ' ' THR . 48.6 mtm -137.45 75.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.582 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 9.3 mp0 -79.91 -47.47 15.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.689 -171.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -120.89 10.78 10.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -93.27 -2.18 55.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.834 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.3 t -167.77 -176.73 3.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.86 -12.52 41.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.808 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.641 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.2 m0 -84.99 164.34 18.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.563 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HZ3' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -82.85 29.94 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.672 0.748 . . . . 0.0 110.86 -178.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.821 HD12 ' HG2' ' A' ' 9' ' ' PRO . 19.4 mt -78.94 127.25 31.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.556 -0.715 . . . . 0.0 109.269 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.582 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 17.2 m-80 -137.82 20.57 2.86 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.766 -0.584 . . . . 0.0 111.364 -175.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.14 1.39 63.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.085 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -76.58 176.51 8.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.26 0.552 . . . . 0.0 110.526 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 7' ' ' GLN . 58.2 t -125.31 123.48 65.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.904 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD12 ' HZ3' ' A' ' 18' ' ' LYS . 51.4 mt -88.05 136.92 32.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.35 110.38 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 120.971 0.415 . . . . 0.0 110.0 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.44 166.33 16.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.593 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 1' ' ' PRO . 6.6 m -126.49 122.59 35.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.806 HD11 ' HZ3' ' A' ' 40' ' ' LYS . 73.4 mt -136.09 154.04 77.2 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.72 152.52 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.87 1.713 . . . . 0.0 110.982 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.65 -8.7 10.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -79.61 -18.38 51.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.44 -175.13 2.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 110.648 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.1 172.83 12.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.342 -173.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.605 HG12 HG13 ' A' ' 61' ' ' ILE . 40.4 t -62.82 -26.81 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.564 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -54.16 -33.16 57.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.316 176.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -74.03 -32.05 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 mm -72.61 -48.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.751 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.7 ptmt -59.86 -40.95 90.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.744 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -72.97 -39.23 57.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.041 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HZ3' HD11 ' A' ' 28' ' ' LEU . 16.4 ptpt -63.5 -35.6 81.01 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.259 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.9 mt -72.35 -43.58 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.264 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -59.84 -34.71 73.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.36 -36.41 39.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.748 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.74 8.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.729 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.8 p -91.66 -43.49 9.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.11 -15.22 9.44 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.949 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.567 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 17.5 ptm -81.36 119.96 77.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.458 0.647 . . . . 0.0 111.565 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.0 Cg_endo -67.85 156.7 64.9 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.77 2.313 . . . . 0.0 112.056 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.97 -12.54 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.483 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.64 -32.58 58.56 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.557 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.68 -3.92 4.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.148 0.499 . . . . 0.0 110.495 -177.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.567 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.68 116.33 28.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.31 0.576 . . . . 0.0 109.547 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.945 ' HA ' ' HZ3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -104.92 140.92 37.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.74 118.69 32.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.146 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 25.9 tt0 -111.48 116.0 30.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.593 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.598 ' HB2' HD11 ' A' ' 78' ' ' ILE . 12.7 t80 -103.85 108.97 20.53 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 61.6 mm-40 57.35 30.23 18.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.741 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.46 10.36 53.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.316 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.8 mt -114.49 118.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 10.1 m-30 -74.11 89.41 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.605 HG13 HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -74.44 154.4 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.75 -175.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.9 pttp -117.14 160.02 21.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.945 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -72.19 -5.28 34.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.468 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -88.71 0.42 56.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.884 0.373 . . . . 0.0 110.748 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -112.47 176.89 4.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.3 p -130.43 170.03 14.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.318 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.52 -43.6 80.42 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.861 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.97 76.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.282 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -57.59 -44.73 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.958 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -88.9 3.38 51.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.264 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' N ' HD21 ' A' ' 71' ' ' ASN . 0.9 OUTLIER 59.26 41.0 20.72 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.021 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -62.8 94.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.446 0.641 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.75 -177.9 2.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.523 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 33.3 t30 -61.83 116.76 5.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.22 39.29 3.79 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.364 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.598 ' HB1' HG22 ' A' ' 4' ' ' ILE . . . -77.53 114.91 16.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.345 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.28 105.11 16.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -93.87 148.82 4.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -117.0 116.9 28.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.05 133.31 34.66 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.0 148.91 31.24 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.392 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 51' ' ' LYS . 26.1 tp -83.21 126.8 33.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.564 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -58.6 -64.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.293 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.46 142.89 47.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.42 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.43 -31.87 0.73 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.672 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.099 -1.39 . . . . 0.0 111.089 -177.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.401 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.4 Cg_endo . . . . . 0 C--O 1.231 0.145 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.96 154.66 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.385 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m -85.55 124.85 32.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.591 HG21 ' HB3' ' A' ' 76' ' ' ALA . 4.6 pt -128.38 148.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.491 ' HD2' HG21 ' A' ' 77' ' ' VAL . 10.1 mttm -128.13 147.53 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 105.81 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 104.72 5.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.979 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.494 HG11 HD21 ' A' ' 19' ' ' LEU . 57.6 t -73.67 133.02 80.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.367 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.831 ' HG2' HD11 ' A' ' 19' ' ' LEU . 38.0 Cg_endo -68.66 151.23 74.97 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.995 1.797 . . . . 0.0 111.772 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.589 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -79.89 88.45 5.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.557 ' HE1' HD12 ' A' ' 19' ' ' LEU . 51.0 mtm -138.84 75.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.6 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.9 mp0 -78.84 -45.95 19.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.86 -168.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -120.21 2.8 10.9 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.133 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -86.33 -4.83 59.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.157 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.522 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.6 t -161.47 -176.46 5.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.826 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.99 -0.33 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.106 0.479 . . . . 0.0 111.627 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.678 ' HZ2' ' HZ3' ' A' ' 51' ' ' LYS . 5.2 m0 -89.84 174.56 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.081 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.724 ' HZ2' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.15 28.51 1.4 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.193 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.831 HD11 ' HG2' ' A' ' 9' ' ' PRO . 15.7 mt -79.56 122.71 26.83 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.6 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.8 m-80 -136.49 20.13 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.255 0.55 . . . . 0.0 110.452 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.589 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.18 -7.85 59.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.976 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.566 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -65.79 176.02 1.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.522 0.677 . . . . 0.0 111.15 -178.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.91 126.69 74.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.919 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 mt -87.51 132.17 34.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.34 107.39 18.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -125.08 167.35 14.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.396 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.1 m -126.51 119.89 28.29 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 4' ' ' ILE . 67.4 mt -134.38 149.89 72.41 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 42.6 Cg_endo -70.01 149.23 65.02 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.387 2.058 . . . . 0.0 111.62 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.6 -12.16 21.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.872 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -72.65 -25.26 61.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -75.01 -173.62 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.136 0.493 . . . . 0.0 110.731 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.55 173.42 12.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.819 0.342 . . . . 0.0 111.714 -172.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.487 ' CG1' HG13 ' A' ' 61' ' ' ILE . 25.6 t -57.28 -31.35 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.74 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.521 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 15.3 m -50.64 -36.07 33.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.126 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 39.0 t -72.04 -33.97 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.615 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.7 -52.6 22.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.816 0.341 . . . . 0.0 110.479 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 49' ' ' ALA . 10.7 ptmt -57.97 -44.59 87.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.513 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.63 -32.72 56.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.65 -46.52 78.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.856 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.47 -38.14 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.159 0.504 . . . . 0.0 110.264 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 47' ' ' MET . 7.6 t-80 -56.9 -34.57 68.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.481 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -90.91 -29.93 17.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.978 0.418 . . . . 0.0 111.024 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.62 -44.92 32.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.431 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.724 HG22 ' HZ2' ' A' ' 18' ' ' LYS . 5.8 p -102.03 -40.5 6.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.57 -8.77 10.91 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.962 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.574 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 15.0 ptm -90.99 117.89 68.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 111.811 -176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.2 Cg_endo -66.92 157.25 62.46 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.7 2.266 . . . . 0.0 111.873 175.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . . . -62.65 -14.2 40.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.682 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.07 -34.12 52.12 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.44 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HZ3' ' HZ2' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -126.9 -7.82 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 110.252 -177.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.574 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.93 116.57 29.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.59 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.974 ' HA ' ' HZ3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -107.13 142.81 36.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.782 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.05 124.56 46.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -116.39 119.52 35.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.038 0.447 . . . . 0.0 111.44 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.632 ' HB2' HD11 ' A' ' 78' ' ' ILE . 8.8 t80 -103.65 104.78 14.86 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 57.24 29.69 17.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.849 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.44 14.51 37.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.916 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -120.69 114.35 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -76.67 92.74 3.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.855 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.487 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -74.89 150.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.42 -177.158 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -125.71 171.26 10.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.125 0.488 . . . . 0.0 111.869 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -18.88 45.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.188 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.409 ' HB2' ' CE ' ' A' ' 62' ' ' LYS . 3.9 m -86.97 10.12 17.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.065 0.459 . . . . 0.0 110.773 -175.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -122.4 171.19 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 79.4 p -129.56 169.93 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.94 -44.13 85.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.11 75.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.54 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.19 -39.96 84.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 49.1 m-85 -91.09 -2.33 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.285 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.71 46.47 20.04 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.638 0.586 . . . . 0.0 110.124 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.6 mtt -62.04 87.79 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.272 0.558 . . . . 0.0 110.747 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.58 179.58 3.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.712 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.18 115.8 4.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.344 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.97 33.61 3.7 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.135 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.591 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -79.22 114.79 18.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.118 0.485 . . . . 0.0 110.031 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.491 HG21 ' HD2' ' A' ' 5' ' ' LYS . 26.5 t -99.1 106.06 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.931 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -94.44 149.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -116.57 119.35 35.29 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 tp -85.74 133.3 34.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.63 34.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.645 HD23 ' HD3' ' A' ' 85' ' ' ARG . 37.4 tp -89.78 124.29 34.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.109 0.48 . . . . 0.0 110.97 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -65.07 -65.3 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.051 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -132.48 141.7 48.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.93 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.645 ' HD3' HD23 ' A' ' 82' ' ' LEU . 12.2 ptt180 -148.78 29.72 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.336 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.489 -1.173 . . . . 0.0 111.355 -177.182 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.496 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 N-CA-C 110.307 -0.69 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.56 158.63 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 m -90.51 122.13 33.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.12 0.486 . . . . 0.0 110.595 -176.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 76' ' ' ALA . 1.8 pt -125.46 138.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.956 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -120.58 146.38 46.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.14 105.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.236 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 101.43 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.872 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 22.3 t -72.24 129.33 87.72 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.7 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.662 ' HG2' HD12 ' A' ' 19' ' ' LEU . 43.1 Cg_endo -66.15 149.19 85.72 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.517 2.145 . . . . 0.0 111.677 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.632 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -73.78 85.43 1.68 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.524 ' HE1' HD13 ' A' ' 19' ' ' LEU . 47.8 mtm -136.09 74.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.965 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 3.6 mp0 -78.99 -44.96 21.22 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.727 0.775 . . . . 0.0 109.557 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -119.79 3.59 11.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.212 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -88.87 -5.06 58.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.028 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.7 t -162.68 -175.74 4.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.675 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -105.19 3.26 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.583 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -90.43 169.52 10.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.126 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.572 ' HE2' HG21 ' A' ' 45' ' ' THR . 0.1 OUTLIER -81.96 31.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.154 0.502 . . . . 0.0 111.631 -178.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.662 HD12 ' HG2' ' A' ' 9' ' ' PRO . 20.8 mt -83.74 132.97 34.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.683 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.6 m-80 -147.29 19.27 1.21 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 110.14 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.632 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.23 -3.26 87.49 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.683 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 3.5 pm0 -70.88 172.11 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.577 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.24 130.57 74.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.544 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 88.8 mt -91.01 147.34 23.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.53 109.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.68 160.68 19.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.241 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -127.1 115.9 19.87 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 4' ' ' ILE . 96.1 mt -134.19 151.88 77.28 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.557 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.27 151.89 80.18 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.207 1.938 . . . . 0.0 111.439 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.3 tp -64.72 -4.53 4.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -83.65 -20.68 33.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.444 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.6 m-20 -77.41 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.268 0.556 . . . . 0.0 110.622 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.81 174.01 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -172.203 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.779 HG13 HG13 ' A' ' 61' ' ' ILE . 39.5 t -61.91 -27.52 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.693 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 29.2 t -51.78 -33.31 34.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.44 175.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 HG21 ' OD2' ' A' ' 32' ' ' ASP . 19.8 t -77.44 -30.75 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.93 0.395 . . . . 0.0 110.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.2 mm -71.84 -49.28 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.368 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HB2' ' HB1' ' A' ' 49' ' ' ALA . 2.9 ptmt -59.07 -40.6 85.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.48 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.601 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.6 p -71.24 -41.09 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.083 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -65.72 -35.58 81.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.893 -177.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.9 -41.57 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.281 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -57.84 -34.75 70.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.088 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 52.9 mt-10 -82.84 -33.02 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.952 0.406 . . . . 0.0 110.419 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.8 -44.14 23.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.769 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.1 p -102.18 -44.94 5.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.763 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.84 -5.84 10.49 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.116 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.555 ' HE2' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -89.57 116.88 67.45 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 111.366 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.12 159.36 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.518 2.145 . . . . 0.0 111.848 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 38' ' ' LYS . . . -64.16 -14.85 57.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.822 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.16 -30.7 55.26 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.081 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -128.66 -3.96 5.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.167 0.508 . . . . 0.0 109.995 -177.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.555 ' HB2' ' HE2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.23 115.52 28.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.734 -178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.7 mmpt? -108.14 141.61 39.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.0 mt -117.51 121.49 41.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.819 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.6 tt0 -113.54 117.36 31.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.238 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.597 ' HB2' HD13 ' A' ' 78' ' ' ILE . 9.9 t80 -103.54 109.45 21.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.027 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 56.4 29.59 15.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.747 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.67 13.05 45.37 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 19.6 mt -116.97 118.99 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -74.04 93.15 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.779 HG13 HG13 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -79.28 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.552 -178.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.22 166.83 12.12 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.59 -12.35 61.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 0.0 111.387 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -78.22 -10.3 59.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 72.7 m-20 -99.47 164.26 12.17 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.6 p -125.09 167.5 14.69 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.04 -43.41 87.63 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.911 0.386 . . . . 0.0 110.028 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.96 -34.85 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -55.64 -45.08 77.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.42 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 29.7 m-85 -97.53 9.48 42.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.631 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.25 45.84 19.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.248 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.3 mtt -69.08 90.09 0.45 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.085 0.469 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.81 -172.34 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.823 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -61.08 115.53 3.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.257 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 31.58 5.46 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.62 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -75.02 114.56 13.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.03 104.53 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 0.0 110.913 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.597 HD13 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.23 148.27 5.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -112.88 118.33 34.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -82.77 132.74 35.16 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.03 147.01 29.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 51' ' ' LYS . 27.3 tp -78.6 148.7 33.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.05 -13.1 14.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.562 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 65.3 17.77 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.138 0.575 . . . . 0.0 111.976 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 6.3 tpm_? -81.81 -42.49 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.993 0.425 . . . . 0.0 110.071 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.993 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 28.9 Cg_endo . . . . . 0 N--CA 1.478 0.584 0 N-CA-C 110.601 -0.577 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.97 157.13 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -90.65 117.83 29.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 110.449 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.8 pt -121.0 143.53 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.739 -176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -126.25 150.51 48.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.804 0.335 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 49.0 t -124.77 107.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.852 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.08 105.75 3.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 19' ' ' LEU . 60.3 t -76.41 131.83 73.97 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.1 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 19' ' ' LEU . 41.4 Cg_endo -68.0 149.58 77.33 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.223 1.949 . . . . 0.0 111.781 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.32 86.98 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -135.55 76.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.679 . . . . 0.0 110.175 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 10.8 mp0 -79.9 -45.38 18.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.572 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.68 -5.59 10.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.006 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 34.7 mmtt -75.71 -8.13 56.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.662 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.3 t -163.81 -172.68 2.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -105.97 0.36 25.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m0 -85.38 168.61 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.01 28.8 0.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.661 . . . . 0.0 111.407 -177.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -81.1 122.0 26.8 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.79 -0.569 . . . . 0.0 109.832 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.638 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 15.9 m-80 -138.06 16.66 2.82 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.943 -0.473 . . . . 0.0 110.665 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.19 -2.46 85.27 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -73.81 179.36 4.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.274 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.56 128.61 76.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.293 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.2 mt -87.77 144.94 26.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.92 111.12 19.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.051 0.453 . . . . 0.0 109.856 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 92.6 m-85 -120.92 162.6 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.353 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.7 m -127.67 119.01 24.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.755 0.312 . . . . 0.0 110.175 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -137.66 149.0 63.41 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.137 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 23.5 Cg_endo -64.99 148.62 89.78 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.302 2.001 . . . . 0.0 111.47 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.6 tp -60.54 -14.51 20.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.961 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -76.99 -21.57 54.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.776 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD2' ' HG2' ' A' ' 29' ' ' PRO . 3.0 m-20 -74.18 -174.81 2.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.608 . . . . 0.0 110.71 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 3.0 pm0 -143.97 174.75 10.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.72 -171.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 44.5 t -58.98 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.847 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 8.5 t -52.56 -34.29 49.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.134 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.05 -32.7 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 22.5 mm -72.0 -50.77 35.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 6.3 ptmt -58.0 -41.88 84.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.473 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 14.2 p -70.8 -41.26 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.009 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -64.65 -35.66 81.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.957 -178.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -69.81 -41.89 79.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.05 0.452 . . . . 0.0 110.362 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -58.73 -31.45 68.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.93 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 5.7 mm-40 -81.69 -36.63 28.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 110.573 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.46 -49.26 17.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.64 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.5 p -96.07 -45.28 6.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.969 0.414 . . . . 0.0 110.51 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.13 -20.14 6.34 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.68 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.486 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.7 ptm -77.81 119.33 76.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.547 . . . . 0.0 111.341 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 19.8 Cg_endo -68.03 157.98 59.39 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.329 2.019 . . . . 0.0 111.831 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.22 -9.57 18.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.419 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.05 -26.53 61.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.886 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -134.05 -5.67 2.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.926 0.394 . . . . 0.0 110.316 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.65 116.03 28.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.9 mmpt? -105.79 140.23 39.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.53 116.82 28.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.338 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.3 tt0 -108.03 112.12 24.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.668 ' HB2' HD12 ' A' ' 78' ' ' ILE . 26.5 t80 -102.61 114.43 28.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.767 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 31.1 mm-40 56.56 29.54 15.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.459 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.52 8.77 57.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.733 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 9.5 mt -115.17 118.51 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.4 m-30 -68.49 94.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 0.0 109.953 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.45 152.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.428 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -122.43 167.3 13.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 6.2 t70 -59.36 -27.93 66.39 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.149 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -75.02 -11.06 60.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.382 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -105.9 170.01 8.15 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.932 0.396 . . . . 0.0 110.141 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.6 p -130.36 175.01 9.3 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.202 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.38 -43.34 73.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.26 -35.11 76.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.452 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -57.18 -42.15 80.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.641 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 73.5 m-85 -95.08 0.34 54.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.96 47.28 12.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.786 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtt -69.96 87.46 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.25 -173.28 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.348 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -63.37 115.69 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 110.035 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.82 2.85 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.041 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.65 114.93 21.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.016 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.27 104.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.041 0.448 . . . . 0.0 110.719 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.13 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.59 114.66 23.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.16 133.58 34.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.92 148.27 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.6 tp . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.479 0.633 0 N-CA-C 109.48 -1.008 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 15.8 m -126.56 153.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.395 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -84.2 124.6 31.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.7 pt -124.48 137.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.249 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG22 ' A' ' 77' ' ' VAL . 11.0 mttm -117.85 146.36 43.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.088 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.0 105.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -72.06 104.24 3.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.654 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 HD22 ' A' ' 19' ' ' LEU . 69.9 t -75.26 128.09 85.2 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.364 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 33.4 Cg_endo -64.87 150.81 87.6 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.152 1.901 . . . . 0.0 111.907 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 17.8 m-80 -77.54 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.713 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.541 ' HB3' HG22 ' A' ' 15' ' ' THR . 41.0 mtm -142.53 75.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.707 0.289 . . . . 0.0 110.251 174.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 7.4 mp0 -78.92 -44.22 23.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 110.134 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.53 -2.54 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.029 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -87.79 -6.92 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.423 -172.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.0 t -161.38 -179.91 7.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.07 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.72 3.0 41.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.548 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.577 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 6.0 m0 -85.94 171.91 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -87.9 26.83 1.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 0.0 110.886 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.9 mt -80.19 128.16 33.19 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.664 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.3 m-80 -140.78 9.13 2.17 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.063 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.4 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 88.23 7.99 72.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.265 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -80.8 175.86 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.54 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 7' ' ' GLN . 44.5 t -124.96 124.19 67.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.73 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -87.62 136.07 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.73 107.51 19.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -122.55 166.2 15.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.717 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 m -126.8 122.02 33.58 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.853 0.359 . . . . 0.0 110.775 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 4' ' ' ILE . 68.9 mt -138.57 152.36 70.8 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.513 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 43.5 Cg_endo -69.86 152.1 68.69 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.215 1.943 . . . . 0.0 111.748 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 tp -62.49 -11.97 19.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.663 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -73.97 -23.98 59.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -76.28 -172.95 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.276 0.56 . . . . 0.0 110.72 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.5 pm0 -144.85 171.97 13.68 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.625 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.666 HG11 HG13 ' A' ' 61' ' ' ILE . 26.1 t -63.05 -26.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.338 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.43 -31.83 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.75 -30.65 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.11 0.481 . . . . 0.0 110.247 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.3 mm -71.16 -51.99 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.2 ptmt -58.03 -43.72 86.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.68 -38.58 79.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.583 0.23 . . . . 0.0 111.004 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.9 ptmt -68.87 -35.29 76.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.498 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.75 -41.88 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' MET . 8.1 t-80 -56.71 -35.2 68.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.022 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.53 -20.86 21.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.44 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.55 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.0 p -107.88 -42.94 4.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.047 0.451 . . . . 0.0 110.721 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.08 -8.42 10.52 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.012 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 17.5 ptm -90.32 119.95 69.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.134 0.492 . . . . 0.0 111.699 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.3 Cg_endo -68.91 156.89 63.95 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.547 2.164 . . . . 0.0 112.266 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.69 -16.87 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.4 -30.61 33.69 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.281 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.35 -6.0 3.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.441 . . . . 0.0 110.005 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.67 112.04 23.84 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.1 mmpt? -103.43 141.03 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.392 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.44 121.61 45.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.448 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.5 tt0 -113.64 115.77 28.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.8 t80 -101.81 107.53 18.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.225 0.536 . . . . 0.0 110.029 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 57.15 30.47 18.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.831 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.5 38.62 Favored Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.49 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.1 mt -118.74 116.02 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.0 m-85 -72.04 91.9 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.167 0.508 . . . . 0.0 110.114 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.666 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -78.12 150.32 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.3 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.57 156.27 20.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.806 0.336 . . . . 0.0 110.827 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 5.7 p-10 -71.37 -2.93 18.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.996 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t -86.12 -5.34 59.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.748 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -104.15 178.44 4.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.524 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 76.6 p -133.38 173.16 11.77 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.44 -33.46 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.231 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' SER . 47.3 t80 -56.47 -45.9 80.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -91.68 -0.62 57.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.744 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 63.82 41.41 6.84 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.365 0.415 . . . . 0.0 110.888 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -64.27 93.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.316 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 177.98 4.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.918 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 36.0 t-20 -64.45 115.37 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.144 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.21 28.14 5.04 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.195 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 115.11 10.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.449 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 5' ' ' LYS . 15.3 t -95.08 103.54 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.793 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.51 146.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -116.41 111.57 20.22 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -76.78 132.41 39.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.407 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 147.24 32.12 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.699 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.06 152.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.945 0.403 . . . . 0.0 110.298 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -88.73 114.99 25.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.244 0.545 . . . . 0.0 110.355 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.1 pt -114.81 136.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.481 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 13.5 mttm -118.63 147.33 43.86 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.122 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.5 t -125.43 105.27 14.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.92 104.52 2.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.655 HG13 HD22 ' A' ' 19' ' ' LEU . 25.9 t -76.53 126.84 85.64 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.798 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.781 ' HG2' HD13 ' A' ' 19' ' ' LEU . 27.5 Cg_endo -63.97 147.26 91.92 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.399 2.066 . . . . 0.0 111.875 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.534 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 21.0 m-80 -73.85 88.5 1.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.771 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.479 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.1 mtm -138.53 75.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.12 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.8 mp0 -79.49 -44.87 20.42 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.311 -173.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -116.44 2.14 13.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.908 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -90.81 -4.87 56.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.493 -171.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.1 t -164.25 -174.21 3.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.887 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -99.02 -3.66 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.407 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.9 m0 -85.78 169.98 12.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.094 0.473 . . . . 0.0 111.176 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.09 22.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.001 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -77.52 133.32 38.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 21.1 m-80 -146.96 10.1 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 86.31 16.08 63.17 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.291 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -87.96 175.69 7.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.55 127.73 75.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.971 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 85.7 mt -87.91 141.71 28.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.39 107.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 24.1 m-85 -121.01 164.83 16.15 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 1' ' ' PRO . 4.9 m -126.44 122.26 34.78 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.218 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 HD11 ' A' ' 4' ' ' ILE . 78.6 mt -137.41 149.81 66.65 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.652 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 33.5 Cg_endo -66.27 152.2 81.61 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.273 1.982 . . . . 0.0 111.471 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 tp -62.82 -8.07 6.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -80.11 -20.71 44.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -74.84 -176.2 2.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.138 0.494 . . . . 0.0 110.217 177.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.9 pm0 -144.97 174.65 10.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.901 0.381 . . . . 0.0 111.563 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 61' ' ' ILE . 39.8 t -60.68 -30.33 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 m -51.69 -36.1 45.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.024 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -72.05 -32.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 23.9 mm -72.5 -51.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.452 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 3.3 ptmt -59.2 -42.56 91.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.498 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.3 p -69.83 -37.45 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.164 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 11.3 ptmt -69.31 -36.67 77.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.745 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.03 -41.35 81.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -58.73 -32.78 69.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.305 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 15.1 mm-40 -85.44 -30.89 23.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.902 0.382 . . . . 0.0 110.798 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.88 -46.62 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.956 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -97.53 -40.56 8.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.477 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.11 -15.92 10.11 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.931 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -82.14 117.0 66.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.385 0.612 . . . . 0.0 111.464 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 22.1 Cg_endo -67.25 159.01 54.24 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.595 2.197 . . . . 0.0 111.882 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.4 -13.58 58.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.45 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -29.25 54.76 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.968 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -132.45 -2.63 3.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 0.0 110.63 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.411 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -95.24 117.65 30.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.114 0.483 . . . . 0.0 109.887 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.7 mmpt? -104.27 139.96 38.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -120.04 118.87 31.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.634 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -112.96 117.32 31.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -102.73 107.98 19.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.947 0.403 . . . . 0.0 110.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 57.18 30.57 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.355 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.58 23.73 25.43 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.064 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 21.1 mt -126.38 116.21 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -72.15 95.9 1.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.474 0.654 . . . . 0.0 110.29 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -80.28 150.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.567 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HE3' HD22 ' A' ' 65' ' ' ASN . 1.0 OUTLIER -118.97 162.54 18.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.593 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 5.5 t70 -54.06 -27.7 34.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.218 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.15 -1.94 16.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.789 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.509 HD22 ' HE3' ' A' ' 62' ' ' LYS . 11.9 m120 -115.69 168.76 9.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.394 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 91.9 p -125.73 173.15 9.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.33 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.12 -42.86 79.57 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.51 -33.92 73.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.222 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.09 -44.87 91.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.19 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.66 5.52 51.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.654 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 60.5 43.28 13.19 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 110.866 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.18 84.89 0.37 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.026 0.441 . . . . 0.0 110.76 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.48 -176.58 2.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.702 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -58.69 115.5 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.56 36.11 3.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.654 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -81.35 114.9 20.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 14.7 t -97.66 105.57 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.101 0.477 . . . . 0.0 110.94 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -95.53 148.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -118.24 117.04 28.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -84.55 133.97 34.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.61 151.8 35.64 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 51' ' ' LYS . 24.3 tp . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.6 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.92 154.43 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -90.81 120.83 32.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.332 0.586 . . . . 0.0 109.851 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.805 HG22 ' HB3' ' A' ' 76' ' ' ALA . 9.5 pt -120.46 143.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.402 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.562 ' HD2' HG22 ' A' ' 77' ' ' VAL . 4.5 mttm -119.26 150.14 40.59 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.889 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.12 105.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.43 106.2 3.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.68 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 79.2 t -77.18 130.0 76.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.741 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.8 Cg_endo -65.82 156.56 63.55 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.636 2.224 . . . . 0.0 111.829 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.499 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 33.2 m-80 -85.32 85.82 7.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.0 mtm -137.95 76.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.725 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.594 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -77.76 -48.03 17.6 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.657 0.742 . . . . 0.0 110.334 -171.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 10.9 10.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.311 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -90.66 -4.89 56.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.678 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -158.24 -172.94 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.796 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -101.17 -5.07 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.54 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.2 m0 -91.6 171.87 8.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.879 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 28.22 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 110.996 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.741 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.5 mt -78.26 127.74 32.68 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -138.74 16.53 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.462 -0.774 . . . . 0.0 111.022 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 82.91 7.86 86.64 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -80.28 175.1 10.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.394 0.616 . . . . 0.0 110.61 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.3 t -120.6 123.01 69.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.603 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.7 mt -87.59 142.11 28.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 5' ' ' LYS . 57.8 t -132.39 107.78 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.529 0.681 . . . . 0.0 109.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.45 164.28 13.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.825 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -126.79 118.7 25.19 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.99 174.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.9 152.66 77.77 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.851 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.11 150.08 82.23 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.389 2.059 . . . . 0.0 111.246 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -61.8 -10.59 9.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.538 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -79.09 -18.94 52.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.867 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.02 -175.44 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -144.44 177.32 8.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.145 0.498 . . . . 0.0 111.567 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.512 ' CG1' HG13 ' A' ' 61' ' ' ILE . 60.3 t -56.14 -33.07 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.742 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m -54.9 -30.76 59.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.22 -27.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 110.532 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.1 mm -72.4 -54.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.0 ptmt -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.13 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.889 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.59 -35.22 78.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.5 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 54' ' ' LEU . 67.4 mt -72.65 -43.08 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.526 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -59.04 -33.4 70.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.536 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -89.24 -20.41 24.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.064 0.459 . . . . 0.0 110.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.75 -54.48 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.153 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.7 p -91.15 -43.01 10.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.3 7.23 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.929 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.4 118.07 70.63 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.395 0.617 . . . . 0.0 111.602 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.36 157.33 62.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.433 2.088 . . . . 0.0 111.9 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.04 -8.02 20.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.384 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.76 -28.9 66.33 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.281 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.6 -2.75 3.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 110.449 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.64 117.26 32.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 mmpt? -110.92 140.33 45.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.391 -176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -111.0 124.21 51.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.436 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.45 117.9 31.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.739 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 14.2 t80 -103.33 108.25 19.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.092 0.473 . . . . 0.0 110.073 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.59 30.95 16.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.031 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.59 45.08 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.203 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.414 HG21 ' HE1' ' A' ' 70' ' ' TYR . 8.7 mt -120.57 113.04 38.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -73.49 92.96 1.93 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.607 0.717 . . . . 0.0 110.409 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.512 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -72.57 158.11 6.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.425 -174.145 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -130.48 163.65 26.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.322 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m-20 -50.58 -32.19 17.98 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.814 0.696 . . . . 0.0 112.236 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -82.45 2.42 32.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.103 0.477 . . . . 0.0 110.95 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.47 163.74 13.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.5 p -129.76 165.94 20.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.87 -44.04 97.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.767 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.14 82.74 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.368 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -59.34 -42.75 92.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HE1' HG21 ' A' ' 59' ' ' ILE . 33.7 m-85 -89.11 1.28 55.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.665 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 58.72 44.22 17.52 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.641 0.588 . . . . 0.0 110.864 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.9 mtt -67.24 89.45 0.2 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.06 -169.65 1.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.712 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -61.74 115.53 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.26 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.29 38.75 3.92 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.768 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.59 115.02 14.83 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.786 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.562 HG22 ' HD2' ' A' ' 5' ' ' LYS . 21.7 t -94.94 102.26 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.192 0.52 . . . . 0.0 110.946 -176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -93.9 146.41 6.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -114.78 113.97 24.96 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.69 133.32 35.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.39 146.07 30.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.156 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.4 tp . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.5 Cg_exo . . . . . 0 N--CA 1.473 0.31 0 N-CA-C 109.974 -0.818 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.0 m -121.05 153.87 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -89.94 116.18 27.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.035 0.445 . . . . 0.0 110.266 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.682 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -118.28 138.52 48.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.752 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 8.6 mttm -118.66 146.97 44.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.903 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -123.31 105.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.38 106.68 4.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.646 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 84.4 t -78.18 130.63 71.64 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.33 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.736 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.5 Cg_endo -66.09 150.0 85.47 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.37 2.047 . . . . 0.0 111.995 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.469 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 37.9 m-80 -76.53 88.54 3.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.505 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.0 mtm -139.49 75.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.549 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.593 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.82 -45.1 19.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.77 0.795 . . . . 0.0 110.226 -175.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -0.6 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.682 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -92.48 -1.52 56.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.623 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.0 t -166.7 -177.5 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.321 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.69 -7.09 38.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.445 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.665 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -86.02 167.24 15.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.17 29.09 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.229 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.9 mt -79.27 130.69 35.72 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.673 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 20.5 m-80 -143.41 11.84 1.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.849 -0.532 . . . . 0.0 110.826 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 88.86 2.43 78.42 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.758 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.4 pm0 -76.21 174.08 10.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.4 124.36 72.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.08 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 86.3 mt -87.97 147.53 24.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -133.19 109.11 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 89.4 m-85 -115.93 159.47 21.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.214 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.6 m -126.78 112.96 15.99 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.02 0.438 . . . . 0.0 110.038 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.6 mt -133.47 149.68 72.96 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.819 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.69 151.36 85.43 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.354 2.036 . . . . 0.0 111.429 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 26.1 tp -63.17 -12.41 27.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.299 0.571 . . . . 0.0 110.567 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.0 p -80.72 -18.39 47.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.824 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.33 -173.27 2.01 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.153 0.502 . . . . 0.0 110.795 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.4 pm0 -144.9 175.97 9.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 112.039 -173.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 26.1 t -64.95 -26.56 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.646 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 9.8 m -52.22 -33.88 43.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 t -73.54 -33.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.23 -48.59 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.692 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.709 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.96 -39.34 89.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.69 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -74.15 -38.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.046 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.52 -36.23 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.971 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 54' ' ' LEU . 78.8 mt -70.47 -42.69 78.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 110.571 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -57.87 -32.38 67.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.232 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.47 -25.17 22.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.03 0.443 . . . . 0.0 111.102 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.33 -47.86 11.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.605 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.1 p -98.77 -45.12 6.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.656 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.42 -20.49 5.54 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.878 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.452 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.1 ptm -77.97 119.94 79.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 0.0 111.615 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.6 Cg_endo -67.24 159.29 52.92 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 111.8 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.46 -11.38 51.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.542 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.5 -30.33 61.84 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.523 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -131.2 -0.98 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.988 0.423 . . . . 0.0 110.399 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -100.56 125.27 46.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -116.19 142.82 46.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.002 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.8 mm? -112.46 117.59 32.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.574 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.4 tt0 -107.04 113.93 27.69 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.008 0.433 . . . . 0.0 111.041 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.4 t80 -103.6 109.52 21.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.212 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 58.09 30.15 18.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.462 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.08 14.15 46.67 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.34 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 24.2 mt -117.23 118.62 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -75.04 90.36 2.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.194 0.521 . . . . 0.0 109.998 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.556 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -79.25 148.48 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.093 -174.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HE3' HD22 ' A' ' 65' ' ' ASN . 0.6 OUTLIER -105.66 162.69 13.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.977 176.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.06 -21.73 66.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 -177.379 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -74.31 5.68 4.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.78 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.737 HD22 ' HE3' ' A' ' 62' ' ' LYS . 10.8 m120 -111.03 166.81 10.74 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 52.8 p -126.15 165.34 19.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.88 -45.01 91.33 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.214 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.3 -33.67 73.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.213 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 66' ' ' SER . 77.9 t80 -57.44 -42.43 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.259 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -98.85 8.17 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.268 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.45 40.26 14.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.43 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -63.75 90.29 0.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.483 . . . . 0.0 111.443 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 178.34 6.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.248 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.32 115.36 2.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.27 29.59 4.76 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.038 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.05 114.3 15.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 27.5 t -95.1 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.543 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -94.31 145.69 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 11.3 m-70 -113.27 114.41 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.44 134.48 35.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.42 145.58 29.28 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.29 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 51' ' ' LYS . 33.1 tp . . . . . 0 C--N 1.316 -0.85 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.482 ' HB2' HG22 ' A' ' 27' ' ' THR . 31.4 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 18.3 m -124.76 154.29 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.0 110.326 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -87.19 114.44 23.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 110.084 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.715 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -113.33 135.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 13.5 mttt -122.11 146.48 47.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.572 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -124.11 105.98 16.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.738 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.22 103.82 2.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 19' ' ' LEU . 91.0 t -74.0 133.15 79.04 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.563 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.5 Cg_endo -66.48 147.48 82.46 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.766 1.644 . . . . 0.0 111.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.428 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 29.2 m-80 -74.37 88.29 2.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.709 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.511 ' HB3' HG22 ' A' ' 15' ' ' THR . 52.6 mtm -140.61 76.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.09 -46.42 18.09 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.448 0.642 . . . . 0.0 110.137 -171.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.64 6.91 9.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.517 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -80.6 -15.98 55.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 109.576 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 11' ' ' MET . 10.8 t -153.0 -178.78 7.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.991 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 16' ' ' GLU . 10.5 pt-20 -91.31 -3.91 56.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.231 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.599 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -86.87 172.81 9.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.588 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.32 29.72 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.872 -177.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.3 mt -81.05 130.14 34.88 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.606 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.6 m-80 -138.29 15.54 2.79 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.103 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.428 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 82.26 -0.95 88.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.377 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -73.18 177.56 5.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.323 0.583 . . . . 0.0 111.136 -177.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.53 124.65 73.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.567 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.588 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 84.9 mt -86.91 142.67 27.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 110.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.047 0.451 . . . . 0.0 109.806 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 95.7 m-85 -122.71 158.58 29.79 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.895 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -126.22 112.91 16.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.106 0.479 . . . . 0.0 109.938 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 4' ' ' ILE . 85.3 mt -131.32 153.08 81.55 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.74 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.23 150.39 87.52 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.906 1.737 . . . . 0.0 111.277 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.7 tp -60.34 -12.21 8.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.725 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.2 p -78.83 -20.28 50.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.833 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -72.66 -176.25 1.91 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.258 0.552 . . . . 0.0 110.268 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 1.6 pm0 -143.42 173.3 11.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.888 0.375 . . . . 0.0 111.684 -172.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.688 HG11 HG13 ' A' ' 61' ' ' ILE . 40.8 t -61.96 -26.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.479 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -53.94 -32.77 54.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.181 176.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.7 t -78.22 -27.7 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.451 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 33.6 mm -73.04 -48.21 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.952 0.406 . . . . 0.0 110.553 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -61.33 -39.66 91.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.456 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.4 p -72.61 -39.96 61.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.038 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -64.4 -39.23 93.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.802 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.413 HD12 HD11 ' A' ' 54' ' ' LEU . 76.4 mt -68.58 -43.29 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.739 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -57.74 -32.54 67.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.544 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 49.3 mt-10 -82.07 -38.18 25.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 110.141 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.09 -51.16 19.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.431 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.578 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 3.1 p -96.57 -43.07 7.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.0 110.303 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.3 -19.49 6.76 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.81 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.424 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.6 ptm -79.05 119.96 79.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.672 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.6 Cg_endo -68.28 156.43 65.74 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.566 2.177 . . . . 0.0 112.037 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.12 -15.99 58.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.66 -33.6 34.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.863 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.42 -3.91 4.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.554 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.72 121.41 38.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 110.009 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -113.06 144.05 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.02 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.3 mm? -112.83 120.04 40.09 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -108.05 110.33 22.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.101 0.477 . . . . 0.0 111.585 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 21.1 t80 -102.52 112.54 25.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.834 0.349 . . . . 0.0 110.136 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 16.2 mm-40 57.3 30.32 18.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.95 11.53 57.59 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.47 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 22.2 mt -113.97 119.08 60.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 6.7 m-30 -70.74 91.12 0.81 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.292 0.568 . . . . 0.0 109.905 174.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.688 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -77.76 153.25 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.272 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -121.82 161.85 21.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.746 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.78 -2.55 17.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.292 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 m -84.22 -2.89 57.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.035 0.445 . . . . 0.0 110.386 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -119.3 175.11 5.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 80.7 p -129.78 170.38 13.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.172 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.65 -44.0 78.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.74 -37.03 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.318 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -58.82 -46.84 86.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.91 -4.23 58.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.752 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 65.4 41.23 4.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.504 0.503 . . . . 0.0 110.854 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtt -68.01 86.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.47 . . . . 0.0 111.408 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.46 -174.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.889 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.6 t-20 -65.71 115.3 5.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.71 29.16 4.79 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.439 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -72.67 114.44 10.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.97 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.38 150.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 2.0 m80 -118.54 117.76 29.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.44 134.13 34.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.58 147.08 31.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.874 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.0 tp . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.579 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' THR . 7.7 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 12.3 m -123.39 151.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 110.296 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 109.02 20.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.71 0.767 . . . . 0.0 110.778 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.745 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -107.38 143.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.414 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.5 mtmm -126.89 152.03 47.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.656 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t -131.3 105.87 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.606 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.19 107.13 4.06 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.002 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 53.8 t -79.37 133.29 60.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.834 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' A' ' 19' ' ' LEU . 57.5 Cg_endo -70.42 151.99 65.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.464 2.109 . . . . 0.0 112.091 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -78.88 100.95 7.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.582 ' HB3' HG22 ' A' ' 15' ' ' THR . 27.6 mtm -147.21 76.8 1.43 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.455 0.169 . . . . 0.0 110.598 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -48.4 15.93 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.014 0.435 . . . . 0.0 110.912 -169.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -121.42 9.33 10.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.965 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -84.52 -5.5 59.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -162.15 -178.84 6.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.239 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.34 1.55 47.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -88.15 175.57 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.684 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -94.88 30.79 1.99 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.605 -177.175 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 8' ' ' VAL . 22.0 mt -86.38 115.33 23.83 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.941 -0.475 . . . . 0.0 110.401 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 23.6 m-80 -130.32 21.65 5.21 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.555 -0.716 . . . . 0.0 110.863 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.63 87.58 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.046 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.6 pm0 -75.13 179.45 5.03 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 111.117 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.83 132.71 69.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.728 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 67.0 mt -87.51 144.26 26.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 5' ' ' LYS . 96.1 t -131.93 114.62 24.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 110.058 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 99.2 m-85 -128.85 160.16 33.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.8 m -126.55 119.09 26.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.82 151.32 70.23 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.83 149.66 89.28 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.006 1.804 . . . . 0.0 111.192 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 32.0 tp -59.5 -14.16 11.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.66 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -76.67 -19.39 57.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.125 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.31 -174.06 2.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.421 0.629 . . . . 0.0 111.029 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 1.2 pm0 -143.11 172.88 12.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 0.0 112.266 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 45.0 t -60.83 -26.42 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.623 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.29 -33.32 52.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.049 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -76.96 -29.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 21.4 mm -73.0 -45.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.573 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.693 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.4 ptmt -62.68 -42.94 99.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.48 -37.48 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.651 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.56 -35.34 80.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.578 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.88 -42.26 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -59.54 -35.87 75.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.355 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -83.85 -31.35 25.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.819 0.342 . . . . 0.0 111.463 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.47 -38.41 26.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.8 p -106.15 -47.91 3.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.043 0.449 . . . . 0.0 110.628 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.87 -6.55 10.33 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.115 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 22.0 ptm -87.19 115.7 63.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.406 0.622 . . . . 0.0 110.978 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.4 157.56 61.29 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.626 2.217 . . . . 0.0 112.127 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.75 -17.15 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.209 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.55 -31.15 52.01 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.859 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -129.84 -5.37 4.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.49 . . . . 0.0 110.535 -178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.693 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -87.52 113.48 23.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mmpt? -104.94 138.72 40.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.7 mt -118.88 122.4 42.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.975 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -112.3 120.27 41.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.191 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.6 t80 -108.84 110.32 21.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.42 30.79 20.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.05 49.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.16 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 mt -121.94 113.58 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -74.63 95.27 2.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.752 0.787 . . . . 0.0 110.287 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.73 168.9 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.098 -176.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE3' HD22 ' A' ' 65' ' ' ASN . 0.8 OUTLIER -130.46 166.04 21.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.365 177.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.36 -2.78 20.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.898 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.6 t -94.32 13.23 24.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.191 0.519 . . . . 0.0 110.237 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.413 HD22 ' HE3' ' A' ' 62' ' ' LYS . 13.1 m120 -123.64 165.69 16.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 71.6 m -126.15 166.38 17.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.02 -46.53 84.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.767 0.318 . . . . 0.0 110.397 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -59.85 -29.99 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.455 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 66' ' ' SER . 56.7 t80 -62.81 -40.99 99.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -97.86 5.17 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.28 46.55 23.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.332 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 mtt -66.05 82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 110.806 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 171.79 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 48.0 t-20 -55.36 115.95 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.73 27.38 4.66 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.058 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.745 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -78.11 115.06 17.56 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.57 104.33 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.3 mm -94.27 150.62 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -116.78 119.71 36.28 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.75 134.27 33.96 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.715 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.9 142.66 27.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.933 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 C--N 1.316 -0.877 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.142 178.228 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.476 0.499 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.15 152.03 24.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.933 0.397 . . . . 0.0 110.389 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -89.02 114.19 25.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.058 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.3 pt -117.64 138.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.696 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -121.53 145.14 48.26 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.233 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.04 105.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.427 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.48 104.61 2.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.567 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.584 HG13 HD22 ' A' ' 19' ' ' LEU . 95.8 t -75.75 127.32 85.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.425 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.827 ' HG2' HD13 ' A' ' 19' ' ' LEU . 26.1 Cg_endo -61.92 151.13 83.14 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.515 2.143 . . . . 0.0 112.2 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.544 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 38.5 m-80 -79.71 83.22 5.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.78 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.49 ' HB3' HG22 ' A' ' 15' ' ' THR . 55.4 mtm -135.81 75.57 1.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.623 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -77.22 -45.8 25.32 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.363 0.601 . . . . 0.0 110.229 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.96 8.86 10.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.984 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -90.39 -4.81 56.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.046 -173.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 17' ' ' TRP . 14.4 t -161.2 -172.71 3.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.942 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.3 4.67 36.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.57 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -96.44 171.65 8.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.81 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 27.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 110.944 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -78.85 129.63 34.78 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.5 m-80 -142.27 15.67 2.04 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.935 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 81.03 5.03 90.42 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.919 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.624 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.04 179.38 6.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.327 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.34 136.59 60.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.184 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.91 142.76 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.28 109.9 19.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -123.19 163.66 20.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.581 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.2 m -127.06 117.34 22.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 110.236 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.33 149.76 72.11 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.617 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.9 151.8 81.57 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.167 1.912 . . . . 0.0 111.256 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' MET . 29.7 tp -61.89 -10.18 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -80.19 -19.05 47.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.848 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.58 -173.05 2.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.69 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.7 pm0 -145.67 175.4 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.485 -173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 61' ' ' ILE . 42.3 t -60.0 -28.49 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.527 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -51.28 -31.61 21.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.86 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.89 -33.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 0.0 110.408 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 19.4 mm -72.12 -49.61 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.572 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 8.4 ptmt -60.01 -40.67 90.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 p -72.05 -38.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.756 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -66.87 -36.12 81.59 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.843 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.77 -41.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.499 . . . . 0.0 110.202 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -58.3 -32.12 68.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.45 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 8.7 mm-40 -87.81 -30.29 20.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.118 0.485 . . . . 0.0 110.724 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.75 -46.39 14.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.784 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.1 p -98.23 -43.4 7.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.348 . . . . 0.0 110.721 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.21 -2.33 18.93 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.401 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -92.0 118.04 68.02 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.353 0.597 . . . . 0.0 111.281 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.41 155.88 67.61 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.434 2.089 . . . . 0.0 112.119 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.66 -16.88 59.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.668 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.52 -29.67 40.14 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.292 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.48 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -130.87 -1.82 4.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.237 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.75 113.37 24.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.557 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -105.22 139.15 40.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.095 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.64 121.3 41.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 109.889 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.3 tt0 -113.46 113.99 25.93 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.333 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.1 t80 -103.05 110.89 22.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.933 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 57.39 29.78 17.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.432 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.23 7.34 57.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.524 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.3 mt -112.34 119.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -72.52 91.8 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.141 0.496 . . . . 0.0 110.196 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.462 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -77.3 154.25 5.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.608 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 28.9 pttt -123.16 162.08 23.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.448 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 38' ' ' LYS . 6.5 t70 -54.48 -30.35 52.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.806 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 16.0 m -69.47 -13.88 62.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.919 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 11.9 m120 -105.43 177.91 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 110.657 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 78.5 p -134.59 171.12 14.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.408 -175.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.7 -44.03 78.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.937 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.82 70.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.493 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -62.37 -45.29 93.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -89.19 1.6 55.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.79 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 64.56 31.27 12.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.416 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.44 ' O ' HD13 ' A' ' 30' ' ' LEU . 58.5 mtt -59.72 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.214 0.531 . . . . 0.0 112.113 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 -172.08 3.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -64.4 116.19 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.905 0.383 . . . . 0.0 110.664 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.08 19.23 7.76 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.552 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 114.45 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.136 0.468 . . . . 0.0 110.102 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.12 104.85 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.0 mm -94.36 148.01 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -115.09 115.42 26.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.04 131.51 35.79 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.01 32.99 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.127 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 51' ' ' LYS . 31.7 tp . . . . . 0 C--N 1.316 -0.89 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.2 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.09 155.41 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.685 0.279 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -87.91 117.01 26.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.138 0.494 . . . . 0.0 110.234 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.3 pt -124.01 142.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.999 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -123.99 146.84 48.24 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.566 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.37 105.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.45 104.17 3.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.609 HG13 HD22 ' A' ' 19' ' ' LEU . 55.9 t -75.89 126.71 86.67 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.316 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.4 Cg_endo -65.74 147.5 85.76 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.3 2.0 . . . . 0.0 112.114 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.435 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 28.6 m-80 -72.61 90.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.518 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 42.3 mtm -141.43 76.56 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.871 0.367 . . . . 0.0 110.367 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -45.54 20.31 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.57 0.7 . . . . 0.0 110.201 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -120.51 7.79 10.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.161 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -94.81 3.53 54.9 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.807 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -168.28 -174.45 2.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.452 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 6.2 pt-20 -106.29 3.65 27.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.289 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.758 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.4 m0 -102.28 170.64 7.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 26.82 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.629 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.83 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -78.5 126.45 30.78 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.0 m-80 -140.99 15.74 2.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 110.667 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 84.53 1.0 89.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.196 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.595 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 1.1 pm0 -75.66 173.66 10.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 110.779 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.04 124.67 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.878 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.55 134.35 33.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -121.43 107.36 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -122.0 162.24 21.49 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.543 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.4 m -125.77 116.78 22.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.996 0.426 . . . . 0.0 110.44 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 4' ' ' ILE . 81.0 mt -133.68 151.31 76.87 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.035 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.04 147.96 80.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.292 1.995 . . . . 0.0 111.687 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.05 -10.66 10.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 110.601 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.9 p -81.98 -15.0 55.22 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.725 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.5 -173.39 4.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.115 0.483 . . . . 0.0 110.573 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.9 pm0 -144.56 173.59 11.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.889 0.376 . . . . 0.0 111.666 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 61' ' ' ILE . 41.8 t -61.43 -27.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.012 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -53.11 -33.28 51.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.399 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.63 -34.01 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.222 0.534 . . . . 0.0 110.264 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.0 mm -70.48 -52.07 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.859 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -58.19 -42.71 86.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.518 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 11.1 p -71.32 -38.98 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.678 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.2 ptmt -66.07 -35.26 80.04 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.39 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.2 mt -72.71 -41.13 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 110.196 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 23.5 t-80 -58.04 -32.4 67.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.339 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 56.8 mm-40 -85.94 -34.52 20.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.992 0.425 . . . . 0.0 110.047 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.06 -46.53 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.637 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.9 p -97.78 -43.6 7.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.067 0.46 . . . . 0.0 110.626 -176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 -7.19 11.24 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.131 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.516 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 13.2 ptm -89.7 119.64 69.48 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 111.827 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.2 Cg_endo -67.65 157.41 61.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.541 2.161 . . . . 0.0 112.057 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.99 -12.07 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.597 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.5 -33.76 62.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.647 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.54 -5.12 6.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.337 0.589 . . . . 0.0 109.979 -177.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -99.83 113.55 26.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 12.0 mmpt? -107.66 135.3 49.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.544 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HB3' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -103.38 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.09 176.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 tt0 -108.5 116.52 32.12 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 78' ' ' ILE . 7.5 t80 -101.04 102.83 13.9 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.457 0.646 . . . . 0.0 109.685 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 6.4 mm-40 57.42 31.01 19.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.076 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . 98.14 19.49 23.59 Favored Glycine 0 CA--C 1.511 -0.167 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.829 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.99 112.06 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 55' ' ' GLN . 5.0 m-85 -72.0 95.4 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.59 0.71 . . . . 0.0 110.002 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.2 162.12 3.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.27 -178.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 165.17 26.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -72.73 -4.85 33.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.622 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -79.97 -7.7 58.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 109.905 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -114.82 178.91 4.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.303 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 53.5 p -136.93 173.43 11.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.336 -175.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.16 -45.08 70.93 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.26 72.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.259 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 66' ' ' SER . 46.2 t80 -56.74 -46.19 81.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.657 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -90.62 1.11 57.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.98 42.25 19.64 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.557 0.536 . . . . 0.0 110.395 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.6 mtt -65.27 88.14 0.08 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.9 -178.07 5.28 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.85 116.28 3.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.287 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.75 29.3 5.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.364 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.11 114.67 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.91 106.35 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.14 0.495 . . . . 0.0 110.58 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.2 mm -94.46 145.47 7.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -116.25 111.69 20.52 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.56 132.37 35.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 144.11 30.56 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.479 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 51' ' ' LYS . 32.1 tp . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.552 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 Cg_endo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 110.258 -0.708 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.73 154.9 37.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 m -86.77 125.15 33.74 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' A' ' 76' ' ' ALA . 12.9 pt -128.71 145.37 35.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.968 0.413 . . . . 0.0 111.045 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -126.5 146.53 50.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.2 t -123.18 105.79 16.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.615 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.53 103.86 3.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 94.3 t -77.03 131.68 72.43 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.843 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.629 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.9 Cg_endo -66.16 155.76 68.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.567 2.178 . . . . 0.0 111.851 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.577 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 26.7 m-80 -84.66 84.16 7.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.587 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.495 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -133.44 75.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.9 mp0 -78.43 -46.3 20.15 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 110.383 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 0.63 10.32 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.046 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HE2' ' OE1' ' A' ' 12' ' ' GLN . 20.6 mmtt -86.14 0.98 52.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.369 0.605 . . . . 0.0 109.63 -173.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -160.38 -173.53 4.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.45 -5.8 24.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 111.508 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.1 m0 -85.37 173.87 9.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.4 29.38 1.28 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.359 -176.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.629 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.0 mt -81.53 124.97 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.562 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 4.8 m-80 -132.33 19.6 4.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.899 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.577 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 75.66 12.96 83.44 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.302 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.562 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -83.22 179.12 7.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.137 0.494 . . . . 0.0 110.754 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.97 126.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 72.5 mt -87.3 139.49 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.16 109.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -124.2 166.02 16.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.394 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 1' ' ' PRO . 9.9 m -126.87 121.98 33.36 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.099 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 4' ' ' ILE . 77.4 mt -136.15 149.28 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.774 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.4 Cg_endo -65.25 150.13 87.8 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.182 1.921 . . . . 0.0 110.947 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 20.0 tp -62.33 -8.82 6.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.652 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -82.52 -18.85 40.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.9 -175.26 2.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 110.063 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 2.5 pm0 -144.93 174.68 10.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.93 0.395 . . . . 0.0 111.546 -174.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.584 HG11 HG13 ' A' ' 61' ' ' ILE . 35.0 t -62.87 -25.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.632 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 1.6 t -53.13 -33.81 54.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.66 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -72.43 -33.36 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.155 0.502 . . . . 0.0 110.553 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -70.54 -47.16 66.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.4 ptmt -63.15 -41.89 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.273 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -68.85 -39.38 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.695 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -39.74 85.5 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.199 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.73 -40.51 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 110.421 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -61.1 -32.8 72.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.566 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.55 -30.23 18.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.586 0.231 . . . . 0.0 111.133 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.11 -39.02 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.595 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 9.3 p -105.69 -45.28 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.548 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.65 -11.81 8.9 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.286 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 23.4 ptm -84.21 117.76 69.51 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.349 0.595 . . . . 0.0 111.116 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 29.3 Cg_endo -68.94 157.1 63.21 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.579 2.186 . . . . 0.0 112.161 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.71 -15.55 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.69 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.71 -30.03 50.79 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.981 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.59 -0.41 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.117 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.13 113.86 25.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 178.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.3 mmpt? -106.73 141.84 37.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.7 mm? -114.42 118.19 33.13 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -107.2 115.14 29.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.413 . . . . 0.0 110.668 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.5 t80 -103.91 111.38 23.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 57.88 29.74 18.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.191 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.41 24.52 26.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.071 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.78 110.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.422 ' HD1' ' HB3' ' A' ' 53' ' ' LYS . 53.9 m-85 -71.69 94.92 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.761 0.791 . . . . 0.0 110.648 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.584 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -80.73 154.61 4.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.159 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.49 162.73 13.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -70.89 -15.71 62.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 111.335 -174.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 m -78.24 7.22 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.801 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 80.9 m-20 -109.99 166.66 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 87.3 p -123.75 164.5 19.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.15 -43.24 92.46 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.192 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.34 -38.03 82.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.231 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -55.66 -43.64 76.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.233 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.99 5.06 53.0 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.709 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.43 46.98 14.36 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.376 0.423 . . . . 0.0 111.399 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.24 84.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 110.775 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.31 -176.64 1.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.074 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -61.37 116.51 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.309 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.41 33.64 4.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.962 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -74.32 114.63 12.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.043 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.58 103.45 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.116 0.484 . . . . 0.0 110.58 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.37 143.39 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -113.19 113.05 24.8 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.11 132.19 36.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.59 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.96 143.96 26.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.628 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HE1' ' A' ' 11' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.146 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.078 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.523 ' HB2' HG22 ' A' ' 27' ' ' THR . 37.0 Cg_endo . . . . . 0 N--CA 1.478 0.577 0 N-CA-C 109.839 -0.869 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 25.8 m -126.27 156.7 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.707 0.289 . . . . 0.0 110.354 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -86.63 121.33 29.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.029 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.2 pt -122.5 137.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.568 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HD3' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -120.25 151.96 38.43 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.474 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.04 106.21 15.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.492 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.52 106.73 3.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.461 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -77.35 127.62 82.54 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.761 ' HG2' HD13 ' A' ' 19' ' ' LEU . 31.9 Cg_endo -64.31 148.59 90.98 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.122 1.882 . . . . 0.0 112.081 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.402 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 28.4 m-80 -74.83 93.85 2.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.775 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 15' ' ' THR . 35.9 mtm -146.45 75.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -78.53 -49.01 14.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.384 0.611 . . . . 0.0 110.543 -169.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.4 17.49 9.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.19 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -91.33 -7.91 49.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.4 t -158.76 -172.5 3.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.685 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.55 -0.44 25.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.913 0.387 . . . . 0.0 111.58 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.8 m0 -85.95 168.66 13.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -84.93 31.64 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.427 0.632 . . . . 0.0 111.045 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 9' ' ' PRO . 13.5 mt -84.77 112.98 20.99 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.814 -0.554 . . . . 0.0 110.096 -175.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.626 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -126.46 16.26 7.65 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.33 -0.856 . . . . 0.0 111.209 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 84.24 5.96 86.76 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -79.6 175.18 10.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.651 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 7' ' ' GLN . 43.9 t -124.84 124.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.099 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.92 142.54 27.72 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 5' ' ' LYS . 58.4 t -132.47 111.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.152 0.501 . . . . 0.0 110.261 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.44 166.25 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.5 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -125.99 116.86 22.11 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.314 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 4' ' ' ILE . 82.3 mt -131.98 153.74 81.48 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.679 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.9 Cg_endo -64.85 149.32 89.75 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.274 1.983 . . . . 0.0 111.533 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -62.67 -12.05 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.726 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -80.93 -16.24 54.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.512 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.93 -174.87 2.35 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.9 pm0 -145.23 173.4 11.98 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG11 HG13 ' A' ' 61' ' ' ILE . 39.9 t -62.47 -25.14 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.598 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.33 -34.34 57.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.246 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.52 -30.29 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.533 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 26.1 mm -72.31 -47.57 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.831 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 4.1 ptmt -61.92 -40.12 94.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -71.12 -39.7 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.013 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.49 -38.44 89.75 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.92 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 54' ' ' LEU . 79.4 mt -71.59 -42.16 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 0.0 110.552 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' MET . 32.7 t60 -57.64 -32.77 67.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.434 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.45 -29.21 18.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.804 0.335 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' LYS . . . -82.8 -31.1 28.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.053 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -112.18 -43.4 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.468 . . . . 0.0 110.548 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.97 -7.06 10.93 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 15.6 ptm -89.97 119.24 69.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.347 0.594 . . . . 0.0 111.586 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 25.9 Cg_endo -67.81 161.36 44.26 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 111.86 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.56 -10.67 57.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -176.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -28.69 62.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.69 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -131.83 -3.05 3.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 110.329 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -98.12 122.19 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.3 mmpt? -114.0 142.56 46.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.513 HD11 ' CD1' ' A' ' 41' ' ' ILE . 1.8 mm? -111.49 119.38 38.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.582 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.1 tt0 -108.55 112.66 25.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.936 0.398 . . . . 0.0 111.026 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.657 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.0 t80 -103.23 109.97 21.76 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 57.34 30.18 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.549 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.93 17.16 38.84 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.35 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 17.6 mt -120.65 116.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 16.2 m-85 -72.75 91.38 1.47 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 110.096 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.565 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.67 157.04 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 -175.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -121.44 160.22 24.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.758 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.3 p-10 -71.14 -8.3 52.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 m -85.24 -1.58 57.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 0.0 110.261 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -109.6 170.67 7.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.449 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 97.0 p -126.33 170.94 11.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.88 -43.65 82.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.18 -35.27 73.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.298 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.14 -46.58 85.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.91 5.58 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.503 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 59.37 43.36 16.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -67.16 92.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.93 -176.46 2.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.755 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.5 t30 -66.08 115.39 6.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.14 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.69 28.68 5.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.358 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.18 114.76 11.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.039 0.447 . . . . 0.0 110.188 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG22 ' HD3' ' A' ' 5' ' ' LYS . 38.9 t -95.68 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.696 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.89 148.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.36 118.37 32.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -80.43 133.67 35.9 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.48 146.43 31.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 51' ' ' LYS . 26.6 tp . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 110.187 -0.736 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.94 155.77 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.267 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -90.72 109.84 21.03 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.444 0.64 . . . . 0.0 110.71 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.8 pt -111.26 147.56 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.591 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.1 mtmm -130.47 150.43 51.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.801 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 48.1 t -127.08 105.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.96 108.64 4.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.598 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.551 HG13 HD22 ' A' ' 19' ' ' LEU . 86.0 t -80.46 129.02 70.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.31 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.742 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.3 Cg_endo -65.71 150.52 86.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.375 2.05 . . . . 0.0 111.912 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.51 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 37.6 m-80 -76.76 91.63 3.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.761 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.525 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.1 mtm -141.95 74.48 1.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.762 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -44.66 17.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.819 0.819 . . . . 0.0 110.163 -176.057 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.9 -12.63 14.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.781 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 39.2 mmtt -75.33 -20.34 59.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.757 -172.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -152.24 -174.47 4.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.41 -175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.06 -2.04 28.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.351 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.559 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -85.4 174.21 9.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.278 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -88.82 30.46 0.92 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.34 0.591 . . . . 0.0 111.453 -176.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' HG2' ' A' ' 9' ' ' PRO . 11.3 mt -85.02 124.52 31.81 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.687 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.3 m-80 -136.19 17.7 3.2 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.857 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.51 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 82.2 11.11 82.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.915 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -82.36 -179.77 7.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.903 0.383 . . . . 0.0 110.301 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.91 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.503 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 85.0 mt -89.86 143.4 26.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.088 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' HG2' ' A' ' 5' ' ' LYS . 48.5 t -127.99 111.16 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -126.04 162.65 24.81 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -125.97 115.68 20.28 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.249 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -134.73 150.9 74.73 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.88 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.54 152.22 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.459 2.106 . . . . 0.0 111.707 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.0 tp -63.99 -9.06 13.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.478 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -80.69 -21.42 41.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.82 -174.79 2.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.293 0.568 . . . . 0.0 110.373 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' SER . 3.0 pm0 -145.74 175.79 10.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.017 0.437 . . . . 0.0 111.495 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG11 HG13 ' A' ' 61' ' ' ILE . 46.0 t -59.74 -27.03 36.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.237 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.5 m -54.63 -34.16 61.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.1 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -74.62 -28.45 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.946 0.403 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.658 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 31.7 mm -72.87 -52.64 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.5 ptmt -57.78 -43.14 85.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.663 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.93 -37.87 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.719 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.7 -35.52 78.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.894 -177.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.84 -42.48 77.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.53 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -57.57 -32.85 67.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.088 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.4 -20.76 23.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.93 0.395 . . . . 0.0 111.271 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.94 -37.22 13.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 5.2 p -108.57 -46.11 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.192 0.52 . . . . 0.0 110.318 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.49 -17.45 5.84 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.422 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.6 ptm -81.13 117.49 68.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.454 0.645 . . . . 0.0 111.35 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.501 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.4 Cg_endo -67.29 159.76 50.77 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 111.948 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.75 -6.71 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.948 0.404 . . . . 0.0 111.87 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.37 -27.05 67.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.501 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.54 -3.48 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.102 0.477 . . . . 0.0 110.409 -177.188 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.58 116.99 32.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.674 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.0 mmpt? -104.68 141.34 36.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.62 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.19 122.13 45.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -112.11 117.84 33.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.102 0.477 . . . . 0.0 111.448 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 25.6 t80 -106.79 112.06 24.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.117 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 8.3 mm-40 57.54 29.82 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.308 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.39 10.23 57.18 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.381 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.01 116.58 52.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -76.85 93.34 3.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.676 0.75 . . . . 0.0 110.071 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.463 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.18 165.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.283 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -139.1 171.93 13.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.439 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.39 -5.45 36.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.7 p -81.37 -4.11 54.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -113.5 172.81 6.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.67 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.448 ' HA ' ' CB ' ' A' ' 33' ' ' GLN . 71.1 p -132.87 167.75 19.64 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.27 -45.11 89.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.56 -37.33 75.49 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -57.37 -44.48 84.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.036 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.434 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 47.4 m-85 -89.46 -0.2 57.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.582 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.5 42.15 14.73 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.461 0.475 . . . . 0.0 110.619 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 mtt -65.09 85.4 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.988 0.423 . . . . 0.0 110.907 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.29 -174.21 3.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -58.81 116.32 3.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.167 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.85 36.5 3.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.369 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.11 114.76 21.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.38 103.69 15.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.788 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.6 mm -94.26 151.01 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.28 119.34 35.4 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -85.31 134.05 34.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.8 149.21 35.06 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.035 0.445 . . . . 0.0 110.527 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 51' ' ' LYS . 35.9 tp . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 N-CA-C 109.692 -0.926 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.452 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 17.3 m -125.67 154.58 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.362 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -86.26 123.94 32.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.671 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -126.73 138.05 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 110.984 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HD2' HG22 ' A' ' 77' ' ' VAL . 12.5 mttm -120.15 147.73 44.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.311 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 59.5 t -123.75 105.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -73.98 103.06 4.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.862 -178.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -73.97 131.83 80.84 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.617 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.71 ' HG2' HD13 ' A' ' 19' ' ' LEU . 44.0 Cg_endo -68.25 153.23 74.95 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.145 1.897 . . . . 0.0 111.794 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.445 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 29.0 m-80 -80.22 93.71 5.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.454 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.2 mtm -142.77 75.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.787 0.327 . . . . 0.0 110.286 174.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.52 -45.12 19.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.555 0.693 . . . . 0.0 110.71 -173.098 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -118.06 15.46 14.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.726 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -102.59 -3.39 26.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 17' ' ' TRP . 11.4 t -164.24 -171.68 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.592 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.74 4.04 37.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.452 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.631 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.5 m0 -94.84 173.77 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.078 0.466 . . . . 0.0 110.858 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.22 29.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.883 -177.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.71 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.6 mt -81.44 119.22 23.44 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.95 -0.469 . . . . 0.0 109.928 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 10.6 m-80 -131.7 15.81 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 83.75 2.63 89.78 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.809 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -76.44 178.05 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 7' ' ' GLN . 48.5 t -121.69 126.64 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.1 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.9 mt -87.35 142.8 27.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.9 t -131.17 108.65 15.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.55 161.37 19.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.03 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -127.1 113.94 17.08 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.031 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 4' ' ' ILE . 87.6 mt -131.2 153.91 81.83 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.806 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.3 150.42 87.32 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.177 1.918 . . . . 0.0 111.226 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -62.88 -13.56 35.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -78.89 -15.22 58.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.425 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.95 -174.42 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 3.4 pm0 -146.31 172.63 13.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -170.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 30.8 t -59.01 -28.28 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.44 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 2.7 t -54.27 -31.44 53.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.829 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.52 -29.66 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.661 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.8 mm -72.3 -51.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.451 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.4 ptmt -57.75 -43.75 85.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.601 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.78 -38.94 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.068 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.24 -35.47 77.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.531 -177.188 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -70.59 -43.44 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 110.297 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -58.03 -32.9 68.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.363 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.66 -22.92 22.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.039 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.87 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.653 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.5 p -101.41 -44.74 5.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.839 0.352 . . . . 0.0 110.734 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.3 -6.39 10.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.102 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.428 ' HG2' ' OG1' ' A' ' 45' ' ' THR . 18.3 ptm -91.16 120.02 68.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.316 0.579 . . . . 0.0 111.508 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.4 Cg_endo -68.72 157.57 61.32 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.467 2.111 . . . . 0.0 112.24 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.74 -8.67 15.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.761 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.69 66.35 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.445 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.47 -10.12 4.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.356 -177.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.58 113.77 25.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.961 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.5 mmpt? -102.57 142.12 34.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.51 130.19 56.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -121.76 120.81 35.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' HB2' HD12 ' A' ' 78' ' ' ILE . 13.8 t80 -103.5 107.45 18.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.389 . . . . 0.0 110.592 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 59.2 mm-40 55.59 30.49 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.735 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.62 19.17 30.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.186 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -123.65 109.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -72.0 95.03 1.54 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.797 0.808 . . . . 0.0 110.499 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.11 164.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.177 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 163.78 29.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.191 0.519 . . . . 0.0 111.989 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -51.8 -32.4 31.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.348 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -75.77 2.46 12.15 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.48 171.63 8.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.398 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 67.2 p -129.22 172.15 11.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.33 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.14 -45.26 74.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.997 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.22 71.65 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.343 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.79 -42.34 97.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -92.31 3.88 54.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.931 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 57.29 39.38 28.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.1 mtt -63.78 92.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.78 176.3 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.401 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 2' ' ' VAL . 33.0 m-80 -57.35 116.4 3.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.144 0.497 . . . . 0.0 110.783 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.36 26.19 5.24 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.694 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.671 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.25 114.42 11.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 ' HD2' ' A' ' 5' ' ' LYS . 25.7 t -96.94 104.68 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.193 0.52 . . . . 0.0 110.75 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.9 mm -94.33 143.33 11.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -110.44 112.02 23.67 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.16 134.12 36.71 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.46 142.2 24.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.534 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 51' ' ' LYS . 19.7 tp . . . . . 0 C--N 1.317 -0.815 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.473 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.477 0.524 0 N-CA-C 109.767 -0.897 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 20.9 m -129.14 155.52 41.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.043 0.449 . . . . 0.0 110.768 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -85.14 122.66 29.67 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.7 HG22 ' HB3' ' A' ' 76' ' ' ALA . 7.3 pt -123.8 144.22 34.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.095 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 77' ' ' VAL . 31.5 mtmt -125.67 151.21 46.87 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.119 0.485 . . . . 0.0 111.172 -175.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.2 105.45 13.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.139 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.7 104.41 3.36 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.2 t -76.81 128.41 81.68 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 30.6 Cg_endo -63.44 149.02 92.19 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 122.517 2.145 . . . . 0.0 112.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.542 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 35.9 m-80 -75.69 93.89 3.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.516 ' HB3' HG22 ' A' ' 15' ' ' THR . 43.6 mtm -143.78 73.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.438 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.598 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -78.84 -45.61 20.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.596 0.713 . . . . 0.0 110.074 -171.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.46 16.69 12.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.814 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -100.8 -6.13 25.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -160.53 -176.01 5.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.157 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.14 -4.0 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.424 -172.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.2 m-90 -95.75 169.94 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -175.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 24.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 111.578 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.7 mt -75.84 131.28 39.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.668 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.6 m-80 -142.43 14.38 1.99 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.542 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 84.91 0.12 89.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.015 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.668 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.6 pm0 -73.66 174.72 7.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 126.74 71.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.158 0.504 . . . . 0.0 109.814 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.68 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 5' ' ' LYS . 45.8 t -124.02 106.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -119.79 164.38 16.07 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.523 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 1' ' ' PRO . 12.6 m -126.29 126.33 43.79 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.406 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 4' ' ' ILE . 53.4 mt -140.9 152.75 66.31 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.263 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.3 152.38 79.32 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.862 1.708 . . . . 0.0 111.048 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.48 -10.79 19.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.8 p -77.39 -19.97 55.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.233 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.87 -173.8 3.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 111.251 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.4 pm0 -146.09 176.8 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.017 0.437 . . . . 0.0 111.932 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.507 ' CG1' HG13 ' A' ' 61' ' ' ILE . 40.0 t -57.96 -31.74 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.403 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 29.0 t -55.66 -28.89 57.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.84 -30.74 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 120.989 0.423 . . . . 0.0 110.784 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mm -71.15 -52.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.6 ptmt -57.72 -43.14 85.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.8 p -69.29 -40.04 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 9.5 ptpt -67.05 -35.71 80.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.607 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.63 -43.54 77.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -60.39 -33.35 72.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.423 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 18.7 mm-40 -88.6 -25.69 22.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.795 0.331 . . . . 0.0 110.635 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.96 -53.08 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.4 p -90.35 -42.98 10.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.95 -8.24 11.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.464 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 19.8 ptm -89.67 117.09 67.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.412 0.625 . . . . 0.0 111.346 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 Cg_endo -67.78 158.47 57.09 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.386 2.057 . . . . 0.0 112.132 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.99 -6.35 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.158 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.38 67.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.371 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.522 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.38 -11.67 4.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.248 0.547 . . . . 0.0 110.019 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.84 112.77 24.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.217 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mmpt? -104.36 140.33 38.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.753 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.1 mm? -110.33 135.8 50.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -128.56 117.61 21.56 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.981 0.42 . . . . 0.0 111.464 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -104.45 111.27 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.943 0.401 . . . . 0.0 110.503 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 33.4 mm-40 56.32 29.94 15.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.357 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.95 21.26 33.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.25 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -125.93 116.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -74.55 96.05 2.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.846 0.831 . . . . 0.0 110.663 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -76.84 153.88 5.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.81 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.2 166.36 14.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.381 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -32.82 21.83 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.83 0.852 . . . . 0.0 111.78 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -74.88 -14.27 60.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.325 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -97.0 165.16 12.21 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.0 p -130.67 167.4 18.86 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.66 -45.52 86.37 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.51 78.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.467 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -56.8 -46.3 81.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 53.9 m-85 -85.8 -3.29 58.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.518 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.77 47.37 15.59 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 123.42 0.45 . . . . 0.0 110.031 -174.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.01 87.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.15 178.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.945 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 16.2 t-20 -60.52 114.87 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.935 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.21 40.38 2.1 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.404 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.61 114.55 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 110.249 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' HE3' ' A' ' 5' ' ' LYS . 15.3 t -94.74 104.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.976 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.5 mm -94.81 146.55 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -113.02 116.42 29.9 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.1 tp -84.64 133.78 34.4 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.32 142.67 27.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.004 0.431 . . . . 0.0 111.071 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.233 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.51 157.9 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -88.93 125.84 35.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.301 0.572 . . . . 0.0 110.277 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.693 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -122.29 135.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.544 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -121.06 145.63 47.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.632 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.96 108.1 19.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.584 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.9 102.99 3.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.007 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 63.0 t -73.75 130.25 83.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.899 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.737 ' HG2' HD13 ' A' ' 19' ' ' LEU . 39.9 Cg_endo -66.44 155.19 71.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.963 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.495 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 34.0 m-80 -82.37 90.81 6.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -142.5 76.78 1.55 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.057 0.455 . . . . 0.0 110.523 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.5 mp0 -78.77 -47.5 16.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.943 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -120.98 2.97 10.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.423 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -76.96 -19.16 57.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.346 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.3 t -150.96 -174.02 4.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.442 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -95.41 -5.76 42.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 0.0 111.509 -173.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.598 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -87.74 174.21 8.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.452 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -89.35 30.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.058 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD13 ' HG2' ' A' ' 9' ' ' PRO . 16.8 mt -83.12 131.7 35.13 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.651 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.8 m120 -143.12 15.84 1.89 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.123 0.487 . . . . 0.0 110.365 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 85.42 2.86 87.19 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.985 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.651 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.1 pm0 -74.35 177.11 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.11 0.481 . . . . 0.0 110.685 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.74 132.82 70.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.181 0.515 . . . . 0.0 110.101 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 81.2 mt -93.75 143.98 25.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.145 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.1 107.68 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 86.3 m-85 -115.47 159.41 21.21 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -126.27 114.31 18.12 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 HD11 ' A' ' 4' ' ' ILE . 80.5 mt -132.59 154.74 81.62 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.446 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.15 152.96 78.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.038 1.825 . . . . 0.0 111.238 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.73 -8.2 9.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.2 p -82.4 -15.92 50.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.108 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.91 -172.95 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 110.928 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 2.7 pm0 -144.94 174.97 10.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.727 -172.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.757 HG11 HG13 ' A' ' 61' ' ' ILE . 24.5 t -63.12 -25.24 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.899 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 23.0 t -52.42 -35.39 51.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.914 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.05 -26.7 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -72.45 -49.85 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.952 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 7.0 ptmt -61.75 -42.13 98.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 13.9 p -67.2 -38.8 81.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 -177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.13 -35.07 76.0 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.132 -177.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 54' ' ' LEU . 74.4 mt -74.18 -42.95 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.138 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -58.25 -32.91 68.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.477 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 61.5 mt-10 -85.93 -32.31 21.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.834 0.35 . . . . 0.0 110.64 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.33 -44.22 25.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.502 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.543 HG22 ' HE2' ' A' ' 18' ' ' LYS . 3.7 p -102.27 -45.62 5.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.044 0.449 . . . . 0.0 110.632 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.58 -19.34 5.93 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.948 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 18.6 ptm -78.38 117.64 67.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.351 0.596 . . . . 0.0 111.466 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 32.0 Cg_endo -68.88 159.03 55.54 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.306 2.004 . . . . 0.0 111.939 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.1 -17.47 63.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.027 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.94 -31.08 38.8 Favored Glycine 0 C--O 1.225 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.1 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.82 -3.47 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.239 0.542 . . . . 0.0 110.178 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.616 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -94.07 113.65 25.66 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.572 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -106.74 139.13 41.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 41' ' ' ILE . 1.4 mm? -110.21 125.03 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -115.89 114.93 25.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.118 0.485 . . . . 0.0 111.395 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.6 t80 -102.68 107.72 18.73 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 27.2 mm-40 56.92 30.93 18.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.546 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.91 57.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.3 mt -107.79 115.17 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -68.62 92.75 0.48 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 109.894 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.757 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.19 149.6 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.642 -177.718 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -109.44 160.79 15.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.722 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' SER . 4.3 p30 -66.81 -16.9 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -86.88 6.23 32.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.434 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 94.5 m-20 -106.28 167.06 10.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 82.6 p -124.43 166.33 16.17 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.242 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -66.0 -44.26 85.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.416 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.85 76.72 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.281 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.04 -47.82 83.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -89.58 5.24 46.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.208 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 56.88 45.66 21.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.075 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.96 88.03 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.597 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.3 -170.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.913 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.11 114.43 3.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.5 39.68 3.62 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.937 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.24 115.13 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 t -95.65 102.45 13.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 111.264 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.8 mm -94.55 147.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -114.09 115.42 27.53 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 52' ' ' GLN . 51.8 tp -81.52 133.82 35.44 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.01 143.69 29.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 51' ' ' LYS . 29.8 tp . . . . . 0 N--CA 1.444 -0.764 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.755 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 109.393 -1.041 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 17.9 m -127.26 152.69 35.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.877 0.37 . . . . 0.0 110.512 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -88.64 122.52 32.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.804 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.0 pt -126.38 145.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -127.04 147.8 50.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.009 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.51 105.68 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.591 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.1 104.96 3.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.894 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 HD22 ' A' ' 19' ' ' LEU . 37.9 t -76.17 130.66 77.18 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HG2' HD13 ' A' ' 19' ' ' LEU . 59.0 Cg_endo -70.06 152.25 67.67 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.073 1.848 . . . . 0.0 111.77 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.447 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 10.6 m120 -75.83 83.67 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 12.6 mtp -133.83 73.32 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 120.927 0.394 . . . . 0.0 110.484 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.633 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -45.13 17.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.622 0.725 . . . . 0.0 110.599 -175.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -113.9 3.67 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.466 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 37.9 mmtt -91.17 -6.89 52.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.061 -173.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.4 t -167.03 -176.03 3.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.935 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.71 7.37 28.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.022 0.439 . . . . 0.0 111.029 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 7.4 m0 -85.23 165.94 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.857 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 27.72 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 111.357 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.617 HD22 HG13 ' A' ' 8' ' ' VAL . 25.5 mt -81.72 123.62 28.91 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.937 -0.477 . . . . 0.0 109.747 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.0 m-80 -137.91 15.3 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.882 -0.511 . . . . 0.0 111.41 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 79.45 14.01 81.93 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.27 -0.966 . . . . 0.0 112.6 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -87.24 176.49 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 177.723 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.86 125.06 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.232 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -86.96 141.62 28.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.07 108.61 16.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.469 0.652 . . . . 0.0 109.906 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -116.64 162.98 16.8 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.95 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -126.6 119.19 26.46 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 4' ' ' ILE . 87.4 mt -134.9 151.42 75.55 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.695 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.21 154.69 73.18 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.7 tp -65.67 -6.77 12.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.6 p -82.83 -17.31 44.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.939 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-20 -75.69 -175.44 2.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 110.643 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.4 pm0 -143.45 171.44 14.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.543 -172.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 61' ' ' ILE . 40.2 t -63.41 -27.86 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -53.62 -31.44 47.14 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.091 175.215 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.2 t -78.61 -28.24 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.639 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 30.4 mm -73.44 -46.48 48.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.39 -41.99 94.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.443 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.84 -40.57 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.9 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -64.89 -38.55 91.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.886 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.85 -43.77 79.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.68 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' MET . 11.3 t-80 -57.52 -33.81 68.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.55 -25.43 20.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.073 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.43 -39.53 24.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.392 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -104.14 -47.86 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.565 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.58 7.89 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 16.0 ptm -86.99 119.73 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.26 0.553 . . . . 0.0 111.517 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.4 Cg_endo -68.82 158.73 56.66 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.397 2.065 . . . . 0.0 112.166 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.05 -9.45 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.889 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.6 -27.31 65.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.663 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.73 -2.53 3.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.037 0.446 . . . . 0.0 110.462 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.69 114.47 26.45 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.238 0.542 . . . . 0.0 109.699 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.5 mmpt? -106.54 142.7 35.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.738 -176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.27 121.46 38.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.87 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -111.77 117.53 33.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.015 0.436 . . . . 0.0 111.605 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.7 t80 -105.28 109.67 21.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 56.88 30.59 18.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.803 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.47 56.15 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.308 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 20.2 mt -111.02 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -72.66 90.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -76.99 158.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.892 -175.336 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.0 pttp -118.69 159.31 23.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.994 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.72 -2.68 21.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.1 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.527 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -91.37 -0.85 57.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.777 0.322 . . . . 0.0 111.23 177.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -112.4 -175.35 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.269 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 39.1 p -137.75 176.57 8.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.784 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.01 -45.73 59.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.764 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.42 -33.0 69.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.127 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.13 -48.64 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 61' ' ' ILE . 72.1 m-85 -88.95 1.75 54.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.292 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.91 45.85 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.38 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.0 mtt -70.5 85.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.774 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.25 -172.31 1.38 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.78 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 53.0 t30 -62.22 114.95 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.224 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 39.49 2.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.645 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.804 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.87 114.62 19.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.171 0.485 . . . . 0.0 110.312 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.75 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.07 0.462 . . . . 0.0 110.851 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.676 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.46 149.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -117.69 119.65 35.61 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -84.47 131.86 34.62 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.588 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.73 144.35 27.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 51' ' ' LYS . 23.1 tp . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.444 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.7 Cg_endo . . . . . 0 N--CA 1.478 0.592 0 N-CA-C 109.773 -0.895 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.1 m -120.36 152.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 0.0 110.544 -177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 m -87.54 119.23 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.685 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.1 pt -120.0 142.36 35.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.275 0.559 . . . . 0.0 110.987 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -125.58 148.2 49.02 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.413 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.79 105.86 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.56 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.441 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -70.7 106.41 3.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.635 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 19' ' ' LEU . 85.6 t -76.94 128.78 80.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.826 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.1 Cg_endo -65.32 149.75 88.0 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.29 1.993 . . . . 0.0 111.698 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.453 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 33.0 m-80 -76.08 84.73 2.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.462 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.577 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 51.0 mtm -137.49 75.58 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.142 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.3 mp0 -79.03 -45.46 20.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.729 0.775 . . . . 0.0 109.747 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -119.61 -0.06 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.737 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 33.9 mmtt -81.17 -6.01 58.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.056 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -164.85 -175.84 3.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.647 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.4 -0.08 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.92 0.39 . . . . 0.0 111.665 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.6 m0 -85.01 168.87 14.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.67 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.9 28.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.454 0.645 . . . . 0.0 110.898 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.0 mt -79.88 128.8 33.89 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 20.7 m-80 -140.55 9.78 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.883 -0.511 . . . . 0.0 111.368 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 85.09 10.49 78.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.882 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -84.02 179.45 7.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.891 0.377 . . . . 0.0 110.426 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 7' ' ' GLN . 62.2 t -125.46 126.83 71.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -87.64 141.87 28.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.16 114.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CD2' ' HE3' ' A' ' 40' ' ' LYS . 56.7 m-85 -130.13 166.46 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.75 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.8 m -126.81 123.38 37.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.775 0.321 . . . . 0.0 110.418 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 2' ' ' VAL . 73.2 mt -139.04 152.41 69.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.953 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.45 152.81 74.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.223 1.948 . . . . 0.0 111.689 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.0 tp -64.3 -7.05 8.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -83.82 -17.26 41.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.491 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.26 -173.78 3.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.237 0.542 . . . . 0.0 110.716 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 3.0 pm0 -146.07 175.22 10.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.419 -172.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 61' ' ' ILE . 19.8 t -59.46 -29.74 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.702 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.594 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.4 m -53.38 -29.35 34.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.397 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.7 t -78.81 -32.61 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.601 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -70.59 -46.99 67.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.306 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.1 ptmt -62.29 -44.46 96.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.922 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 p -67.48 -35.39 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.703 -176.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.34 -34.63 74.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.624 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 54' ' ' LEU . 82.6 mt -74.57 -42.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.361 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -57.41 -32.38 66.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.561 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 14.1 mm-40 -87.7 -29.13 21.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.45 -44.94 18.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.2 p -99.58 -45.04 5.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.649 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.79 -17.17 6.85 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.681 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.601 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.5 ptm -82.86 116.17 62.63 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.541 0.686 . . . . 0.0 111.451 -175.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.7 Cg_endo -68.07 162.9 38.04 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.522 2.148 . . . . 0.0 111.992 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.96 -8.46 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.847 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.39 66.64 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.399 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.536 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -128.07 -24.25 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 109.92 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.714 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.44 113.53 10.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.082 176.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 6.7 mmpt? -107.34 140.6 40.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 41' ' ' ILE . 1.9 mm? -112.27 123.98 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.829 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.0 tt0 -115.57 115.59 26.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD12 ' A' ' 78' ' ' ILE . 10.8 t80 -101.6 107.82 19.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.258 0.552 . . . . 0.0 110.108 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 5.2 mm-40 56.74 29.44 15.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.053 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.0 14.95 37.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.026 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 25.7 mt -117.51 116.0 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -72.36 95.65 1.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -84.52 154.09 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -132.51 174.84 9.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.839 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -28.79 20.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.568 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.441 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 4.6 m -86.16 10.52 14.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.174 -169.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 14.5 m120 -114.71 172.66 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.4 p -130.08 166.58 19.88 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.05 -44.12 85.5 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.65 -38.88 79.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.628 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.14 -40.8 77.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -95.57 6.4 49.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.452 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.54 38.89 22.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.967 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.1 mtt -67.48 87.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 111.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.55 -168.64 2.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.302 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.51 115.12 2.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.121 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.7 3.25 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.648 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.66 114.65 21.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.029 0.415 . . . . 0.0 109.978 177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.85 102.2 13.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.57 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.24 150.52 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.16 116.47 27.88 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.539 HD11 ' HG3' ' A' ' 52' ' ' GLN . 38.0 tp -82.53 131.68 35.21 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.24 145.59 27.17 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 C--N 1.318 -0.784 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.817 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.51 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.5 Cg_endo . . . . . 0 N--CA 1.479 0.643 0 N-CA-C 110.159 -0.747 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 16.1 m -122.49 156.21 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.813 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -82.52 127.24 33.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.021 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.5 pt -130.71 136.64 57.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.129 0.49 . . . . 0.0 110.826 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 17.5 mttt -123.35 145.47 48.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.764 -173.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.8 108.44 24.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.527 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -74.03 104.01 4.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.649 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.539 HG13 HD22 ' A' ' 19' ' ' LEU . 62.1 t -76.71 131.19 74.38 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.455 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.825 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.1 Cg_endo -66.62 155.68 69.24 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.14 1.894 . . . . 0.0 112.214 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.433 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 26.1 m-80 -82.54 84.2 7.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.599 ' HB3' HG22 ' A' ' 15' ' ' THR . 48.6 mtm -137.45 75.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.605 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 9.3 mp0 -79.91 -47.47 15.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.689 -171.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -120.89 10.78 10.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -93.27 -2.18 55.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.834 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.3 t -167.77 -176.73 3.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.86 -12.52 41.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.808 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.67 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.2 m0 -84.99 164.34 18.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.563 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.85 29.94 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.672 0.748 . . . . 0.0 110.86 -178.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.825 HD13 ' HG2' ' A' ' 9' ' ' PRO . 19.4 mt -78.94 127.25 31.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.556 -0.715 . . . . 0.0 109.269 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 17.2 m-80 -137.82 20.57 2.86 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.766 -0.584 . . . . 0.0 111.364 -175.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 75.14 1.39 63.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.085 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -76.58 176.51 8.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.26 0.552 . . . . 0.0 110.526 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 7' ' ' GLN . 58.2 t -125.31 123.48 65.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.904 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 51.4 mt -88.05 136.92 32.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.35 110.38 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 120.971 0.415 . . . . 0.0 110.0 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.44 166.33 16.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.593 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.6 m -126.49 122.59 35.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 4' ' ' ILE . 73.4 mt -136.09 154.04 77.2 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.72 152.52 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.87 1.713 . . . . 0.0 110.982 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.65 -8.7 10.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -79.61 -18.38 51.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.44 -175.13 2.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 110.648 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.8 pm0 -145.1 172.83 12.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.342 -173.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HG13 ' A' ' 61' ' ' ILE . 40.4 t -62.82 -26.81 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.564 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -54.16 -33.16 57.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.316 176.546 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -74.03 -32.05 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 mm -72.61 -48.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.751 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.7 ptmt -59.86 -40.95 90.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.744 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -72.97 -39.23 57.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.041 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 16.4 ptpt -63.5 -35.6 81.01 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.259 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.9 mt -72.35 -43.58 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.264 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -59.84 -34.71 73.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.36 -36.41 39.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.748 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.74 8.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.729 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.8 p -91.66 -43.49 9.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.11 -15.22 9.44 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.949 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -81.36 119.96 77.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.458 0.647 . . . . 0.0 111.565 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.0 Cg_endo -67.85 156.7 64.9 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.77 2.313 . . . . 0.0 112.056 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.97 -12.54 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.483 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.64 -32.58 58.56 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.557 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HD2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.68 -3.92 4.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.148 0.499 . . . . 0.0 110.495 -177.116 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.68 116.33 28.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.31 0.576 . . . . 0.0 109.547 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.76 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -104.92 140.92 37.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.74 118.69 32.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.146 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 25.9 tt0 -111.48 116.0 30.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.593 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.637 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.7 t80 -103.85 108.97 20.53 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 61.6 mm-40 57.35 30.23 18.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.741 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.46 10.36 53.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.316 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.8 mt -114.49 118.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 10.1 m-30 -74.11 89.41 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.627 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -74.44 154.4 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.75 -175.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.9 pttp -117.14 160.02 21.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.945 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -72.19 -5.28 34.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.46 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -88.71 0.42 56.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.884 0.373 . . . . 0.0 110.748 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -112.47 176.89 4.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.3 p -130.43 170.03 14.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.318 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.52 -43.6 80.42 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.861 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.97 76.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.282 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -57.59 -44.73 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.958 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -88.9 3.38 51.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.264 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.26 41.0 20.72 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.021 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -62.8 94.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.446 0.641 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.75 -177.9 2.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 33.3 t30 -61.83 116.76 5.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.22 39.29 3.79 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.364 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.53 114.91 16.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.345 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.28 105.11 16.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -93.87 148.82 4.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -117.0 116.9 28.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.05 133.31 34.66 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.0 148.91 31.24 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.392 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 51' ' ' LYS . 26.1 tp . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.564 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.4 Cg_endo . . . . . 0 C--O 1.231 0.145 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.96 154.66 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.385 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m -85.55 124.85 32.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 76' ' ' ALA . 4.6 pt -128.38 148.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 77' ' ' VAL . 10.1 mttm -128.13 147.53 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 105.81 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.4 104.72 5.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.979 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 19' ' ' LEU . 57.6 t -73.67 133.02 80.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.367 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.835 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.0 Cg_endo -68.66 151.23 74.97 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.995 1.797 . . . . 0.0 111.772 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.457 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 24.7 m-80 -79.89 88.45 5.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.517 ' HB3' HG22 ' A' ' 15' ' ' THR . 51.0 mtm -138.84 75.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.9 mp0 -78.84 -45.95 19.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.86 -168.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -120.21 2.8 10.9 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.133 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -86.33 -4.83 59.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.157 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.6 t -161.47 -176.46 5.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.826 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.99 -0.33 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.106 0.479 . . . . 0.0 111.627 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.662 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -89.84 174.56 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.081 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 28.51 1.4 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.193 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.7 mt -79.56 122.71 26.83 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.634 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.8 m-80 -136.49 20.13 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.255 0.55 . . . . 0.0 110.452 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 81.18 -7.85 59.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.976 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.576 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -65.79 176.02 1.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.522 0.677 . . . . 0.0 111.15 -178.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.91 126.69 74.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.919 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 mt -87.51 132.17 34.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.34 107.39 18.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -125.08 167.35 14.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.396 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.1 m -126.51 119.89 28.29 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 4' ' ' ILE . 67.4 mt -134.38 149.89 72.41 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 42.6 Cg_endo -70.01 149.23 65.02 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.387 2.058 . . . . 0.0 111.62 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.6 -12.16 21.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.872 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -72.65 -25.26 61.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -75.01 -173.62 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.136 0.493 . . . . 0.0 110.731 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.3 pm0 -145.55 173.42 12.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.819 0.342 . . . . 0.0 111.714 -172.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 61' ' ' ILE . 25.6 t -57.28 -31.35 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.74 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 15.3 m -50.64 -36.07 33.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.126 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 39.0 t -72.04 -33.97 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.615 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.7 -52.6 22.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.816 0.341 . . . . 0.0 110.479 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 10.7 ptmt -57.97 -44.59 87.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.513 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.63 -32.72 56.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.65 -46.52 78.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.856 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.47 -38.14 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.159 0.504 . . . . 0.0 110.264 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' MET . 7.6 t-80 -56.9 -34.57 68.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.481 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -90.91 -29.93 17.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.978 0.418 . . . . 0.0 111.024 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.62 -44.92 32.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.431 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -102.03 -40.5 6.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.57 -8.77 10.91 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.962 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.546 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.0 ptm -90.99 117.89 68.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 111.811 -176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.2 Cg_endo -66.92 157.25 62.46 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.7 2.266 . . . . 0.0 111.873 175.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.65 -14.2 40.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.682 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.07 -34.12 52.12 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.44 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -126.9 -7.82 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 110.252 -177.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.93 116.57 29.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.59 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.726 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -107.13 142.81 36.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.782 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.05 124.56 46.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -116.39 119.52 35.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.038 0.447 . . . . 0.0 111.44 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 8.8 t80 -103.65 104.78 14.86 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 57.24 29.69 17.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.849 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.44 14.51 37.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.916 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -120.69 114.35 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -76.67 92.74 3.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.855 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.506 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -74.89 150.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.42 -177.158 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -125.71 171.26 10.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.125 0.488 . . . . 0.0 111.869 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -18.88 45.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.188 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.432 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 3.9 m -86.97 10.12 17.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.065 0.459 . . . . 0.0 110.773 -175.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -122.4 171.19 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 79.4 p -129.56 169.93 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.94 -44.13 85.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.11 75.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.54 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.19 -39.96 84.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 49.1 m-85 -91.09 -2.33 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.285 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.71 46.47 20.04 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.638 0.586 . . . . 0.0 110.124 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.6 mtt -62.04 87.79 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.272 0.558 . . . . 0.0 110.747 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.58 179.58 3.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.712 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -61.18 115.8 4.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.344 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.97 33.61 3.7 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.135 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.22 114.79 18.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.118 0.485 . . . . 0.0 110.031 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 5' ' ' LYS . 26.5 t -99.1 106.06 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.931 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -94.44 149.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -116.57 119.35 35.29 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 tp -85.74 133.3 34.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.63 34.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 51' ' ' LYS . 37.4 tp . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.109 0.48 . . . . 0.0 110.97 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 N-CA-C 110.307 -0.69 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.56 158.63 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 m -90.51 122.13 33.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.12 0.486 . . . . 0.0 110.595 -176.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.736 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -125.46 138.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.956 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -120.58 146.38 46.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.14 105.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.236 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 101.43 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.872 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 22.3 t -72.24 129.33 87.72 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.7 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HG2' HD13 ' A' ' 19' ' ' LEU . 43.1 Cg_endo -66.15 149.19 85.72 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.517 2.145 . . . . 0.0 111.677 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.493 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 25.8 m-80 -73.78 85.43 1.68 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.459 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -136.09 74.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.965 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.6 mp0 -78.99 -44.96 21.22 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.727 0.775 . . . . 0.0 109.557 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -119.79 3.59 11.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.212 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -88.87 -5.06 58.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.028 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.7 t -162.68 -175.74 4.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.675 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -105.19 3.26 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -90.43 169.52 10.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.126 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -81.96 31.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.154 0.502 . . . . 0.0 111.631 -178.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' HG2' ' A' ' 9' ' ' PRO . 20.8 mt -83.74 132.97 34.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.69 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.6 m-80 -147.29 19.27 1.21 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 110.14 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.493 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 85.23 -3.26 87.49 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 3.5 pm0 -70.88 172.11 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.577 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.24 130.57 74.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 88.8 mt -91.01 147.34 23.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.53 109.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.68 160.68 19.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.241 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -127.1 115.9 19.87 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.1 mt -134.19 151.88 77.28 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.557 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.27 151.89 80.18 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.207 1.938 . . . . 0.0 111.439 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.3 tp -64.72 -4.53 4.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -83.65 -20.68 33.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.444 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.6 m-20 -77.41 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.268 0.556 . . . . 0.0 110.622 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.7 pm0 -144.81 174.01 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 61' ' ' ILE . 39.5 t -61.91 -27.52 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.693 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 29.2 t -51.78 -33.31 34.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.44 175.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.469 HG21 ' OD2' ' A' ' 32' ' ' ASP . 19.8 t -77.44 -30.75 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.93 0.395 . . . . 0.0 110.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.2 mm -71.84 -49.28 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.368 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 ptmt -59.07 -40.6 85.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.48 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.6 p -71.24 -41.09 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.083 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -65.72 -35.58 81.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.893 -177.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.9 -41.57 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.281 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -57.84 -34.75 70.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.088 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 52.9 mt-10 -82.84 -33.02 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.952 0.406 . . . . 0.0 110.419 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.8 -44.14 23.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.769 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.1 p -102.18 -44.94 5.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.763 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.84 -5.84 10.49 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.116 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.457 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -89.57 116.88 67.45 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 111.366 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.12 159.36 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.518 2.145 . . . . 0.0 111.848 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.16 -14.85 57.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.822 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.16 -30.7 55.26 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.081 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -128.66 -3.96 5.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.167 0.508 . . . . 0.0 109.995 -177.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.23 115.52 28.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.734 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.7 mmpt? -108.14 141.61 39.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.0 mt -117.51 121.49 41.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.819 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.6 tt0 -113.54 117.36 31.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.238 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.623 ' HB2' HD12 ' A' ' 78' ' ' ILE . 9.9 t80 -103.54 109.45 21.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.027 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 56.4 29.59 15.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.747 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.67 13.05 45.37 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 19.6 mt -116.97 118.99 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -74.04 93.15 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -79.28 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.552 -178.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.22 166.83 12.12 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.59 -12.35 61.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 0.0 111.387 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -78.22 -10.3 59.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 72.7 m-20 -99.47 164.26 12.17 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.6 p -125.09 167.5 14.69 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.04 -43.41 87.63 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.911 0.386 . . . . 0.0 110.028 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.96 -34.85 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' SER . 67.3 t80 -55.64 -45.08 77.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.422 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 29.7 m-85 -97.53 9.48 42.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.631 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 57.25 45.84 19.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.248 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.3 mtt -69.08 90.09 0.45 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.085 0.469 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.81 -172.34 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.823 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -61.08 115.53 3.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.257 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 31.58 5.46 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.62 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.02 114.56 13.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.03 104.53 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 0.0 110.913 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.23 148.27 5.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -112.88 118.33 34.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -82.77 132.74 35.16 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.03 147.01 29.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.3 tp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 28.9 Cg_endo . . . . . 0 N--CA 1.478 0.584 0 N-CA-C 110.601 -0.577 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.97 157.13 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -90.65 117.83 29.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 110.449 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.8 pt -121.0 143.53 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.739 -176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -126.25 150.51 48.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.804 0.335 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 49.0 t -124.77 107.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.852 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.08 105.75 3.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 19' ' ' LEU . 60.3 t -76.41 131.83 73.97 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.1 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 19' ' ' LEU . 41.4 Cg_endo -68.0 149.58 77.33 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.223 1.949 . . . . 0.0 111.781 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -76.32 86.98 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -135.55 76.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.679 . . . . 0.0 110.175 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 10.8 mp0 -79.9 -45.38 18.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.572 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.68 -5.59 10.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.006 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 34.7 mmtt -75.71 -8.13 56.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.662 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.3 t -163.81 -172.68 2.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -105.97 0.36 25.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m0 -85.38 168.61 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.01 28.8 0.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.661 . . . . 0.0 111.407 -177.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -81.1 122.0 26.8 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.79 -0.569 . . . . 0.0 109.832 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.638 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 15.9 m-80 -138.06 16.66 2.82 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.943 -0.473 . . . . 0.0 110.665 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.19 -2.46 85.27 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.29 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -73.81 179.36 4.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.274 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.56 128.61 76.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.293 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.2 mt -87.77 144.94 26.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.92 111.12 19.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.051 0.453 . . . . 0.0 109.856 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 92.6 m-85 -120.92 162.6 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.353 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.7 m -127.67 119.01 24.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.755 0.312 . . . . 0.0 110.175 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -137.66 149.0 63.41 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.137 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 23.5 Cg_endo -64.99 148.62 89.78 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.302 2.001 . . . . 0.0 111.47 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.6 tp -60.54 -14.51 20.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.961 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -76.99 -21.57 54.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.776 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD2' ' HG2' ' A' ' 29' ' ' PRO . 3.0 m-20 -74.18 -174.81 2.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.608 . . . . 0.0 110.71 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 3.0 pm0 -143.97 174.75 10.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.72 -171.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 44.5 t -58.98 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.847 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 8.5 t -52.56 -34.29 49.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.134 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.05 -32.7 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 22.5 mm -72.0 -50.77 35.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 6.3 ptmt -58.0 -41.88 84.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.473 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 14.2 p -70.8 -41.26 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.009 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -64.65 -35.66 81.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.957 -178.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -69.81 -41.89 79.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.05 0.452 . . . . 0.0 110.362 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -58.73 -31.45 68.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.93 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 5.7 mm-40 -81.69 -36.63 28.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 110.573 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.46 -49.26 17.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.64 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.5 p -96.07 -45.28 6.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.969 0.414 . . . . 0.0 110.51 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.13 -20.14 6.34 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.68 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.486 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.7 ptm -77.81 119.33 76.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.547 . . . . 0.0 111.341 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 19.8 Cg_endo -68.03 157.98 59.39 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.329 2.019 . . . . 0.0 111.831 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.22 -9.57 18.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.419 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.05 -26.53 61.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.886 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.643 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.05 -5.67 2.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.926 0.394 . . . . 0.0 110.316 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.65 116.03 28.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.9 mmpt? -105.79 140.23 39.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.53 116.82 28.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.338 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.3 tt0 -108.03 112.12 24.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.668 ' HB2' HD12 ' A' ' 78' ' ' ILE . 26.5 t80 -102.61 114.43 28.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.767 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 31.1 mm-40 56.56 29.54 15.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.459 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.52 8.77 57.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.733 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 9.5 mt -115.17 118.51 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.4 m-30 -68.49 94.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 0.0 109.953 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.45 152.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.428 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -122.43 167.3 13.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 6.2 t70 -59.36 -27.93 66.39 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.149 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -75.02 -11.06 60.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.382 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -105.9 170.01 8.15 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.932 0.396 . . . . 0.0 110.141 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.6 p -130.36 175.01 9.3 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.202 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.38 -43.34 73.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.26 -35.11 76.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.452 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -57.18 -42.15 80.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.641 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 73.5 m-85 -95.08 0.34 54.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.96 47.28 12.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.786 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtt -69.96 87.46 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.25 -173.28 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.348 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -63.37 115.69 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 110.035 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.82 2.85 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.041 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.65 114.93 21.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.016 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.27 104.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.041 0.448 . . . . 0.0 110.719 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.13 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.59 114.66 23.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.16 133.58 34.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.92 148.27 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.6 tp -76.72 129.07 35.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 25.2 ttpp -56.91 -51.1 70.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.408 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -148.23 110.63 4.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 -175.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HE ' ' N ' ' A' ' 86' ' ' GLY . 6.8 tpm_? -84.35 98.4 10.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.673 0.749 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' N ' ' HE ' ' A' ' 85' ' ' ARG . . . . . . . . 0 N--CA 1.438 -1.2 0 CA-C-O 117.87 -1.516 . . . . 0.0 110.181 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.479 0.633 0 N-CA-C 109.48 -1.008 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 15.8 m -126.56 153.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.395 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -84.2 124.6 31.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.7 pt -124.48 137.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.249 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG22 ' A' ' 77' ' ' VAL . 11.0 mttm -117.85 146.36 43.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.088 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.0 105.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -72.06 104.24 3.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.654 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 HD22 ' A' ' 19' ' ' LEU . 69.9 t -75.26 128.09 85.2 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.364 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 33.4 Cg_endo -64.87 150.81 87.6 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.152 1.901 . . . . 0.0 111.907 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 17.8 m-80 -77.54 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.713 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.541 ' HB3' HG22 ' A' ' 15' ' ' THR . 41.0 mtm -142.53 75.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.707 0.289 . . . . 0.0 110.251 174.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 7.4 mp0 -78.92 -44.22 23.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 110.134 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.53 -2.54 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.029 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -87.79 -6.92 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.423 -172.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.0 t -161.38 -179.91 7.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.07 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.72 3.0 41.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.548 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.577 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 6.0 m0 -85.94 171.91 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -87.9 26.83 1.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 0.0 110.886 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.9 mt -80.19 128.16 33.19 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.664 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.3 m-80 -140.78 9.13 2.17 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.063 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.4 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 88.23 7.99 72.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.265 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -80.8 175.86 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.54 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 7' ' ' GLN . 44.5 t -124.96 124.19 67.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.73 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -87.62 136.07 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.73 107.51 19.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -122.55 166.2 15.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.717 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 m -126.8 122.02 33.58 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.853 0.359 . . . . 0.0 110.775 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 4' ' ' ILE . 68.9 mt -138.57 152.36 70.8 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.513 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 43.5 Cg_endo -69.86 152.1 68.69 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.215 1.943 . . . . 0.0 111.748 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 tp -62.49 -11.97 19.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.663 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -73.97 -23.98 59.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -76.28 -172.95 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.276 0.56 . . . . 0.0 110.72 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.5 pm0 -144.85 171.97 13.68 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.625 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.666 HG11 HG13 ' A' ' 61' ' ' ILE . 26.1 t -63.05 -26.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.338 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.43 -31.83 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.75 -30.65 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.11 0.481 . . . . 0.0 110.247 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.3 mm -71.16 -51.99 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.2 ptmt -58.03 -43.72 86.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.68 -38.58 79.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.583 0.23 . . . . 0.0 111.004 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.9 ptmt -68.87 -35.29 76.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.498 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.75 -41.88 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' MET . 8.1 t-80 -56.71 -35.2 68.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.022 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.53 -20.86 21.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.44 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.55 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.0 p -107.88 -42.94 4.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.047 0.451 . . . . 0.0 110.721 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.08 -8.42 10.52 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.012 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 17.5 ptm -90.32 119.95 69.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.134 0.492 . . . . 0.0 111.699 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.3 Cg_endo -68.91 156.89 63.95 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.547 2.164 . . . . 0.0 112.266 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.69 -16.87 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.547 ' O ' ' HE2' ' A' ' 83' ' ' LYS . . . -52.4 -30.61 33.69 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.281 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.63 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -131.35 -6.0 3.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.441 . . . . 0.0 110.005 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.67 112.04 23.84 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.1 mmpt? -103.43 141.03 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.392 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.44 121.61 45.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.448 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.5 tt0 -113.64 115.77 28.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.8 t80 -101.81 107.53 18.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.225 0.536 . . . . 0.0 110.029 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 57.15 30.47 18.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.831 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.5 38.62 Favored Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.49 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.1 mt -118.74 116.02 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.0 m-85 -72.04 91.9 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.167 0.508 . . . . 0.0 110.114 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.666 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -78.12 150.32 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.3 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.57 156.27 20.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.806 0.336 . . . . 0.0 110.827 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 5.7 p-10 -71.37 -2.93 18.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.996 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t -86.12 -5.34 59.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.748 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -104.15 178.44 4.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.524 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 76.6 p -133.38 173.16 11.77 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.44 -33.46 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.231 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' SER . 47.3 t80 -56.47 -45.9 80.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -91.68 -0.62 57.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.744 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 63.82 41.41 6.84 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.365 0.415 . . . . 0.0 110.888 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -64.27 93.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.316 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 177.98 4.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.918 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 36.0 t-20 -64.45 115.37 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.144 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.21 28.14 5.04 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.195 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 115.11 10.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.449 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 5' ' ' LYS . 15.3 t -95.08 103.54 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.793 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.51 146.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -116.41 111.57 20.22 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -76.78 132.41 39.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.407 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 147.24 32.12 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.3 tp -78.15 135.39 37.64 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 17.8 ttpp -50.83 143.22 10.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.896 0.747 . . . . 0.0 111.506 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -46.43 127.68 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.798 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -56.25 -42.4 77.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.713 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.012 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.084 -179.509 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.06 152.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.945 0.403 . . . . 0.0 110.298 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -88.73 114.99 25.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.244 0.545 . . . . 0.0 110.355 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.1 pt -114.81 136.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.481 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 13.5 mttm -118.63 147.33 43.86 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.122 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.5 t -125.43 105.27 14.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.92 104.52 2.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.655 HG13 HD22 ' A' ' 19' ' ' LEU . 25.9 t -76.53 126.84 85.64 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.798 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.781 ' HG2' HD13 ' A' ' 19' ' ' LEU . 27.5 Cg_endo -63.97 147.26 91.92 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.399 2.066 . . . . 0.0 111.875 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.534 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 21.0 m-80 -73.85 88.5 1.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.771 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.479 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.1 mtm -138.53 75.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.12 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.8 mp0 -79.49 -44.87 20.42 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.311 -173.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -116.44 2.14 13.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.908 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -90.81 -4.87 56.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.493 -171.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.1 t -164.25 -174.21 3.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.887 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -99.02 -3.66 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.407 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.9 m0 -85.78 169.98 12.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.094 0.473 . . . . 0.0 111.176 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.09 22.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.001 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -77.52 133.32 38.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 21.1 m-80 -146.96 10.1 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 86.31 16.08 63.17 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.291 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -87.96 175.69 7.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.55 127.73 75.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.971 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 85.7 mt -87.91 141.71 28.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.39 107.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 24.1 m-85 -121.01 164.83 16.15 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 1' ' ' PRO . 4.9 m -126.44 122.26 34.78 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.218 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 HD11 ' A' ' 4' ' ' ILE . 78.6 mt -137.41 149.81 66.65 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.652 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 33.5 Cg_endo -66.27 152.2 81.61 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.273 1.982 . . . . 0.0 111.471 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 tp -62.82 -8.07 6.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -80.11 -20.71 44.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -74.84 -176.2 2.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.138 0.494 . . . . 0.0 110.217 177.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.9 pm0 -144.97 174.65 10.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.901 0.381 . . . . 0.0 111.563 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 61' ' ' ILE . 39.8 t -60.68 -30.33 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 m -51.69 -36.1 45.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.024 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -72.05 -32.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 23.9 mm -72.5 -51.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.452 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 3.3 ptmt -59.2 -42.56 91.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.498 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.3 p -69.83 -37.45 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.164 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 11.3 ptmt -69.31 -36.67 77.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.745 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.03 -41.35 81.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -58.73 -32.78 69.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.305 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 15.1 mm-40 -85.44 -30.89 23.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.902 0.382 . . . . 0.0 110.798 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.88 -46.62 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.956 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -97.53 -40.56 8.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.477 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.11 -15.92 10.11 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.931 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -82.14 117.0 66.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.385 0.612 . . . . 0.0 111.464 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 22.1 Cg_endo -67.25 159.01 54.24 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.595 2.197 . . . . 0.0 111.882 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.4 -13.58 58.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.45 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -29.25 54.76 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.968 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -132.45 -2.63 3.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 0.0 110.63 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -95.24 117.65 30.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.114 0.483 . . . . 0.0 109.887 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.7 mmpt? -104.27 139.96 38.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -120.04 118.87 31.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.634 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -112.96 117.32 31.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -102.73 107.98 19.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.947 0.403 . . . . 0.0 110.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 57.18 30.57 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.355 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.58 23.73 25.43 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.064 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 21.1 mt -126.38 116.21 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -72.15 95.9 1.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.474 0.654 . . . . 0.0 110.29 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -80.28 150.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.567 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HE3' HD22 ' A' ' 65' ' ' ASN . 1.0 OUTLIER -118.97 162.54 18.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.593 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 5.5 t70 -54.06 -27.7 34.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.218 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.15 -1.94 16.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.789 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.509 HD22 ' HE3' ' A' ' 62' ' ' LYS . 11.9 m120 -115.69 168.76 9.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.394 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 91.9 p -125.73 173.15 9.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.33 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.12 -42.86 79.57 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.51 -33.92 73.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.222 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.09 -44.87 91.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.19 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.66 5.52 51.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.654 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 60.5 43.28 13.19 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 110.866 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.18 84.89 0.37 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.026 0.441 . . . . 0.0 110.76 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.48 -176.58 2.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.702 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -58.69 115.5 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.56 36.11 3.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.654 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -81.35 114.9 20.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 14.7 t -97.66 105.57 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.101 0.477 . . . . 0.0 110.94 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -95.53 148.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -118.24 117.04 28.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -84.55 133.97 34.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.61 151.8 35.64 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 51' ' ' LYS . 24.3 tp -81.87 143.45 31.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.78 -42.79 99.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.542 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -87.92 143.37 27.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -149.33 100.67 3.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.816 0.341 . . . . 0.0 111.14 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.828 -0.984 . . . . 0.0 111.625 176.919 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.6 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.92 154.43 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -90.81 120.83 32.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.332 0.586 . . . . 0.0 109.851 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.805 HG22 ' HB3' ' A' ' 76' ' ' ALA . 9.5 pt -120.46 143.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.402 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.562 ' HD2' HG22 ' A' ' 77' ' ' VAL . 4.5 mttm -119.26 150.14 40.59 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.889 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.12 105.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.43 106.2 3.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.68 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 79.2 t -77.18 130.0 76.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.741 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.8 Cg_endo -65.82 156.56 63.55 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.636 2.224 . . . . 0.0 111.829 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.499 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 33.2 m-80 -85.32 85.82 7.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.0 mtm -137.95 76.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.725 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.594 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -77.76 -48.03 17.6 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.657 0.742 . . . . 0.0 110.334 -171.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 10.9 10.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.311 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -90.66 -4.89 56.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.678 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -158.24 -172.94 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.796 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -101.17 -5.07 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.54 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.2 m0 -91.6 171.87 8.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.879 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 28.22 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 110.996 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.741 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.5 mt -78.26 127.74 32.68 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -138.74 16.53 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.462 -0.774 . . . . 0.0 111.022 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 82.91 7.86 86.64 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -80.28 175.1 10.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.394 0.616 . . . . 0.0 110.61 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.3 t -120.6 123.01 69.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.603 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.7 mt -87.59 142.11 28.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 5' ' ' LYS . 57.8 t -132.39 107.78 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.529 0.681 . . . . 0.0 109.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.45 164.28 13.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.825 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -126.79 118.7 25.19 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.99 174.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.9 152.66 77.77 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.851 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.11 150.08 82.23 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.389 2.059 . . . . 0.0 111.246 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -61.8 -10.59 9.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.538 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -79.09 -18.94 52.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.867 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.02 -175.44 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -144.44 177.32 8.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.145 0.498 . . . . 0.0 111.567 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.512 ' CG1' HG13 ' A' ' 61' ' ' ILE . 60.3 t -56.14 -33.07 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.742 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m -54.9 -30.76 59.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.22 -27.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 110.532 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.1 mm -72.4 -54.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.0 ptmt -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.13 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.889 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.59 -35.22 78.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.5 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 54' ' ' LEU . 67.4 mt -72.65 -43.08 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.526 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -59.04 -33.4 70.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.536 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -89.24 -20.41 24.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.064 0.459 . . . . 0.0 110.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.75 -54.48 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.153 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.7 p -91.15 -43.01 10.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.3 7.23 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.929 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.4 118.07 70.63 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.395 0.617 . . . . 0.0 111.602 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.36 157.33 62.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.433 2.088 . . . . 0.0 111.9 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.04 -8.02 20.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.384 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.76 -28.9 66.33 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.281 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.6 -2.75 3.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 110.449 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.64 117.26 32.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 mmpt? -110.92 140.33 45.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.391 -176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -111.0 124.21 51.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.436 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.45 117.9 31.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.739 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 14.2 t80 -103.33 108.25 19.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.092 0.473 . . . . 0.0 110.073 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.59 30.95 16.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.031 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.59 45.08 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.203 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.414 HG21 ' HE1' ' A' ' 70' ' ' TYR . 8.7 mt -120.57 113.04 38.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -73.49 92.96 1.93 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.607 0.717 . . . . 0.0 110.409 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.512 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -72.57 158.11 6.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.425 -174.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -130.48 163.65 26.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.322 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m-20 -50.58 -32.19 17.98 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.814 0.696 . . . . 0.0 112.236 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -82.45 2.42 32.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.103 0.477 . . . . 0.0 110.95 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -110.47 163.74 13.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.5 p -129.76 165.94 20.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.87 -44.04 97.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.767 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.14 82.74 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.368 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -59.34 -42.75 92.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HE1' HG21 ' A' ' 59' ' ' ILE . 33.7 m-85 -89.11 1.28 55.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.665 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 58.72 44.22 17.52 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.641 0.588 . . . . 0.0 110.864 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.9 mtt -67.24 89.45 0.2 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.06 -169.65 1.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.712 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -61.74 115.53 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.26 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.29 38.75 3.92 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.768 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.59 115.02 14.83 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.786 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.562 HG22 ' HD2' ' A' ' 5' ' ' LYS . 21.7 t -94.94 102.26 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.192 0.52 . . . . 0.0 110.946 -176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -93.9 146.41 6.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -114.78 113.97 24.96 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.69 133.32 35.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.39 146.07 30.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.156 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.4 tp -78.99 139.73 38.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -50.99 132.75 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.392 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -46.55 -57.74 4.46 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.984 0.802 . . . . 0.0 112.166 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -98.79 116.85 31.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.8 177.809 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.5 Cg_exo . . . . . 0 N--CA 1.473 0.31 0 N-CA-C 109.974 -0.818 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.0 m -121.05 153.87 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -89.94 116.18 27.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.035 0.445 . . . . 0.0 110.266 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.682 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -118.28 138.52 48.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.752 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 8.6 mttm -118.66 146.97 44.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.903 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -123.31 105.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.38 106.68 4.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.646 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 84.4 t -78.18 130.63 71.64 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.33 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.736 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.5 Cg_endo -66.09 150.0 85.47 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.37 2.047 . . . . 0.0 111.995 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.469 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 37.9 m-80 -76.53 88.54 3.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.505 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.0 mtm -139.49 75.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.549 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.593 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.82 -45.1 19.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.77 0.795 . . . . 0.0 110.226 -175.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -0.6 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.682 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -92.48 -1.52 56.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.623 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.0 t -166.7 -177.5 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.321 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.69 -7.09 38.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.445 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.665 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -86.02 167.24 15.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.17 29.09 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.229 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.9 mt -79.27 130.69 35.72 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.673 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 20.5 m-80 -143.41 11.84 1.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.849 -0.532 . . . . 0.0 110.826 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 88.86 2.43 78.42 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.758 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.4 pm0 -76.21 174.08 10.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.4 124.36 72.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.08 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 86.3 mt -87.97 147.53 24.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -133.19 109.11 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 89.4 m-85 -115.93 159.47 21.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.214 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.6 m -126.78 112.96 15.99 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.02 0.438 . . . . 0.0 110.038 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.6 mt -133.47 149.68 72.96 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.819 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.69 151.36 85.43 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.354 2.036 . . . . 0.0 111.429 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 26.1 tp -63.17 -12.41 27.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.299 0.571 . . . . 0.0 110.567 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.0 p -80.72 -18.39 47.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.824 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.33 -173.27 2.01 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.153 0.502 . . . . 0.0 110.795 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.4 pm0 -144.9 175.97 9.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 112.039 -173.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 26.1 t -64.95 -26.56 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.646 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 9.8 m -52.22 -33.88 43.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 t -73.54 -33.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.23 -48.59 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.692 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.709 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.96 -39.34 89.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.69 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -74.15 -38.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.046 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.52 -36.23 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.971 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 54' ' ' LEU . 78.8 mt -70.47 -42.69 78.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 110.571 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -57.87 -32.38 67.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.232 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.47 -25.17 22.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.03 0.443 . . . . 0.0 111.102 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.33 -47.86 11.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.605 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.1 p -98.77 -45.12 6.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.656 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.42 -20.49 5.54 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.878 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.452 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.1 ptm -77.97 119.94 79.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 0.0 111.615 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.6 Cg_endo -67.24 159.29 52.92 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 111.8 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.46 -11.38 51.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.542 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.5 -30.33 61.84 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.523 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -131.2 -0.98 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.988 0.423 . . . . 0.0 110.399 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -100.56 125.27 46.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -116.19 142.82 46.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.002 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.8 mm? -112.46 117.59 32.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.574 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.4 tt0 -107.04 113.93 27.69 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.008 0.433 . . . . 0.0 111.041 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.4 t80 -103.6 109.52 21.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.212 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 58.09 30.15 18.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.462 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.08 14.15 46.67 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.34 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 24.2 mt -117.23 118.62 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -75.04 90.36 2.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.194 0.521 . . . . 0.0 109.998 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.556 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -79.25 148.48 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.093 -174.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.737 ' HE3' HD22 ' A' ' 65' ' ' ASN . 0.6 OUTLIER -105.66 162.69 13.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.977 176.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.06 -21.73 66.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 -177.379 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -74.31 5.68 4.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.78 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.737 HD22 ' HE3' ' A' ' 62' ' ' LYS . 10.8 m120 -111.03 166.81 10.74 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 52.8 p -126.15 165.34 19.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.88 -45.01 91.33 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.214 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.3 -33.67 73.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.213 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 66' ' ' SER . 77.9 t80 -57.44 -42.43 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.259 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -98.85 8.17 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.268 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.45 40.26 14.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.43 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -63.75 90.29 0.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.483 . . . . 0.0 111.443 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 178.34 6.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.248 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.32 115.36 2.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.27 29.59 4.76 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.038 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.05 114.3 15.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 27.5 t -95.1 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.543 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -94.31 145.69 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 11.3 m-70 -113.27 114.41 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.44 134.48 35.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.42 145.58 29.28 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.29 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 85' ' ' ARG . 33.1 tp -75.51 145.12 41.61 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 2.1 tppp? -44.62 -69.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.936 0.772 . . . . 0.0 109.991 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -142.31 122.88 14.14 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 170.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.57 ' HA ' HD23 ' A' ' 82' ' ' LEU . 19.5 ptp180 -65.95 -23.73 66.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.171 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.765 -1.019 . . . . 0.0 111.969 177.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.482 ' HB2' HG22 ' A' ' 27' ' ' THR . 31.4 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 18.3 m -124.76 154.29 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.0 110.326 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -87.19 114.44 23.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 110.084 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.715 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -113.33 135.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 13.5 mttt -122.11 146.48 47.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.572 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -124.11 105.98 16.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.738 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.22 103.82 2.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 19' ' ' LEU . 91.0 t -74.0 133.15 79.04 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.563 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.5 Cg_endo -66.48 147.48 82.46 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.766 1.644 . . . . 0.0 111.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.428 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 29.2 m-80 -74.37 88.29 2.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.709 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.511 ' HB3' HG22 ' A' ' 15' ' ' THR . 52.6 mtm -140.61 76.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.09 -46.42 18.09 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.448 0.642 . . . . 0.0 110.137 -171.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.64 6.91 9.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.517 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -80.6 -15.98 55.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 109.576 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 11' ' ' MET . 10.8 t -153.0 -178.78 7.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.991 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 16' ' ' GLU . 10.5 pt-20 -91.31 -3.91 56.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.231 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.599 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -86.87 172.81 9.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.588 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.32 29.72 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.872 -177.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.3 mt -81.05 130.14 34.88 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.606 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.6 m-80 -138.29 15.54 2.79 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.103 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.428 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 82.26 -0.95 88.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.377 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -73.18 177.56 5.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.323 0.583 . . . . 0.0 111.136 -177.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.53 124.65 73.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.567 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.588 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 84.9 mt -86.91 142.67 27.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 110.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.047 0.451 . . . . 0.0 109.806 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 95.7 m-85 -122.71 158.58 29.79 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.895 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -126.22 112.91 16.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.106 0.479 . . . . 0.0 109.938 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 4' ' ' ILE . 85.3 mt -131.32 153.08 81.55 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.74 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.23 150.39 87.52 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.906 1.737 . . . . 0.0 111.277 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.7 tp -60.34 -12.21 8.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.725 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.2 p -78.83 -20.28 50.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.833 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -72.66 -176.25 1.91 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.258 0.552 . . . . 0.0 110.268 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 1.6 pm0 -143.42 173.3 11.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.888 0.375 . . . . 0.0 111.684 -172.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.688 HG11 HG13 ' A' ' 61' ' ' ILE . 40.8 t -61.96 -26.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.479 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -53.94 -32.77 54.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.181 176.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.7 t -78.22 -27.7 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.451 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 33.6 mm -73.04 -48.21 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.952 0.406 . . . . 0.0 110.553 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -61.33 -39.66 91.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.456 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.4 p -72.61 -39.96 61.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.038 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -64.4 -39.23 93.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.802 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.413 HD12 HD11 ' A' ' 54' ' ' LEU . 76.4 mt -68.58 -43.29 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.739 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -57.74 -32.54 67.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.544 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 49.3 mt-10 -82.07 -38.18 25.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 110.141 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.09 -51.16 19.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.431 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.578 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 3.1 p -96.57 -43.07 7.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.0 110.303 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.3 -19.49 6.76 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.81 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.424 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.6 ptm -79.05 119.96 79.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.672 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.6 Cg_endo -68.28 156.43 65.74 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.566 2.177 . . . . 0.0 112.037 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.12 -15.99 58.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.66 -33.6 34.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.863 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.42 -3.91 4.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.554 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.72 121.41 38.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 110.009 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -113.06 144.05 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.02 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.3 mm? -112.83 120.04 40.09 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -108.05 110.33 22.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.101 0.477 . . . . 0.0 111.585 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 21.1 t80 -102.52 112.54 25.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.834 0.349 . . . . 0.0 110.136 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 16.2 mm-40 57.3 30.32 18.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.95 11.53 57.59 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.47 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 22.2 mt -113.97 119.08 60.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 6.7 m-30 -70.74 91.12 0.81 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.292 0.568 . . . . 0.0 109.905 174.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.688 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -77.76 153.25 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.272 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -121.82 161.85 21.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.746 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.78 -2.55 17.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.292 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 m -84.22 -2.89 57.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.035 0.445 . . . . 0.0 110.386 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -119.3 175.11 5.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 80.7 p -129.78 170.38 13.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.172 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.65 -44.0 78.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.74 -37.03 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.318 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -58.82 -46.84 86.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.91 -4.23 58.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.752 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 65.4 41.23 4.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.504 0.503 . . . . 0.0 110.854 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtt -68.01 86.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.47 . . . . 0.0 111.408 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.46 -174.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.889 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.6 t-20 -65.71 115.3 5.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.71 29.16 4.79 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.439 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -72.67 114.44 10.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.97 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.38 150.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 2.0 m80 -118.54 117.76 29.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.44 134.13 34.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.58 147.08 31.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.874 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.0 tp -84.87 127.25 34.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.579 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.82 -45.94 87.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.994 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.04 155.8 44.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.88 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -160.34 177.03 11.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.572 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.423 -1.209 . . . . 0.0 111.247 175.444 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' THR . 7.7 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 12.3 m -123.39 151.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 110.296 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 109.02 20.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.71 0.767 . . . . 0.0 110.778 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.745 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -107.38 143.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.414 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.5 mtmm -126.89 152.03 47.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.656 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t -131.3 105.87 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.606 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.19 107.13 4.06 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.002 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 53.8 t -79.37 133.29 60.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.834 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' A' ' 19' ' ' LEU . 57.5 Cg_endo -70.42 151.99 65.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.464 2.109 . . . . 0.0 112.091 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -78.88 100.95 7.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.582 ' HB3' HG22 ' A' ' 15' ' ' THR . 27.6 mtm -147.21 76.8 1.43 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.455 0.169 . . . . 0.0 110.598 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -48.4 15.93 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.014 0.435 . . . . 0.0 110.912 -169.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -121.42 9.33 10.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.965 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -84.52 -5.5 59.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -162.15 -178.84 6.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.239 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.34 1.55 47.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -88.15 175.57 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.684 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -94.88 30.79 1.99 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.605 -177.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 8' ' ' VAL . 22.0 mt -86.38 115.33 23.83 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.941 -0.475 . . . . 0.0 110.401 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 23.6 m-80 -130.32 21.65 5.21 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.555 -0.716 . . . . 0.0 110.863 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 1.63 87.58 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.046 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.6 pm0 -75.13 179.45 5.03 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 111.117 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.83 132.71 69.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.728 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 67.0 mt -87.51 144.26 26.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 5' ' ' LYS . 96.1 t -131.93 114.62 24.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 110.058 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 99.2 m-85 -128.85 160.16 33.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.8 m -126.55 119.09 26.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.82 151.32 70.23 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.83 149.66 89.28 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.006 1.804 . . . . 0.0 111.192 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 32.0 tp -59.5 -14.16 11.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.66 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -76.67 -19.39 57.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.125 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.31 -174.06 2.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.421 0.629 . . . . 0.0 111.029 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 1.2 pm0 -143.11 172.88 12.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 0.0 112.266 -172.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 45.0 t -60.83 -26.42 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.623 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.29 -33.32 52.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.049 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -76.96 -29.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 21.4 mm -73.0 -45.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.573 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.693 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.4 ptmt -62.68 -42.94 99.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.48 -37.48 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.651 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.56 -35.34 80.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.578 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.88 -42.26 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -59.54 -35.87 75.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.355 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -83.85 -31.35 25.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.819 0.342 . . . . 0.0 111.463 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.47 -38.41 26.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.8 p -106.15 -47.91 3.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.043 0.449 . . . . 0.0 110.628 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.87 -6.55 10.33 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.115 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 22.0 ptm -87.19 115.7 63.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.406 0.622 . . . . 0.0 110.978 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.4 157.56 61.29 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.626 2.217 . . . . 0.0 112.127 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.75 -17.15 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.209 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.55 -31.15 52.01 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.859 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -129.84 -5.37 4.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.49 . . . . 0.0 110.535 -178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.693 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -87.52 113.48 23.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mmpt? -104.94 138.72 40.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.7 mt -118.88 122.4 42.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.975 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -112.3 120.27 41.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.191 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.6 t80 -108.84 110.32 21.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.42 30.79 20.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.05 49.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.16 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 mt -121.94 113.58 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -74.63 95.27 2.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.752 0.787 . . . . 0.0 110.287 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.73 168.9 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.098 -176.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE3' HD22 ' A' ' 65' ' ' ASN . 0.8 OUTLIER -130.46 166.04 21.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.365 177.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.36 -2.78 20.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.898 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.6 t -94.32 13.23 24.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.191 0.519 . . . . 0.0 110.237 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.413 HD22 ' HE3' ' A' ' 62' ' ' LYS . 13.1 m120 -123.64 165.69 16.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 71.6 m -126.15 166.38 17.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.02 -46.53 84.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.767 0.318 . . . . 0.0 110.397 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -59.85 -29.99 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.455 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 66' ' ' SER . 56.7 t80 -62.81 -40.99 99.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -97.86 5.17 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.28 46.55 23.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.332 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 mtt -66.05 82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 110.806 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 171.79 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 48.0 t-20 -55.36 115.95 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.73 27.38 4.66 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.058 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.745 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -78.11 115.06 17.56 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.57 104.33 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.3 mm -94.27 150.62 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -116.78 119.71 36.28 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.75 134.27 33.96 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.715 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.9 142.66 27.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.933 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 85' ' ' ARG . 40.2 tp -81.5 130.21 34.96 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.142 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.3 -55.58 31.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.058 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -174.05 151.12 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.735 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HB2' HD21 ' A' ' 82' ' ' LEU . 34.8 ttt180 -121.69 100.1 6.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.472 -177.209 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.476 0.499 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.15 152.03 24.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.933 0.397 . . . . 0.0 110.389 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -89.02 114.19 25.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.058 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.3 pt -117.64 138.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.696 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -121.53 145.14 48.26 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.233 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.04 105.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.427 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.48 104.61 2.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.567 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.584 HG13 HD22 ' A' ' 19' ' ' LEU . 95.8 t -75.75 127.32 85.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.425 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.827 ' HG2' HD13 ' A' ' 19' ' ' LEU . 26.1 Cg_endo -61.92 151.13 83.14 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.515 2.143 . . . . 0.0 112.2 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.544 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 38.5 m-80 -79.71 83.22 5.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.78 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.49 ' HB3' HG22 ' A' ' 15' ' ' THR . 55.4 mtm -135.81 75.57 1.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.623 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -77.22 -45.8 25.32 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.363 0.601 . . . . 0.0 110.229 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.96 8.86 10.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.984 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -90.39 -4.81 56.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.046 -173.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 17' ' ' TRP . 14.4 t -161.2 -172.71 3.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.942 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.3 4.67 36.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.57 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -96.44 171.65 8.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.81 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 27.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 110.944 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -78.85 129.63 34.78 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.5 m-80 -142.27 15.67 2.04 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.935 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.544 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 81.03 5.03 90.42 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.919 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.624 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.04 179.38 6.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.34 136.59 60.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.184 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.91 142.76 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.28 109.9 19.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -123.19 163.66 20.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.581 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.2 m -127.06 117.34 22.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 110.236 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.33 149.76 72.11 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.617 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.9 151.8 81.57 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.167 1.912 . . . . 0.0 111.256 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' MET . 29.7 tp -61.89 -10.18 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -80.19 -19.05 47.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.848 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.58 -173.05 2.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.69 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.7 pm0 -145.67 175.4 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.485 -173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 61' ' ' ILE . 42.3 t -60.0 -28.49 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.527 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -51.28 -31.61 21.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.86 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.89 -33.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 0.0 110.408 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 19.4 mm -72.12 -49.61 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.572 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 8.4 ptmt -60.01 -40.67 90.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 p -72.05 -38.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.756 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -66.87 -36.12 81.59 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.843 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.77 -41.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.499 . . . . 0.0 110.202 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -58.3 -32.12 68.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.45 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 8.7 mm-40 -87.81 -30.29 20.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.118 0.485 . . . . 0.0 110.724 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.75 -46.39 14.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.784 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.1 p -98.23 -43.4 7.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.348 . . . . 0.0 110.721 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.21 -2.33 18.93 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.401 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -92.0 118.04 68.02 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.353 0.597 . . . . 0.0 111.281 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.41 155.88 67.61 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.434 2.089 . . . . 0.0 112.119 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.66 -16.88 59.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.668 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.52 -29.67 40.14 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.292 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -130.87 -1.82 4.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.237 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.75 113.37 24.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.557 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -105.22 139.15 40.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.095 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.64 121.3 41.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 109.889 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.3 tt0 -113.46 113.99 25.93 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.333 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.1 t80 -103.05 110.89 22.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.933 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 57.39 29.78 17.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.432 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.23 7.34 57.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.524 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.3 mt -112.34 119.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -72.52 91.8 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.141 0.496 . . . . 0.0 110.196 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.462 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -77.3 154.25 5.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.608 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 28.9 pttt -123.16 162.08 23.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.448 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 38' ' ' LYS . 6.5 t70 -54.48 -30.35 52.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.806 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 16.0 m -69.47 -13.88 62.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.919 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 11.9 m120 -105.43 177.91 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 110.657 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 78.5 p -134.59 171.12 14.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.408 -175.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.7 -44.03 78.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.937 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.82 70.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.493 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -62.37 -45.29 93.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -89.19 1.6 55.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.79 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 64.56 31.27 12.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.416 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.44 ' O ' HD13 ' A' ' 30' ' ' LEU . 58.5 mtt -59.72 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.214 0.531 . . . . 0.0 112.113 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 -172.08 3.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -64.4 116.19 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.905 0.383 . . . . 0.0 110.664 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.08 19.23 7.76 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.552 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 114.45 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.136 0.468 . . . . 0.0 110.102 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.12 104.85 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.0 mm -94.36 148.01 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -115.09 115.42 26.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.04 131.51 35.79 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.01 32.99 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.127 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 51' ' ' LYS . 31.7 tp -83.56 138.01 33.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -51.11 -53.48 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.036 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -179.94 140.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.939 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.58 128.27 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.14 0.495 . . . . 0.0 110.788 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.813 -0.993 . . . . 0.0 111.155 174.557 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.2 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.09 155.41 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.685 0.279 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -87.91 117.01 26.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.138 0.494 . . . . 0.0 110.234 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.3 pt -124.01 142.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.999 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -123.99 146.84 48.24 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.566 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.37 105.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.45 104.17 3.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.609 HG13 HD22 ' A' ' 19' ' ' LEU . 55.9 t -75.89 126.71 86.67 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.316 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.4 Cg_endo -65.74 147.5 85.76 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.3 2.0 . . . . 0.0 112.114 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.435 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 28.6 m-80 -72.61 90.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.518 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 42.3 mtm -141.43 76.56 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.871 0.367 . . . . 0.0 110.367 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -45.54 20.31 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.57 0.7 . . . . 0.0 110.201 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -120.51 7.79 10.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.161 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -94.81 3.53 54.9 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.807 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -168.28 -174.45 2.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.452 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 6.2 pt-20 -106.29 3.65 27.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.289 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.758 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.4 m0 -102.28 170.64 7.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 26.82 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.629 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.83 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -78.5 126.45 30.78 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.0 m-80 -140.99 15.74 2.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 110.667 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 84.53 1.0 89.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.196 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.595 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 1.1 pm0 -75.66 173.66 10.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 110.779 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.04 124.67 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.878 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.55 134.35 33.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -121.43 107.36 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -122.0 162.24 21.49 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.543 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.4 m -125.77 116.78 22.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.996 0.426 . . . . 0.0 110.44 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 4' ' ' ILE . 81.0 mt -133.68 151.31 76.87 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.035 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.04 147.96 80.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.292 1.995 . . . . 0.0 111.687 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.05 -10.66 10.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 110.601 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.9 p -81.98 -15.0 55.22 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.725 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.5 -173.39 4.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.115 0.483 . . . . 0.0 110.573 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.9 pm0 -144.56 173.59 11.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.889 0.376 . . . . 0.0 111.666 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 61' ' ' ILE . 41.8 t -61.43 -27.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.012 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -53.11 -33.28 51.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.399 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.63 -34.01 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.222 0.534 . . . . 0.0 110.264 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.0 mm -70.48 -52.07 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.859 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -58.19 -42.71 86.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.518 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 11.1 p -71.32 -38.98 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.678 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.2 ptmt -66.07 -35.26 80.04 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.39 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.2 mt -72.71 -41.13 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 110.196 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 23.5 t-80 -58.04 -32.4 67.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.339 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 56.8 mm-40 -85.94 -34.52 20.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.992 0.425 . . . . 0.0 110.047 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.06 -46.53 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.637 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.9 p -97.78 -43.6 7.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.067 0.46 . . . . 0.0 110.626 -176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 -7.19 11.24 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.131 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.516 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 13.2 ptm -89.7 119.64 69.48 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 111.827 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.2 Cg_endo -67.65 157.41 61.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.541 2.161 . . . . 0.0 112.057 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.99 -12.07 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.597 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.5 -33.76 62.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.647 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.54 -5.12 6.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.337 0.589 . . . . 0.0 109.979 -177.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -99.83 113.55 26.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 12.0 mmpt? -107.66 135.3 49.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.544 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HB3' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -103.38 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.09 176.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 tt0 -108.5 116.52 32.12 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 78' ' ' ILE . 7.5 t80 -101.04 102.83 13.9 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.457 0.646 . . . . 0.0 109.685 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 6.4 mm-40 57.42 31.01 19.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.076 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . 98.14 19.49 23.59 Favored Glycine 0 CA--C 1.511 -0.167 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.829 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.99 112.06 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 55' ' ' GLN . 5.0 m-85 -72.0 95.4 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.59 0.71 . . . . 0.0 110.002 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.2 162.12 3.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.27 -178.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 165.17 26.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -72.73 -4.85 33.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.622 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -79.97 -7.7 58.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 109.905 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -114.82 178.91 4.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.303 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 53.5 p -136.93 173.43 11.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.336 -175.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.16 -45.08 70.93 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.26 72.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.259 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 66' ' ' SER . 46.2 t80 -56.74 -46.19 81.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.657 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -90.62 1.11 57.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.98 42.25 19.64 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.557 0.536 . . . . 0.0 110.395 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.6 mtt -65.27 88.14 0.08 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.9 -178.07 5.28 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.85 116.28 3.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.287 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.75 29.3 5.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.364 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.11 114.67 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.91 106.35 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.14 0.495 . . . . 0.0 110.58 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.2 mm -94.46 145.47 7.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -116.25 111.69 20.52 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.56 132.37 35.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 144.11 30.56 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.479 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 51' ' ' LYS . 32.1 tp -76.6 137.5 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -46.2 -47.1 17.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.978 0.799 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -157.81 111.22 2.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -98.95 -34.13 10.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 CA-C-O 118.847 -0.974 . . . . 0.0 111.736 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.552 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 Cg_endo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 110.258 -0.708 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.73 154.9 37.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 m -86.77 125.15 33.74 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' A' ' 76' ' ' ALA . 12.9 pt -128.71 145.37 35.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.968 0.413 . . . . 0.0 111.045 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -126.5 146.53 50.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.2 t -123.18 105.79 16.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.615 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.53 103.86 3.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 94.3 t -77.03 131.68 72.43 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.843 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.629 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.9 Cg_endo -66.16 155.76 68.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.567 2.178 . . . . 0.0 111.851 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.577 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 26.7 m-80 -84.66 84.16 7.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.587 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.495 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -133.44 75.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.9 mp0 -78.43 -46.3 20.15 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 110.383 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 0.63 10.32 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.046 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HE2' ' OE1' ' A' ' 12' ' ' GLN . 20.6 mmtt -86.14 0.98 52.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.369 0.605 . . . . 0.0 109.63 -173.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -160.38 -173.53 4.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.45 -5.8 24.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 111.508 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.1 m0 -85.37 173.87 9.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.4 29.38 1.28 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.359 -176.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.629 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.0 mt -81.53 124.97 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.562 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 4.8 m-80 -132.33 19.6 4.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.899 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.577 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 75.66 12.96 83.44 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.302 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.562 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -83.22 179.12 7.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.137 0.494 . . . . 0.0 110.754 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.97 126.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 72.5 mt -87.3 139.49 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.16 109.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -124.2 166.02 16.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.394 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 1' ' ' PRO . 9.9 m -126.87 121.98 33.36 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.099 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 4' ' ' ILE . 77.4 mt -136.15 149.28 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.774 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.4 Cg_endo -65.25 150.13 87.8 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.182 1.921 . . . . 0.0 110.947 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 20.0 tp -62.33 -8.82 6.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.652 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -82.52 -18.85 40.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.9 -175.26 2.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 110.063 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 2.5 pm0 -144.93 174.68 10.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.93 0.395 . . . . 0.0 111.546 -174.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.584 HG11 HG13 ' A' ' 61' ' ' ILE . 35.0 t -62.87 -25.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.632 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 1.6 t -53.13 -33.81 54.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.66 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -72.43 -33.36 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.155 0.502 . . . . 0.0 110.553 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -70.54 -47.16 66.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.4 ptmt -63.15 -41.89 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.273 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -68.85 -39.38 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.695 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -39.74 85.5 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.199 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.73 -40.51 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 110.421 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -61.1 -32.8 72.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.566 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.55 -30.23 18.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.586 0.231 . . . . 0.0 111.133 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.11 -39.02 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.595 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 9.3 p -105.69 -45.28 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.548 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.65 -11.81 8.9 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.286 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 23.4 ptm -84.21 117.76 69.51 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.349 0.595 . . . . 0.0 111.116 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 29.3 Cg_endo -68.94 157.1 63.21 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.579 2.186 . . . . 0.0 112.161 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.71 -15.55 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.69 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.71 -30.03 50.79 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.981 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.59 -0.41 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.117 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.13 113.86 25.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 178.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.3 mmpt? -106.73 141.84 37.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.7 mm? -114.42 118.19 33.13 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -107.2 115.14 29.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.413 . . . . 0.0 110.668 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.5 t80 -103.91 111.38 23.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 57.88 29.74 18.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.191 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.41 24.52 26.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.071 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.78 110.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.422 ' HD1' ' HB3' ' A' ' 53' ' ' LYS . 53.9 m-85 -71.69 94.92 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.761 0.791 . . . . 0.0 110.648 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.584 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -80.73 154.61 4.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.159 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.49 162.73 13.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -70.89 -15.71 62.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 111.335 -174.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 m -78.24 7.22 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.801 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 80.9 m-20 -109.99 166.66 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 87.3 p -123.75 164.5 19.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.15 -43.24 92.46 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.192 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.34 -38.03 82.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.231 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -55.66 -43.64 76.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.233 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.99 5.06 53.0 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.709 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.43 46.98 14.36 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.376 0.423 . . . . 0.0 111.399 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.24 84.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 110.775 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.31 -176.64 1.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.074 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -61.37 116.51 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.309 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.41 33.64 4.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.962 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -74.32 114.63 12.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.043 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.58 103.45 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.116 0.484 . . . . 0.0 110.58 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.37 143.39 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -113.19 113.05 24.8 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.11 132.19 36.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.59 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.96 143.96 26.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.628 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -82.34 136.88 34.92 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.078 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.403 ' N ' HD23 ' A' ' 82' ' ' LEU . 37.7 ttmt -62.03 -32.69 73.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.528 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HG3' ' H ' ' A' ' 85' ' ' ARG . 9.7 tp10 -149.42 -153.09 0.47 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.805 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.41 -63.09 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.039 -1.423 . . . . 0.0 111.244 175.646 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.523 ' HB2' HG22 ' A' ' 27' ' ' THR . 37.0 Cg_endo . . . . . 0 N--CA 1.478 0.577 0 N-CA-C 109.839 -0.869 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 25.8 m -126.27 156.7 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.707 0.289 . . . . 0.0 110.354 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -86.63 121.33 29.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.029 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.2 pt -122.5 137.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.568 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HD3' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -120.25 151.96 38.43 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.474 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.04 106.21 15.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.492 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -69.52 106.73 3.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.461 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -77.35 127.62 82.54 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.761 ' HG2' HD13 ' A' ' 19' ' ' LEU . 31.9 Cg_endo -64.31 148.59 90.98 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.122 1.882 . . . . 0.0 112.081 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.402 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 28.4 m-80 -74.83 93.85 2.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.775 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 15' ' ' THR . 35.9 mtm -146.45 75.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -78.53 -49.01 14.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.384 0.611 . . . . 0.0 110.543 -169.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.4 17.49 9.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.19 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -91.33 -7.91 49.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.4 t -158.76 -172.5 3.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.685 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.55 -0.44 25.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.913 0.387 . . . . 0.0 111.58 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.8 m0 -85.95 168.66 13.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -84.93 31.64 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.427 0.632 . . . . 0.0 111.045 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 9' ' ' PRO . 13.5 mt -84.77 112.98 20.99 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.814 -0.554 . . . . 0.0 110.096 -175.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.626 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -126.46 16.26 7.65 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.33 -0.856 . . . . 0.0 111.209 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 84.24 5.96 86.76 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -79.6 175.18 10.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.651 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 7' ' ' GLN . 43.9 t -124.84 124.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.099 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.92 142.54 27.72 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 5' ' ' LYS . 58.4 t -132.47 111.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.152 0.501 . . . . 0.0 110.261 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.44 166.25 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.5 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -125.99 116.86 22.11 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.314 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 4' ' ' ILE . 82.3 mt -131.98 153.74 81.48 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.679 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.9 Cg_endo -64.85 149.32 89.75 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.274 1.983 . . . . 0.0 111.533 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -62.67 -12.05 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.726 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -80.93 -16.24 54.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.512 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.93 -174.87 2.35 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.9 pm0 -145.23 173.4 11.98 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -171.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG11 HG13 ' A' ' 61' ' ' ILE . 39.9 t -62.47 -25.14 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.598 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.33 -34.34 57.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.246 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.52 -30.29 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.533 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 26.1 mm -72.31 -47.57 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.831 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 4.1 ptmt -61.92 -40.12 94.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -71.12 -39.7 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.013 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.49 -38.44 89.75 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.92 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 54' ' ' LEU . 79.4 mt -71.59 -42.16 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 0.0 110.552 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' MET . 32.7 t60 -57.64 -32.77 67.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.434 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.45 -29.21 18.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.804 0.335 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' LYS . . . -82.8 -31.1 28.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.053 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -112.18 -43.4 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.468 . . . . 0.0 110.548 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.97 -7.06 10.93 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 15.6 ptm -89.97 119.24 69.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.347 0.594 . . . . 0.0 111.586 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 25.9 Cg_endo -67.81 161.36 44.26 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 111.86 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.56 -10.67 57.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -176.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -28.69 62.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.69 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -131.83 -3.05 3.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 110.329 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -98.12 122.19 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.3 mmpt? -114.0 142.56 46.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.513 HD11 ' CD1' ' A' ' 41' ' ' ILE . 1.8 mm? -111.49 119.38 38.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.582 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.1 tt0 -108.55 112.66 25.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.936 0.398 . . . . 0.0 111.026 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.657 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.0 t80 -103.23 109.97 21.76 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 57.34 30.18 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.549 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.93 17.16 38.84 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.35 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 17.6 mt -120.65 116.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 16.2 m-85 -72.75 91.38 1.47 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 110.096 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.565 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.67 157.04 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 -175.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -121.44 160.22 24.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.758 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.3 p-10 -71.14 -8.3 52.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 m -85.24 -1.58 57.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 0.0 110.261 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -109.6 170.67 7.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.449 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 97.0 p -126.33 170.94 11.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.88 -43.65 82.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.18 -35.27 73.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.298 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.14 -46.58 85.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.91 5.58 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.503 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 59.37 43.36 16.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -67.16 92.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.93 -176.46 2.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.755 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.5 t30 -66.08 115.39 6.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.14 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.69 28.68 5.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.358 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.18 114.76 11.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.039 0.447 . . . . 0.0 110.188 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG22 ' HD3' ' A' ' 5' ' ' LYS . 38.9 t -95.68 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.696 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.89 148.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.36 118.37 32.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -80.43 133.67 35.9 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.48 146.43 31.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.594 HD23 ' HG2' ' A' ' 85' ' ' ARG . 26.6 tp -79.76 138.48 37.29 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -50.62 -54.52 22.14 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.525 0.515 . . . . 0.0 110.217 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -173.05 138.17 0.74 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.894 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HG2' HD23 ' A' ' 82' ' ' LEU . 49.5 mtp180 -83.96 -49.61 8.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.078 0.466 . . . . 0.0 110.523 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 CA-C-O 118.733 -1.037 . . . . 0.0 111.416 -177.34 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 110.187 -0.736 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.94 155.77 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.267 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -90.72 109.84 21.03 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.444 0.64 . . . . 0.0 110.71 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.8 pt -111.26 147.56 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.591 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.1 mtmm -130.47 150.43 51.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.801 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 48.1 t -127.08 105.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.96 108.64 4.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.598 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.551 HG13 HD22 ' A' ' 19' ' ' LEU . 86.0 t -80.46 129.02 70.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.31 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.742 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.3 Cg_endo -65.71 150.52 86.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.375 2.05 . . . . 0.0 111.912 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.51 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 37.6 m-80 -76.76 91.63 3.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.761 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.525 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.1 mtm -141.95 74.48 1.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.762 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -44.66 17.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.819 0.819 . . . . 0.0 110.163 -176.057 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.9 -12.63 14.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.781 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 39.2 mmtt -75.33 -20.34 59.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.757 -172.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -152.24 -174.47 4.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.41 -175.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.06 -2.04 28.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.351 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.559 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -85.4 174.21 9.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.278 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -88.82 30.46 0.92 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.34 0.591 . . . . 0.0 111.453 -176.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' HG2' ' A' ' 9' ' ' PRO . 11.3 mt -85.02 124.52 31.81 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.687 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.3 m-80 -136.19 17.7 3.2 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.857 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.51 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 82.2 11.11 82.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.915 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -82.36 -179.77 7.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.903 0.383 . . . . 0.0 110.301 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.91 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.503 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 85.0 mt -89.86 143.4 26.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.088 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' HG2' ' A' ' 5' ' ' LYS . 48.5 t -127.99 111.16 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -126.04 162.65 24.81 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -125.97 115.68 20.28 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.249 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -134.73 150.9 74.73 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.88 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.54 152.22 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.459 2.106 . . . . 0.0 111.707 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.0 tp -63.99 -9.06 13.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.478 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -80.69 -21.42 41.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.82 -174.79 2.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.293 0.568 . . . . 0.0 110.373 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' SER . 3.0 pm0 -145.74 175.79 10.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.017 0.437 . . . . 0.0 111.495 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG11 HG13 ' A' ' 61' ' ' ILE . 46.0 t -59.74 -27.03 36.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.237 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.5 m -54.63 -34.16 61.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.1 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -74.62 -28.45 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.946 0.403 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.658 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 31.7 mm -72.87 -52.64 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.5 ptmt -57.78 -43.14 85.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.663 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.93 -37.87 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.719 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.7 -35.52 78.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.894 -177.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.84 -42.48 77.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.53 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -57.57 -32.85 67.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.088 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.4 -20.76 23.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.93 0.395 . . . . 0.0 111.271 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.94 -37.22 13.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 5.2 p -108.57 -46.11 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.192 0.52 . . . . 0.0 110.318 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.49 -17.45 5.84 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.422 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.6 ptm -81.13 117.49 68.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.454 0.645 . . . . 0.0 111.35 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.501 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.4 Cg_endo -67.29 159.76 50.77 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 111.948 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.75 -6.71 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.948 0.404 . . . . 0.0 111.87 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.37 -27.05 67.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.501 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -133.54 -3.48 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.102 0.477 . . . . 0.0 110.409 -177.188 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.58 116.99 32.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.674 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.0 mmpt? -104.68 141.34 36.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.62 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.19 122.13 45.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -112.11 117.84 33.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.102 0.477 . . . . 0.0 111.448 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 25.6 t80 -106.79 112.06 24.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.117 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 8.3 mm-40 57.54 29.82 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.308 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.39 10.23 57.18 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.381 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.01 116.58 52.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -76.85 93.34 3.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.676 0.75 . . . . 0.0 110.071 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.463 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.18 165.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.283 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -139.1 171.93 13.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.439 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.39 -5.45 36.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.7 p -81.37 -4.11 54.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -113.5 172.81 6.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.67 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.448 ' HA ' ' CB ' ' A' ' 33' ' ' GLN . 71.1 p -132.87 167.75 19.64 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.27 -45.11 89.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.56 -37.33 75.49 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -57.37 -44.48 84.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.036 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.434 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 47.4 m-85 -89.46 -0.2 57.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.582 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 60.5 42.15 14.73 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.461 0.475 . . . . 0.0 110.619 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 mtt -65.09 85.4 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.988 0.423 . . . . 0.0 110.907 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.29 -174.21 3.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -58.81 116.32 3.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.167 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.85 36.5 3.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.369 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.11 114.76 21.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.38 103.69 15.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.788 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.6 mm -94.26 151.01 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.28 119.34 35.4 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -85.31 134.05 34.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.8 149.21 35.06 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.035 0.445 . . . . 0.0 110.527 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 51' ' ' LYS . 35.9 tp -84.58 153.05 23.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 1.1 tppp? -50.38 -41.66 52.21 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.401 0.438 . . . . 0.0 111.07 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -128.26 137.57 52.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 86' ' ' GLY . 3.9 tmm_? -154.94 -58.04 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' C ' ' HE ' ' A' ' 85' ' ' ARG . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.035 -176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 N-CA-C 109.692 -0.926 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.452 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 17.3 m -125.67 154.58 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.362 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -86.26 123.94 32.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.671 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -126.73 138.05 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 110.984 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HD2' HG22 ' A' ' 77' ' ' VAL . 12.5 mttm -120.15 147.73 44.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.311 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 59.5 t -123.75 105.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -73.98 103.06 4.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.862 -178.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -73.97 131.83 80.84 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.617 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.71 ' HG2' HD13 ' A' ' 19' ' ' LEU . 44.0 Cg_endo -68.25 153.23 74.95 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.145 1.897 . . . . 0.0 111.794 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.445 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 29.0 m-80 -80.22 93.71 5.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.454 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.2 mtm -142.77 75.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.787 0.327 . . . . 0.0 110.286 174.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.52 -45.12 19.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.555 0.693 . . . . 0.0 110.71 -173.098 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -118.06 15.46 14.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.726 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -102.59 -3.39 26.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 17' ' ' TRP . 11.4 t -164.24 -171.68 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.592 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.74 4.04 37.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.452 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.631 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.5 m0 -94.84 173.77 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.078 0.466 . . . . 0.0 110.858 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.22 29.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.883 -177.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.71 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.6 mt -81.44 119.22 23.44 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.95 -0.469 . . . . 0.0 109.928 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 10.6 m-80 -131.7 15.81 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 83.75 2.63 89.78 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.809 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -76.44 178.05 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 7' ' ' GLN . 48.5 t -121.69 126.64 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.1 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.9 mt -87.35 142.8 27.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.9 t -131.17 108.65 15.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.55 161.37 19.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.03 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -127.1 113.94 17.08 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.031 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 4' ' ' ILE . 87.6 mt -131.2 153.91 81.83 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.806 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.3 150.42 87.32 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.177 1.918 . . . . 0.0 111.226 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -62.88 -13.56 35.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -78.89 -15.22 58.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.425 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.95 -174.42 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 3.4 pm0 -146.31 172.63 13.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -170.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 30.8 t -59.01 -28.28 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.44 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 2.7 t -54.27 -31.44 53.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.829 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.52 -29.66 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.661 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.8 mm -72.3 -51.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.451 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.4 ptmt -57.75 -43.75 85.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.601 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.78 -38.94 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.068 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.24 -35.47 77.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.531 -177.188 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -70.59 -43.44 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 110.297 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -58.03 -32.9 68.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.363 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.66 -22.92 22.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.039 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.87 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.653 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.5 p -101.41 -44.74 5.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.839 0.352 . . . . 0.0 110.734 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.3 -6.39 10.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.102 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.428 ' HG2' ' OG1' ' A' ' 45' ' ' THR . 18.3 ptm -91.16 120.02 68.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.316 0.579 . . . . 0.0 111.508 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.4 Cg_endo -68.72 157.57 61.32 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.467 2.111 . . . . 0.0 112.24 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.74 -8.67 15.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.761 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . -59.27 -29.69 66.35 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.445 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.01 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -129.47 -10.12 4.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.356 -177.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.58 113.77 25.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.961 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.5 mmpt? -102.57 142.12 34.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.51 130.19 56.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -121.76 120.81 35.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' HB2' HD12 ' A' ' 78' ' ' ILE . 13.8 t80 -103.5 107.45 18.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.389 . . . . 0.0 110.592 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 59.2 mm-40 55.59 30.49 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.735 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.62 19.17 30.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.186 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -123.65 109.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -72.0 95.03 1.54 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.797 0.808 . . . . 0.0 110.499 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.11 164.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.177 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.25 163.78 29.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.191 0.519 . . . . 0.0 111.989 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -51.8 -32.4 31.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.348 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -75.77 2.46 12.15 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -118.48 171.63 8.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.398 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 67.2 p -129.22 172.15 11.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.33 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.14 -45.26 74.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.997 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.22 71.65 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.343 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.79 -42.34 97.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -92.31 3.88 54.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.931 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 57.29 39.38 28.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.1 mtt -63.78 92.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.78 176.3 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.401 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 2' ' ' VAL . 33.0 m-80 -57.35 116.4 3.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.144 0.497 . . . . 0.0 110.783 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.36 26.19 5.24 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.694 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.671 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.25 114.42 11.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 ' HD2' ' A' ' 5' ' ' LYS . 25.7 t -96.94 104.68 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.193 0.52 . . . . 0.0 110.75 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.9 mm -94.33 143.33 11.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -110.44 112.02 23.67 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.16 134.12 36.71 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.46 142.2 24.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.534 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.595 HD23 ' HB2' ' A' ' 85' ' ' ARG . 19.7 tp -74.39 134.28 42.43 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 1.01 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 3.4 ptmm? -57.37 -22.47 42.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -165.01 119.96 1.34 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.176 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.595 ' HB2' HD23 ' A' ' 82' ' ' LEU . 2.9 tmm_? -167.02 93.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.253 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.584 177.206 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.473 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.477 0.524 0 N-CA-C 109.767 -0.897 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 20.9 m -129.14 155.52 41.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.043 0.449 . . . . 0.0 110.768 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -85.14 122.66 29.67 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.7 HG22 ' HB3' ' A' ' 76' ' ' ALA . 7.3 pt -123.8 144.22 34.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.095 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 77' ' ' VAL . 31.5 mtmt -125.67 151.21 46.87 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.119 0.485 . . . . 0.0 111.172 -175.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.2 105.45 13.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.139 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.7 104.41 3.36 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.2 t -76.81 128.41 81.68 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 30.6 Cg_endo -63.44 149.02 92.19 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 122.517 2.145 . . . . 0.0 112.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.542 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 35.9 m-80 -75.69 93.89 3.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.516 ' HB3' HG22 ' A' ' 15' ' ' THR . 43.6 mtm -143.78 73.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.438 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.598 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -78.84 -45.61 20.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.596 0.713 . . . . 0.0 110.074 -171.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.46 16.69 12.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.814 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -100.8 -6.13 25.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -160.53 -176.01 5.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.157 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.14 -4.0 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.424 -172.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.2 m-90 -95.75 169.94 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -175.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 24.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 111.578 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.7 mt -75.84 131.28 39.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.668 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.6 m-80 -142.43 14.38 1.99 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.542 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 84.91 0.12 89.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.015 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.668 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.6 pm0 -73.66 174.72 7.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 126.74 71.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.158 0.504 . . . . 0.0 109.814 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.68 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 5' ' ' LYS . 45.8 t -124.02 106.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -119.79 164.38 16.07 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.523 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 1' ' ' PRO . 12.6 m -126.29 126.33 43.79 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.406 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 4' ' ' ILE . 53.4 mt -140.9 152.75 66.31 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.263 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.3 152.38 79.32 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.862 1.708 . . . . 0.0 111.048 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.48 -10.79 19.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.8 p -77.39 -19.97 55.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.233 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.87 -173.8 3.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 111.251 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.4 pm0 -146.09 176.8 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.017 0.437 . . . . 0.0 111.932 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.507 ' CG1' HG13 ' A' ' 61' ' ' ILE . 40.0 t -57.96 -31.74 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.403 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 29.0 t -55.66 -28.89 57.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.84 -30.74 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 120.989 0.423 . . . . 0.0 110.784 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mm -71.15 -52.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.6 ptmt -57.72 -43.14 85.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.8 p -69.29 -40.04 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 9.5 ptpt -67.05 -35.71 80.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.607 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.63 -43.54 77.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -60.39 -33.35 72.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.423 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 18.7 mm-40 -88.6 -25.69 22.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.795 0.331 . . . . 0.0 110.635 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.96 -53.08 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.4 p -90.35 -42.98 10.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.95 -8.24 11.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.464 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 19.8 ptm -89.67 117.09 67.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.412 0.625 . . . . 0.0 111.346 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 Cg_endo -67.78 158.47 57.09 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.386 2.057 . . . . 0.0 112.132 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.99 -6.35 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.158 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . -60.68 -28.38 67.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.371 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.063 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -129.38 -11.67 4.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.248 0.547 . . . . 0.0 110.019 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.84 112.77 24.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.217 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mmpt? -104.36 140.33 38.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.753 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.1 mm? -110.33 135.8 50.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -128.56 117.61 21.56 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.981 0.42 . . . . 0.0 111.464 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -104.45 111.27 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.943 0.401 . . . . 0.0 110.503 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 33.4 mm-40 56.32 29.94 15.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.357 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.95 21.26 33.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.25 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -125.93 116.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -74.55 96.05 2.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.846 0.831 . . . . 0.0 110.663 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -76.84 153.88 5.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.81 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.2 166.36 14.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.381 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -32.82 21.83 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.83 0.852 . . . . 0.0 111.78 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -74.88 -14.27 60.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.325 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -97.0 165.16 12.21 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.0 p -130.67 167.4 18.86 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.66 -45.52 86.37 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.51 78.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.467 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -56.8 -46.3 81.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 53.9 m-85 -85.8 -3.29 58.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.518 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.77 47.37 15.59 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 123.42 0.45 . . . . 0.0 110.031 -174.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.01 87.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.15 178.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.945 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 16.2 t-20 -60.52 114.87 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.935 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.21 40.38 2.1 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.404 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.61 114.55 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 110.249 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' HE3' ' A' ' 5' ' ' LYS . 15.3 t -94.74 104.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.976 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.5 mm -94.81 146.55 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -113.02 116.42 29.9 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.1 tp -84.64 133.78 34.4 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.32 142.67 27.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.004 0.431 . . . . 0.0 111.071 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.14 130.04 37.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 6.0 ptmm? -52.26 -37.5 55.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -161.57 124.81 3.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 111.019 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 85' ' ' ARG . 2.5 ttp180 -113.04 -67.85 0.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.857 172.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.857 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.519 -178.238 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.51 157.9 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -88.93 125.84 35.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.301 0.572 . . . . 0.0 110.277 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.693 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -122.29 135.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.544 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -121.06 145.63 47.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.632 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.96 108.1 19.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.584 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.9 102.99 3.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.007 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 63.0 t -73.75 130.25 83.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.899 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.737 ' HG2' HD13 ' A' ' 19' ' ' LEU . 39.9 Cg_endo -66.44 155.19 71.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.963 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.495 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 34.0 m-80 -82.37 90.81 6.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -142.5 76.78 1.55 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.057 0.455 . . . . 0.0 110.523 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.5 mp0 -78.77 -47.5 16.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.943 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -120.98 2.97 10.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.423 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -76.96 -19.16 57.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.346 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.3 t -150.96 -174.02 4.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.442 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -95.41 -5.76 42.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 0.0 111.509 -173.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.598 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -87.74 174.21 8.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.452 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -89.35 30.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.058 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD13 ' HG2' ' A' ' 9' ' ' PRO . 16.8 mt -83.12 131.7 35.13 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.651 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.8 m120 -143.12 15.84 1.89 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.123 0.487 . . . . 0.0 110.365 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.495 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 85.42 2.86 87.19 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.985 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.651 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.1 pm0 -74.35 177.11 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.11 0.481 . . . . 0.0 110.685 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.74 132.82 70.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.181 0.515 . . . . 0.0 110.101 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 81.2 mt -93.75 143.98 25.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.145 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.1 107.68 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 86.3 m-85 -115.47 159.41 21.21 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -126.27 114.31 18.12 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 HD11 ' A' ' 4' ' ' ILE . 80.5 mt -132.59 154.74 81.62 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.446 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.15 152.96 78.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.038 1.825 . . . . 0.0 111.238 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.73 -8.2 9.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.2 p -82.4 -15.92 50.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.108 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.91 -172.95 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 110.928 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 2.7 pm0 -144.94 174.97 10.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.727 -172.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.757 HG11 HG13 ' A' ' 61' ' ' ILE . 24.5 t -63.12 -25.24 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.899 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 23.0 t -52.42 -35.39 51.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.914 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.05 -26.7 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -72.45 -49.85 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.952 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 7.0 ptmt -61.75 -42.13 98.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 13.9 p -67.2 -38.8 81.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 -177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.13 -35.07 76.0 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.132 -177.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 54' ' ' LEU . 74.4 mt -74.18 -42.95 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.138 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -58.25 -32.91 68.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.477 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 61.5 mt-10 -85.93 -32.31 21.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.834 0.35 . . . . 0.0 110.64 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.33 -44.22 25.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.502 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.543 HG22 ' HE2' ' A' ' 18' ' ' LYS . 3.7 p -102.27 -45.62 5.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.044 0.449 . . . . 0.0 110.632 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.58 -19.34 5.93 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.948 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 18.6 ptm -78.38 117.64 67.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.351 0.596 . . . . 0.0 111.466 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 32.0 Cg_endo -68.88 159.03 55.54 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.306 2.004 . . . . 0.0 111.939 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.1 -17.47 63.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.027 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.94 -31.08 38.8 Favored Glycine 0 C--O 1.225 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.1 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.82 -3.47 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.239 0.542 . . . . 0.0 110.178 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.616 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -94.07 113.65 25.66 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.572 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -106.74 139.13 41.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 41' ' ' ILE . 1.4 mm? -110.21 125.03 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -115.89 114.93 25.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.118 0.485 . . . . 0.0 111.395 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.6 t80 -102.68 107.72 18.73 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 27.2 mm-40 56.92 30.93 18.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.546 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.91 57.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.3 mt -107.79 115.17 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -68.62 92.75 0.48 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 109.894 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.757 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.19 149.6 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.642 -177.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -109.44 160.79 15.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.722 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' SER . 4.3 p30 -66.81 -16.9 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -86.88 6.23 32.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.434 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 94.5 m-20 -106.28 167.06 10.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 82.6 p -124.43 166.33 16.17 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.242 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -66.0 -44.26 85.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.416 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.85 76.72 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.281 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.04 -47.82 83.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -89.58 5.24 46.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.208 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 56.88 45.66 21.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.075 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.96 88.03 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.597 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.3 -170.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.913 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.11 114.43 3.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.5 39.68 3.62 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.937 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.24 115.13 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 t -95.65 102.45 13.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 111.264 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.8 mm -94.55 147.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -114.09 115.42 27.53 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 52' ' ' GLN . 51.8 tp -81.52 133.82 35.44 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.01 143.69 29.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 51' ' ' LYS . 29.8 tp -80.93 137.33 36.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.755 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -49.7 107.4 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.754 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 52.48 57.95 5.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.835 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 67.0 -73.72 0.07 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.21 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.326 -1.263 . . . . 0.0 111.246 -175.771 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 109.393 -1.041 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 17.9 m -127.26 152.69 35.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.877 0.37 . . . . 0.0 110.512 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -88.64 122.52 32.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.804 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.0 pt -126.38 145.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -127.04 147.8 50.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.009 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.51 105.68 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.591 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.1 104.96 3.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.894 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 HD22 ' A' ' 19' ' ' LEU . 37.9 t -76.17 130.66 77.18 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HG2' HD13 ' A' ' 19' ' ' LEU . 59.0 Cg_endo -70.06 152.25 67.67 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.073 1.848 . . . . 0.0 111.77 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.447 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 10.6 m120 -75.83 83.67 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 12.6 mtp -133.83 73.32 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 120.927 0.394 . . . . 0.0 110.484 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.633 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -45.13 17.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.622 0.725 . . . . 0.0 110.599 -175.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -113.9 3.67 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.466 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 37.9 mmtt -91.17 -6.89 52.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.061 -173.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.4 t -167.03 -176.03 3.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.935 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.71 7.37 28.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.022 0.439 . . . . 0.0 111.029 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 7.4 m0 -85.23 165.94 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.857 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 27.72 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 111.357 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.617 HD22 HG13 ' A' ' 8' ' ' VAL . 25.5 mt -81.72 123.62 28.91 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.937 -0.477 . . . . 0.0 109.747 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.0 m-80 -137.91 15.3 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.882 -0.511 . . . . 0.0 111.41 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 79.45 14.01 81.93 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.27 -0.966 . . . . 0.0 112.6 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -87.24 176.49 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 177.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.86 125.06 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.232 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -86.96 141.62 28.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.07 108.61 16.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.469 0.652 . . . . 0.0 109.906 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -116.64 162.98 16.8 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.95 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -126.6 119.19 26.46 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 4' ' ' ILE . 87.4 mt -134.9 151.42 75.55 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.695 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.21 154.69 73.18 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.7 tp -65.67 -6.77 12.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.6 p -82.83 -17.31 44.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.939 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-20 -75.69 -175.44 2.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 110.643 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.4 pm0 -143.45 171.44 14.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.543 -172.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 61' ' ' ILE . 40.2 t -63.41 -27.86 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -53.62 -31.44 47.14 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.091 175.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.2 t -78.61 -28.24 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.639 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 30.4 mm -73.44 -46.48 48.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.39 -41.99 94.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.443 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.84 -40.57 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.9 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -64.89 -38.55 91.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.886 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.85 -43.77 79.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.68 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' MET . 11.3 t-80 -57.52 -33.81 68.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.55 -25.43 20.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.073 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.43 -39.53 24.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.392 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -104.14 -47.86 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.565 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.58 7.89 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 16.0 ptm -86.99 119.73 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.26 0.553 . . . . 0.0 111.517 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.4 Cg_endo -68.82 158.73 56.66 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.397 2.065 . . . . 0.0 112.166 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.05 -9.45 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.889 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.6 -27.31 65.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.663 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.73 -2.53 3.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.037 0.446 . . . . 0.0 110.462 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.69 114.47 26.45 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.238 0.542 . . . . 0.0 109.699 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.5 mmpt? -106.54 142.7 35.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.738 -176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.27 121.46 38.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.87 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -111.77 117.53 33.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.015 0.436 . . . . 0.0 111.605 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.7 t80 -105.28 109.67 21.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 56.88 30.59 18.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.803 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.47 56.15 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.308 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 20.2 mt -111.02 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -72.66 90.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -76.99 158.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.892 -175.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.0 pttp -118.69 159.31 23.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.994 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.72 -2.68 21.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.1 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.527 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -91.37 -0.85 57.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.777 0.322 . . . . 0.0 111.23 177.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -112.4 -175.35 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.269 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 39.1 p -137.75 176.57 8.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.784 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.01 -45.73 59.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.764 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.42 -33.0 69.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.127 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.13 -48.64 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 61' ' ' ILE . 72.1 m-85 -88.95 1.75 54.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.292 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.91 45.85 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.38 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.0 mtt -70.5 85.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.774 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.25 -172.31 1.38 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.78 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 53.0 t30 -62.22 114.95 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.224 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 39.49 2.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.645 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.804 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.87 114.62 19.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.171 0.485 . . . . 0.0 110.312 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.75 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.07 0.462 . . . . 0.0 110.851 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.676 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.46 149.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -117.69 119.65 35.61 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -84.47 131.86 34.62 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.588 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.73 144.35 27.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 51' ' ' LYS . 23.1 tp -75.3 144.62 42.36 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -45.52 -53.01 9.57 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.835 0.709 . . . . 0.0 110.128 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -165.97 147.37 6.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 5.3 ptp85 -77.67 101.27 6.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.386 0.613 . . . . 0.0 110.94 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.742 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.444 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.7 Cg_endo . . . . . 0 N--CA 1.478 0.592 0 N-CA-C 109.773 -0.895 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.1 m -120.36 152.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 0.0 110.544 -177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 m -87.54 119.23 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.685 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.1 pt -120.0 142.36 35.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.275 0.559 . . . . 0.0 110.987 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -125.58 148.2 49.02 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.413 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.79 105.86 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.56 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.441 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -70.7 106.41 3.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.635 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 19' ' ' LEU . 85.6 t -76.94 128.78 80.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.826 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.1 Cg_endo -65.32 149.75 88.0 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.29 1.993 . . . . 0.0 111.698 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.453 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 33.0 m-80 -76.08 84.73 2.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.462 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.577 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 51.0 mtm -137.49 75.58 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.142 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.3 mp0 -79.03 -45.46 20.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.729 0.775 . . . . 0.0 109.747 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -119.61 -0.06 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.737 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 33.9 mmtt -81.17 -6.01 58.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.056 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -164.85 -175.84 3.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.647 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.4 -0.08 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.92 0.39 . . . . 0.0 111.665 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.6 m0 -85.01 168.87 14.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.67 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.9 28.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.454 0.645 . . . . 0.0 110.898 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.0 mt -79.88 128.8 33.89 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 20.7 m-80 -140.55 9.78 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.883 -0.511 . . . . 0.0 111.368 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 85.09 10.49 78.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.882 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -84.02 179.45 7.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.891 0.377 . . . . 0.0 110.426 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 7' ' ' GLN . 62.2 t -125.46 126.83 71.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -87.64 141.87 28.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.16 114.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CD2' ' HE3' ' A' ' 40' ' ' LYS . 56.7 m-85 -130.13 166.46 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.75 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.8 m -126.81 123.38 37.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.775 0.321 . . . . 0.0 110.418 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 2' ' ' VAL . 73.2 mt -139.04 152.41 69.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.953 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.45 152.81 74.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.223 1.948 . . . . 0.0 111.689 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.0 tp -64.3 -7.05 8.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -83.82 -17.26 41.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.491 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.26 -173.78 3.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.237 0.542 . . . . 0.0 110.716 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 3.0 pm0 -146.07 175.22 10.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.419 -172.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 61' ' ' ILE . 19.8 t -59.46 -29.74 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.702 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.594 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.4 m -53.38 -29.35 34.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.397 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.7 t -78.81 -32.61 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.601 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -70.59 -46.99 67.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.306 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.1 ptmt -62.29 -44.46 96.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.922 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 p -67.48 -35.39 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.703 -176.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.34 -34.63 74.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.624 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 54' ' ' LEU . 82.6 mt -74.57 -42.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.361 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -57.41 -32.38 66.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.561 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 14.1 mm-40 -87.7 -29.13 21.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.45 -44.94 18.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.2 p -99.58 -45.04 5.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.649 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.79 -17.17 6.85 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.681 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.601 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.5 ptm -82.86 116.17 62.63 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.541 0.686 . . . . 0.0 111.451 -175.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.7 Cg_endo -68.07 162.9 38.04 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.522 2.148 . . . . 0.0 111.992 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.96 -8.46 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.847 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.39 66.64 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.399 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -128.07 -24.25 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 109.92 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.714 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.44 113.53 10.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.082 176.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 6.7 mmpt? -107.34 140.6 40.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 41' ' ' ILE . 1.9 mm? -112.27 123.98 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.829 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.0 tt0 -115.57 115.59 26.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD12 ' A' ' 78' ' ' ILE . 10.8 t80 -101.6 107.82 19.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.258 0.552 . . . . 0.0 110.108 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 5.2 mm-40 56.74 29.44 15.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.053 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.0 14.95 37.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.026 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 25.7 mt -117.51 116.0 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -72.36 95.65 1.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -84.52 154.09 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -132.51 174.84 9.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.839 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -28.79 20.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.568 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.441 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 4.6 m -86.16 10.52 14.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.174 -169.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 14.5 m120 -114.71 172.66 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.4 p -130.08 166.58 19.88 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.05 -44.12 85.5 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.65 -38.88 79.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.628 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.14 -40.8 77.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -95.57 6.4 49.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.452 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.54 38.89 22.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.967 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.1 mtt -67.48 87.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 111.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.55 -168.64 2.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.302 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.51 115.12 2.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.121 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.7 3.25 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.648 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.66 114.65 21.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.029 0.415 . . . . 0.0 109.978 177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.85 102.2 13.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.57 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.24 150.52 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.16 116.47 27.88 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.539 HD11 ' HG3' ' A' ' 52' ' ' GLN . 38.0 tp -82.53 131.68 35.21 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.24 145.59 27.17 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.7 tp -76.0 144.63 40.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 11.2 ptpt -58.1 -179.75 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -47.85 -48.37 31.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.046 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 -96.64 130.6 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.286 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.627 -1.096 . . . . 0.0 111.891 -178.516 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.51 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.5 Cg_endo . . . . . 0 N--CA 1.479 0.643 0 N-CA-C 110.159 -0.747 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 16.1 m -122.49 156.21 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.813 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -82.52 127.24 33.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.021 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.5 pt -130.71 136.64 57.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.129 0.49 . . . . 0.0 110.826 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 17.5 mttt -123.35 145.47 48.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.764 -173.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.8 108.44 24.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.527 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -74.03 104.01 4.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.649 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.539 HG13 HD22 ' A' ' 19' ' ' LEU . 62.1 t -76.71 131.19 74.38 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.455 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.825 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.1 Cg_endo -66.62 155.68 69.24 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.14 1.894 . . . . 0.0 112.214 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.433 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 26.1 m-80 -82.54 84.2 7.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.599 ' HB3' HG22 ' A' ' 15' ' ' THR . 48.6 mtm -137.45 75.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.605 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 9.3 mp0 -79.91 -47.47 15.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.689 -171.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -120.89 10.78 10.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -93.27 -2.18 55.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.834 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.3 t -167.77 -176.73 3.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.86 -12.52 41.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.808 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.67 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.2 m0 -84.99 164.34 18.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.563 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.85 29.94 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.672 0.748 . . . . 0.0 110.86 -178.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.825 HD13 ' HG2' ' A' ' 9' ' ' PRO . 19.4 mt -78.94 127.25 31.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.556 -0.715 . . . . 0.0 109.269 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 17.2 m-80 -137.82 20.57 2.86 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.766 -0.584 . . . . 0.0 111.364 -175.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 75.14 1.39 63.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.085 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -76.58 176.51 8.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.26 0.552 . . . . 0.0 110.526 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 7' ' ' GLN . 58.2 t -125.31 123.48 65.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.904 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 51.4 mt -88.05 136.92 32.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.35 110.38 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 120.971 0.415 . . . . 0.0 110.0 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.44 166.33 16.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.593 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.6 m -126.49 122.59 35.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 4' ' ' ILE . 73.4 mt -136.09 154.04 77.2 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.72 152.52 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.87 1.713 . . . . 0.0 110.982 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.65 -8.7 10.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -79.61 -18.38 51.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.44 -175.13 2.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 110.648 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.8 pm0 -145.1 172.83 12.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.342 -173.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HG13 ' A' ' 61' ' ' ILE . 40.4 t -62.82 -26.81 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.564 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -54.16 -33.16 57.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.316 176.546 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -74.03 -32.05 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 mm -72.61 -48.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.751 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.7 ptmt -59.86 -40.95 90.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.744 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -72.97 -39.23 57.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.041 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 16.4 ptpt -63.5 -35.6 81.01 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.259 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.9 mt -72.35 -43.58 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.264 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -59.84 -34.71 73.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.36 -36.41 39.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.748 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.74 8.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.729 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.8 p -91.66 -43.49 9.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.11 -15.22 9.44 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.949 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -81.36 119.96 77.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.458 0.647 . . . . 0.0 111.565 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.0 Cg_endo -67.85 156.7 64.9 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.77 2.313 . . . . 0.0 112.056 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.97 -12.54 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.483 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.64 -32.58 58.56 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.557 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HD2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.68 -3.92 4.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.148 0.499 . . . . 0.0 110.495 -177.116 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.68 116.33 28.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.31 0.576 . . . . 0.0 109.547 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.76 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -104.92 140.92 37.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.74 118.69 32.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.146 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 25.9 tt0 -111.48 116.0 30.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.593 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.637 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.7 t80 -103.85 108.97 20.53 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 61.6 mm-40 57.35 30.23 18.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.741 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.46 10.36 53.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.316 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.8 mt -114.49 118.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 10.1 m-30 -74.11 89.41 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.627 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -74.44 154.4 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.75 -175.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.9 pttp -117.14 160.02 21.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.945 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -72.19 -5.28 34.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.46 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -88.71 0.42 56.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.884 0.373 . . . . 0.0 110.748 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -112.47 176.89 4.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.3 p -130.43 170.03 14.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.318 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.52 -43.6 80.42 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.861 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.97 76.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.282 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -57.59 -44.73 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.958 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -88.9 3.38 51.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.264 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.26 41.0 20.72 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.021 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -62.8 94.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.446 0.641 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.75 -177.9 2.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 33.3 t30 -61.83 116.76 5.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.22 39.29 3.79 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.364 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.53 114.91 16.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.345 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.28 105.11 16.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -93.87 148.82 4.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -117.0 116.9 28.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.05 133.31 34.66 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.0 148.91 31.24 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.392 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 51' ' ' LYS . 26.1 tp -83.21 126.8 33.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.564 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -58.6 -64.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.293 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.46 142.89 47.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.42 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.43 -31.87 0.73 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.672 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.099 -1.39 . . . . 0.0 111.089 -177.953 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.4 Cg_endo . . . . . 0 C--O 1.231 0.145 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.96 154.66 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.385 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m -85.55 124.85 32.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 76' ' ' ALA . 4.6 pt -128.38 148.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 77' ' ' VAL . 10.1 mttm -128.13 147.53 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 105.81 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.4 104.72 5.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.979 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 19' ' ' LEU . 57.6 t -73.67 133.02 80.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.367 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.835 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.0 Cg_endo -68.66 151.23 74.97 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.995 1.797 . . . . 0.0 111.772 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.457 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 24.7 m-80 -79.89 88.45 5.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.517 ' HB3' HG22 ' A' ' 15' ' ' THR . 51.0 mtm -138.84 75.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.9 mp0 -78.84 -45.95 19.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.86 -168.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -120.21 2.8 10.9 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.133 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -86.33 -4.83 59.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.157 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.6 t -161.47 -176.46 5.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.826 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.99 -0.33 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.106 0.479 . . . . 0.0 111.627 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.662 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -89.84 174.56 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.081 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 28.51 1.4 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.193 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.7 mt -79.56 122.71 26.83 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.634 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.8 m-80 -136.49 20.13 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.255 0.55 . . . . 0.0 110.452 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 81.18 -7.85 59.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.976 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.576 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -65.79 176.02 1.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.522 0.677 . . . . 0.0 111.15 -178.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.91 126.69 74.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.919 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 mt -87.51 132.17 34.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.34 107.39 18.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -125.08 167.35 14.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.396 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.1 m -126.51 119.89 28.29 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 4' ' ' ILE . 67.4 mt -134.38 149.89 72.41 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 42.6 Cg_endo -70.01 149.23 65.02 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.387 2.058 . . . . 0.0 111.62 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.6 -12.16 21.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.872 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -72.65 -25.26 61.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -75.01 -173.62 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.136 0.493 . . . . 0.0 110.731 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.3 pm0 -145.55 173.42 12.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.819 0.342 . . . . 0.0 111.714 -172.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 61' ' ' ILE . 25.6 t -57.28 -31.35 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.74 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 15.3 m -50.64 -36.07 33.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.126 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 39.0 t -72.04 -33.97 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.615 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.7 -52.6 22.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.816 0.341 . . . . 0.0 110.479 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 10.7 ptmt -57.97 -44.59 87.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.513 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.63 -32.72 56.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.65 -46.52 78.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.856 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.47 -38.14 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.159 0.504 . . . . 0.0 110.264 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' MET . 7.6 t-80 -56.9 -34.57 68.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.481 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -90.91 -29.93 17.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.978 0.418 . . . . 0.0 111.024 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.62 -44.92 32.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.431 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -102.03 -40.5 6.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.57 -8.77 10.91 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.962 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.546 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.0 ptm -90.99 117.89 68.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 111.811 -176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.2 Cg_endo -66.92 157.25 62.46 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.7 2.266 . . . . 0.0 111.873 175.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.65 -14.2 40.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.682 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.07 -34.12 52.12 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.44 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -126.9 -7.82 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 110.252 -177.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.93 116.57 29.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.59 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.726 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -107.13 142.81 36.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.782 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.05 124.56 46.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -116.39 119.52 35.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.038 0.447 . . . . 0.0 111.44 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 8.8 t80 -103.65 104.78 14.86 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 57.24 29.69 17.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.849 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.44 14.51 37.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.916 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -120.69 114.35 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -76.67 92.74 3.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.855 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.506 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -74.89 150.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.42 -177.158 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -125.71 171.26 10.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.125 0.488 . . . . 0.0 111.869 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -18.88 45.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.188 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.432 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 3.9 m -86.97 10.12 17.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.065 0.459 . . . . 0.0 110.773 -175.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -122.4 171.19 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 79.4 p -129.56 169.93 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.94 -44.13 85.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.11 75.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.54 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.19 -39.96 84.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 49.1 m-85 -91.09 -2.33 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.285 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.71 46.47 20.04 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.638 0.586 . . . . 0.0 110.124 -174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.6 mtt -62.04 87.79 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.272 0.558 . . . . 0.0 110.747 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.58 179.58 3.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.712 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -61.18 115.8 4.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.344 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.97 33.61 3.7 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.135 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.22 114.79 18.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.118 0.485 . . . . 0.0 110.031 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 5' ' ' LYS . 26.5 t -99.1 106.06 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.931 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -94.44 149.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -116.57 119.35 35.29 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 tp -85.74 133.3 34.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.63 34.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.649 HD23 ' HD3' ' A' ' 85' ' ' ARG . 37.4 tp -89.78 124.29 34.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.109 0.48 . . . . 0.0 110.97 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -65.07 -65.3 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.051 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -132.48 141.7 48.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.93 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.649 ' HD3' HD23 ' A' ' 82' ' ' LEU . 12.2 ptt180 -148.78 29.72 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.336 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.489 -1.173 . . . . 0.0 111.355 -177.182 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 N-CA-C 110.307 -0.69 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.56 158.63 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 m -90.51 122.13 33.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.12 0.486 . . . . 0.0 110.595 -176.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.736 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -125.46 138.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.956 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -120.58 146.38 46.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.14 105.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.236 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 101.43 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.872 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 22.3 t -72.24 129.33 87.72 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.7 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HG2' HD13 ' A' ' 19' ' ' LEU . 43.1 Cg_endo -66.15 149.19 85.72 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.517 2.145 . . . . 0.0 111.677 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.493 ' OD1' ' HA3' ' A' ' 21' ' ' GLY . 25.8 m-80 -73.78 85.43 1.68 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.459 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -136.09 74.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.965 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.6 mp0 -78.99 -44.96 21.22 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.727 0.775 . . . . 0.0 109.557 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -119.79 3.59 11.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.212 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -88.87 -5.06 58.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.028 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.7 t -162.68 -175.74 4.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.675 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -105.19 3.26 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -90.43 169.52 10.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.126 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -81.96 31.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.154 0.502 . . . . 0.0 111.631 -178.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' HG2' ' A' ' 9' ' ' PRO . 20.8 mt -83.74 132.97 34.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.69 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.6 m-80 -147.29 19.27 1.21 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 110.14 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.493 ' HA3' ' OD1' ' A' ' 10' ' ' ASN . . . 85.23 -3.26 87.49 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 3.5 pm0 -70.88 172.11 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.577 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.24 130.57 74.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 88.8 mt -91.01 147.34 23.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.53 109.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.68 160.68 19.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.241 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -127.1 115.9 19.87 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.1 mt -134.19 151.88 77.28 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.557 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.27 151.89 80.18 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.207 1.938 . . . . 0.0 111.439 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.3 tp -64.72 -4.53 4.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -83.65 -20.68 33.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.444 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.6 m-20 -77.41 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.268 0.556 . . . . 0.0 110.622 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 2.7 pm0 -144.81 174.01 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 61' ' ' ILE . 39.5 t -61.91 -27.52 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.693 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 29.2 t -51.78 -33.31 34.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.44 175.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.469 HG21 ' OD2' ' A' ' 32' ' ' ASP . 19.8 t -77.44 -30.75 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.93 0.395 . . . . 0.0 110.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.2 mm -71.84 -49.28 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.368 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 ptmt -59.07 -40.6 85.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.48 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.6 p -71.24 -41.09 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.083 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -65.72 -35.58 81.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.893 -177.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.9 -41.57 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.281 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -57.84 -34.75 70.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.088 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 52.9 mt-10 -82.84 -33.02 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.952 0.406 . . . . 0.0 110.419 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.8 -44.14 23.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.769 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.1 p -102.18 -44.94 5.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.763 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.84 -5.84 10.49 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.116 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.457 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -89.57 116.88 67.45 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 111.366 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.12 159.36 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.518 2.145 . . . . 0.0 111.848 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.16 -14.85 57.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.822 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.16 -30.7 55.26 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.081 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -128.66 -3.96 5.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.167 0.508 . . . . 0.0 109.995 -177.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.23 115.52 28.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.734 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.7 mmpt? -108.14 141.61 39.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.0 mt -117.51 121.49 41.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.819 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.6 tt0 -113.54 117.36 31.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.238 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.623 ' HB2' HD12 ' A' ' 78' ' ' ILE . 9.9 t80 -103.54 109.45 21.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.027 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 56.4 29.59 15.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.747 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.67 13.05 45.37 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 19.6 mt -116.97 118.99 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -74.04 93.15 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -79.28 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.552 -178.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.22 166.83 12.12 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.59 -12.35 61.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 0.0 111.387 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -78.22 -10.3 59.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 72.7 m-20 -99.47 164.26 12.17 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.6 p -125.09 167.5 14.69 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.04 -43.41 87.63 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.911 0.386 . . . . 0.0 110.028 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.96 -34.85 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' SER . 67.3 t80 -55.64 -45.08 77.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.422 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 29.7 m-85 -97.53 9.48 42.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.631 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 57.25 45.84 19.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.248 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.3 mtt -69.08 90.09 0.45 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.085 0.469 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.81 -172.34 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.823 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -61.08 115.53 3.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.257 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 31.58 5.46 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.62 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.02 114.56 13.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.03 104.53 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 0.0 110.913 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.23 148.27 5.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -112.88 118.33 34.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -82.77 132.74 35.16 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.03 147.01 29.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.3 tp -78.6 148.7 33.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.05 -13.1 14.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.562 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 65.3 17.77 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.138 0.575 . . . . 0.0 111.976 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 6.3 tpm_? -81.81 -42.49 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.993 0.425 . . . . 0.0 110.071 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.993 179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 28.9 Cg_endo . . . . . 0 N--CA 1.478 0.584 0 N-CA-C 110.601 -0.577 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.97 157.13 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -90.65 117.83 29.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 110.449 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.8 pt -121.0 143.53 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.739 -176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -126.25 150.51 48.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.804 0.335 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 49.0 t -124.77 107.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.852 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.494 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -70.08 105.75 3.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 19' ' ' LEU . 60.3 t -76.41 131.83 73.97 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.1 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 19' ' ' LEU . 41.4 Cg_endo -68.0 149.58 77.33 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.223 1.949 . . . . 0.0 111.781 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.54 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -76.32 86.98 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -135.55 76.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.679 . . . . 0.0 110.175 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 10.8 mp0 -79.9 -45.38 18.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.572 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.68 -5.59 10.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.006 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 34.7 mmtt -75.71 -8.13 56.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.662 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.3 t -163.81 -172.68 2.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -105.97 0.36 25.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m0 -85.38 168.61 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.01 28.8 0.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.661 . . . . 0.0 111.407 -177.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -81.1 122.0 26.8 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.79 -0.569 . . . . 0.0 109.832 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.638 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 15.9 m-80 -138.06 16.66 2.82 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.943 -0.473 . . . . 0.0 110.665 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.54 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.19 -2.46 85.27 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.29 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -73.81 179.36 4.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.274 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.56 128.61 76.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.293 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.2 mt -87.77 144.94 26.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.92 111.12 19.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.051 0.453 . . . . 0.0 109.856 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 92.6 m-85 -120.92 162.6 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.353 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.7 m -127.67 119.01 24.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.755 0.312 . . . . 0.0 110.175 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -137.66 149.0 63.41 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.137 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 23.5 Cg_endo -64.99 148.62 89.78 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.302 2.001 . . . . 0.0 111.47 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.6 tp -60.54 -14.51 20.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.961 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -76.99 -21.57 54.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.776 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD2' ' HG2' ' A' ' 29' ' ' PRO . 3.0 m-20 -74.18 -174.81 2.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.608 . . . . 0.0 110.71 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.97 174.75 10.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.72 -171.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 44.5 t -58.98 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.847 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 8.5 t -52.56 -34.29 49.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.134 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.05 -32.7 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 22.5 mm -72.0 -50.77 35.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 6.3 ptmt -58.0 -41.88 84.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.473 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 14.2 p -70.8 -41.26 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.009 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -64.65 -35.66 81.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.957 -178.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -69.81 -41.89 79.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.05 0.452 . . . . 0.0 110.362 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -58.73 -31.45 68.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.93 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 5.7 mm-40 -81.69 -36.63 28.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 110.573 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.46 -49.26 17.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.64 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.5 p -96.07 -45.28 6.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.969 0.414 . . . . 0.0 110.51 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.13 -20.14 6.34 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.68 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.486 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.7 ptm -77.81 119.33 76.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.547 . . . . 0.0 111.341 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 19.8 Cg_endo -68.03 157.98 59.39 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.329 2.019 . . . . 0.0 111.831 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.22 -9.57 18.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.419 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.05 -26.53 61.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.886 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -134.05 -5.67 2.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.926 0.394 . . . . 0.0 110.316 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.65 116.03 28.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.9 mmpt? -105.79 140.23 39.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.53 116.82 28.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.338 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.3 tt0 -108.03 112.12 24.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.668 ' HB2' HD12 ' A' ' 78' ' ' ILE . 26.5 t80 -102.61 114.43 28.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.767 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 31.1 mm-40 56.56 29.54 15.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.459 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.52 8.77 57.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.733 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 9.5 mt -115.17 118.51 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.4 m-30 -68.49 94.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 0.0 109.953 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.45 152.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.428 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -122.43 167.3 13.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 6.2 t70 -59.36 -27.93 66.39 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.149 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -75.02 -11.06 60.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.382 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.9 170.01 8.15 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.932 0.396 . . . . 0.0 110.141 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.6 p -130.36 175.01 9.3 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.202 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.38 -43.34 73.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.26 -35.11 76.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.452 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -57.18 -42.15 80.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.641 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 73.5 m-85 -95.08 0.34 54.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 71' ' ' ASN . 0.9 OUTLIER 58.96 47.28 12.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.786 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtt -69.96 87.46 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.25 -173.28 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.348 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -63.37 115.69 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 110.035 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.82 2.85 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.041 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.65 114.93 21.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.016 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.27 104.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.041 0.448 . . . . 0.0 110.719 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.13 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.59 114.66 23.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.16 133.58 34.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.92 148.27 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.6 tp . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.479 0.633 0 N-CA-C 109.48 -1.008 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 15.8 m -126.56 153.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.395 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -84.2 124.6 31.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.7 pt -124.48 137.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.249 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG22 ' A' ' 77' ' ' VAL . 11.0 mttm -117.85 146.36 43.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.088 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.0 105.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -72.06 104.24 3.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.654 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 HD22 ' A' ' 19' ' ' LEU . 69.9 t -75.26 128.09 85.2 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.364 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 33.4 Cg_endo -64.87 150.81 87.6 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.152 1.901 . . . . 0.0 111.907 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.565 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 12.8 m120 -77.54 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.713 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.541 ' HB3' HG22 ' A' ' 15' ' ' THR . 41.0 mtm -142.53 75.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.707 0.289 . . . . 0.0 110.251 174.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 7.4 mp0 -78.92 -44.22 23.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 110.134 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.53 -2.54 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.029 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -87.79 -6.92 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.423 -172.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.0 t -161.38 -179.91 7.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.07 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.72 3.0 41.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.548 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.577 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 6.0 m0 -85.94 171.91 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -87.9 26.83 1.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 0.0 110.886 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.9 mt -80.19 128.16 33.19 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.664 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.3 m-80 -140.78 9.13 2.17 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.063 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.565 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.23 7.99 72.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.265 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -80.8 175.86 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.54 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 7' ' ' GLN . 44.5 t -124.96 124.19 67.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.73 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -87.62 136.07 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.73 107.51 19.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -122.55 166.2 15.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.717 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 m -126.8 122.02 33.58 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.853 0.359 . . . . 0.0 110.775 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 4' ' ' ILE . 68.9 mt -138.57 152.36 70.8 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.513 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 43.5 Cg_endo -69.86 152.1 68.69 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.215 1.943 . . . . 0.0 111.748 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 tp -62.49 -11.97 19.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.663 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -73.97 -23.98 59.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -76.28 -172.95 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.276 0.56 . . . . 0.0 110.72 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.85 171.97 13.68 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.625 -171.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.666 HG11 HG13 ' A' ' 61' ' ' ILE . 26.1 t -63.05 -26.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.338 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.43 -31.83 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.75 -30.65 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.11 0.481 . . . . 0.0 110.247 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.3 mm -71.16 -51.99 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.2 ptmt -58.03 -43.72 86.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.68 -38.58 79.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.583 0.23 . . . . 0.0 111.004 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.9 ptmt -68.87 -35.29 76.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.498 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.75 -41.88 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' MET . 8.1 t-80 -56.71 -35.2 68.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.022 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.53 -20.86 21.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.44 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.55 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.0 p -107.88 -42.94 4.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.047 0.451 . . . . 0.0 110.721 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.08 -8.42 10.52 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.012 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 17.5 ptm -90.32 119.95 69.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.134 0.492 . . . . 0.0 111.699 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.3 Cg_endo -68.91 156.89 63.95 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.547 2.164 . . . . 0.0 112.266 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.69 -16.87 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.4 -30.61 33.69 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.281 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.35 -6.0 3.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.441 . . . . 0.0 110.005 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.67 112.04 23.84 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.1 mmpt? -103.43 141.03 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.392 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.44 121.61 45.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.448 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.5 tt0 -113.64 115.77 28.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.8 t80 -101.81 107.53 18.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.225 0.536 . . . . 0.0 110.029 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 57.15 30.47 18.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.831 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.5 38.62 Favored Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.49 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.1 mt -118.74 116.02 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.0 m-85 -72.04 91.9 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.167 0.508 . . . . 0.0 110.114 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.666 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -78.12 150.32 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.3 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.489 ' HE3' HD21 ' A' ' 65' ' ' ASN . 0.6 OUTLIER -109.57 156.27 20.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.806 0.336 . . . . 0.0 110.827 177.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.461 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 5.7 p-10 -71.37 -2.93 18.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.996 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t -86.12 -5.34 59.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.748 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.489 HD21 ' HE3' ' A' ' 62' ' ' LYS . 95.7 m-20 -104.15 178.44 4.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.524 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 76.6 p -133.38 173.16 11.77 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.44 -33.46 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.231 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' SER . 47.3 t80 -56.47 -45.9 80.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -91.68 -0.62 57.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.744 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 m120 63.82 41.41 6.84 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.365 0.415 . . . . 0.0 110.888 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -64.27 93.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.316 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 177.98 4.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.918 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 36.0 t-20 -64.45 115.37 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.144 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.21 28.14 5.04 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.195 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 115.11 10.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.449 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 5' ' ' LYS . 15.3 t -95.08 103.54 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.793 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.51 146.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -116.41 111.57 20.22 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -76.78 132.41 39.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.407 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 147.24 32.12 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.699 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.06 152.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.945 0.403 . . . . 0.0 110.298 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -88.73 114.99 25.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.244 0.545 . . . . 0.0 110.355 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.1 pt -114.81 136.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.481 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 13.5 mttm -118.63 147.33 43.86 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.122 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.5 t -125.43 105.27 14.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 104.52 2.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.655 HG13 HD22 ' A' ' 19' ' ' LEU . 25.9 t -76.53 126.84 85.64 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.798 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.781 ' HG2' HD13 ' A' ' 19' ' ' LEU . 27.5 Cg_endo -63.97 147.26 91.92 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.399 2.066 . . . . 0.0 111.875 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.68 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -73.85 88.5 1.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.771 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.479 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.1 mtm -138.53 75.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.12 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.8 mp0 -79.49 -44.87 20.42 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.311 -173.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -116.44 2.14 13.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.908 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -90.81 -4.87 56.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.493 -171.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.1 t -164.25 -174.21 3.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.887 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -99.02 -3.66 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.407 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.9 m0 -85.78 169.98 12.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.094 0.473 . . . . 0.0 111.176 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.09 22.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.001 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -77.52 133.32 38.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 21.1 m-80 -146.96 10.1 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.68 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 86.31 16.08 63.17 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.291 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -87.96 175.69 7.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.55 127.73 75.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.971 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 85.7 mt -87.91 141.71 28.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.39 107.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 24.1 m-85 -121.01 164.83 16.15 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 1' ' ' PRO . 4.9 m -126.44 122.26 34.78 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.218 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 HD11 ' A' ' 4' ' ' ILE . 78.6 mt -137.41 149.81 66.65 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.652 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 33.5 Cg_endo -66.27 152.2 81.61 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.273 1.982 . . . . 0.0 111.471 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 tp -62.82 -8.07 6.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -80.11 -20.71 44.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -74.84 -176.2 2.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.138 0.494 . . . . 0.0 110.217 177.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.97 174.65 10.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.901 0.381 . . . . 0.0 111.563 -173.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 61' ' ' ILE . 39.8 t -60.68 -30.33 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 m -51.69 -36.1 45.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.024 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -72.05 -32.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 23.9 mm -72.5 -51.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.452 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 3.3 ptmt -59.2 -42.56 91.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.498 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.3 p -69.83 -37.45 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.164 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 11.3 ptmt -69.31 -36.67 77.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.745 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.03 -41.35 81.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -58.73 -32.78 69.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.305 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 15.1 mm-40 -85.44 -30.89 23.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.902 0.382 . . . . 0.0 110.798 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.88 -46.62 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.956 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -97.53 -40.56 8.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.477 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.11 -15.92 10.11 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.931 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -82.14 117.0 66.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.385 0.612 . . . . 0.0 111.464 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 22.1 Cg_endo -67.25 159.01 54.24 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.595 2.197 . . . . 0.0 111.882 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.4 -13.58 58.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.45 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -29.25 54.76 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.968 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -132.45 -2.63 3.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 0.0 110.63 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.411 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -95.24 117.65 30.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.114 0.483 . . . . 0.0 109.887 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.7 mmpt? -104.27 139.96 38.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -120.04 118.87 31.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.634 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -112.96 117.32 31.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -102.73 107.98 19.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.947 0.403 . . . . 0.0 110.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 57.18 30.57 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.355 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.58 23.73 25.43 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.064 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 21.1 mt -126.38 116.21 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -72.15 95.9 1.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.474 0.654 . . . . 0.0 110.29 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -80.28 150.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.567 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.97 162.54 18.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.593 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 5.5 t70 -54.06 -27.7 34.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.218 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.15 -1.94 16.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.789 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.489 HD22 ' HE2' ' A' ' 70' ' ' TYR . 77.4 m-20 -115.69 168.76 9.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.394 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 91.9 p -125.73 173.15 9.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.33 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.12 -42.86 79.57 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.51 -33.92 73.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.222 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.09 -44.87 91.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.19 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HE2' HD22 ' A' ' 65' ' ' ASN . 27.9 m-85 -94.66 5.52 51.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.654 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 43.28 13.19 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 110.866 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.18 84.89 0.37 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.026 0.441 . . . . 0.0 110.76 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.48 -176.58 2.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.702 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -58.69 115.5 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.56 36.11 3.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.654 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -81.35 114.9 20.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 14.7 t -97.66 105.57 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.101 0.477 . . . . 0.0 110.94 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -95.53 148.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -118.24 117.04 28.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -84.55 133.97 34.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.61 151.8 35.64 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 51' ' ' LYS . 24.3 tp . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.6 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.92 154.43 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -90.81 120.83 32.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.332 0.586 . . . . 0.0 109.851 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.805 HG22 ' HB3' ' A' ' 76' ' ' ALA . 9.5 pt -120.46 143.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.402 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.562 ' HD2' HG22 ' A' ' 77' ' ' VAL . 4.5 mttm -119.26 150.14 40.59 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.889 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.12 105.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.43 106.2 3.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.68 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 79.2 t -77.18 130.0 76.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.741 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.8 Cg_endo -65.82 156.56 63.55 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.636 2.224 . . . . 0.0 111.829 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.648 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 13.3 m120 -85.32 85.82 7.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.0 mtm -137.95 76.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.725 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.594 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -77.76 -48.03 17.6 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.657 0.742 . . . . 0.0 110.334 -171.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 10.9 10.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.311 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -90.66 -4.89 56.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.678 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -158.24 -172.94 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.796 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -101.17 -5.07 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.54 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.2 m0 -91.6 171.87 8.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.879 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 28.22 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 110.996 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.741 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.5 mt -78.26 127.74 32.68 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -138.74 16.53 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.462 -0.774 . . . . 0.0 111.022 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.648 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.91 7.86 86.64 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -80.28 175.1 10.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.394 0.616 . . . . 0.0 110.61 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.3 t -120.6 123.01 69.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.603 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.7 mt -87.59 142.11 28.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 5' ' ' LYS . 57.8 t -132.39 107.78 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.529 0.681 . . . . 0.0 109.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.45 164.28 13.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.825 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -126.79 118.7 25.19 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.99 174.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.9 152.66 77.77 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.851 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.11 150.08 82.23 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.389 2.059 . . . . 0.0 111.246 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -61.8 -10.59 9.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.538 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -79.09 -18.94 52.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.867 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.02 -175.44 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -144.44 177.32 8.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.145 0.498 . . . . 0.0 111.567 -175.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.512 ' CG1' HG13 ' A' ' 61' ' ' ILE . 60.3 t -56.14 -33.07 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.742 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m -54.9 -30.76 59.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.22 -27.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 110.532 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.1 mm -72.4 -54.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.0 ptmt -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.13 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.889 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.59 -35.22 78.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.5 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 54' ' ' LEU . 67.4 mt -72.65 -43.08 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.526 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -59.04 -33.4 70.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.536 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -89.24 -20.41 24.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.064 0.459 . . . . 0.0 110.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.75 -54.48 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.153 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.7 p -91.15 -43.01 10.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.3 7.23 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.929 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.4 118.07 70.63 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.395 0.617 . . . . 0.0 111.602 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.36 157.33 62.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.433 2.088 . . . . 0.0 111.9 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.04 -8.02 20.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.384 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.76 -28.9 66.33 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.281 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.6 -2.75 3.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 110.449 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.64 117.26 32.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 mmpt? -110.92 140.33 45.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.391 -176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -111.0 124.21 51.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.436 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.45 117.9 31.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.739 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 14.2 t80 -103.33 108.25 19.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.092 0.473 . . . . 0.0 110.073 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.59 30.95 16.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.031 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.59 45.08 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.203 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.414 HG21 ' HE1' ' A' ' 70' ' ' TYR . 8.7 mt -120.57 113.04 38.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -73.49 92.96 1.93 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.607 0.717 . . . . 0.0 110.409 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.512 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -72.57 158.11 6.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.425 -174.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HE3' HD21 ' A' ' 65' ' ' ASN . 4.6 pttp -130.48 163.65 26.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.322 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m-20 -50.58 -32.19 17.98 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.814 0.696 . . . . 0.0 112.236 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -82.45 2.42 32.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.103 0.477 . . . . 0.0 110.95 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.409 HD21 ' HE3' ' A' ' 62' ' ' LYS . 92.6 m-20 -110.47 163.74 13.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.5 p -129.76 165.94 20.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.87 -44.04 97.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.767 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.14 82.74 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.368 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -59.34 -42.75 92.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HE1' HG21 ' A' ' 59' ' ' ILE . 33.7 m-85 -89.11 1.28 55.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.665 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.72 44.22 17.52 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.641 0.588 . . . . 0.0 110.864 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.9 mtt -67.24 89.45 0.2 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.06 -169.65 1.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.712 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -61.74 115.53 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.26 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.29 38.75 3.92 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.768 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.59 115.02 14.83 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.786 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.562 HG22 ' HD2' ' A' ' 5' ' ' LYS . 21.7 t -94.94 102.26 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.192 0.52 . . . . 0.0 110.946 -176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -93.9 146.41 6.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -114.78 113.97 24.96 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.69 133.32 35.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.39 146.07 30.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.156 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.4 tp . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.5 Cg_exo . . . . . 0 N--CA 1.473 0.31 0 N-CA-C 109.974 -0.818 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.0 m -121.05 153.87 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -89.94 116.18 27.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.035 0.445 . . . . 0.0 110.266 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.682 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -118.28 138.52 48.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.752 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 8.6 mttm -118.66 146.97 44.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.903 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -123.31 105.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.38 106.68 4.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.646 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 84.4 t -78.18 130.63 71.64 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.33 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.736 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.5 Cg_endo -66.09 150.0 85.47 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.37 2.047 . . . . 0.0 111.995 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.611 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.6 m120 -76.53 88.54 3.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.505 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.0 mtm -139.49 75.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.549 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.593 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.82 -45.1 19.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.77 0.795 . . . . 0.0 110.226 -175.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -0.6 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.682 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -92.48 -1.52 56.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.623 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.0 t -166.7 -177.5 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.321 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.69 -7.09 38.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.445 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.665 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -86.02 167.24 15.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.17 29.09 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.229 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.9 mt -79.27 130.69 35.72 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.673 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 20.5 m-80 -143.41 11.84 1.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.849 -0.532 . . . . 0.0 110.826 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.611 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.86 2.43 78.42 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.758 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.4 pm0 -76.21 174.08 10.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.4 124.36 72.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.08 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 86.3 mt -87.97 147.53 24.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -133.19 109.11 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 89.4 m-85 -115.93 159.47 21.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.214 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.6 m -126.78 112.96 15.99 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.02 0.438 . . . . 0.0 110.038 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.6 mt -133.47 149.68 72.96 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.819 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.69 151.36 85.43 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.354 2.036 . . . . 0.0 111.429 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 26.1 tp -63.17 -12.41 27.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.299 0.571 . . . . 0.0 110.567 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.0 p -80.72 -18.39 47.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.824 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.33 -173.27 2.01 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.153 0.502 . . . . 0.0 110.795 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.9 175.97 9.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 112.039 -173.041 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 26.1 t -64.95 -26.56 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.646 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 9.8 m -52.22 -33.88 43.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 t -73.54 -33.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.23 -48.59 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.692 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.709 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.96 -39.34 89.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.69 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -74.15 -38.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.046 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.52 -36.23 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.971 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 54' ' ' LEU . 78.8 mt -70.47 -42.69 78.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 110.571 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -57.87 -32.38 67.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.232 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.47 -25.17 22.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.03 0.443 . . . . 0.0 111.102 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.33 -47.86 11.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.605 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.1 p -98.77 -45.12 6.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.656 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.42 -20.49 5.54 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.878 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.452 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.1 ptm -77.97 119.94 79.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 0.0 111.615 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.6 Cg_endo -67.24 159.29 52.92 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 111.8 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.46 -11.38 51.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.542 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.5 -30.33 61.84 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.523 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -131.2 -0.98 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.988 0.423 . . . . 0.0 110.399 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -100.56 125.27 46.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -116.19 142.82 46.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.002 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.8 mm? -112.46 117.59 32.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.574 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.4 tt0 -107.04 113.93 27.69 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.008 0.433 . . . . 0.0 111.041 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.4 t80 -103.6 109.52 21.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.212 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 58.09 30.15 18.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.462 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.08 14.15 46.67 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.34 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 24.2 mt -117.23 118.62 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -75.04 90.36 2.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.194 0.521 . . . . 0.0 109.998 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.556 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -79.25 148.48 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.093 -174.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.66 162.69 13.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.977 176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.06 -21.73 66.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 -177.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -74.31 5.68 4.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.78 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' ND2' ' HE2' ' A' ' 70' ' ' TYR . 58.6 m-20 -111.03 166.81 10.74 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 52.8 p -126.15 165.34 19.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.88 -45.01 91.33 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.214 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.3 -33.67 73.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.213 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 66' ' ' SER . 77.9 t80 -57.44 -42.43 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.259 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.478 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 34.5 m-85 -98.85 8.17 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.268 177.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER 61.45 40.26 14.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.43 176.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -63.75 90.29 0.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.483 . . . . 0.0 111.443 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 178.34 6.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.248 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.32 115.36 2.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.27 29.59 4.76 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.038 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.05 114.3 15.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 27.5 t -95.1 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.543 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -94.31 145.69 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 11.3 m-70 -113.27 114.41 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.44 134.48 35.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.42 145.58 29.28 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.29 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 51' ' ' LYS . 33.1 tp . . . . . 0 C--N 1.316 -0.85 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.482 ' HB2' HG22 ' A' ' 27' ' ' THR . 31.4 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 18.3 m -124.76 154.29 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.0 110.326 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -87.19 114.44 23.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 110.084 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.715 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -113.33 135.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 13.5 mttt -122.11 146.48 47.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.572 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -124.11 105.98 16.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.738 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.509 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -69.22 103.82 2.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 19' ' ' LEU . 91.0 t -74.0 133.15 79.04 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.563 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.5 Cg_endo -66.48 147.48 82.46 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.766 1.644 . . . . 0.0 111.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -74.37 88.29 2.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.709 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.511 ' HB3' HG22 ' A' ' 15' ' ' THR . 52.6 mtm -140.61 76.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.09 -46.42 18.09 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.448 0.642 . . . . 0.0 110.137 -171.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.64 6.91 9.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.517 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -80.6 -15.98 55.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 109.576 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 11' ' ' MET . 10.8 t -153.0 -178.78 7.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.991 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 16' ' ' GLU . 10.5 pt-20 -91.31 -3.91 56.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.231 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.599 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -86.87 172.81 9.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.588 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.32 29.72 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.872 -177.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.3 mt -81.05 130.14 34.88 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.606 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.6 m-80 -138.29 15.54 2.79 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.103 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.26 -0.95 88.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.377 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -73.18 177.56 5.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.323 0.583 . . . . 0.0 111.136 -177.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.53 124.65 73.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.567 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.588 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 84.9 mt -86.91 142.67 27.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 110.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.047 0.451 . . . . 0.0 109.806 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 95.7 m-85 -122.71 158.58 29.79 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.895 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -126.22 112.91 16.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.106 0.479 . . . . 0.0 109.938 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 4' ' ' ILE . 85.3 mt -131.32 153.08 81.55 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.74 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.23 150.39 87.52 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.906 1.737 . . . . 0.0 111.277 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.7 tp -60.34 -12.21 8.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.725 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.2 p -78.83 -20.28 50.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.833 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -72.66 -176.25 1.91 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.258 0.552 . . . . 0.0 110.268 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.42 173.3 11.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.888 0.375 . . . . 0.0 111.684 -172.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.688 HG11 HG13 ' A' ' 61' ' ' ILE . 40.8 t -61.96 -26.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.479 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -53.94 -32.77 54.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.181 176.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.7 t -78.22 -27.7 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.451 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 33.6 mm -73.04 -48.21 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.952 0.406 . . . . 0.0 110.553 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -61.33 -39.66 91.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.456 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.4 p -72.61 -39.96 61.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.038 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -64.4 -39.23 93.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.802 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.413 HD12 HD11 ' A' ' 54' ' ' LEU . 76.4 mt -68.58 -43.29 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.739 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -57.74 -32.54 67.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.544 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 49.3 mt-10 -82.07 -38.18 25.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 110.141 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.09 -51.16 19.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.431 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.578 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 3.1 p -96.57 -43.07 7.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.0 110.303 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.3 -19.49 6.76 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.81 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.424 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.6 ptm -79.05 119.96 79.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.672 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.6 Cg_endo -68.28 156.43 65.74 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.566 2.177 . . . . 0.0 112.037 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.12 -15.99 58.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.66 -33.6 34.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.863 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.42 -3.91 4.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.554 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.72 121.41 38.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 110.009 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -113.06 144.05 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.02 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.3 mm? -112.83 120.04 40.09 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -108.05 110.33 22.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.101 0.477 . . . . 0.0 111.585 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 21.1 t80 -102.52 112.54 25.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.834 0.349 . . . . 0.0 110.136 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 16.2 mm-40 57.3 30.32 18.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.95 11.53 57.59 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.47 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 22.2 mt -113.97 119.08 60.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 6.7 m-30 -70.74 91.12 0.81 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.292 0.568 . . . . 0.0 109.905 174.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.688 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -77.76 153.25 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.272 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE2' HD21 ' A' ' 65' ' ' ASN . 15.5 pttt -121.82 161.85 21.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.746 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.78 -2.55 17.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.292 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 m -84.22 -2.89 57.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.035 0.445 . . . . 0.0 110.386 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.413 HD21 ' HE2' ' A' ' 62' ' ' LYS . 89.4 m-20 -119.3 175.11 5.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 80.7 p -129.78 170.38 13.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.172 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.65 -44.0 78.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.74 -37.03 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.318 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -58.82 -46.84 86.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.91 -4.23 58.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.752 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.4 41.23 4.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.504 0.503 . . . . 0.0 110.854 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtt -68.01 86.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.47 . . . . 0.0 111.408 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.46 -174.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.889 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.6 t-20 -65.71 115.3 5.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.71 29.16 4.79 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.439 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -72.67 114.44 10.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.97 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.38 150.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 7.6 m-70 -118.54 117.76 29.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.44 134.13 34.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.58 147.08 31.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.874 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.0 tp . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.579 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' THR . 7.7 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 12.3 m -123.39 151.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 110.296 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 109.02 20.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.71 0.767 . . . . 0.0 110.778 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.745 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -107.38 143.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.414 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.5 mtmm -126.89 152.03 47.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.656 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t -131.3 105.87 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.606 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 107.13 4.06 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.002 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 53.8 t -79.37 133.29 60.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.834 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' A' ' 19' ' ' LEU . 57.5 Cg_endo -70.42 151.99 65.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.464 2.109 . . . . 0.0 112.091 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.534 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -78.88 100.95 7.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.582 ' HB3' HG22 ' A' ' 15' ' ' THR . 27.6 mtm -147.21 76.8 1.43 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.455 0.169 . . . . 0.0 110.598 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.2 -48.4 15.93 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.014 0.435 . . . . 0.0 110.912 -169.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -121.42 9.33 10.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.965 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -84.52 -5.5 59.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -162.15 -178.84 6.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.239 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.34 1.55 47.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -88.15 175.57 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.684 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -94.88 30.79 1.99 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.605 -177.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 8' ' ' VAL . 22.0 mt -86.38 115.33 23.83 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.941 -0.475 . . . . 0.0 110.401 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 23.6 m-80 -130.32 21.65 5.21 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.555 -0.716 . . . . 0.0 110.863 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.55 1.63 87.58 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.046 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.6 pm0 -75.13 179.45 5.03 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 111.117 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.83 132.71 69.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.728 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 67.0 mt -87.51 144.26 26.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 5' ' ' LYS . 96.1 t -131.93 114.62 24.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 110.058 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 99.2 m-85 -128.85 160.16 33.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.8 m -126.55 119.09 26.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.82 151.32 70.23 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.83 149.66 89.28 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.006 1.804 . . . . 0.0 111.192 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 32.0 tp -59.5 -14.16 11.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.66 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -76.67 -19.39 57.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.125 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.31 -174.06 2.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.421 0.629 . . . . 0.0 111.029 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.11 172.88 12.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 0.0 112.266 -172.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 45.0 t -60.83 -26.42 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.623 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.29 -33.32 52.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.049 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -76.96 -29.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 21.4 mm -73.0 -45.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.573 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.693 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.4 ptmt -62.68 -42.94 99.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.48 -37.48 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.651 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.56 -35.34 80.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.578 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.88 -42.26 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -59.54 -35.87 75.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.355 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -83.85 -31.35 25.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.819 0.342 . . . . 0.0 111.463 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.47 -38.41 26.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.8 p -106.15 -47.91 3.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.043 0.449 . . . . 0.0 110.628 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.87 -6.55 10.33 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.115 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 22.0 ptm -87.19 115.7 63.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.406 0.622 . . . . 0.0 110.978 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.4 157.56 61.29 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.626 2.217 . . . . 0.0 112.127 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.75 -17.15 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.209 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.55 -31.15 52.01 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.859 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -129.84 -5.37 4.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.49 . . . . 0.0 110.535 -178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.693 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -87.52 113.48 23.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mmpt? -104.94 138.72 40.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.7 mt -118.88 122.4 42.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.975 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -112.3 120.27 41.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.191 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.6 t80 -108.84 110.32 21.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.42 30.79 20.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.05 49.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.16 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 mt -121.94 113.58 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -74.63 95.27 2.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.752 0.787 . . . . 0.0 110.287 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.73 168.9 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.098 -176.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.46 166.04 21.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.365 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.36 -2.78 20.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.898 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.6 t -94.32 13.23 24.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.191 0.519 . . . . 0.0 110.237 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.64 165.69 16.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 71.6 m -126.15 166.38 17.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.02 -46.53 84.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.767 0.318 . . . . 0.0 110.397 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -59.85 -29.99 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.455 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 66' ' ' SER . 56.7 t80 -62.81 -40.99 99.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -97.86 5.17 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.28 46.55 23.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.332 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 mtt -66.05 82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 110.806 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 171.79 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 48.0 t-20 -55.36 115.95 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.73 27.38 4.66 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.058 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.745 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -78.11 115.06 17.56 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.57 104.33 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.3 mm -94.27 150.62 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -116.78 119.71 36.28 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.75 134.27 33.96 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.715 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.9 142.66 27.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.933 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 C--N 1.316 -0.877 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.142 178.228 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.476 0.499 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.15 152.03 24.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.933 0.397 . . . . 0.0 110.389 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -89.02 114.19 25.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.058 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.3 pt -117.64 138.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.696 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -121.53 145.14 48.26 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.233 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.04 105.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.427 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.48 104.61 2.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.567 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.584 HG13 HD22 ' A' ' 19' ' ' LEU . 95.8 t -75.75 127.32 85.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.425 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.827 ' HG2' HD13 ' A' ' 19' ' ' LEU . 26.1 Cg_endo -61.92 151.13 83.14 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.515 2.143 . . . . 0.0 112.2 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.691 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -79.71 83.22 5.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.78 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.49 ' HB3' HG22 ' A' ' 15' ' ' THR . 55.4 mtm -135.81 75.57 1.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.623 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -77.22 -45.8 25.32 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.363 0.601 . . . . 0.0 110.229 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.96 8.86 10.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.984 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -90.39 -4.81 56.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.046 -173.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 17' ' ' TRP . 14.4 t -161.2 -172.71 3.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.942 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.3 4.67 36.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.57 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -96.44 171.65 8.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.81 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 27.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 110.944 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -78.85 129.63 34.78 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.5 m-80 -142.27 15.67 2.04 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.935 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.691 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.03 5.03 90.42 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.919 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.624 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.04 179.38 6.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.34 136.59 60.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.184 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.91 142.76 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.28 109.9 19.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -123.19 163.66 20.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.581 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.2 m -127.06 117.34 22.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 110.236 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.33 149.76 72.11 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.617 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.9 151.8 81.57 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.167 1.912 . . . . 0.0 111.256 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' MET . 29.7 tp -61.89 -10.18 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -80.19 -19.05 47.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.848 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.58 -173.05 2.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.69 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.67 175.4 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.485 -173.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 61' ' ' ILE . 42.3 t -60.0 -28.49 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.527 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -51.28 -31.61 21.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.86 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.89 -33.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 0.0 110.408 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 19.4 mm -72.12 -49.61 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.572 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 8.4 ptmt -60.01 -40.67 90.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 p -72.05 -38.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.756 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -66.87 -36.12 81.59 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.843 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.77 -41.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.499 . . . . 0.0 110.202 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -58.3 -32.12 68.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.45 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 8.7 mm-40 -87.81 -30.29 20.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.118 0.485 . . . . 0.0 110.724 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.75 -46.39 14.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.784 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.1 p -98.23 -43.4 7.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.348 . . . . 0.0 110.721 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.21 -2.33 18.93 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.401 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -92.0 118.04 68.02 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.353 0.597 . . . . 0.0 111.281 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.41 155.88 67.61 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.434 2.089 . . . . 0.0 112.119 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.66 -16.88 59.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.668 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.52 -29.67 40.14 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.292 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.48 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -130.87 -1.82 4.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.237 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.75 113.37 24.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.557 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -105.22 139.15 40.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.095 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.64 121.3 41.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 109.889 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.3 tt0 -113.46 113.99 25.93 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.333 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.1 t80 -103.05 110.89 22.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.933 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 57.39 29.78 17.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.432 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.23 7.34 57.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.524 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.3 mt -112.34 119.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -72.52 91.8 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.141 0.496 . . . . 0.0 110.196 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.462 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -77.3 154.25 5.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.608 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 28.9 pttt -123.16 162.08 23.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.448 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 38' ' ' LYS . 6.5 t70 -54.48 -30.35 52.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.806 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 16.0 m -69.47 -13.88 62.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.919 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 90.0 m-20 -105.43 177.91 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 110.657 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 78.5 p -134.59 171.12 14.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.408 -175.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.7 -44.03 78.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.937 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.82 70.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.493 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -62.37 -45.29 93.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -89.19 1.6 55.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.79 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 m120 64.56 31.27 12.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.416 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.44 ' O ' HD13 ' A' ' 30' ' ' LEU . 58.5 mtt -59.72 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.214 0.531 . . . . 0.0 112.113 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 -172.08 3.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -64.4 116.19 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.905 0.383 . . . . 0.0 110.664 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.08 19.23 7.76 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.552 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 114.45 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.136 0.468 . . . . 0.0 110.102 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.12 104.85 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.0 mm -94.36 148.01 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -115.09 115.42 26.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.04 131.51 35.79 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.01 32.99 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.127 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 51' ' ' LYS . 31.7 tp . . . . . 0 C--N 1.316 -0.89 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.2 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.09 155.41 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.685 0.279 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -87.91 117.01 26.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.138 0.494 . . . . 0.0 110.234 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.3 pt -124.01 142.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.999 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -123.99 146.84 48.24 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.566 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.37 105.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 104.17 3.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.609 HG13 HD22 ' A' ' 19' ' ' LEU . 55.9 t -75.89 126.71 86.67 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.316 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.4 Cg_endo -65.74 147.5 85.76 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.3 2.0 . . . . 0.0 112.114 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.58 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -72.61 90.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.518 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 42.3 mtm -141.43 76.56 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.871 0.367 . . . . 0.0 110.367 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.624 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.92 -45.54 20.31 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.57 0.7 . . . . 0.0 110.201 -172.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -120.51 7.79 10.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.161 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -94.81 3.53 54.9 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.807 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -168.28 -174.45 2.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.452 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 6.2 pt-20 -106.29 3.65 27.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.289 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.758 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.4 m0 -102.28 170.64 7.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 26.82 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.629 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.83 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -78.5 126.45 30.78 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.0 m-80 -140.99 15.74 2.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 110.667 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.53 1.0 89.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.196 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.595 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 1.1 pm0 -75.66 173.66 10.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 110.779 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.04 124.67 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.878 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.55 134.35 33.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -121.43 107.36 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -122.0 162.24 21.49 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.543 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.4 m -125.77 116.78 22.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.996 0.426 . . . . 0.0 110.44 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 4' ' ' ILE . 81.0 mt -133.68 151.31 76.87 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.035 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.04 147.96 80.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.292 1.995 . . . . 0.0 111.687 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.05 -10.66 10.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 110.601 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.9 p -81.98 -15.0 55.22 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.725 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.5 -173.39 4.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.115 0.483 . . . . 0.0 110.573 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.56 173.59 11.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.889 0.376 . . . . 0.0 111.666 -172.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 61' ' ' ILE . 41.8 t -61.43 -27.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.012 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -53.11 -33.28 51.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.399 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.63 -34.01 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.222 0.534 . . . . 0.0 110.264 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.0 mm -70.48 -52.07 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.859 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -58.19 -42.71 86.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.518 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 11.1 p -71.32 -38.98 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.678 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.2 ptmt -66.07 -35.26 80.04 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.39 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.2 mt -72.71 -41.13 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 110.196 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 23.5 t-80 -58.04 -32.4 67.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.339 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 56.8 mm-40 -85.94 -34.52 20.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.992 0.425 . . . . 0.0 110.047 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.06 -46.53 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.637 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.9 p -97.78 -43.6 7.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.067 0.46 . . . . 0.0 110.626 -176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 -7.19 11.24 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.131 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.516 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 13.2 ptm -89.7 119.64 69.48 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 111.827 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.2 Cg_endo -67.65 157.41 61.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.541 2.161 . . . . 0.0 112.057 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.99 -12.07 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.597 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.5 -33.76 62.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.647 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.54 -5.12 6.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.337 0.589 . . . . 0.0 109.979 -177.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -99.83 113.55 26.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 12.0 mmpt? -107.66 135.3 49.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.544 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HB3' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -103.38 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.09 176.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 tt0 -108.5 116.52 32.12 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 78' ' ' ILE . 7.5 t80 -101.04 102.83 13.9 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.457 0.646 . . . . 0.0 109.685 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 6.4 mm-40 57.42 31.01 19.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.076 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . 98.14 19.49 23.59 Favored Glycine 0 CA--C 1.511 -0.167 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.829 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.99 112.06 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 55' ' ' GLN . 5.0 m-85 -72.0 95.4 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.59 0.71 . . . . 0.0 110.002 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.2 162.12 3.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.27 -178.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE2' HD21 ' A' ' 65' ' ' ASN . 0.0 OUTLIER -135.46 165.17 26.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -72.73 -4.85 33.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.622 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -79.97 -7.7 58.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 109.905 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.413 HD21 ' HE2' ' A' ' 62' ' ' LYS . 86.0 m-20 -114.82 178.91 4.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.303 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 53.5 p -136.93 173.43 11.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.336 -175.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.16 -45.08 70.93 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.26 72.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.259 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 66' ' ' SER . 46.2 t80 -56.74 -46.19 81.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.657 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -90.62 1.11 57.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 58.98 42.25 19.64 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.557 0.536 . . . . 0.0 110.395 -178.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.6 mtt -65.27 88.14 0.08 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.9 -178.07 5.28 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.85 116.28 3.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.287 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.75 29.3 5.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.364 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.11 114.67 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.91 106.35 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.14 0.495 . . . . 0.0 110.58 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.2 mm -94.46 145.47 7.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -116.25 111.69 20.52 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.56 132.37 35.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 144.11 30.56 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.479 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 51' ' ' LYS . 32.1 tp . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.552 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 Cg_endo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 110.258 -0.708 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.73 154.9 37.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 m -86.77 125.15 33.74 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' A' ' 76' ' ' ALA . 12.9 pt -128.71 145.37 35.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.968 0.413 . . . . 0.0 111.045 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -126.5 146.53 50.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.2 t -123.18 105.79 16.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.615 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.53 103.86 3.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 94.3 t -77.03 131.68 72.43 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.843 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.629 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.9 Cg_endo -66.16 155.76 68.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.567 2.178 . . . . 0.0 111.851 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.74 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -84.66 84.16 7.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.587 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.495 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -133.44 75.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.9 mp0 -78.43 -46.3 20.15 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 110.383 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 0.63 10.32 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.046 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HE2' ' OE1' ' A' ' 12' ' ' GLN . 20.6 mmtt -86.14 0.98 52.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.369 0.605 . . . . 0.0 109.63 -173.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -160.38 -173.53 4.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.45 -5.8 24.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 111.508 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.1 m0 -85.37 173.87 9.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.4 29.38 1.28 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.359 -176.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.629 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.0 mt -81.53 124.97 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.562 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 4.8 m-80 -132.33 19.6 4.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.899 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.74 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.66 12.96 83.44 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.302 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.562 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -83.22 179.12 7.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.137 0.494 . . . . 0.0 110.754 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.97 126.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 72.5 mt -87.3 139.49 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.16 109.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -124.2 166.02 16.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.394 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 1' ' ' PRO . 9.9 m -126.87 121.98 33.36 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.099 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 4' ' ' ILE . 77.4 mt -136.15 149.28 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.774 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.4 Cg_endo -65.25 150.13 87.8 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.182 1.921 . . . . 0.0 110.947 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 20.0 tp -62.33 -8.82 6.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.652 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -82.52 -18.85 40.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.9 -175.26 2.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 110.063 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.93 174.68 10.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.93 0.395 . . . . 0.0 111.546 -174.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.584 HG11 HG13 ' A' ' 61' ' ' ILE . 35.0 t -62.87 -25.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.632 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 1.6 t -53.13 -33.81 54.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.66 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -72.43 -33.36 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.155 0.502 . . . . 0.0 110.553 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -70.54 -47.16 66.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.4 ptmt -63.15 -41.89 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.273 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -68.85 -39.38 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.695 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -39.74 85.5 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.199 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.73 -40.51 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 110.421 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -61.1 -32.8 72.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.566 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.55 -30.23 18.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.586 0.231 . . . . 0.0 111.133 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.11 -39.02 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.595 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 9.3 p -105.69 -45.28 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.548 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.65 -11.81 8.9 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.286 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 23.4 ptm -84.21 117.76 69.51 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.349 0.595 . . . . 0.0 111.116 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 29.3 Cg_endo -68.94 157.1 63.21 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.579 2.186 . . . . 0.0 112.161 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.71 -15.55 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.69 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.71 -30.03 50.79 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.981 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.59 -0.41 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.117 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.13 113.86 25.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 178.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.3 mmpt? -106.73 141.84 37.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.7 mm? -114.42 118.19 33.13 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -107.2 115.14 29.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.413 . . . . 0.0 110.668 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.5 t80 -103.91 111.38 23.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 57.88 29.74 18.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.191 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.41 24.52 26.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.071 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.78 110.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.422 ' HD1' ' HB3' ' A' ' 53' ' ' LYS . 53.9 m-85 -71.69 94.92 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.761 0.791 . . . . 0.0 110.648 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.584 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -80.73 154.61 4.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.159 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.49 162.73 13.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -70.89 -15.71 62.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 111.335 -174.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 m -78.24 7.22 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.801 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 80.9 m-20 -109.99 166.66 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 87.3 p -123.75 164.5 19.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.15 -43.24 92.46 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.192 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.34 -38.03 82.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.231 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -55.66 -43.64 76.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.233 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.99 5.06 53.0 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.709 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.43 46.98 14.36 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.376 0.423 . . . . 0.0 111.399 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.24 84.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 110.775 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.31 -176.64 1.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.074 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -61.37 116.51 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.309 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.41 33.64 4.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.962 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -74.32 114.63 12.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.043 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.58 103.45 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.116 0.484 . . . . 0.0 110.58 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.37 143.39 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -113.19 113.05 24.8 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.11 132.19 36.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.59 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.96 143.96 26.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.628 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HE1' ' A' ' 11' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.436 -1.146 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.078 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.523 ' HB2' HG22 ' A' ' 27' ' ' THR . 37.0 Cg_endo . . . . . 0 N--CA 1.478 0.577 0 N-CA-C 109.839 -0.869 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 25.8 m -126.27 156.7 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.707 0.289 . . . . 0.0 110.354 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -86.63 121.33 29.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.029 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.2 pt -122.5 137.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.568 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HD3' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -120.25 151.96 38.43 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.474 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.04 106.21 15.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.492 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.52 106.73 3.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.461 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -77.35 127.62 82.54 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.761 ' HG2' HD13 ' A' ' 19' ' ' LEU . 31.9 Cg_endo -64.31 148.59 90.98 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.122 1.882 . . . . 0.0 112.081 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.567 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -74.83 93.85 2.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.775 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 15' ' ' THR . 35.9 mtm -146.45 75.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -78.53 -49.01 14.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.384 0.611 . . . . 0.0 110.543 -169.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.4 17.49 9.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.19 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -91.33 -7.91 49.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.4 t -158.76 -172.5 3.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.685 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.55 -0.44 25.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.913 0.387 . . . . 0.0 111.58 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.8 m0 -85.95 168.66 13.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -84.93 31.64 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.427 0.632 . . . . 0.0 111.045 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 9' ' ' PRO . 13.5 mt -84.77 112.98 20.99 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.814 -0.554 . . . . 0.0 110.096 -175.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.626 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -126.46 16.26 7.65 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.33 -0.856 . . . . 0.0 111.209 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.24 5.96 86.76 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -79.6 175.18 10.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.651 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 7' ' ' GLN . 43.9 t -124.84 124.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.099 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.92 142.54 27.72 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 5' ' ' LYS . 58.4 t -132.47 111.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.152 0.501 . . . . 0.0 110.261 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.44 166.25 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.5 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -125.99 116.86 22.11 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.314 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 4' ' ' ILE . 82.3 mt -131.98 153.74 81.48 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.679 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.9 Cg_endo -64.85 149.32 89.75 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.274 1.983 . . . . 0.0 111.533 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -62.67 -12.05 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.726 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -80.93 -16.24 54.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.512 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.93 -174.87 2.35 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.23 173.4 11.98 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -171.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG11 HG13 ' A' ' 61' ' ' ILE . 39.9 t -62.47 -25.14 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.598 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.33 -34.34 57.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.246 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.52 -30.29 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.533 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 26.1 mm -72.31 -47.57 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.831 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 4.1 ptmt -61.92 -40.12 94.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -71.12 -39.7 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.013 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.49 -38.44 89.75 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.92 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 54' ' ' LEU . 79.4 mt -71.59 -42.16 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 0.0 110.552 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' MET . 32.7 t60 -57.64 -32.77 67.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.434 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.45 -29.21 18.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.804 0.335 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' LYS . . . -82.8 -31.1 28.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.053 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -112.18 -43.4 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.468 . . . . 0.0 110.548 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.97 -7.06 10.93 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 15.6 ptm -89.97 119.24 69.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.347 0.594 . . . . 0.0 111.586 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 25.9 Cg_endo -67.81 161.36 44.26 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 111.86 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.56 -10.67 57.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -176.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -28.69 62.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.69 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -131.83 -3.05 3.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 110.329 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -98.12 122.19 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.3 mmpt? -114.0 142.56 46.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.513 HD11 ' CD1' ' A' ' 41' ' ' ILE . 1.8 mm? -111.49 119.38 38.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.582 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.1 tt0 -108.55 112.66 25.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.936 0.398 . . . . 0.0 111.026 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.657 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.0 t80 -103.23 109.97 21.76 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 57.34 30.18 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.549 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.93 17.16 38.84 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.35 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 17.6 mt -120.65 116.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 16.2 m-85 -72.75 91.38 1.47 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 110.096 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.565 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.67 157.04 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 -175.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HE3' HD21 ' A' ' 65' ' ' ASN . 3.1 pttp -121.44 160.22 24.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.758 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.3 p-10 -71.14 -8.3 52.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 m -85.24 -1.58 57.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 0.0 110.261 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.446 HD21 ' HE3' ' A' ' 62' ' ' LYS . 94.2 m-20 -109.6 170.67 7.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.449 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 97.0 p -126.33 170.94 11.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.88 -43.65 82.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.18 -35.27 73.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.298 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.14 -46.58 85.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.91 5.58 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.503 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 m120 59.37 43.36 16.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -67.16 92.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.93 -176.46 2.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.755 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.5 t30 -66.08 115.39 6.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.14 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.69 28.68 5.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.358 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.18 114.76 11.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.039 0.447 . . . . 0.0 110.188 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG22 ' HD3' ' A' ' 5' ' ' LYS . 38.9 t -95.68 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.696 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.89 148.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.36 118.37 32.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -80.43 133.67 35.9 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.48 146.43 31.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 51' ' ' LYS . 26.6 tp . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 110.187 -0.736 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.94 155.77 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.267 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -90.72 109.84 21.03 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.444 0.64 . . . . 0.0 110.71 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.8 pt -111.26 147.56 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.591 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.1 mtmm -130.47 150.43 51.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.801 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 48.1 t -127.08 105.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.96 108.64 4.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.598 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.551 HG13 HD22 ' A' ' 19' ' ' LEU . 86.0 t -80.46 129.02 70.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.31 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.742 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.3 Cg_endo -65.71 150.52 86.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.375 2.05 . . . . 0.0 111.912 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.675 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -76.76 91.63 3.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.761 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.525 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.1 mtm -141.95 74.48 1.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.762 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -44.66 17.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.819 0.819 . . . . 0.0 110.163 -176.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.9 -12.63 14.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.781 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 39.2 mmtt -75.33 -20.34 59.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.757 -172.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -152.24 -174.47 4.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.41 -175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.06 -2.04 28.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.351 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.559 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -85.4 174.21 9.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.278 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -88.82 30.46 0.92 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.34 0.591 . . . . 0.0 111.453 -176.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' HG2' ' A' ' 9' ' ' PRO . 11.3 mt -85.02 124.52 31.81 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.687 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.3 m-80 -136.19 17.7 3.2 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.857 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.675 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.2 11.11 82.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.915 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -82.36 -179.77 7.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.903 0.383 . . . . 0.0 110.301 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.91 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.503 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 85.0 mt -89.86 143.4 26.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.088 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' HG2' ' A' ' 5' ' ' LYS . 48.5 t -127.99 111.16 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -126.04 162.65 24.81 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -125.97 115.68 20.28 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.249 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -134.73 150.9 74.73 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.88 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.54 152.22 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.459 2.106 . . . . 0.0 111.707 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.0 tp -63.99 -9.06 13.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.478 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -80.69 -21.42 41.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.82 -174.79 2.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.293 0.568 . . . . 0.0 110.373 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.74 175.79 10.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.017 0.437 . . . . 0.0 111.495 -174.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG11 HG13 ' A' ' 61' ' ' ILE . 46.0 t -59.74 -27.03 36.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.237 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.5 m -54.63 -34.16 61.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.1 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -74.62 -28.45 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.946 0.403 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.658 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 31.7 mm -72.87 -52.64 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.5 ptmt -57.78 -43.14 85.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.663 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.93 -37.87 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.719 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.7 -35.52 78.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.894 -177.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.84 -42.48 77.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.53 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -57.57 -32.85 67.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.088 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.4 -20.76 23.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.93 0.395 . . . . 0.0 111.271 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.94 -37.22 13.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 5.2 p -108.57 -46.11 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.192 0.52 . . . . 0.0 110.318 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.49 -17.45 5.84 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.422 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.6 ptm -81.13 117.49 68.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.454 0.645 . . . . 0.0 111.35 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.501 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.4 Cg_endo -67.29 159.76 50.77 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 111.948 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.75 -6.71 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.948 0.404 . . . . 0.0 111.87 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.37 -27.05 67.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.501 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.54 -3.48 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.102 0.477 . . . . 0.0 110.409 -177.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.58 116.99 32.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.674 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.0 mmpt? -104.68 141.34 36.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.62 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.19 122.13 45.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -112.11 117.84 33.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.102 0.477 . . . . 0.0 111.448 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 25.6 t80 -106.79 112.06 24.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.117 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 8.3 mm-40 57.54 29.82 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.308 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.39 10.23 57.18 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.381 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.01 116.58 52.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -76.85 93.34 3.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.676 0.75 . . . . 0.0 110.071 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.463 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.18 165.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.283 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -139.1 171.93 13.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.439 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.39 -5.45 36.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.7 p -81.37 -4.11 54.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -113.5 172.81 6.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.67 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.448 ' HA ' ' CB ' ' A' ' 33' ' ' GLN . 71.1 p -132.87 167.75 19.64 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.27 -45.11 89.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.56 -37.33 75.49 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -57.37 -44.48 84.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.036 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.434 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 47.4 m-85 -89.46 -0.2 57.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.582 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 42.15 14.73 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.461 0.475 . . . . 0.0 110.619 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 mtt -65.09 85.4 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.988 0.423 . . . . 0.0 110.907 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.29 -174.21 3.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -58.81 116.32 3.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.167 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.85 36.5 3.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.369 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.11 114.76 21.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.38 103.69 15.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.788 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.6 mm -94.26 151.01 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.28 119.34 35.4 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -85.31 134.05 34.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.8 149.21 35.06 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.035 0.445 . . . . 0.0 110.527 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 51' ' ' LYS . 35.9 tp . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 N-CA-C 109.692 -0.926 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.452 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 17.3 m -125.67 154.58 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.362 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -86.26 123.94 32.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.671 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -126.73 138.05 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 110.984 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HD2' HG22 ' A' ' 77' ' ' VAL . 12.5 mttm -120.15 147.73 44.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.311 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 59.5 t -123.75 105.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -73.98 103.06 4.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.862 -178.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -73.97 131.83 80.84 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.617 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.71 ' HG2' HD13 ' A' ' 19' ' ' LEU . 44.0 Cg_endo -68.25 153.23 74.95 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.145 1.897 . . . . 0.0 111.794 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.586 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.5 m120 -80.22 93.71 5.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.454 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.2 mtm -142.77 75.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.787 0.327 . . . . 0.0 110.286 174.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -79.52 -45.12 19.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.555 0.693 . . . . 0.0 110.71 -173.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -118.06 15.46 14.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.726 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -102.59 -3.39 26.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 17' ' ' TRP . 11.4 t -164.24 -171.68 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.592 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.74 4.04 37.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.452 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.631 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.5 m0 -94.84 173.77 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.078 0.466 . . . . 0.0 110.858 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.442 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.22 29.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.883 -177.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.71 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.6 mt -81.44 119.22 23.44 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.95 -0.469 . . . . 0.0 109.928 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 10.6 m-80 -131.7 15.81 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 83.75 2.63 89.78 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.809 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -76.44 178.05 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 7' ' ' GLN . 48.5 t -121.69 126.64 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.1 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.9 mt -87.35 142.8 27.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.9 t -131.17 108.65 15.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.55 161.37 19.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.03 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -127.1 113.94 17.08 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.031 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 4' ' ' ILE . 87.6 mt -131.2 153.91 81.83 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.806 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.3 150.42 87.32 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.177 1.918 . . . . 0.0 111.226 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -62.88 -13.56 35.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -78.89 -15.22 58.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.425 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.95 -174.42 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -146.31 172.63 13.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -170.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 30.8 t -59.01 -28.28 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.44 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 2.7 t -54.27 -31.44 53.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.829 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.52 -29.66 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.661 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.8 mm -72.3 -51.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.451 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.4 ptmt -57.75 -43.75 85.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.601 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.78 -38.94 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.068 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.24 -35.47 77.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.531 -177.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -70.59 -43.44 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 110.297 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.03 -32.9 68.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.363 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.66 -22.92 22.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.039 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.87 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.653 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.5 p -101.41 -44.74 5.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.839 0.352 . . . . 0.0 110.734 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.3 -6.39 10.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.102 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.428 ' HG2' ' OG1' ' A' ' 45' ' ' THR . 18.3 ptm -91.16 120.02 68.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.316 0.579 . . . . 0.0 111.508 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.4 Cg_endo -68.72 157.57 61.32 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.467 2.111 . . . . 0.0 112.24 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.74 -8.67 15.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.761 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.27 -29.69 66.35 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.445 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.47 -10.12 4.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.356 -177.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.58 113.77 25.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.961 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.5 mmpt? -102.57 142.12 34.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.51 130.19 56.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -121.76 120.81 35.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.64 ' HB2' HD12 ' A' ' 78' ' ' ILE . 13.8 t80 -103.5 107.45 18.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.389 . . . . 0.0 110.592 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 59.2 mm-40 55.59 30.49 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.735 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.62 19.17 30.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.186 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -123.65 109.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -72.0 95.03 1.54 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.797 0.808 . . . . 0.0 110.499 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.11 164.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.177 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HE2' HD21 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -135.25 163.78 29.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.191 0.519 . . . . 0.0 111.989 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -51.8 -32.4 31.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.348 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -75.77 2.46 12.15 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.456 HD21 ' HE2' ' A' ' 62' ' ' LYS . 89.5 m-20 -118.48 171.63 8.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.398 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 67.2 p -129.22 172.15 11.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.33 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.14 -45.26 74.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.997 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.22 71.65 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.343 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.79 -42.34 97.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -92.31 3.88 54.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.931 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.6 m120 57.29 39.38 28.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.1 mtt -63.78 92.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.78 176.3 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.401 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 2' ' ' VAL . 33.0 m-80 -57.35 116.4 3.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.144 0.497 . . . . 0.0 110.783 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.36 26.19 5.24 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.694 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.671 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.25 114.42 11.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 ' HD2' ' A' ' 5' ' ' LYS . 25.7 t -96.94 104.68 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.193 0.52 . . . . 0.0 110.75 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.9 mm -94.33 143.33 11.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -110.44 112.02 23.67 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.16 134.12 36.71 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.46 142.2 24.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.534 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 51' ' ' LYS . 19.7 tp . . . . . 0 C--N 1.317 -0.815 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.473 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.477 0.524 0 N-CA-C 109.767 -0.897 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 20.9 m -129.14 155.52 41.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.043 0.449 . . . . 0.0 110.768 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -85.14 122.66 29.67 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.7 HG22 ' HB3' ' A' ' 76' ' ' ALA . 7.3 pt -123.8 144.22 34.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.095 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 77' ' ' VAL . 31.5 mtmt -125.67 151.21 46.87 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.119 0.485 . . . . 0.0 111.172 -175.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.2 105.45 13.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.139 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 104.41 3.36 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.2 t -76.81 128.41 81.68 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 30.6 Cg_endo -63.44 149.02 92.19 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 122.517 2.145 . . . . 0.0 112.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.692 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.8 m120 -75.69 93.89 3.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.516 ' HB3' HG22 ' A' ' 15' ' ' THR . 43.6 mtm -143.78 73.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.438 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.598 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -78.84 -45.61 20.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.596 0.713 . . . . 0.0 110.074 -171.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.46 16.69 12.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.814 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -100.8 -6.13 25.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -160.53 -176.01 5.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.157 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.14 -4.0 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.424 -172.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.2 m-90 -95.75 169.94 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -175.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 24.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 111.578 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.7 mt -75.84 131.28 39.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.668 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.6 m-80 -142.43 14.38 1.99 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.692 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.91 0.12 89.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.015 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.668 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.6 pm0 -73.66 174.72 7.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 126.74 71.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.158 0.504 . . . . 0.0 109.814 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.68 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 5' ' ' LYS . 45.8 t -124.02 106.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -119.79 164.38 16.07 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.523 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 1' ' ' PRO . 12.6 m -126.29 126.33 43.79 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.406 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 4' ' ' ILE . 53.4 mt -140.9 152.75 66.31 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.263 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.3 152.38 79.32 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.862 1.708 . . . . 0.0 111.048 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.48 -10.79 19.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.8 p -77.39 -19.97 55.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.233 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.87 -173.8 3.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 111.251 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -146.09 176.8 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.017 0.437 . . . . 0.0 111.932 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.507 ' CG1' HG13 ' A' ' 61' ' ' ILE . 40.0 t -57.96 -31.74 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.403 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 29.0 t -55.66 -28.89 57.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.84 -30.74 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 120.989 0.423 . . . . 0.0 110.784 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mm -71.15 -52.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.6 ptmt -57.72 -43.14 85.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.8 p -69.29 -40.04 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 9.5 ptpt -67.05 -35.71 80.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.607 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.63 -43.54 77.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -60.39 -33.35 72.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.423 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 18.7 mm-40 -88.6 -25.69 22.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.795 0.331 . . . . 0.0 110.635 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.96 -53.08 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.4 p -90.35 -42.98 10.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.95 -8.24 11.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.464 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 19.8 ptm -89.67 117.09 67.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.412 0.625 . . . . 0.0 111.346 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 Cg_endo -67.78 158.47 57.09 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.386 2.057 . . . . 0.0 112.132 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.99 -6.35 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.158 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.38 67.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.371 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.522 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.38 -11.67 4.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.248 0.547 . . . . 0.0 110.019 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.84 112.77 24.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.217 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mmpt? -104.36 140.33 38.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.753 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.1 mm? -110.33 135.8 50.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -128.56 117.61 21.56 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.981 0.42 . . . . 0.0 111.464 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -104.45 111.27 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.943 0.401 . . . . 0.0 110.503 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 33.4 mm-40 56.32 29.94 15.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.357 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.95 21.26 33.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.25 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -125.93 116.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -74.55 96.05 2.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.846 0.831 . . . . 0.0 110.663 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -76.84 153.88 5.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.81 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.2 166.36 14.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.381 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -32.82 21.83 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.83 0.852 . . . . 0.0 111.78 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -74.88 -14.27 60.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.325 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -97.0 165.16 12.21 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.0 p -130.67 167.4 18.86 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.66 -45.52 86.37 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.51 78.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.467 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -56.8 -46.3 81.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 53.9 m-85 -85.8 -3.29 58.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.518 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.77 47.37 15.59 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 123.42 0.45 . . . . 0.0 110.031 -174.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.01 87.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.15 178.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.945 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 16.2 t-20 -60.52 114.87 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.935 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.21 40.38 2.1 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.404 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.61 114.55 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 110.249 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' HE3' ' A' ' 5' ' ' LYS . 15.3 t -94.74 104.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.976 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.5 mm -94.81 146.55 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -113.02 116.42 29.9 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.1 tp -84.64 133.78 34.4 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.32 142.67 27.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.004 0.431 . . . . 0.0 111.071 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.233 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.51 157.9 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -88.93 125.84 35.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.301 0.572 . . . . 0.0 110.277 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.693 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -122.29 135.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.544 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -121.06 145.63 47.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.632 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.96 108.1 19.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.584 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 102.99 3.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.007 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 63.0 t -73.75 130.25 83.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.899 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.737 ' HG2' HD13 ' A' ' 19' ' ' LEU . 39.9 Cg_endo -66.44 155.19 71.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.963 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.657 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.2 m120 -82.37 90.81 6.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -142.5 76.78 1.55 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.057 0.455 . . . . 0.0 110.523 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.5 mp0 -78.77 -47.5 16.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.943 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -120.98 2.97 10.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.423 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -76.96 -19.16 57.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.346 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.3 t -150.96 -174.02 4.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.442 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -95.41 -5.76 42.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 0.0 111.509 -173.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.598 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -87.74 174.21 8.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.452 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -89.35 30.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.058 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD13 ' HG2' ' A' ' 9' ' ' PRO . 16.8 mt -83.12 131.7 35.13 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.651 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.3 m-80 -143.12 15.84 1.89 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.123 0.487 . . . . 0.0 110.365 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.657 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.42 2.86 87.19 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.985 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.651 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.1 pm0 -74.35 177.11 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.11 0.481 . . . . 0.0 110.685 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.74 132.82 70.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.181 0.515 . . . . 0.0 110.101 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 81.2 mt -93.75 143.98 25.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.145 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.1 107.68 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 86.3 m-85 -115.47 159.41 21.21 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -126.27 114.31 18.12 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 HD11 ' A' ' 4' ' ' ILE . 80.5 mt -132.59 154.74 81.62 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.446 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.15 152.96 78.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.038 1.825 . . . . 0.0 111.238 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.73 -8.2 9.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.2 p -82.4 -15.92 50.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.108 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.91 -172.95 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 110.928 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.94 174.97 10.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.727 -172.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.757 HG11 HG13 ' A' ' 61' ' ' ILE . 24.5 t -63.12 -25.24 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.899 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 23.0 t -52.42 -35.39 51.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.914 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.05 -26.7 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -72.45 -49.85 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.952 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 7.0 ptmt -61.75 -42.13 98.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 13.9 p -67.2 -38.8 81.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 -177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.13 -35.07 76.0 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.132 -177.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 54' ' ' LEU . 74.4 mt -74.18 -42.95 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.138 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -58.25 -32.91 68.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.477 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 61.5 mt-10 -85.93 -32.31 21.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.834 0.35 . . . . 0.0 110.64 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.33 -44.22 25.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.502 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.543 HG22 ' HE2' ' A' ' 18' ' ' LYS . 3.7 p -102.27 -45.62 5.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.044 0.449 . . . . 0.0 110.632 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.58 -19.34 5.93 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.948 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 18.6 ptm -78.38 117.64 67.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.351 0.596 . . . . 0.0 111.466 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 32.0 Cg_endo -68.88 159.03 55.54 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.306 2.004 . . . . 0.0 111.939 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.1 -17.47 63.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.027 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.94 -31.08 38.8 Favored Glycine 0 C--O 1.225 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.1 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.82 -3.47 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.239 0.542 . . . . 0.0 110.178 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.616 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -94.07 113.65 25.66 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.572 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -106.74 139.13 41.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 41' ' ' ILE . 1.4 mm? -110.21 125.03 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -115.89 114.93 25.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.118 0.485 . . . . 0.0 111.395 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.6 t80 -102.68 107.72 18.73 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 27.2 mm-40 56.92 30.93 18.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.546 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.91 57.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.3 mt -107.79 115.17 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -68.62 92.75 0.48 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 109.894 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.757 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.19 149.6 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.642 -177.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -109.44 160.79 15.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.722 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' SER . 4.3 p30 -66.81 -16.9 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -86.88 6.23 32.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.434 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 94.5 m-20 -106.28 167.06 10.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 82.6 p -124.43 166.33 16.17 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.242 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -66.0 -44.26 85.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.416 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.85 76.72 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.281 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.04 -47.82 83.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -89.58 5.24 46.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.208 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.88 45.66 21.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.075 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.96 88.03 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.597 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.3 -170.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.913 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.11 114.43 3.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.5 39.68 3.62 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.937 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.24 115.13 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 t -95.65 102.45 13.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 111.264 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.8 mm -94.55 147.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -114.09 115.42 27.53 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 52' ' ' GLN . 51.8 tp -81.52 133.82 35.44 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.01 143.69 29.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 51' ' ' LYS . 29.8 tp . . . . . 0 N--CA 1.444 -0.764 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.755 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 109.393 -1.041 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 17.9 m -127.26 152.69 35.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.877 0.37 . . . . 0.0 110.512 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -88.64 122.52 32.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.804 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.0 pt -126.38 145.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -127.04 147.8 50.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.009 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.51 105.68 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.591 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.1 104.96 3.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.894 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 HD22 ' A' ' 19' ' ' LEU . 37.9 t -76.17 130.66 77.18 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HG2' HD13 ' A' ' 19' ' ' LEU . 59.0 Cg_endo -70.06 152.25 67.67 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.073 1.848 . . . . 0.0 111.77 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.447 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 10.6 m120 -75.83 83.67 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 12.6 mtp -133.83 73.32 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 120.927 0.394 . . . . 0.0 110.484 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.633 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -80.98 -45.13 17.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.622 0.725 . . . . 0.0 110.599 -175.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -113.9 3.67 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.466 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 37.9 mmtt -91.17 -6.89 52.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.061 -173.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.4 t -167.03 -176.03 3.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.935 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.71 7.37 28.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.022 0.439 . . . . 0.0 111.029 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 7.4 m0 -85.23 165.94 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.857 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 27.72 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 111.357 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.617 HD22 HG13 ' A' ' 8' ' ' VAL . 25.5 mt -81.72 123.62 28.91 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.937 -0.477 . . . . 0.0 109.747 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.0 m-80 -137.91 15.3 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.882 -0.511 . . . . 0.0 111.41 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 79.45 14.01 81.93 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.27 -0.966 . . . . 0.0 112.6 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -87.24 176.49 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 177.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.86 125.06 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.232 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -86.96 141.62 28.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.07 108.61 16.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.469 0.652 . . . . 0.0 109.906 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -116.64 162.98 16.8 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.95 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -126.6 119.19 26.46 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 4' ' ' ILE . 87.4 mt -134.9 151.42 75.55 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.695 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.21 154.69 73.18 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.7 tp -65.67 -6.77 12.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.6 p -82.83 -17.31 44.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.939 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-20 -75.69 -175.44 2.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 110.643 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.45 171.44 14.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.543 -172.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 61' ' ' ILE . 40.2 t -63.41 -27.86 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -53.62 -31.44 47.14 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.091 175.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.2 t -78.61 -28.24 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.639 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 30.4 mm -73.44 -46.48 48.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.39 -41.99 94.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.443 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.84 -40.57 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.9 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -64.89 -38.55 91.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.886 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.85 -43.77 79.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.68 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' MET . 11.3 t-80 -57.52 -33.81 68.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.55 -25.43 20.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.073 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.43 -39.53 24.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.392 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -104.14 -47.86 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.565 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.58 7.89 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 16.0 ptm -86.99 119.73 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.26 0.553 . . . . 0.0 111.517 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.4 Cg_endo -68.82 158.73 56.66 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.397 2.065 . . . . 0.0 112.166 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.05 -9.45 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.889 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.6 -27.31 65.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.663 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.73 -2.53 3.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.037 0.446 . . . . 0.0 110.462 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.69 114.47 26.45 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.238 0.542 . . . . 0.0 109.699 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.5 mmpt? -106.54 142.7 35.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.738 -176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.27 121.46 38.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.87 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -111.77 117.53 33.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.015 0.436 . . . . 0.0 111.605 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.7 t80 -105.28 109.67 21.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 56.88 30.59 18.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.803 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.47 56.15 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.308 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 20.2 mt -111.02 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -72.66 90.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -76.99 158.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.892 -175.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.0 pttp -118.69 159.31 23.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.994 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.72 -2.68 21.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.1 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.527 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -91.37 -0.85 57.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.777 0.322 . . . . 0.0 111.23 177.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.428 HD21 ' HE3' ' A' ' 62' ' ' LYS . 94.7 m-20 -112.4 -175.35 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.269 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 39.1 p -137.75 176.57 8.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.784 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.01 -45.73 59.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.764 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.42 -33.0 69.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.127 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.13 -48.64 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 61' ' ' ILE . 72.1 m-85 -88.95 1.75 54.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.292 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 60.91 45.85 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.38 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.0 mtt -70.5 85.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.774 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.25 -172.31 1.38 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.78 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 53.0 t30 -62.22 114.95 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.224 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 39.49 2.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.645 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.804 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.87 114.62 19.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.171 0.485 . . . . 0.0 110.312 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.75 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.07 0.462 . . . . 0.0 110.851 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.676 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.46 149.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -117.69 119.65 35.61 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -84.47 131.86 34.62 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.588 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.73 144.35 27.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 51' ' ' LYS . 23.1 tp . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.444 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.7 Cg_endo . . . . . 0 N--CA 1.478 0.592 0 N-CA-C 109.773 -0.895 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.1 m -120.36 152.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 0.0 110.544 -177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 m -87.54 119.23 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.685 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.1 pt -120.0 142.36 35.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.275 0.559 . . . . 0.0 110.987 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -125.58 148.2 49.02 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.413 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.79 105.86 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.56 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.441 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -70.7 106.41 3.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.635 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 19' ' ' LEU . 85.6 t -76.94 128.78 80.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.826 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.1 Cg_endo -65.32 149.75 88.0 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.29 1.993 . . . . 0.0 111.698 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.595 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.1 m120 -76.08 84.73 2.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.462 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.577 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 51.0 mtm -137.49 75.58 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.142 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.3 mp0 -79.03 -45.46 20.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.729 0.775 . . . . 0.0 109.747 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -119.61 -0.06 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.737 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 33.9 mmtt -81.17 -6.01 58.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.056 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -164.85 -175.84 3.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.647 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.4 -0.08 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.92 0.39 . . . . 0.0 111.665 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.6 m0 -85.01 168.87 14.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.67 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.9 28.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.454 0.645 . . . . 0.0 110.898 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.0 mt -79.88 128.8 33.89 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 20.7 m-80 -140.55 9.78 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.883 -0.511 . . . . 0.0 111.368 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.595 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.09 10.49 78.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.882 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -84.02 179.45 7.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.891 0.377 . . . . 0.0 110.426 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 7' ' ' GLN . 62.2 t -125.46 126.83 71.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -87.64 141.87 28.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.16 114.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CD2' ' HE3' ' A' ' 40' ' ' LYS . 56.7 m-85 -130.13 166.46 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.75 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.8 m -126.81 123.38 37.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.775 0.321 . . . . 0.0 110.418 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 2' ' ' VAL . 73.2 mt -139.04 152.41 69.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.953 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.45 152.81 74.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.223 1.948 . . . . 0.0 111.689 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.0 tp -64.3 -7.05 8.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -83.82 -17.26 41.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.491 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.26 -173.78 3.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.237 0.542 . . . . 0.0 110.716 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -146.07 175.22 10.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.419 -172.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 61' ' ' ILE . 19.8 t -59.46 -29.74 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.702 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.594 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.4 m -53.38 -29.35 34.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.397 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.7 t -78.81 -32.61 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.601 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -70.59 -46.99 67.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.306 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.1 ptmt -62.29 -44.46 96.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.922 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 p -67.48 -35.39 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.703 -176.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.34 -34.63 74.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.624 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 54' ' ' LEU . 82.6 mt -74.57 -42.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.361 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -57.41 -32.38 66.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.561 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 14.1 mm-40 -87.7 -29.13 21.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.45 -44.94 18.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.2 p -99.58 -45.04 5.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.649 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.79 -17.17 6.85 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.681 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.601 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.5 ptm -82.86 116.17 62.63 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.541 0.686 . . . . 0.0 111.451 -175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.7 Cg_endo -68.07 162.9 38.04 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.522 2.148 . . . . 0.0 111.992 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.96 -8.46 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.847 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.39 66.64 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.399 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.536 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -128.07 -24.25 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 109.92 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.714 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.44 113.53 10.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.082 176.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 6.7 mmpt? -107.34 140.6 40.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 41' ' ' ILE . 1.9 mm? -112.27 123.98 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.829 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.0 tt0 -115.57 115.59 26.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD12 ' A' ' 78' ' ' ILE . 10.8 t80 -101.6 107.82 19.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.258 0.552 . . . . 0.0 110.108 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 5.2 mm-40 56.74 29.44 15.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.053 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.0 14.95 37.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.026 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 25.7 mt -117.51 116.0 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -72.36 95.65 1.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -84.52 154.09 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -132.51 174.84 9.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.839 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -28.79 20.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.568 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.441 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 4.6 m -86.16 10.52 14.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.174 -169.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 87.9 m-20 -114.71 172.66 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.4 p -130.08 166.58 19.88 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.05 -44.12 85.5 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.65 -38.88 79.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.628 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.14 -40.8 77.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -95.57 6.4 49.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.452 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.54 38.89 22.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.967 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.1 mtt -67.48 87.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 111.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.55 -168.64 2.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.302 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.51 115.12 2.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.121 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.7 3.25 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.648 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.66 114.65 21.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.029 0.415 . . . . 0.0 109.978 177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.85 102.2 13.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.57 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.24 150.52 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.16 116.47 27.88 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.539 HD11 ' HG3' ' A' ' 52' ' ' GLN . 38.0 tp -82.53 131.68 35.21 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.24 145.59 27.17 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 C--N 1.318 -0.784 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.817 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.51 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.5 Cg_endo . . . . . 0 N--CA 1.479 0.643 0 N-CA-C 110.159 -0.747 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 16.1 m -122.49 156.21 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.813 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -82.52 127.24 33.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.021 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.5 pt -130.71 136.64 57.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.129 0.49 . . . . 0.0 110.826 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 17.5 mttt -123.35 145.47 48.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.764 -173.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.8 108.44 24.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.527 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.03 104.01 4.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.649 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.539 HG13 HD22 ' A' ' 19' ' ' LEU . 62.1 t -76.71 131.19 74.38 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.455 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.825 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.1 Cg_endo -66.62 155.68 69.24 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.14 1.894 . . . . 0.0 112.214 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.58 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.0 m120 -82.54 84.2 7.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.599 ' HB3' HG22 ' A' ' 15' ' ' THR . 48.6 mtm -137.45 75.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.605 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 9.3 mp0 -79.91 -47.47 15.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.689 -171.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -120.89 10.78 10.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -93.27 -2.18 55.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.834 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.3 t -167.77 -176.73 3.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.86 -12.52 41.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.808 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.67 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.2 m0 -84.99 164.34 18.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.563 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.85 29.94 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.672 0.748 . . . . 0.0 110.86 -178.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.825 HD13 ' HG2' ' A' ' 9' ' ' PRO . 19.4 mt -78.94 127.25 31.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.556 -0.715 . . . . 0.0 109.269 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 17.2 m-80 -137.82 20.57 2.86 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.766 -0.584 . . . . 0.0 111.364 -175.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.14 1.39 63.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.085 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -76.58 176.51 8.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.26 0.552 . . . . 0.0 110.526 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 7' ' ' GLN . 58.2 t -125.31 123.48 65.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.904 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 51.4 mt -88.05 136.92 32.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.35 110.38 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 120.971 0.415 . . . . 0.0 110.0 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.44 166.33 16.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.593 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.6 m -126.49 122.59 35.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 4' ' ' ILE . 73.4 mt -136.09 154.04 77.2 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.72 152.52 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.87 1.713 . . . . 0.0 110.982 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.65 -8.7 10.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -79.61 -18.38 51.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.44 -175.13 2.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 110.648 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.1 172.83 12.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.342 -173.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HG13 ' A' ' 61' ' ' ILE . 40.4 t -62.82 -26.81 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.564 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -54.16 -33.16 57.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.316 176.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -74.03 -32.05 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 mm -72.61 -48.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.751 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.7 ptmt -59.86 -40.95 90.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.744 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -72.97 -39.23 57.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.041 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 16.4 ptpt -63.5 -35.6 81.01 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.259 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.9 mt -72.35 -43.58 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.264 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -59.84 -34.71 73.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.36 -36.41 39.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.748 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.74 8.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.729 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.8 p -91.66 -43.49 9.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.11 -15.22 9.44 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.949 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -81.36 119.96 77.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.458 0.647 . . . . 0.0 111.565 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.0 Cg_endo -67.85 156.7 64.9 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.77 2.313 . . . . 0.0 112.056 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.97 -12.54 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.483 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.64 -32.58 58.56 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.557 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HD2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.68 -3.92 4.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.148 0.499 . . . . 0.0 110.495 -177.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.68 116.33 28.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.31 0.576 . . . . 0.0 109.547 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.76 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -104.92 140.92 37.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.74 118.69 32.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.146 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 25.9 tt0 -111.48 116.0 30.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.593 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.637 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.7 t80 -103.85 108.97 20.53 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 61.6 mm-40 57.35 30.23 18.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.741 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.46 10.36 53.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.316 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.8 mt -114.49 118.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 10.1 m-30 -74.11 89.41 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.627 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -74.44 154.4 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.75 -175.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.9 pttp -117.14 160.02 21.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.945 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -72.19 -5.28 34.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.46 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -88.71 0.42 56.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.884 0.373 . . . . 0.0 110.748 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -112.47 176.89 4.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.3 p -130.43 170.03 14.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.318 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.52 -43.6 80.42 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.861 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.97 76.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.282 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -57.59 -44.73 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.958 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -88.9 3.38 51.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.264 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 59.26 41.0 20.72 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.021 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -62.8 94.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.446 0.641 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.75 -177.9 2.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 33.3 t30 -61.83 116.76 5.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.22 39.29 3.79 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.364 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.53 114.91 16.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.345 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.28 105.11 16.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -93.87 148.82 4.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -117.0 116.9 28.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.05 133.31 34.66 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.0 148.91 31.24 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.392 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 51' ' ' LYS . 26.1 tp . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.564 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.4 Cg_endo . . . . . 0 C--O 1.231 0.145 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.96 154.66 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.385 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m -85.55 124.85 32.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 76' ' ' ALA . 4.6 pt -128.38 148.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 77' ' ' VAL . 10.1 mttm -128.13 147.53 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 105.81 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 104.72 5.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.979 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 19' ' ' LEU . 57.6 t -73.67 133.02 80.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.367 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.835 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.0 Cg_endo -68.66 151.23 74.97 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.995 1.797 . . . . 0.0 111.772 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.607 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -79.89 88.45 5.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.517 ' HB3' HG22 ' A' ' 15' ' ' THR . 51.0 mtm -138.84 75.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.9 mp0 -78.84 -45.95 19.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.86 -168.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -120.21 2.8 10.9 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.133 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -86.33 -4.83 59.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.157 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.6 t -161.47 -176.46 5.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.826 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.99 -0.33 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.106 0.479 . . . . 0.0 111.627 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.662 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -89.84 174.56 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.081 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 28.51 1.4 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.193 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.7 mt -79.56 122.71 26.83 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.634 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.8 m-80 -136.49 20.13 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.255 0.55 . . . . 0.0 110.452 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.607 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.18 -7.85 59.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.976 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.576 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -65.79 176.02 1.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.522 0.677 . . . . 0.0 111.15 -178.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.91 126.69 74.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.919 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 mt -87.51 132.17 34.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.34 107.39 18.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -125.08 167.35 14.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.396 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.1 m -126.51 119.89 28.29 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 4' ' ' ILE . 67.4 mt -134.38 149.89 72.41 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 42.6 Cg_endo -70.01 149.23 65.02 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.387 2.058 . . . . 0.0 111.62 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.6 -12.16 21.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.872 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -72.65 -25.26 61.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -75.01 -173.62 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.136 0.493 . . . . 0.0 110.731 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.55 173.42 12.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.819 0.342 . . . . 0.0 111.714 -172.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 61' ' ' ILE . 25.6 t -57.28 -31.35 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.74 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 15.3 m -50.64 -36.07 33.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.126 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 39.0 t -72.04 -33.97 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.615 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.7 -52.6 22.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.816 0.341 . . . . 0.0 110.479 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 10.7 ptmt -57.97 -44.59 87.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.513 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.63 -32.72 56.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.65 -46.52 78.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.856 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.47 -38.14 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.159 0.504 . . . . 0.0 110.264 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' MET . 7.6 t-80 -56.9 -34.57 68.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.481 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -90.91 -29.93 17.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.978 0.418 . . . . 0.0 111.024 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.62 -44.92 32.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.431 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -102.03 -40.5 6.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.57 -8.77 10.91 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.962 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.546 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.0 ptm -90.99 117.89 68.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 111.811 -176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.2 Cg_endo -66.92 157.25 62.46 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.7 2.266 . . . . 0.0 111.873 175.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.65 -14.2 40.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.682 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.07 -34.12 52.12 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.44 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -126.9 -7.82 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 110.252 -177.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.93 116.57 29.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.59 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.726 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -107.13 142.81 36.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.782 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.05 124.56 46.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -116.39 119.52 35.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.038 0.447 . . . . 0.0 111.44 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 8.8 t80 -103.65 104.78 14.86 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 57.24 29.69 17.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.849 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.44 14.51 37.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.916 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -120.69 114.35 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -76.67 92.74 3.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.855 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.506 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -74.89 150.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.42 -177.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -125.71 171.26 10.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.125 0.488 . . . . 0.0 111.869 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -18.88 45.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.188 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.432 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 3.9 m -86.97 10.12 17.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.065 0.459 . . . . 0.0 110.773 -175.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -122.4 171.19 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 79.4 p -129.56 169.93 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.94 -44.13 85.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.11 75.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.54 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.19 -39.96 84.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 49.1 m-85 -91.09 -2.33 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.285 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.71 46.47 20.04 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.638 0.586 . . . . 0.0 110.124 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.6 mtt -62.04 87.79 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.272 0.558 . . . . 0.0 110.747 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.58 179.58 3.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.712 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.18 115.8 4.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.344 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.97 33.61 3.7 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.135 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.22 114.79 18.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.118 0.485 . . . . 0.0 110.031 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 5' ' ' LYS . 26.5 t -99.1 106.06 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.931 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -94.44 149.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -116.57 119.35 35.29 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 tp -85.74 133.3 34.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.63 34.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 51' ' ' LYS . 37.4 tp . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.109 0.48 . . . . 0.0 110.97 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 N-CA-C 110.307 -0.69 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.56 158.63 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 m -90.51 122.13 33.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.12 0.486 . . . . 0.0 110.595 -176.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.736 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -125.46 138.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.956 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -120.58 146.38 46.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.14 105.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.236 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 101.43 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.872 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 22.3 t -72.24 129.33 87.72 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.7 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HG2' HD13 ' A' ' 19' ' ' LEU . 43.1 Cg_endo -66.15 149.19 85.72 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.517 2.145 . . . . 0.0 111.677 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.643 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -73.78 85.43 1.68 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.459 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -136.09 74.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.965 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.6 mp0 -78.99 -44.96 21.22 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.727 0.775 . . . . 0.0 109.557 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -119.79 3.59 11.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.212 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -88.87 -5.06 58.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.028 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.7 t -162.68 -175.74 4.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.675 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -105.19 3.26 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -90.43 169.52 10.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.126 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -81.96 31.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.154 0.502 . . . . 0.0 111.631 -178.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' HG2' ' A' ' 9' ' ' PRO . 20.8 mt -83.74 132.97 34.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.69 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.6 m-80 -147.29 19.27 1.21 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 110.14 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.643 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.23 -3.26 87.49 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 3.5 pm0 -70.88 172.11 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.577 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.24 130.57 74.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 88.8 mt -91.01 147.34 23.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.53 109.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.68 160.68 19.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.241 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -127.1 115.9 19.87 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.1 mt -134.19 151.88 77.28 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.557 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.27 151.89 80.18 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.207 1.938 . . . . 0.0 111.439 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.3 tp -64.72 -4.53 4.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -83.65 -20.68 33.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.444 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.6 m-20 -77.41 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.268 0.556 . . . . 0.0 110.622 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.81 174.01 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -172.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 61' ' ' ILE . 39.5 t -61.91 -27.52 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.693 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 29.2 t -51.78 -33.31 34.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.44 175.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.469 HG21 ' OD2' ' A' ' 32' ' ' ASP . 19.8 t -77.44 -30.75 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.93 0.395 . . . . 0.0 110.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.2 mm -71.84 -49.28 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.368 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 ptmt -59.07 -40.6 85.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.48 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.6 p -71.24 -41.09 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.083 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -65.72 -35.58 81.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.893 -177.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.9 -41.57 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.281 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -57.84 -34.75 70.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.088 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 52.9 mt-10 -82.84 -33.02 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.952 0.406 . . . . 0.0 110.419 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.8 -44.14 23.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.769 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.1 p -102.18 -44.94 5.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.763 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.84 -5.84 10.49 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.116 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.457 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -89.57 116.88 67.45 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 111.366 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.12 159.36 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.518 2.145 . . . . 0.0 111.848 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.16 -14.85 57.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.822 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.16 -30.7 55.26 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.081 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -128.66 -3.96 5.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.167 0.508 . . . . 0.0 109.995 -177.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.23 115.52 28.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.734 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.7 mmpt? -108.14 141.61 39.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.0 mt -117.51 121.49 41.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.819 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.6 tt0 -113.54 117.36 31.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.238 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.623 ' HB2' HD12 ' A' ' 78' ' ' ILE . 9.9 t80 -103.54 109.45 21.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.027 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 56.4 29.59 15.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.747 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.67 13.05 45.37 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 19.6 mt -116.97 118.99 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -74.04 93.15 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -79.28 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.552 -178.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.22 166.83 12.12 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.59 -12.35 61.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 0.0 111.387 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -78.22 -10.3 59.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 72.7 m-20 -99.47 164.26 12.17 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.6 p -125.09 167.5 14.69 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.04 -43.41 87.63 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.911 0.386 . . . . 0.0 110.028 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.96 -34.85 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' SER . 67.3 t80 -55.64 -45.08 77.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.422 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 29.7 m-85 -97.53 9.48 42.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.631 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.25 45.84 19.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.248 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.3 mtt -69.08 90.09 0.45 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.085 0.469 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.81 -172.34 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.823 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -61.08 115.53 3.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.257 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 31.58 5.46 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.62 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.02 114.56 13.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.03 104.53 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 0.0 110.913 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.23 148.27 5.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -112.88 118.33 34.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -82.77 132.74 35.16 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.03 147.01 29.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.3 tp . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 29' ' ' PRO . 28.9 Cg_endo . . . . . 0 N--CA 1.478 0.584 0 N-CA-C 110.601 -0.577 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.97 157.13 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -90.65 117.83 29.62 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 110.449 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.8 pt -121.0 143.53 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.739 -176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -126.25 150.51 48.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.804 0.335 . . . . 0.0 110.613 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 49.0 t -124.77 107.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.852 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.494 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -70.08 105.75 3.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.595 HG13 HD22 ' A' ' 19' ' ' LEU . 60.3 t -76.41 131.83 73.97 Favored Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.1 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 19' ' ' LEU . 41.4 Cg_endo -68.0 149.58 77.33 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.223 1.949 . . . . 0.0 111.781 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.54 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -76.32 86.98 3.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -135.55 76.13 1.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.525 0.679 . . . . 0.0 110.175 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 10.8 mp0 -79.9 -45.38 18.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.572 -171.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.68 -5.59 10.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.006 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 34.7 mmtt -75.71 -8.13 56.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.662 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.3 t -163.81 -172.68 2.94 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.529 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -105.97 0.36 25.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m0 -85.38 168.61 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.01 28.8 0.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.661 . . . . 0.0 111.407 -177.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -81.1 122.0 26.8 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.79 -0.569 . . . . 0.0 109.832 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.638 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 15.9 m-80 -138.06 16.66 2.82 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.943 -0.473 . . . . 0.0 110.665 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.54 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.19 -2.46 85.27 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.29 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -73.81 179.36 4.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.274 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.56 128.61 76.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.293 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.2 mt -87.77 144.94 26.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.0 t -130.92 111.12 19.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.051 0.453 . . . . 0.0 109.856 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 92.6 m-85 -120.92 162.6 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.353 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.7 m -127.67 119.01 24.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.755 0.312 . . . . 0.0 110.175 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -137.66 149.0 63.41 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.137 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 23.5 Cg_endo -64.99 148.62 89.78 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.302 2.001 . . . . 0.0 111.47 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.6 tp -60.54 -14.51 20.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.961 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -76.99 -21.57 54.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.776 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD2' ' HG2' ' A' ' 29' ' ' PRO . 3.0 m-20 -74.18 -174.81 2.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.608 . . . . 0.0 110.71 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.97 174.75 10.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.72 -171.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 44.5 t -58.98 -30.07 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.847 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.484 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 8.5 t -52.56 -34.29 49.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.134 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.05 -32.7 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 22.5 mm -72.0 -50.77 35.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 6.3 ptmt -58.0 -41.88 84.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.473 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 14.2 p -70.8 -41.26 77.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.009 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -64.65 -35.66 81.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.957 -178.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.4 mt -69.81 -41.89 79.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.05 0.452 . . . . 0.0 110.362 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -58.73 -31.45 68.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.93 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 5.7 mm-40 -81.69 -36.63 28.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 0.0 110.573 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.46 -49.26 17.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.64 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.5 p -96.07 -45.28 6.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.969 0.414 . . . . 0.0 110.51 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.13 -20.14 6.34 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.68 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.486 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.7 ptm -77.81 119.33 76.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.25 0.547 . . . . 0.0 111.341 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 19.8 Cg_endo -68.03 157.98 59.39 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.329 2.019 . . . . 0.0 111.831 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.22 -9.57 18.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.419 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.05 -26.53 61.15 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.886 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.643 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -134.05 -5.67 2.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.926 0.394 . . . . 0.0 110.316 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.65 116.03 28.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.9 mmpt? -105.79 140.23 39.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.53 116.82 28.83 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.338 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.3 tt0 -108.03 112.12 24.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.668 ' HB2' HD12 ' A' ' 78' ' ' ILE . 26.5 t80 -102.61 114.43 28.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.767 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 31.1 mm-40 56.56 29.54 15.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.459 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.52 8.77 57.17 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.733 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 9.5 mt -115.17 118.51 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.4 m-30 -68.49 94.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.312 0.577 . . . . 0.0 109.953 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.45 152.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.428 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -122.43 167.3 13.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 6.2 t70 -59.36 -27.93 66.39 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.149 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -75.02 -11.06 60.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.382 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.9 170.01 8.15 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.932 0.396 . . . . 0.0 110.141 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.6 p -130.36 175.01 9.3 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.202 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.38 -43.34 73.74 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.26 -35.11 76.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.452 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -57.18 -42.15 80.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.641 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 73.5 m-85 -95.08 0.34 54.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.451 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 71' ' ' ASN . 0.9 OUTLIER 58.96 47.28 12.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.786 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtt -69.96 87.46 0.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.25 -173.28 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.348 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -63.37 115.69 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 110.035 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.82 2.85 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.041 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.65 114.93 21.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.016 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -96.27 104.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.041 0.448 . . . . 0.0 110.719 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.13 150.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.59 114.66 23.74 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.16 133.58 34.6 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.92 148.27 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.315 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.6 tp -76.72 129.07 35.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 25.2 ttpp -56.91 -51.1 70.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.408 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -148.23 110.63 4.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.991 -175.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HE ' ' N ' ' A' ' 86' ' ' GLY . 6.8 tpm_? -84.35 98.4 10.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.673 0.749 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' N ' ' HE ' ' A' ' 85' ' ' ARG . . . . . . . . 0 N--CA 1.438 -1.2 0 CA-C-O 117.87 -1.516 . . . . 0.0 110.181 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.479 0.633 0 N-CA-C 109.48 -1.008 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 15.8 m -126.56 153.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.94 0.4 . . . . 0.0 110.395 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -84.2 124.6 31.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.023 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.7 pt -124.48 137.07 58.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.249 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HG22 ' A' ' 77' ' ' VAL . 11.0 mttm -117.85 146.36 43.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.088 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.0 105.23 15.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -72.06 104.24 3.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.654 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 HD22 ' A' ' 19' ' ' LEU . 69.9 t -75.26 128.09 85.2 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.364 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 33.4 Cg_endo -64.87 150.81 87.6 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.152 1.901 . . . . 0.0 111.907 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.565 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 12.8 m120 -77.54 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.713 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.541 ' HB3' HG22 ' A' ' 15' ' ' THR . 41.0 mtm -142.53 75.08 1.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.707 0.289 . . . . 0.0 110.251 174.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 7.4 mp0 -78.92 -44.22 23.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 110.134 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.53 -2.54 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.029 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -87.79 -6.92 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.423 -172.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.0 t -161.38 -179.91 7.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.07 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.72 3.0 41.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.548 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.577 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 6.0 m0 -85.94 171.91 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -87.9 26.83 1.26 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 0.0 110.886 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.9 mt -80.19 128.16 33.19 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.664 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.3 m-80 -140.78 9.13 2.17 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.063 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.565 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.23 7.99 72.33 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.265 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.0 pm0 -80.8 175.86 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.54 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 7' ' ' GLN . 44.5 t -124.96 124.19 67.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.73 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -87.62 136.07 33.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.73 107.51 19.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -122.55 166.2 15.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.717 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 m -126.8 122.02 33.58 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.853 0.359 . . . . 0.0 110.775 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 4' ' ' ILE . 68.9 mt -138.57 152.36 70.8 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.513 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 43.5 Cg_endo -69.86 152.1 68.69 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.215 1.943 . . . . 0.0 111.748 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.6 tp -62.49 -11.97 19.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.663 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -73.97 -23.98 59.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -76.28 -172.95 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.276 0.56 . . . . 0.0 110.72 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.85 171.97 13.68 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.625 -171.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.666 HG11 HG13 ' A' ' 61' ' ' ILE . 26.1 t -63.05 -26.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.338 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.43 -31.83 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.75 -30.65 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.11 0.481 . . . . 0.0 110.247 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.3 mm -71.16 -51.99 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.587 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.2 ptmt -58.03 -43.72 86.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.618 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.68 -38.58 79.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.583 0.23 . . . . 0.0 111.004 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.9 ptmt -68.87 -35.29 76.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.498 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.75 -41.88 61.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' MET . 8.1 t-80 -56.71 -35.2 68.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.022 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.53 -20.86 21.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.44 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.04 -33.55 18.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.0 p -107.88 -42.94 4.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.047 0.451 . . . . 0.0 110.721 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.08 -8.42 10.52 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.012 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 17.5 ptm -90.32 119.95 69.13 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.134 0.492 . . . . 0.0 111.699 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.3 Cg_endo -68.91 156.89 63.95 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.547 2.164 . . . . 0.0 112.266 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.69 -16.87 62.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.547 ' O ' ' HE2' ' A' ' 83' ' ' LYS . . . -52.4 -30.61 33.69 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.281 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.63 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -131.35 -6.0 3.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.027 0.441 . . . . 0.0 110.005 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.46 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.67 112.04 23.84 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.1 mmpt? -103.43 141.03 36.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.392 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.44 121.61 45.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.448 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.5 tt0 -113.64 115.77 28.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.8 t80 -101.81 107.53 18.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.225 0.536 . . . . 0.0 110.029 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 57.15 30.47 18.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.831 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.23 14.5 38.62 Favored Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.49 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.1 mt -118.74 116.02 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 11.0 m-85 -72.04 91.9 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.167 0.508 . . . . 0.0 110.114 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.666 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -78.12 150.32 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.3 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.489 ' HE3' HD21 ' A' ' 65' ' ' ASN . 0.6 OUTLIER -109.57 156.27 20.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.806 0.336 . . . . 0.0 110.827 177.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 5.7 p-10 -71.37 -2.93 18.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.996 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.7 t -86.12 -5.34 59.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 0.0 109.748 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.489 HD21 ' HE3' ' A' ' 62' ' ' LYS . 95.7 m-20 -104.15 178.44 4.56 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.524 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 76.6 p -133.38 173.16 11.77 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.44 -33.46 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.231 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 66' ' ' SER . 47.3 t80 -56.47 -45.9 80.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.855 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -91.68 -0.62 57.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.744 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.2 m120 63.82 41.41 6.84 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.365 0.415 . . . . 0.0 110.888 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -64.27 93.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.336 0.589 . . . . 0.0 111.316 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 177.98 4.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.918 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 36.0 t-20 -64.45 115.37 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.144 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.21 28.14 5.04 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.195 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.701 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 115.11 10.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.449 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 5' ' ' LYS . 15.3 t -95.08 103.54 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.793 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.51 146.5 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -116.41 111.57 20.22 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.2 tp -76.78 132.41 39.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.407 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 147.24 32.12 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.3 tp -78.15 135.39 37.64 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 17.8 ttpp -50.83 143.22 10.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.896 0.747 . . . . 0.0 111.506 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -46.43 127.68 9.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.798 -173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -56.25 -42.4 77.29 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.713 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.012 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.084 -179.509 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.06 152.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.945 0.403 . . . . 0.0 110.298 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -88.73 114.99 25.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.244 0.545 . . . . 0.0 110.355 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.1 pt -114.81 136.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.481 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 13.5 mttm -118.63 147.33 43.86 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.122 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.5 t -125.43 105.27 14.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 104.52 2.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.655 HG13 HD22 ' A' ' 19' ' ' LEU . 25.9 t -76.53 126.84 85.64 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.798 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.781 ' HG2' HD13 ' A' ' 19' ' ' LEU . 27.5 Cg_endo -63.97 147.26 91.92 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.399 2.066 . . . . 0.0 111.875 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.68 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -73.85 88.5 1.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.771 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.479 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.1 mtm -138.53 75.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.954 0.407 . . . . 0.0 110.12 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.8 mp0 -79.49 -44.87 20.42 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.311 -173.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -116.44 2.14 13.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.908 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -90.81 -4.87 56.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.493 -171.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.1 t -164.25 -174.21 3.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.887 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -99.02 -3.66 34.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.407 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.9 m0 -85.78 169.98 12.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.094 0.473 . . . . 0.0 111.176 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.09 22.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.001 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -77.52 133.32 38.57 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 21.1 m-80 -146.96 10.1 1.01 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.915 0.388 . . . . 0.0 110.615 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.68 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 86.31 16.08 63.17 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.291 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -87.96 175.69 7.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.335 175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -121.55 127.73 75.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.971 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 85.7 mt -87.91 141.71 28.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.39 107.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 24.1 m-85 -121.01 164.83 16.15 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 1' ' ' PRO . 4.9 m -126.44 122.26 34.78 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.218 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 HD11 ' A' ' 4' ' ' ILE . 78.6 mt -137.41 149.81 66.65 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.652 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 33.5 Cg_endo -66.27 152.2 81.61 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.273 1.982 . . . . 0.0 111.471 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 tp -62.82 -8.07 6.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.684 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -80.11 -20.71 44.4 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.756 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -74.84 -176.2 2.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.138 0.494 . . . . 0.0 110.217 177.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.97 174.65 10.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.901 0.381 . . . . 0.0 111.563 -173.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 61' ' ' ILE . 39.8 t -60.68 -30.33 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.8 m -51.69 -36.1 45.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.024 177.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -72.05 -32.44 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 23.9 mm -72.5 -51.16 30.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.452 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 3.3 ptmt -59.2 -42.56 91.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.498 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 8.3 p -69.83 -37.45 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.164 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 11.3 ptmt -69.31 -36.67 77.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.745 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.03 -41.35 81.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -58.73 -32.78 69.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.305 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 15.1 mm-40 -85.44 -30.89 23.17 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.902 0.382 . . . . 0.0 110.798 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.88 -46.62 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.956 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -97.53 -40.56 8.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.477 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.11 -15.92 10.11 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.931 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -82.14 117.0 66.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.385 0.612 . . . . 0.0 111.464 -175.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 22.1 Cg_endo -67.25 159.01 54.24 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.595 2.197 . . . . 0.0 111.882 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.4 -13.58 58.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.45 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -29.25 54.76 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.968 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -132.45 -2.63 3.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.079 0.466 . . . . 0.0 110.63 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -95.24 117.65 30.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.114 0.483 . . . . 0.0 109.887 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.7 mmpt? -104.27 139.96 38.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.456 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -120.04 118.87 31.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.634 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -112.96 117.32 31.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.681 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -102.73 107.98 19.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.947 0.403 . . . . 0.0 110.148 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 57.18 30.57 18.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.355 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.58 23.73 25.43 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.064 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 21.1 mt -126.38 116.21 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -72.15 95.9 1.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.474 0.654 . . . . 0.0 110.29 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -80.28 150.4 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.567 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.97 162.54 18.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.083 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.593 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 5.5 t70 -54.06 -27.7 34.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.218 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -72.15 -1.94 16.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.789 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.489 HD22 ' HE2' ' A' ' 70' ' ' TYR . 77.4 m-20 -115.69 168.76 9.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.394 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 91.9 p -125.73 173.15 9.23 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.33 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 mt -68.12 -42.86 79.57 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.51 -33.92 73.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.222 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.09 -44.87 91.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.19 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HE2' HD22 ' A' ' 65' ' ' ASN . 27.9 m-85 -94.66 5.52 51.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.654 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 43.28 13.19 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 110.866 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.18 84.89 0.37 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.026 0.441 . . . . 0.0 110.76 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.48 -176.58 2.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.702 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -58.69 115.5 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.95 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.56 36.11 3.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.654 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.711 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -81.35 114.9 20.43 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 14.7 t -97.66 105.57 17.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.101 0.477 . . . . 0.0 110.94 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.681 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -95.53 148.64 5.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -118.24 117.04 28.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -84.55 133.97 34.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.983 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.61 151.8 35.64 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 51' ' ' LYS . 24.3 tp -81.87 143.45 31.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -62.78 -42.79 99.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.542 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -87.92 143.37 27.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -149.33 100.67 3.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.816 0.341 . . . . 0.0 111.14 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.828 -0.984 . . . . 0.0 111.625 176.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.6 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.92 154.43 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.7 m -90.81 120.83 32.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.332 0.586 . . . . 0.0 109.851 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.805 HG22 ' HB3' ' A' ' 76' ' ' ALA . 9.5 pt -120.46 143.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.402 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.562 ' HD2' HG22 ' A' ' 77' ' ' VAL . 4.5 mttm -119.26 150.14 40.59 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.889 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.12 105.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.43 106.2 3.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.68 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 79.2 t -77.18 130.0 76.39 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.741 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.8 Cg_endo -65.82 156.56 63.55 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.636 2.224 . . . . 0.0 111.829 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.648 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 13.3 m120 -85.32 85.82 7.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 15' ' ' THR . 49.0 mtm -137.95 76.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.725 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.594 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -77.76 -48.03 17.6 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.657 0.742 . . . . 0.0 110.334 -171.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.85 10.9 10.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.311 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -90.66 -4.89 56.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.678 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -158.24 -172.94 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.796 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -101.17 -5.07 26.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.54 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.2 m0 -91.6 171.87 8.88 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.879 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.52 28.22 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 110.996 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.741 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.5 mt -78.26 127.74 32.68 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -138.74 16.53 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.462 -0.774 . . . . 0.0 111.022 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.648 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.91 7.86 86.64 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -80.28 175.1 10.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.394 0.616 . . . . 0.0 110.61 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.3 t -120.6 123.01 69.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.603 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.7 mt -87.59 142.11 28.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 5' ' ' LYS . 57.8 t -132.39 107.78 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.529 0.681 . . . . 0.0 109.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.45 164.28 13.46 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.825 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -126.79 118.7 25.19 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.371 -0.531 . . . . 0.0 109.99 174.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.408 HD12 HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.9 152.66 77.77 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.851 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.11 150.08 82.23 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.389 2.059 . . . . 0.0 111.246 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -61.8 -10.59 9.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.538 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -79.09 -18.94 52.43 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.867 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -77.02 -175.44 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -144.44 177.32 8.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.145 0.498 . . . . 0.0 111.567 -175.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.512 ' CG1' HG13 ' A' ' 61' ' ' ILE . 60.3 t -56.14 -33.07 35.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.742 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m -54.9 -30.76 59.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.315 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.22 -27.95 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 110.532 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.721 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.1 mm -72.4 -54.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.0 ptmt -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.768 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.13 -37.58 78.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.889 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.59 -35.22 78.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 110.5 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 54' ' ' LEU . 67.4 mt -72.65 -43.08 62.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.526 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -59.04 -33.4 70.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.536 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -89.24 -20.41 24.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.064 0.459 . . . . 0.0 110.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.75 -54.48 4.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.153 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.7 p -91.15 -43.01 10.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.3 7.23 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.929 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.9 ptm -82.4 118.07 70.63 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.395 0.617 . . . . 0.0 111.602 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.36 157.33 62.26 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.433 2.088 . . . . 0.0 111.9 175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.04 -8.02 20.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.384 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.76 -28.9 66.33 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.281 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -133.6 -2.75 3.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 110.449 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -98.64 117.26 32.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 mmpt? -110.92 140.33 45.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.391 -176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -111.0 124.21 51.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.436 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -116.45 117.9 31.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.739 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 14.2 t80 -103.33 108.25 19.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.092 0.473 . . . . 0.0 110.073 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 55.59 30.95 16.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.031 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.21 12.59 45.08 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.203 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.414 HG21 ' HE1' ' A' ' 70' ' ' TYR . 8.7 mt -120.57 113.04 38.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -73.49 92.96 1.93 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.607 0.717 . . . . 0.0 110.409 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.512 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -72.57 158.11 6.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.425 -174.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HE3' HD21 ' A' ' 65' ' ' ASN . 4.6 pttp -130.48 163.65 26.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.322 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' A' ' 38' ' ' LYS . 1.2 m-20 -50.58 -32.19 17.98 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.814 0.696 . . . . 0.0 112.236 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -82.45 2.42 32.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.103 0.477 . . . . 0.0 110.95 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.409 HD21 ' HE3' ' A' ' 62' ' ' LYS . 92.6 m-20 -110.47 163.74 13.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.5 p -129.76 165.94 20.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.87 -44.04 97.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.767 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.14 82.74 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.368 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -59.34 -42.75 92.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.414 ' HE1' HG21 ' A' ' 59' ' ' ILE . 33.7 m-85 -89.11 1.28 55.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.665 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.2 m120 58.72 44.22 17.52 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.641 0.588 . . . . 0.0 110.864 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.9 mtt -67.24 89.45 0.2 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.044 0.449 . . . . 0.0 110.777 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.06 -169.65 1.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.712 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -61.74 115.53 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.26 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.29 38.75 3.92 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.768 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.59 115.02 14.83 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.786 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.562 HG22 ' HD2' ' A' ' 5' ' ' LYS . 21.7 t -94.94 102.26 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.192 0.52 . . . . 0.0 110.946 -176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -93.9 146.41 6.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -114.78 113.97 24.96 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -81.69 133.32 35.34 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.39 146.07 30.5 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.156 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.4 tp -78.99 139.73 38.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -50.99 132.75 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.392 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -46.55 -57.74 4.46 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.984 0.802 . . . . 0.0 112.166 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -98.79 116.85 31.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.8 177.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HB2' HG22 ' A' ' 27' ' ' THR . 5.5 Cg_exo . . . . . 0 N--CA 1.473 0.31 0 N-CA-C 109.974 -0.818 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.0 m -121.05 153.87 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -89.94 116.18 27.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.035 0.445 . . . . 0.0 110.266 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.682 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -118.28 138.52 48.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.752 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 77' ' ' VAL . 8.6 mttm -118.66 146.97 44.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.903 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -123.31 105.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.38 106.68 4.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.646 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.569 HG13 HD22 ' A' ' 19' ' ' LEU . 84.4 t -78.18 130.63 71.64 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.33 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.736 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.5 Cg_endo -66.09 150.0 85.47 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.37 2.047 . . . . 0.0 111.995 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.611 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.6 m120 -76.53 88.54 3.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.505 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.0 mtm -139.49 75.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.003 0.43 . . . . 0.0 110.549 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.593 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.82 -45.1 19.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.77 0.795 . . . . 0.0 110.226 -175.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -0.6 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.682 -174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -92.48 -1.52 56.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.623 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.0 t -166.7 -177.5 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.321 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -95.69 -7.09 38.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.445 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.665 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -86.02 167.24 15.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.17 29.09 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.229 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.9 mt -79.27 130.69 35.72 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.673 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 20.5 m-80 -143.41 11.84 1.72 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.849 -0.532 . . . . 0.0 110.826 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.611 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 88.86 2.43 78.42 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.758 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.673 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.4 pm0 -76.21 174.08 10.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.4 124.36 72.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.08 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 26' ' ' PHE . 86.3 mt -87.97 147.53 24.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -133.19 109.11 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 0.0 109.757 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 89.4 m-85 -115.93 159.47 21.53 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.214 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.411 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.6 m -126.78 112.96 15.99 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.02 0.438 . . . . 0.0 110.038 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.6 mt -133.47 149.68 72.96 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.819 -177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.69 151.36 85.43 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.354 2.036 . . . . 0.0 111.429 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 26.1 tp -63.17 -12.41 27.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.299 0.571 . . . . 0.0 110.567 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.0 p -80.72 -18.39 47.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.824 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.33 -173.27 2.01 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.153 0.502 . . . . 0.0 110.795 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.9 175.97 9.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.138 0.494 . . . . 0.0 112.039 -173.041 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 26.1 t -64.95 -26.56 40.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.646 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 9.8 m -52.22 -33.88 43.13 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.281 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 t -73.54 -33.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.131 0.491 . . . . 0.0 110.417 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.23 -48.59 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.692 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.709 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.96 -39.34 89.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.69 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.6 p -74.15 -38.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.046 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.52 -36.23 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.971 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 54' ' ' LEU . 78.8 mt -70.47 -42.69 78.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 110.571 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -57.87 -32.38 67.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.232 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.47 -25.17 22.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.03 0.443 . . . . 0.0 111.102 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.33 -47.86 11.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.605 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.1 p -98.77 -45.12 6.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.656 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.42 -20.49 5.54 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.878 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.452 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.1 ptm -77.97 119.94 79.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 0.0 111.615 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.6 Cg_endo -67.24 159.29 52.92 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.484 2.123 . . . . 0.0 111.8 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.709 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.46 -11.38 51.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.542 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.5 -30.33 61.84 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.523 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -131.2 -0.98 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.988 0.423 . . . . 0.0 110.399 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -100.56 125.27 46.9 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -116.19 142.82 46.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.002 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.8 mm? -112.46 117.59 32.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.574 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.4 tt0 -107.04 113.93 27.69 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.008 0.433 . . . . 0.0 111.041 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.4 t80 -103.6 109.52 21.23 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.212 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 58.09 30.15 18.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.462 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.08 14.15 46.67 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.34 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 24.2 mt -117.23 118.62 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -75.04 90.36 2.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.194 0.521 . . . . 0.0 109.998 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.556 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -79.25 148.48 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.093 -174.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.66 162.69 13.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.977 176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -65.06 -21.73 66.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 -177.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -74.31 5.68 4.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.78 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' ND2' ' HE2' ' A' ' 70' ' ' TYR . 58.6 m-20 -111.03 166.81 10.74 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 52.8 p -126.15 165.34 19.06 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.88 -45.01 91.33 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.214 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.3 -33.67 73.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.213 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 66' ' ' SER . 77.9 t80 -57.44 -42.43 82.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.259 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.478 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 34.5 m-85 -98.85 8.17 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.268 177.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER 61.45 40.26 14.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.43 176.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -63.75 90.29 0.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.483 . . . . 0.0 111.443 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 178.34 6.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.248 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.32 115.36 2.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.27 29.59 4.76 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.038 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.05 114.3 15.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 5' ' ' LYS . 27.5 t -95.1 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.543 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.4 mm -94.31 145.69 7.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 11.3 m-70 -113.27 114.41 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.44 134.48 35.99 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.42 145.58 29.28 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.29 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 85' ' ' ARG . 33.1 tp -75.51 145.12 41.61 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 2.1 tppp? -44.62 -69.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.936 0.772 . . . . 0.0 109.991 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -142.31 122.88 14.14 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 170.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.57 ' HA ' HD23 ' A' ' 82' ' ' LEU . 19.5 ptp180 -65.95 -23.73 66.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.171 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.765 -1.019 . . . . 0.0 111.969 177.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.482 ' HB2' HG22 ' A' ' 27' ' ' THR . 31.4 Cg_endo . . . . . 0 N--CA 1.466 -0.124 0 N-CA-C 110.473 -0.626 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 18.3 m -124.76 154.29 32.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.769 0.319 . . . . 0.0 110.326 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 m -87.19 114.44 23.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 110.084 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.715 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -113.33 135.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 13.5 mttt -122.11 146.48 47.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.572 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.0 t -124.11 105.98 16.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.738 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.509 HE21 ' CA ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -69.22 103.82 2.03 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 19' ' ' LEU . 91.0 t -74.0 133.15 79.04 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.563 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.5 Cg_endo -66.48 147.48 82.46 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.766 1.644 . . . . 0.0 111.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -74.37 88.29 2.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.709 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.511 ' HB3' HG22 ' A' ' 15' ' ' THR . 52.6 mtm -140.61 76.0 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -79.09 -46.42 18.09 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.448 0.642 . . . . 0.0 110.137 -171.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.64 6.91 9.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.517 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -80.6 -15.98 55.26 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.561 0.696 . . . . 0.0 109.576 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 11' ' ' MET . 10.8 t -153.0 -178.78 7.14 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.991 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 16' ' ' GLU . 10.5 pt-20 -91.31 -3.91 56.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.231 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.599 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -86.87 172.81 9.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.588 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -92.32 29.72 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.872 -177.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.3 mt -81.05 130.14 34.88 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.606 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.6 m-80 -138.29 15.54 2.79 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.103 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.26 -0.95 88.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.377 -177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -73.18 177.56 5.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.323 0.583 . . . . 0.0 111.136 -177.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.53 124.65 73.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.567 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.588 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 84.9 mt -86.91 142.67 27.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.5 t -129.59 110.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.047 0.451 . . . . 0.0 109.806 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 95.7 m-85 -122.71 158.58 29.79 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.895 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -126.22 112.91 16.3 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.106 0.479 . . . . 0.0 109.938 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 4' ' ' ILE . 85.3 mt -131.32 153.08 81.55 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.74 -178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.23 150.39 87.52 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.906 1.737 . . . . 0.0 111.277 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.7 tp -60.34 -12.21 8.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.725 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.2 p -78.83 -20.28 50.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.833 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -72.66 -176.25 1.91 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.258 0.552 . . . . 0.0 110.268 176.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.42 173.3 11.74 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.888 0.375 . . . . 0.0 111.684 -172.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.688 HG11 HG13 ' A' ' 61' ' ' ILE . 40.8 t -61.96 -26.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.479 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -53.94 -32.77 54.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.181 176.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.7 t -78.22 -27.7 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.451 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 33.6 mm -73.04 -48.21 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.952 0.406 . . . . 0.0 110.553 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -61.33 -39.66 91.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.456 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.4 p -72.61 -39.96 61.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.038 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -64.4 -39.23 93.44 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.802 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.413 HD12 HD11 ' A' ' 54' ' ' LEU . 76.4 mt -68.58 -43.29 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.739 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -57.74 -32.54 67.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.544 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 49.3 mt-10 -82.07 -38.18 25.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 110.141 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.09 -51.16 19.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.431 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.578 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 3.1 p -96.57 -43.07 7.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.0 110.303 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.3 -19.49 6.76 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.81 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.424 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.6 ptm -79.05 119.96 79.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.311 0.577 . . . . 0.0 111.672 -174.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.6 Cg_endo -68.28 156.43 65.74 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.566 2.177 . . . . 0.0 112.037 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.12 -15.99 58.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.66 -33.6 34.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.863 177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.42 -3.91 4.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.056 0.455 . . . . 0.0 110.554 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -96.72 121.41 38.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.309 0.576 . . . . 0.0 110.009 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -113.06 144.05 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.02 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.3 mm? -112.83 120.04 40.09 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -108.05 110.33 22.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.101 0.477 . . . . 0.0 111.585 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 21.1 t80 -102.52 112.54 25.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.834 0.349 . . . . 0.0 110.136 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 16.2 mm-40 57.3 30.32 18.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.95 11.53 57.59 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.47 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 22.2 mt -113.97 119.08 60.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 6.7 m-30 -70.74 91.12 0.81 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.292 0.568 . . . . 0.0 109.905 174.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.688 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -77.76 153.25 5.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.272 -176.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE2' HD21 ' A' ' 65' ' ' ASN . 15.5 pttt -121.82 161.85 21.97 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.746 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.78 -2.55 17.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.292 -174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 m -84.22 -2.89 57.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.035 0.445 . . . . 0.0 110.386 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.413 HD21 ' HE2' ' A' ' 62' ' ' LYS . 89.4 m-20 -119.3 175.11 5.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.485 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 80.7 p -129.78 170.38 13.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.172 -174.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.65 -44.0 78.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.981 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.74 -37.03 75.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.318 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -58.82 -46.84 86.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.695 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.91 -4.23 58.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.752 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.4 41.23 4.35 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.504 0.503 . . . . 0.0 110.854 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.9 mtt -68.01 86.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.47 . . . . 0.0 111.408 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.46 -174.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.889 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.6 t-20 -65.71 115.3 5.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.71 29.16 4.79 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.439 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -72.67 114.44 10.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.97 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.1 mm -94.38 150.86 3.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 7.6 m-70 -118.54 117.76 29.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.1 tp -83.44 134.13 34.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.58 147.08 31.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.874 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 51' ' ' LYS . 21.0 tp -84.87 127.25 34.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.579 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.82 -45.94 87.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.994 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.04 155.8 44.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.88 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -160.34 177.03 11.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.572 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.423 -1.209 . . . . 0.0 111.247 175.444 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' THR . 7.7 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 N-CA-C 109.928 -0.835 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 12.3 m -123.39 151.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 110.296 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -91.78 109.02 20.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.71 0.767 . . . . 0.0 110.778 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.745 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -107.38 143.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.414 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.5 mtmm -126.89 152.03 47.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.656 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 46.6 t -131.3 105.87 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.606 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 107.13 4.06 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.002 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 53.8 t -79.37 133.29 60.35 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.834 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HG2' HD13 ' A' ' 19' ' ' LEU . 57.5 Cg_endo -70.42 151.99 65.62 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.464 2.109 . . . . 0.0 112.091 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.534 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -78.88 100.95 7.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.582 ' HB3' HG22 ' A' ' 15' ' ' THR . 27.6 mtm -147.21 76.8 1.43 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.455 0.169 . . . . 0.0 110.598 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.2 -48.4 15.93 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.014 0.435 . . . . 0.0 110.912 -169.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -121.42 9.33 10.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.965 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -84.52 -5.5 59.3 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -162.15 -178.84 6.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.239 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.34 1.55 47.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -88.15 175.57 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.684 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -94.88 30.79 1.99 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.605 -177.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 8' ' ' VAL . 22.0 mt -86.38 115.33 23.83 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.941 -0.475 . . . . 0.0 110.401 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.614 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 23.6 m-80 -130.32 21.65 5.21 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.555 -0.716 . . . . 0.0 110.863 -175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.534 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.55 1.63 87.58 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.046 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.614 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.6 pm0 -75.13 179.45 5.03 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 111.117 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.83 132.71 69.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.728 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 67.0 mt -87.51 144.26 26.8 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.502 HG22 ' HG2' ' A' ' 5' ' ' LYS . 96.1 t -131.93 114.62 24.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.157 0.503 . . . . 0.0 110.058 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 99.2 m-85 -128.85 160.16 33.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.456 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.8 m -126.55 119.09 26.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.3 mt -137.82 151.32 70.23 Favored Pre-proline 0 C--N 1.318 -0.798 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.83 149.66 89.28 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.006 1.804 . . . . 0.0 111.192 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 32.0 tp -59.5 -14.16 11.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.66 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -76.67 -19.39 57.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.125 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.31 -174.06 2.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.421 0.629 . . . . 0.0 111.029 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.11 172.88 12.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.339 0.59 . . . . 0.0 112.266 -172.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG11 HG13 ' A' ' 61' ' ' ILE . 45.0 t -60.83 -26.42 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.623 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.29 -33.32 52.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.049 176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -76.96 -29.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 21.4 mm -73.0 -45.24 55.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.573 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.693 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.4 ptmt -62.68 -42.94 99.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.48 -37.48 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.651 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.56 -35.34 80.57 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.578 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.88 -42.26 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.47 . . . . 0.0 109.956 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -59.54 -35.87 75.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.355 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -83.85 -31.35 25.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.819 0.342 . . . . 0.0 111.463 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.47 -38.41 26.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.8 p -106.15 -47.91 3.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.043 0.449 . . . . 0.0 110.628 -176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.87 -6.55 10.33 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.115 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.521 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 22.0 ptm -87.19 115.7 63.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.406 0.622 . . . . 0.0 110.978 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.4 157.56 61.29 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.626 2.217 . . . . 0.0 112.127 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.75 -17.15 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.209 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.55 -31.15 52.01 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.859 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -129.84 -5.37 4.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.49 . . . . 0.0 110.535 -178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.693 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -87.52 113.48 23.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.1 mmpt? -104.94 138.72 40.73 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.702 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.7 mt -118.88 122.4 42.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.975 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -112.3 120.27 41.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.191 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.6 t80 -108.84 110.32 21.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.42 30.79 20.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.05 49.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.16 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 mt -121.94 113.58 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -74.63 95.27 2.8 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.752 0.787 . . . . 0.0 110.287 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.591 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.73 168.9 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.098 -176.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.46 166.04 21.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.365 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.36 -2.78 20.55 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.898 -174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.6 t -94.32 13.23 24.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.191 0.519 . . . . 0.0 110.237 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.64 165.69 16.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 71.6 m -126.15 166.38 17.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.02 -46.53 84.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.767 0.318 . . . . 0.0 110.397 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -59.85 -29.99 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.455 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 66' ' ' SER . 56.7 t80 -62.81 -40.99 99.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.681 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -97.86 5.17 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.28 46.55 23.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.332 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 mtt -66.05 82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 110.806 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 171.79 8.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.684 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 48.0 t-20 -55.36 115.95 2.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.73 27.38 4.66 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.058 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.745 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -78.11 115.06 17.56 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.57 104.33 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.3 mm -94.27 150.62 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -116.78 119.71 36.28 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.75 134.27 33.96 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.715 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.9 142.66 27.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.933 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 85' ' ' ARG . 40.2 tp -81.5 130.21 34.96 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.142 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.3 -55.58 31.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.058 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -174.05 151.12 1.67 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.735 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HB2' HD21 ' A' ' 82' ' ' LEU . 34.8 ttt180 -121.69 100.1 6.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.472 -177.209 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.476 0.499 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.15 152.03 24.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.933 0.397 . . . . 0.0 110.389 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -89.02 114.19 25.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.058 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.3 pt -117.64 138.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.696 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -121.53 145.14 48.26 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.233 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.04 105.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.427 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.48 104.61 2.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.567 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.584 HG13 HD22 ' A' ' 19' ' ' LEU . 95.8 t -75.75 127.32 85.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.425 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.827 ' HG2' HD13 ' A' ' 19' ' ' LEU . 26.1 Cg_endo -61.92 151.13 83.14 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 122.515 2.143 . . . . 0.0 112.2 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.691 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.9 m120 -79.71 83.22 5.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.78 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.49 ' HB3' HG22 ' A' ' 15' ' ' THR . 55.4 mtm -135.81 75.57 1.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.623 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -77.22 -45.8 25.32 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.363 0.601 . . . . 0.0 110.229 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -120.96 8.86 10.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.984 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -90.39 -4.81 56.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.046 -173.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 17' ' ' TRP . 14.4 t -161.2 -172.71 3.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.942 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -103.3 4.67 36.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.57 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.672 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -96.44 171.65 8.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.81 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 27.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.257 0.551 . . . . 0.0 110.944 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.827 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.8 mt -78.85 129.63 34.78 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 12.5 m-80 -142.27 15.67 2.04 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.935 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.691 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.03 5.03 90.42 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.919 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.624 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.04 179.38 6.84 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.34 136.59 60.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.184 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.91 142.76 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.28 109.9 19.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -123.19 163.66 20.18 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.581 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.2 m -127.06 117.34 22.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.024 0.44 . . . . 0.0 110.236 176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 4' ' ' ILE . 89.9 mt -134.33 149.76 72.11 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.617 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.9 151.8 81.57 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.167 1.912 . . . . 0.0 111.256 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' MET . 29.7 tp -61.89 -10.18 8.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -80.19 -19.05 47.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.848 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.58 -173.05 2.41 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.69 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.67 175.4 10.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.485 -173.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 61' ' ' ILE . 42.3 t -60.0 -28.49 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.527 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -51.28 -31.61 21.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.86 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.89 -33.64 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.109 0.481 . . . . 0.0 110.408 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 19.4 mm -72.12 -49.61 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.572 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.6 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 8.4 ptmt -60.01 -40.67 90.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.337 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.0 p -72.05 -38.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.756 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -66.87 -36.12 81.59 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.843 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.77 -41.87 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.499 . . . . 0.0 110.202 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -58.3 -32.12 68.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.45 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 8.7 mm-40 -87.81 -30.29 20.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.118 0.485 . . . . 0.0 110.724 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.75 -46.39 14.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.784 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.672 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.1 p -98.23 -43.4 7.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.832 0.348 . . . . 0.0 110.721 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.21 -2.33 18.93 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.401 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -92.0 118.04 68.02 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.353 0.597 . . . . 0.0 111.281 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.5 Cg_endo -68.41 155.88 67.61 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.434 2.089 . . . . 0.0 112.119 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.66 -16.88 59.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.668 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.52 -29.67 40.14 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.292 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -130.87 -1.82 4.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.237 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.75 113.37 24.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.557 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.4 mmpt? -105.22 139.15 40.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.095 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.4 mt -116.64 121.3 41.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.092 0.472 . . . . 0.0 109.889 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.3 tt0 -113.46 113.99 25.93 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.333 -175.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' HB2' HD12 ' A' ' 78' ' ' ILE . 17.1 t80 -103.05 110.89 22.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.933 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 57.39 29.78 17.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.432 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.23 7.34 57.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.524 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.3 mt -112.34 119.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -72.52 91.8 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.141 0.496 . . . . 0.0 110.196 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.462 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -77.3 154.25 5.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.608 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 28.9 pttt -123.16 162.08 23.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.448 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.6 ' OD1' ' HD3' ' A' ' 38' ' ' LYS . 6.5 t70 -54.48 -30.35 52.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.806 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.477 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 16.0 m -69.47 -13.88 62.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.919 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 90.0 m-20 -105.43 177.91 4.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.095 0.474 . . . . 0.0 110.657 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 78.5 p -134.59 171.12 14.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.408 -175.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.7 -44.03 78.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.937 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.82 70.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.493 176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -62.37 -45.29 93.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -89.19 1.6 55.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.79 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.6 m120 64.56 31.27 12.42 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.416 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.44 ' O ' HD13 ' A' ' 30' ' ' LEU . 58.5 mtt -59.72 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.214 0.531 . . . . 0.0 112.113 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 -172.08 3.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -64.4 116.19 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.905 0.383 . . . . 0.0 110.664 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.08 19.23 7.76 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.552 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -71.98 114.45 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.136 0.468 . . . . 0.0 110.102 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.12 104.85 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.709 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.0 mm -94.36 148.01 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -115.09 115.42 26.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -80.04 131.51 35.79 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.56 146.01 32.99 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.127 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 51' ' ' LYS . 31.7 tp -83.56 138.01 33.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -51.11 -53.48 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.036 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -179.94 140.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.939 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.58 128.27 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.14 0.495 . . . . 0.0 110.788 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.813 -0.993 . . . . 0.0 111.155 174.557 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 27' ' ' THR . 2.2 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.09 155.41 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.685 0.279 . . . . 0.0 110.417 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -87.91 117.01 26.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.138 0.494 . . . . 0.0 110.234 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.3 pt -124.01 142.73 39.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.999 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -123.99 146.84 48.24 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.566 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.37 105.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 104.17 3.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.609 HG13 HD22 ' A' ' 19' ' ' LEU . 55.9 t -75.89 126.71 86.67 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.316 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.4 Cg_endo -65.74 147.5 85.76 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.3 2.0 . . . . 0.0 112.114 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.58 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -72.61 90.76 1.38 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.518 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 42.3 mtm -141.43 76.56 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.871 0.367 . . . . 0.0 110.367 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.624 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -78.92 -45.54 20.31 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.57 0.7 . . . . 0.0 110.201 -172.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -120.51 7.79 10.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.161 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -94.81 3.53 54.9 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.807 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.5 t -168.28 -174.45 2.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.452 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 6.2 pt-20 -106.29 3.65 27.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.289 -171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.758 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.4 m0 -102.28 170.64 7.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 26.82 0.23 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.629 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.83 HD13 ' HG2' ' A' ' 9' ' ' PRO . 17.3 mt -78.5 126.45 30.78 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.0 m-80 -140.99 15.74 2.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 110.667 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.53 1.0 89.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.196 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.595 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 1.1 pm0 -75.66 173.66 10.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.396 0.617 . . . . 0.0 110.779 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.04 124.67 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.878 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.55 134.35 33.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -121.43 107.36 20.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -122.0 162.24 21.49 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.543 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.4 m -125.77 116.78 22.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.996 0.426 . . . . 0.0 110.44 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 4' ' ' ILE . 81.0 mt -133.68 151.31 76.87 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.035 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.04 147.96 80.74 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.292 1.995 . . . . 0.0 111.687 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.05 -10.66 10.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.469 0.652 . . . . 0.0 110.601 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.9 p -81.98 -15.0 55.22 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.725 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -81.5 -173.39 4.35 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.115 0.483 . . . . 0.0 110.573 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.56 173.59 11.68 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.889 0.376 . . . . 0.0 111.666 -172.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 61' ' ' ILE . 41.8 t -61.43 -27.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.012 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -53.11 -33.28 51.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.399 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -73.63 -34.01 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.222 0.534 . . . . 0.0 110.264 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.0 mm -70.48 -52.07 32.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.859 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.2 ptmt -58.19 -42.71 86.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.518 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 11.1 p -71.32 -38.98 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.678 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 13.2 ptmt -66.07 -35.26 80.04 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.39 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.2 mt -72.71 -41.13 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.11 0.481 . . . . 0.0 110.196 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 48' ' ' PRO . 23.5 t-80 -58.04 -32.4 67.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.339 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 56.8 mm-40 -85.94 -34.52 20.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.992 0.425 . . . . 0.0 110.047 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.06 -46.53 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.637 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.9 p -97.78 -43.6 7.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.067 0.46 . . . . 0.0 110.626 -176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 -7.19 11.24 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.131 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.516 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 13.2 ptm -89.7 119.64 69.48 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.371 0.605 . . . . 0.0 111.827 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.2 Cg_endo -67.65 157.41 61.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.541 2.161 . . . . 0.0 112.057 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -65.99 -12.07 52.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.597 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -56.5 -33.76 62.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.647 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.54 -5.12 6.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.337 0.589 . . . . 0.0 109.979 -177.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -99.83 113.55 26.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 12.0 mmpt? -107.66 135.3 49.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.544 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.409 ' HB3' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -103.38 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.09 176.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 tt0 -108.5 116.52 32.12 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.526 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 78' ' ' ILE . 7.5 t80 -101.04 102.83 13.9 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.457 0.646 . . . . 0.0 109.685 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 6.4 mm-40 57.42 31.01 19.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.084 -1.417 . . . . 0.0 112.076 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 55' ' ' GLN . . . 98.14 19.49 23.59 Favored Glycine 0 CA--C 1.511 -0.167 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.829 177.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.99 112.06 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 55' ' ' GLN . 5.0 m-85 -72.0 95.4 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.59 0.71 . . . . 0.0 110.002 178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.712 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.2 162.12 3.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.27 -178.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE2' HD21 ' A' ' 65' ' ' ASN . 0.0 OUTLIER -135.46 165.17 26.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.775 0.321 . . . . 0.0 110.96 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -72.73 -4.85 33.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.622 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t -79.97 -7.7 58.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.177 0.513 . . . . 0.0 109.905 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.413 HD21 ' HE2' ' A' ' 62' ' ' LYS . 86.0 m-20 -114.82 178.91 4.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.303 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 69' ' ' TYR . 53.5 p -136.93 173.43 11.71 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.336 -175.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 mt -69.16 -45.08 70.93 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.26 72.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.259 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 66' ' ' SER . 46.2 t80 -56.74 -46.19 81.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.657 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -90.62 1.11 57.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 58.98 42.25 19.64 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.557 0.536 . . . . 0.0 110.395 -178.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.6 mtt -65.27 88.14 0.08 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.9 -178.07 5.28 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.516 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.85 116.28 3.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.287 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.75 29.3 5.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.364 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.11 114.67 18.24 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.91 106.35 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.14 0.495 . . . . 0.0 110.58 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.2 mm -94.46 145.47 7.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -116.25 111.69 20.52 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -80.56 132.37 35.65 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.31 144.11 30.56 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.479 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 51' ' ' LYS . 32.1 tp -76.6 137.5 39.54 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -46.2 -47.1 17.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.978 0.799 . . . . 0.0 111.938 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -157.81 111.22 2.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -98.95 -34.13 10.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 CA-C-O 118.847 -0.974 . . . . 0.0 111.736 -179.347 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.552 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 Cg_endo . . . . . 0 N--CA 1.479 0.627 0 N-CA-C 110.258 -0.708 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.73 154.9 37.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 m -86.77 125.15 33.74 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' A' ' 76' ' ' ALA . 12.9 pt -128.71 145.37 35.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 120.968 0.413 . . . . 0.0 111.045 -178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -126.5 146.53 50.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.892 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 47.2 t -123.18 105.79 16.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.615 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.53 103.86 3.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.968 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 94.3 t -77.03 131.68 72.43 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.843 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.629 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.9 Cg_endo -66.16 155.76 68.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.567 2.178 . . . . 0.0 111.851 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.74 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.7 m120 -84.66 84.16 7.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.587 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.495 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -133.44 75.47 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.9 mp0 -78.43 -46.3 20.15 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.54 0.686 . . . . 0.0 110.383 -171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 0.63 10.32 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.046 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HE2' ' OE1' ' A' ' 12' ' ' GLN . 20.6 mmtt -86.14 0.98 52.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.369 0.605 . . . . 0.0 109.63 -173.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -160.38 -173.53 4.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.1 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.45 -5.8 24.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 111.508 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.1 m0 -85.37 173.87 9.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.4 29.38 1.28 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.359 -176.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.629 HD13 ' HG2' ' A' ' 9' ' ' PRO . 14.0 mt -81.53 124.97 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.562 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 4.8 m-80 -132.33 19.6 4.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.899 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.74 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.66 12.96 83.44 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.302 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.562 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -83.22 179.12 7.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.137 0.494 . . . . 0.0 110.754 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.97 126.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.82 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 72.5 mt -87.3 139.49 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.16 109.26 18.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -124.2 166.02 16.58 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.394 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 1' ' ' PRO . 9.9 m -126.87 121.98 33.36 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.099 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 4' ' ' ILE . 77.4 mt -136.15 149.28 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.774 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.4 Cg_endo -65.25 150.13 87.8 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.182 1.921 . . . . 0.0 110.947 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 20.0 tp -62.33 -8.82 6.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.652 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -82.52 -18.85 40.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -74.9 -175.26 2.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.157 0.503 . . . . 0.0 110.063 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.93 174.68 10.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.93 0.395 . . . . 0.0 111.546 -174.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.584 HG11 HG13 ' A' ' 61' ' ' ILE . 35.0 t -62.87 -25.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.632 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 1.6 t -53.13 -33.81 54.0 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.66 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -72.43 -33.36 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.155 0.502 . . . . 0.0 110.553 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.6 mm -70.54 -47.16 66.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.754 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.4 ptmt -63.15 -41.89 99.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.273 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -68.85 -39.38 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.695 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.42 -39.74 85.5 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.199 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.6 mt -68.73 -40.51 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.23 0.538 . . . . 0.0 110.421 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -61.1 -32.8 72.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.566 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.55 -30.23 18.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.586 0.231 . . . . 0.0 111.133 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.11 -39.02 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.595 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 9.3 p -105.69 -45.28 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 0.0 110.548 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.65 -11.81 8.9 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.286 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 23.4 ptm -84.21 117.76 69.51 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.349 0.595 . . . . 0.0 111.116 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 29.3 Cg_endo -68.94 157.1 63.21 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.579 2.186 . . . . 0.0 112.161 177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -63.71 -15.55 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.69 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.71 -30.03 50.79 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.981 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.59 -0.41 3.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.117 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -97.13 113.86 25.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.9 178.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 10.3 mmpt? -106.73 141.84 37.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.862 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 78' ' ' ILE . 1.7 mm? -114.42 118.19 33.13 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -107.2 115.14 29.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.968 0.413 . . . . 0.0 110.668 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.5 t80 -103.91 111.38 23.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.337 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 57.88 29.74 18.02 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.191 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.41 24.52 26.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.071 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -130.78 110.26 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.422 ' HD1' ' HB3' ' A' ' 53' ' ' LYS . 53.9 m-85 -71.69 94.92 1.4 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.761 0.791 . . . . 0.0 110.648 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.584 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -80.73 154.61 4.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.159 -174.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.49 162.73 13.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -70.89 -15.71 62.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 111.335 -174.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 m -78.24 7.22 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.801 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 80.9 m-20 -109.99 166.66 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 87.3 p -123.75 164.5 19.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.15 -43.24 92.46 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.192 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -60.34 -38.03 82.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.231 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -55.66 -43.64 76.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.233 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.99 5.06 53.0 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.709 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.43 46.98 14.36 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.376 0.423 . . . . 0.0 111.399 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.24 84.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 110.775 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.31 -176.64 1.24 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.074 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -61.37 116.51 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.309 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.41 33.64 4.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.962 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -74.32 114.63 12.91 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.043 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -96.58 103.45 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.116 0.484 . . . . 0.0 110.58 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.37 143.39 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -113.19 113.05 24.8 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.8 tp -79.11 132.19 36.5 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.59 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.96 143.96 26.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.628 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -82.34 136.88 34.92 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.078 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.403 ' N ' HD23 ' A' ' 82' ' ' LEU . 37.7 ttmt -62.03 -32.69 73.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.528 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HG3' ' H ' ' A' ' 85' ' ' ARG . 9.7 tp10 -149.42 -153.09 0.47 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.805 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -109.41 -63.09 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.039 -1.423 . . . . 0.0 111.244 175.646 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.523 ' HB2' HG22 ' A' ' 27' ' ' THR . 37.0 Cg_endo . . . . . 0 N--CA 1.478 0.577 0 N-CA-C 109.839 -0.869 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 25.8 m -126.27 156.7 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.707 0.289 . . . . 0.0 110.354 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -86.63 121.33 29.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.029 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.691 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.2 pt -122.5 137.63 55.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.568 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.464 ' HD3' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -120.25 151.96 38.43 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.474 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.8 t -126.04 106.21 15.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.492 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -69.52 106.73 3.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.461 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -77.35 127.62 82.54 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.254 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.761 ' HG2' HD13 ' A' ' 19' ' ' LEU . 31.9 Cg_endo -64.31 148.59 90.98 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.122 1.882 . . . . 0.0 112.081 -177.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.567 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.7 m120 -74.83 93.85 2.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.775 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 15' ' ' THR . 35.9 mtm -146.45 75.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -78.53 -49.01 14.09 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.384 0.611 . . . . 0.0 110.543 -169.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.4 17.49 9.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.19 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -91.33 -7.91 49.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.679 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.4 t -158.76 -172.5 3.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.685 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.55 -0.44 25.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.913 0.387 . . . . 0.0 111.58 -174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.684 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.8 m0 -85.95 168.66 13.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.623 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -84.93 31.64 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.427 0.632 . . . . 0.0 111.045 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 9' ' ' PRO . 13.5 mt -84.77 112.98 20.99 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.814 -0.554 . . . . 0.0 110.096 -175.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.626 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.8 m-80 -126.46 16.26 7.65 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 121.33 -0.856 . . . . 0.0 111.209 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.24 5.96 86.76 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.5 pm0 -79.6 175.18 10.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.651 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 7' ' ' GLN . 43.9 t -124.84 124.0 66.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.099 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.92 142.54 27.72 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' HG2' ' A' ' 5' ' ' LYS . 58.4 t -132.47 111.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.152 0.501 . . . . 0.0 110.261 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -123.44 166.25 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.5 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 1' ' ' PRO . 5.6 m -125.99 116.86 22.11 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.314 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 4' ' ' ILE . 82.3 mt -131.98 153.74 81.48 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.679 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 1' ' ' PRO . 29.9 Cg_endo -64.85 149.32 89.75 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.274 1.983 . . . . 0.0 111.533 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -62.67 -12.05 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.726 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.6 p -80.93 -16.24 54.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.512 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.93 -174.87 2.35 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.243 0.544 . . . . 0.0 110.152 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.23 173.4 11.98 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.476 -171.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG11 HG13 ' A' ' 61' ' ' ILE . 39.9 t -62.47 -25.14 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.598 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 1.1 m -53.33 -34.34 57.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.246 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.52 -30.29 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.533 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 26.1 mm -72.31 -47.57 52.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.831 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 4.1 ptmt -61.92 -40.12 94.39 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.7 p -71.12 -39.7 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.013 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -65.49 -38.44 89.75 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.92 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CD1' HD11 ' A' ' 54' ' ' LEU . 79.4 mt -71.59 -42.16 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 0.0 110.552 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 47' ' ' MET . 32.7 t60 -57.64 -32.77 67.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.434 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.45 -29.21 18.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.804 0.335 . . . . 0.0 111.212 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' LYS . . . -82.8 -31.1 28.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.053 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -112.18 -43.4 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.084 0.468 . . . . 0.0 110.548 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.97 -7.06 10.93 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.006 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 15.6 ptm -89.97 119.24 69.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.347 0.594 . . . . 0.0 111.586 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 25.9 Cg_endo -67.81 161.36 44.26 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 111.86 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.56 -10.67 57.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -176.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -28.69 62.83 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.69 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -131.83 -3.05 3.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 110.329 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -98.12 122.19 40.96 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.3 mmpt? -114.0 142.56 46.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.741 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.513 HD11 ' CD1' ' A' ' 41' ' ' ILE . 1.8 mm? -111.49 119.38 38.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.582 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 29.1 tt0 -108.55 112.66 25.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.936 0.398 . . . . 0.0 111.026 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.657 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.0 t80 -103.23 109.97 21.76 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 57.34 30.18 18.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.549 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.93 17.16 38.84 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.35 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 17.6 mt -120.65 116.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 16.2 m-85 -72.75 91.38 1.47 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.073 0.463 . . . . 0.0 110.096 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.565 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -76.67 157.04 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.811 -175.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HE3' HD21 ' A' ' 65' ' ' ASN . 3.1 pttp -121.44 160.22 24.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.758 -178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 8.3 p-10 -71.14 -8.3 52.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.574 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 m -85.24 -1.58 57.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 0.0 110.261 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.446 HD21 ' HE3' ' A' ' 62' ' ' LYS . 94.2 m-20 -109.6 170.67 7.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.449 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 97.0 p -126.33 170.94 11.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.88 -43.65 82.95 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.18 -35.27 73.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.298 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.14 -46.58 85.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -90.91 5.58 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.503 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 m120 59.37 43.36 16.67 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.9 mtt -67.16 92.83 0.27 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.998 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.93 -176.46 2.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.755 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 44.5 t30 -66.08 115.39 6.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.14 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.69 28.68 5.29 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.358 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.18 114.76 11.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.039 0.447 . . . . 0.0 110.188 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG22 ' HD3' ' A' ' 5' ' ' LYS . 38.9 t -95.68 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.696 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.89 148.0 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -116.36 118.37 32.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -80.43 133.67 35.9 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -145.48 146.43 31.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.108 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.594 HD23 ' HG2' ' A' ' 85' ' ' ARG . 26.6 tp -79.76 138.48 37.29 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -50.62 -54.52 22.14 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.525 0.515 . . . . 0.0 110.217 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -173.05 138.17 0.74 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.894 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HG2' HD23 ' A' ' 82' ' ' LEU . 49.5 mtp180 -83.96 -49.61 8.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.078 0.466 . . . . 0.0 110.523 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 CA-C-O 118.733 -1.037 . . . . 0.0 111.416 -177.34 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.48 0.726 0 N-CA-C 110.187 -0.736 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.94 155.77 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.839 0.352 . . . . 0.0 110.267 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 p -90.72 109.84 21.03 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.444 0.64 . . . . 0.0 110.71 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 2.8 pt -111.26 147.56 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.591 -176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HG2' HG22 ' A' ' 25' ' ' VAL . 10.1 mtmm -130.47 150.43 51.69 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.801 -178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 48.1 t -127.08 105.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.96 108.64 4.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.598 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.551 HG13 HD22 ' A' ' 19' ' ' LEU . 86.0 t -80.46 129.02 70.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.31 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.742 ' HG2' HD13 ' A' ' 19' ' ' LEU . 37.3 Cg_endo -65.71 150.52 86.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.375 2.05 . . . . 0.0 111.912 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.675 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -76.76 91.63 3.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.761 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.525 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.1 mtm -141.95 74.48 1.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.762 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -80.98 -44.66 17.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.819 0.819 . . . . 0.0 110.163 -176.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.9 -12.63 14.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.781 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 39.2 mmtt -75.33 -20.34 59.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.757 -172.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -152.24 -174.47 4.89 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.41 -175.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.06 -2.04 28.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.351 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.559 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.6 m0 -85.4 174.21 9.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.278 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -88.82 30.46 0.92 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.34 0.591 . . . . 0.0 111.453 -176.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' HG2' ' A' ' 9' ' ' PRO . 11.3 mt -85.02 124.52 31.81 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.687 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.3 m-80 -136.19 17.7 3.2 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.857 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.675 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 82.2 11.11 82.81 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.915 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.8 pm0 -82.36 -179.77 7.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.903 0.383 . . . . 0.0 110.301 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.91 134.15 65.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.503 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 85.0 mt -89.86 143.4 26.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.088 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.506 HG22 ' HG2' ' A' ' 5' ' ' LYS . 48.5 t -127.99 111.16 23.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -126.04 162.65 24.81 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 m -125.97 115.68 20.28 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.249 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -134.73 150.9 74.73 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.88 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.54 152.22 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.459 2.106 . . . . 0.0 111.707 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 29.0 tp -63.99 -9.06 13.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.478 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -80.69 -21.42 41.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.696 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.82 -174.79 2.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.293 0.568 . . . . 0.0 110.373 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.74 175.79 10.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.017 0.437 . . . . 0.0 111.495 -174.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG11 HG13 ' A' ' 61' ' ' ILE . 46.0 t -59.74 -27.03 36.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.237 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.5 m -54.63 -34.16 61.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.1 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -74.62 -28.45 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 120.946 0.403 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.658 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 31.7 mm -72.87 -52.64 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.78 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.5 ptmt -57.78 -43.14 85.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.663 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.93 -37.87 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.719 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -67.7 -35.52 78.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.894 -177.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.84 -42.48 77.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 110.53 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -57.57 -32.85 67.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.088 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -89.4 -20.76 23.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.93 0.395 . . . . 0.0 111.271 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.94 -37.22 13.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.742 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 5.2 p -108.57 -46.11 3.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.192 0.52 . . . . 0.0 110.318 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.49 -17.45 5.84 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.422 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.6 ptm -81.13 117.49 68.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 121.454 0.645 . . . . 0.0 111.35 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.501 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.4 Cg_endo -67.29 159.76 50.77 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 111.948 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.75 -6.71 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.948 0.404 . . . . 0.0 111.87 -178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.37 -27.05 67.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.501 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -133.54 -3.48 2.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.102 0.477 . . . . 0.0 110.409 -177.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.58 116.99 32.02 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.674 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.0 mmpt? -104.68 141.34 36.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.62 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.19 122.13 45.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -112.11 117.84 33.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.102 0.477 . . . . 0.0 111.448 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.661 ' HB2' HD12 ' A' ' 78' ' ' ILE . 25.6 t80 -106.79 112.06 24.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.117 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 8.3 mm-40 57.54 29.82 17.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.308 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.39 10.23 57.18 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.381 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.01 116.58 52.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -76.85 93.34 3.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.676 0.75 . . . . 0.0 110.071 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.463 HG13 HG11 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.18 165.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.283 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -139.1 171.93 13.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.439 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.39 -5.45 36.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.7 p -81.37 -4.11 54.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -113.5 172.81 6.74 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.67 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.448 ' HA ' ' CB ' ' A' ' 33' ' ' GLN . 71.1 p -132.87 167.75 19.64 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.27 -45.11 89.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.56 -37.33 75.49 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -57.37 -44.48 84.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.036 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.434 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 47.4 m-85 -89.46 -0.2 57.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.582 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.5 42.15 14.73 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.461 0.475 . . . . 0.0 110.619 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 mtt -65.09 85.4 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.988 0.423 . . . . 0.0 110.907 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.29 -174.21 3.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.953 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -58.81 116.32 3.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.167 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.85 36.5 3.44 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.369 -177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.11 114.76 21.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.38 103.69 15.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.788 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.6 mm -94.26 151.01 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.28 119.34 35.4 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.8 tp -85.31 134.05 34.13 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -144.8 149.21 35.06 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.035 0.445 . . . . 0.0 110.527 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 51' ' ' LYS . 35.9 tp -84.58 153.05 23.46 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 1.1 tppp? -50.38 -41.66 52.21 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.401 0.438 . . . . 0.0 111.07 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -128.26 137.57 52.05 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 86' ' ' GLY . 3.9 tmm_? -154.94 -58.04 0.1 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' C ' ' HE ' ' A' ' 85' ' ' ARG . . . . . . . . 0 C--O 1.247 0.917 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.035 -176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.481 0.753 0 N-CA-C 109.692 -0.926 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.452 ' HA ' ' OD1' ' A' ' 74' ' ' ASN . 17.3 m -125.67 154.58 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.362 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -86.26 123.94 32.09 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.671 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.4 pt -126.73 138.05 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 110.984 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HD2' HG22 ' A' ' 77' ' ' VAL . 12.5 mttm -120.15 147.73 44.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.311 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 59.5 t -123.75 105.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -73.98 103.06 4.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.862 -178.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG13 HD22 ' A' ' 19' ' ' LEU . 59.0 t -73.97 131.83 80.84 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.617 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.71 ' HG2' HD13 ' A' ' 19' ' ' LEU . 44.0 Cg_endo -68.25 153.23 74.95 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.145 1.897 . . . . 0.0 111.794 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.586 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.5 m120 -80.22 93.71 5.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.63 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.454 ' HB3' HG22 ' A' ' 15' ' ' THR . 46.2 mtm -142.77 75.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.787 0.327 . . . . 0.0 110.286 174.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.606 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -79.52 -45.12 19.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.555 0.693 . . . . 0.0 110.71 -173.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -118.06 15.46 14.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.726 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -102.59 -3.39 26.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 17' ' ' TRP . 11.4 t -164.24 -171.68 2.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.592 -176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.74 4.04 37.59 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.452 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.631 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.5 m0 -94.84 173.77 7.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.078 0.466 . . . . 0.0 110.858 -176.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' NZ ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.22 29.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.883 -177.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.71 HD13 ' HG2' ' A' ' 9' ' ' PRO . 12.6 mt -81.44 119.22 23.44 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.95 -0.469 . . . . 0.0 109.928 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.649 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 10.6 m-80 -131.7 15.81 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.658 -0.651 . . . . 0.0 110.885 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 83.75 2.63 89.78 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.809 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.649 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -76.44 178.05 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.153 0.501 . . . . 0.0 111.014 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 7' ' ' GLN . 48.5 t -121.69 126.64 74.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.1 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 86.9 mt -87.35 142.8 27.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.9 t -131.17 108.65 15.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -116.55 161.37 19.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.03 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -127.1 113.94 17.08 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.031 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 4' ' ' ILE . 87.6 mt -131.2 153.91 81.83 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.806 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.3 150.42 87.32 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.177 1.918 . . . . 0.0 111.226 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -62.88 -13.56 35.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 0.0 110.524 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -78.89 -15.22 58.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.425 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.95 -174.42 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -146.31 172.63 13.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -170.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 30.8 t -59.01 -28.28 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.44 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 2.7 t -54.27 -31.44 53.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.829 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.52 -29.66 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.661 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 30.8 mm -72.3 -51.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.847 0.356 . . . . 0.0 110.451 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.4 ptmt -57.75 -43.75 85.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.601 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.78 -38.94 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.068 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.24 -35.47 77.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.531 -177.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.7 mt -70.59 -43.44 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 110.297 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.03 -32.9 68.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.363 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.66 -22.92 22.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.039 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -86.17 -42.87 13.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.653 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.5 p -101.41 -44.74 5.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.839 0.352 . . . . 0.0 110.734 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.3 -6.39 10.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.102 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.428 ' HG2' ' OG1' ' A' ' 45' ' ' THR . 18.3 ptm -91.16 120.02 68.63 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.316 0.579 . . . . 0.0 111.508 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 28.4 Cg_endo -68.72 157.57 61.32 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.467 2.111 . . . . 0.0 112.24 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.74 -8.67 15.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.761 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.425 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . -59.27 -29.69 66.35 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.445 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.01 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -129.47 -10.12 4.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.01 0.433 . . . . 0.0 110.356 -177.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.58 113.77 25.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.961 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 11.5 mmpt? -102.57 142.12 34.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.51 130.19 56.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -121.76 120.81 35.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.736 0.303 . . . . 0.0 111.196 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.64 ' HB2' HD12 ' A' ' 78' ' ' ILE . 13.8 t80 -103.5 107.45 18.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.389 . . . . 0.0 110.592 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 59.2 mm-40 55.59 30.49 15.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.735 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.62 19.17 30.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.186 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 mt -123.65 109.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -72.0 95.03 1.54 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.797 0.808 . . . . 0.0 110.499 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -77.11 164.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.177 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.456 ' HE2' HD21 ' A' ' 65' ' ' ASN . 0.1 OUTLIER -135.25 163.78 29.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.191 0.519 . . . . 0.0 111.989 -179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -51.8 -32.4 31.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.348 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -75.77 2.46 12.15 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.456 HD21 ' HE2' ' A' ' 62' ' ' LYS . 89.5 m-20 -118.48 171.63 8.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.398 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 67.2 p -129.22 172.15 11.73 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.33 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.14 -45.26 74.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.997 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.22 71.65 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.343 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.79 -42.34 97.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -92.31 3.88 54.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.931 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.6 m120 57.29 39.38 28.58 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 60.1 mtt -63.78 92.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.72 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.78 176.3 8.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.401 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 2' ' ' VAL . 33.0 m-80 -57.35 116.4 3.29 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.144 0.497 . . . . 0.0 110.783 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.36 26.19 5.24 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.694 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.671 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -73.25 114.42 11.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG22 ' HD2' ' A' ' 5' ' ' LYS . 25.7 t -96.94 104.68 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.193 0.52 . . . . 0.0 110.75 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.9 mm -94.33 143.33 11.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -110.44 112.02 23.67 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -79.16 134.12 36.71 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.46 142.2 24.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.534 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.595 HD23 ' HB2' ' A' ' 85' ' ' ARG . 19.7 tp -74.39 134.28 42.43 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 1.01 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 3.4 ptmm? -57.37 -22.47 42.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -165.01 119.96 1.34 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.176 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.595 ' HB2' HD23 ' A' ' 82' ' ' LEU . 2.9 tmm_? -167.02 93.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.253 0 CA-C-O 118.693 -1.059 . . . . 0.0 112.584 177.206 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.473 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.477 0.524 0 N-CA-C 109.767 -0.897 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 20.9 m -129.14 155.52 41.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.043 0.449 . . . . 0.0 110.768 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -85.14 122.66 29.67 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.7 HG22 ' HB3' ' A' ' 76' ' ' ALA . 7.3 pt -123.8 144.22 34.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.095 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.513 ' HE3' HG22 ' A' ' 77' ' ' VAL . 31.5 mtmt -125.67 151.21 46.87 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.119 0.485 . . . . 0.0 111.172 -175.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.2 105.45 13.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.139 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 104.41 3.36 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 55.2 t -76.81 128.41 81.68 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.655 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.733 ' HG2' HD13 ' A' ' 19' ' ' LEU . 30.6 Cg_endo -63.44 149.02 92.19 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 122.517 2.145 . . . . 0.0 112.045 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.692 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.8 m120 -75.69 93.89 3.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.516 ' HB3' HG22 ' A' ' 15' ' ' THR . 43.6 mtm -143.78 73.78 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.438 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.598 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -78.84 -45.61 20.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.596 0.713 . . . . 0.0 110.074 -171.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -120.46 16.69 12.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.814 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -100.8 -6.13 25.3 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.8 t -160.53 -176.01 5.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.157 -174.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.14 -4.0 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.424 -172.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 3.2 m-90 -95.75 169.94 9.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -175.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 24.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 111.578 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.7 mt -75.84 131.28 39.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.668 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 18.6 m-80 -142.43 14.38 1.99 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.248 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.692 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 84.91 0.12 89.08 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.015 -177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.668 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 1.6 pm0 -73.66 174.72 7.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 126.74 71.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.158 0.504 . . . . 0.0 109.814 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.68 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 5' ' ' LYS . 45.8 t -124.02 106.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -119.79 164.38 16.07 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.523 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 1' ' ' PRO . 12.6 m -126.29 126.33 43.79 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.406 176.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 4' ' ' ILE . 53.4 mt -140.9 152.75 66.31 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.263 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.3 152.38 79.32 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.862 1.708 . . . . 0.0 111.048 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.48 -10.79 19.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.8 p -77.39 -19.97 55.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.233 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.87 -173.8 3.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 111.251 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -146.09 176.8 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.017 0.437 . . . . 0.0 111.932 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.507 ' CG1' HG13 ' A' ' 61' ' ' ILE . 40.0 t -57.96 -31.74 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.403 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 29.0 t -55.66 -28.89 57.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.779 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.84 -30.74 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 120.989 0.423 . . . . 0.0 110.784 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mm -71.15 -52.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.929 0.395 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 9.6 ptmt -57.72 -43.14 85.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.8 p -69.29 -40.04 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 9.5 ptpt -67.05 -35.71 80.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.607 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.63 -43.54 77.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -60.39 -33.35 72.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.423 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 18.7 mm-40 -88.6 -25.69 22.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.795 0.331 . . . . 0.0 110.635 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.96 -53.08 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.4 p -90.35 -42.98 10.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.122 0.487 . . . . 0.0 110.63 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.95 -8.24 11.67 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.464 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 19.8 ptm -89.67 117.09 67.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.412 0.625 . . . . 0.0 111.346 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 Cg_endo -67.78 158.47 57.09 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.386 2.057 . . . . 0.0 112.132 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.99 -6.35 16.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.158 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . -60.68 -28.38 67.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.371 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.063 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -129.38 -11.67 4.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.248 0.547 . . . . 0.0 110.019 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.84 112.77 24.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.217 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mmpt? -104.36 140.33 38.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.753 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 54' ' ' LEU . 1.1 mm? -110.33 135.8 50.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -128.56 117.61 21.56 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.981 0.42 . . . . 0.0 111.464 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.2 t80 -104.45 111.27 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.943 0.401 . . . . 0.0 110.503 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 33.4 mm-40 56.32 29.94 15.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.357 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.95 21.26 33.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.25 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mt -125.93 116.07 44.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -74.55 96.05 2.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.846 0.831 . . . . 0.0 110.663 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.507 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -76.84 153.88 5.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.81 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.2 166.36 14.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.381 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -32.82 21.83 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.83 0.852 . . . . 0.0 111.78 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -74.88 -14.27 60.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.325 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -97.0 165.16 12.21 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.0 p -130.67 167.4 18.86 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.66 -45.52 86.37 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.51 78.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.467 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -56.8 -46.3 81.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.895 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 53.9 m-85 -85.8 -3.29 58.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.518 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.77 47.37 15.59 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 123.42 0.45 . . . . 0.0 110.031 -174.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 62.3 mtt -63.01 87.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.15 178.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.945 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 16.2 t-20 -60.52 114.87 3.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.935 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.21 40.38 2.1 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.404 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -83.61 114.55 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 110.249 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.513 HG22 ' HE3' ' A' ' 5' ' ' LYS . 15.3 t -94.74 104.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.976 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.5 mm -94.81 146.55 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -113.02 116.42 29.9 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.1 tp -84.64 133.78 34.4 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.32 142.67 27.38 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.004 0.431 . . . . 0.0 111.071 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.14 130.04 37.69 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 173.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 6.0 ptmm? -52.26 -37.5 55.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -161.57 124.81 3.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 111.019 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 85' ' ' ARG . 2.5 ttp180 -113.04 -67.85 0.97 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.857 172.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.857 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.519 -178.238 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 m -128.51 157.9 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -88.93 125.84 35.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.301 0.572 . . . . 0.0 110.277 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.693 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -122.29 135.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.544 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -121.06 145.63 47.58 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.632 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.6 t -124.96 108.1 19.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.584 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 102.99 3.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.007 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 63.0 t -73.75 130.25 83.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.899 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.737 ' HG2' HD13 ' A' ' 19' ' ' LEU . 39.9 Cg_endo -66.44 155.19 71.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.553 2.169 . . . . 0.0 111.963 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.657 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 16.2 m120 -82.37 90.81 6.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.552 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.5 mtm -142.5 76.78 1.55 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.057 0.455 . . . . 0.0 110.523 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.5 mp0 -78.77 -47.5 16.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.943 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -120.98 2.97 10.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.423 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -76.96 -19.16 57.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.346 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.3 t -150.96 -174.02 4.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.442 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -95.41 -5.76 42.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 0.0 111.509 -173.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.598 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 3.8 m0 -87.74 174.21 8.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.452 -174.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -89.35 30.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.058 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD13 ' HG2' ' A' ' 9' ' ' PRO . 16.8 mt -83.12 131.7 35.13 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.651 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 17.3 m-80 -143.12 15.84 1.89 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.123 0.487 . . . . 0.0 110.365 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.657 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.42 2.86 87.19 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.985 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.651 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 2.1 pm0 -74.35 177.11 6.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.11 0.481 . . . . 0.0 110.685 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.74 132.82 70.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.181 0.515 . . . . 0.0 110.101 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 81.2 mt -93.75 143.98 25.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.145 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.1 107.68 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 86.3 m-85 -115.47 159.41 21.21 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -126.27 114.31 18.12 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD12 HD11 ' A' ' 4' ' ' ILE . 80.5 mt -132.59 154.74 81.62 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.446 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -67.15 152.96 78.93 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.038 1.825 . . . . 0.0 111.238 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.73 -8.2 9.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.347 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.2 p -82.4 -15.92 50.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.108 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.91 -172.95 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.249 0.547 . . . . 0.0 110.928 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -144.94 174.97 10.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.727 -172.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.757 HG11 HG13 ' A' ' 61' ' ' ILE . 24.5 t -63.12 -25.24 38.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.899 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 63' ' ' ASP . 23.0 t -52.42 -35.39 51.86 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.914 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.05 -26.7 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.109 0.48 . . . . 0.0 110.458 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.676 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -72.45 -49.85 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.952 177.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 7.0 ptmt -61.75 -42.13 98.57 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 13.9 p -67.2 -38.8 81.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 -177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.13 -35.07 76.0 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.132 -177.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.453 HD12 HD11 ' A' ' 54' ' ' LEU . 74.4 mt -74.18 -42.95 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.124 0.488 . . . . 0.0 110.138 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -58.25 -32.91 68.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.477 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 61.5 mt-10 -85.93 -32.31 21.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.834 0.35 . . . . 0.0 110.64 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.33 -44.22 25.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.502 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.543 HG22 ' HE2' ' A' ' 18' ' ' LYS . 3.7 p -102.27 -45.62 5.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.044 0.449 . . . . 0.0 110.632 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.58 -19.34 5.93 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.948 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 18.6 ptm -78.38 117.64 67.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.351 0.596 . . . . 0.0 111.466 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 32.0 Cg_endo -68.88 159.03 55.54 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.306 2.004 . . . . 0.0 111.939 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.1 -17.47 63.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.027 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.94 -31.08 38.8 Favored Glycine 0 C--O 1.225 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.1 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.506 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -129.82 -3.47 4.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.239 0.542 . . . . 0.0 110.178 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.616 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -94.07 113.65 25.66 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.572 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -106.74 139.13 41.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.453 HD11 HD12 ' A' ' 41' ' ' ILE . 1.4 mm? -110.21 125.03 52.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 26.7 tt0 -115.89 114.93 25.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.118 0.485 . . . . 0.0 111.395 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HB2' HD12 ' A' ' 78' ' ' ILE . 11.6 t80 -102.68 107.72 18.73 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 27.2 mm-40 56.92 30.93 18.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.546 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.91 57.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.417 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 18.3 mt -107.79 115.17 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.5 m-30 -68.62 92.75 0.48 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 109.894 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.757 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -80.19 149.6 5.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.642 -177.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -109.44 160.79 15.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.722 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' SER . 4.3 p30 -66.81 -16.9 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.2 t -86.88 6.23 32.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.434 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 94.5 m-20 -106.28 167.06 10.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 82.6 p -124.43 166.33 16.17 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.242 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -66.0 -44.26 85.32 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.416 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.85 76.72 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.281 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -59.04 -47.82 83.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -89.58 5.24 46.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.208 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 m120 56.88 45.66 21.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.075 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.96 88.03 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.597 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.3 -170.72 1.03 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.913 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -61.11 114.43 3.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.5 39.68 3.62 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.937 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.24 115.13 16.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.5 t -95.65 102.45 13.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.212 0.53 . . . . 0.0 111.264 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 56' ' ' TYR . 6.8 mm -94.55 147.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -114.09 115.42 27.53 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 52' ' ' GLN . 51.8 tp -81.52 133.82 35.44 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.01 143.69 29.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 51' ' ' LYS . 29.8 tp -80.93 137.33 36.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.755 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -49.7 107.4 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.754 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 52.48 57.95 5.89 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.835 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 67.0 -73.72 0.07 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.21 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.326 -1.263 . . . . 0.0 111.246 -175.771 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 N-CA-C 109.393 -1.041 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 17.9 m -127.26 152.69 35.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.877 0.37 . . . . 0.0 110.512 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -88.64 122.52 32.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.804 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.0 pt -126.38 145.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -127.04 147.8 50.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.009 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.51 105.68 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.591 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.1 104.96 3.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.894 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 HD22 ' A' ' 19' ' ' LEU . 37.9 t -76.17 130.66 77.18 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HG2' HD13 ' A' ' 19' ' ' LEU . 59.0 Cg_endo -70.06 152.25 67.67 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.073 1.848 . . . . 0.0 111.77 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.447 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 10.6 m120 -75.83 83.67 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.435 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 12.6 mtp -133.83 73.32 1.5 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 120.927 0.394 . . . . 0.0 110.484 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.633 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -80.98 -45.13 17.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.622 0.725 . . . . 0.0 110.599 -175.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -113.9 3.67 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.466 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 37.9 mmtt -91.17 -6.89 52.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.061 -173.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 11' ' ' MET . 12.4 t -167.03 -176.03 3.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.935 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.71 7.37 28.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.022 0.439 . . . . 0.0 111.029 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 7.4 m0 -85.23 165.94 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.857 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 27.72 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 111.357 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.617 HD22 HG13 ' A' ' 8' ' ' VAL . 25.5 mt -81.72 123.62 28.91 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.937 -0.477 . . . . 0.0 109.747 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.0 m-80 -137.91 15.3 2.87 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.882 -0.511 . . . . 0.0 111.41 -176.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 79.45 14.01 81.93 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.27 -0.966 . . . . 0.0 112.6 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -87.24 176.49 7.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 177.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.86 125.06 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.232 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -86.96 141.62 28.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.07 108.61 16.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.469 0.652 . . . . 0.0 109.906 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -116.64 162.98 16.8 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.95 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -126.6 119.19 26.46 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 4' ' ' ILE . 87.4 mt -134.9 151.42 75.55 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.695 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.21 154.69 73.18 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 28.7 tp -65.67 -6.77 12.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.306 0.574 . . . . 0.0 110.472 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.6 p -82.83 -17.31 44.42 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.939 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.3 m-20 -75.69 -175.44 2.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.32 0.581 . . . . 0.0 110.643 176.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -143.45 171.44 14.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.543 -172.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.632 HG11 HG13 ' A' ' 61' ' ' ILE . 40.2 t -63.41 -27.86 43.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.366 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.517 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -53.62 -31.44 47.14 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.091 175.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 3.2 t -78.61 -28.24 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.639 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HA ' ' HG2' ' A' ' 40' ' ' LYS . 30.4 mm -73.44 -46.48 48.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.348 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 7.0 ptmt -60.39 -41.99 94.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.443 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 p -69.84 -40.57 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.9 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -64.89 -38.55 91.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.886 -179.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.85 -43.77 79.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.68 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' MET . 11.3 t-80 -57.52 -33.81 68.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.55 -25.43 20.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.004 -0.279 . . . . 0.0 111.073 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.43 -39.53 24.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.392 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 6.8 p -104.14 -47.86 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.565 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.58 7.89 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 42' ' ' HIS . 16.0 ptm -86.99 119.73 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.26 0.553 . . . . 0.0 111.517 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.4 Cg_endo -68.82 158.73 56.66 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.397 2.065 . . . . 0.0 112.166 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -66.05 -9.45 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.889 -177.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.6 -27.31 65.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.663 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -131.73 -2.53 3.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.037 0.446 . . . . 0.0 110.462 -178.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.69 114.47 26.45 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.238 0.542 . . . . 0.0 109.699 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 8.5 mmpt? -106.54 142.7 35.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.738 -176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.27 121.46 38.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.87 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.0 tt0 -111.77 117.53 33.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.015 0.436 . . . . 0.0 111.605 -176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.676 ' HB2' HD12 ' A' ' 78' ' ' ILE . 16.7 t80 -105.28 109.67 21.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 56.88 30.59 18.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.803 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.47 56.15 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.308 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 20.2 mt -111.02 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -72.66 90.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.632 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -76.99 158.35 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.892 -175.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.0 pttp -118.69 159.31 23.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.994 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.72 -2.68 21.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.1 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.527 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -91.37 -0.85 57.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.777 0.322 . . . . 0.0 111.23 177.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.428 HD21 ' HE3' ' A' ' 62' ' ' LYS . 94.7 m-20 -112.4 -175.35 2.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.269 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 39.1 p -137.75 176.57 8.59 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.784 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.01 -45.73 59.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.764 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.412 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.42 -33.0 69.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.127 175.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -59.13 -48.64 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.438 ' CE2' ' HB ' ' A' ' 61' ' ' ILE . 72.1 m-85 -88.95 1.75 54.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.292 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 60.91 45.85 9.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.38 -179.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.0 mtt -70.5 85.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.774 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.25 -172.31 1.38 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.78 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.507 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 53.0 t30 -62.22 114.95 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.224 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.96 39.49 2.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.645 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.804 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.87 114.62 19.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.171 0.485 . . . . 0.0 110.312 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -96.75 103.03 14.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.07 0.462 . . . . 0.0 110.851 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.676 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.6 mm -94.46 149.62 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -117.69 119.65 35.61 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -84.47 131.86 34.62 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.588 177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.73 144.35 27.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.944 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 51' ' ' LYS . 23.1 tp -75.3 144.62 42.36 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -45.52 -53.01 9.57 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.835 0.709 . . . . 0.0 110.128 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -165.97 147.37 6.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 5.3 ptp85 -77.67 101.27 6.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.386 0.613 . . . . 0.0 110.94 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.742 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.444 ' HB2' HG22 ' A' ' 27' ' ' THR . 9.7 Cg_endo . . . . . 0 N--CA 1.478 0.592 0 N-CA-C 109.773 -0.895 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 28' ' ' LEU . 11.1 m -120.36 152.45 23.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 0.0 110.544 -177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 m -87.54 119.23 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.685 HG22 ' HB3' ' A' ' 76' ' ' ALA . 3.1 pt -120.0 142.36 35.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.275 0.559 . . . . 0.0 110.987 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -125.58 148.2 49.02 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.413 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.79 105.86 14.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.56 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.441 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -70.7 106.41 3.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.635 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 19' ' ' LEU . 85.6 t -76.94 128.78 80.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.235 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.826 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.1 Cg_endo -65.32 149.75 88.0 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.29 1.993 . . . . 0.0 111.698 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.595 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 14.1 m120 -76.08 84.73 2.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.462 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.577 ' HA ' ' HG2' ' A' ' 14' ' ' LYS . 51.0 mtm -137.49 75.58 1.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.142 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 8.3 mp0 -79.03 -45.46 20.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.729 0.775 . . . . 0.0 109.747 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -119.61 -0.06 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.737 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.577 ' HG2' ' HA ' ' A' ' 11' ' ' MET . 33.9 mmtt -81.17 -6.01 58.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.056 -177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.5 t -164.85 -175.84 3.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.647 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -102.4 -0.08 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.92 0.39 . . . . 0.0 111.665 -174.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 5.6 m0 -85.01 168.87 14.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.67 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -80.9 28.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.454 0.645 . . . . 0.0 110.898 -178.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 9' ' ' PRO . 18.0 mt -79.88 128.8 33.89 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 20.7 m-80 -140.55 9.78 2.24 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.883 -0.511 . . . . 0.0 111.368 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.595 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.09 10.49 78.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.882 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -84.02 179.45 7.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.891 0.377 . . . . 0.0 110.426 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' A' ' 7' ' ' GLN . 62.2 t -125.46 126.83 71.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -87.64 141.87 28.28 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.16 114.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CD2' ' HE3' ' A' ' 40' ' ' LYS . 56.7 m-85 -130.13 166.46 20.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.75 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 1' ' ' PRO . 3.8 m -126.81 123.38 37.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.775 0.321 . . . . 0.0 110.418 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 2' ' ' VAL . 73.2 mt -139.04 152.41 69.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.953 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.45 152.81 74.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.223 1.948 . . . . 0.0 111.689 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 31.0 tp -64.3 -7.05 8.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -83.82 -17.26 41.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.491 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.26 -173.78 3.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.237 0.542 . . . . 0.0 110.716 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -146.07 175.22 10.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.419 -172.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 61' ' ' ILE . 19.8 t -59.46 -29.74 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.702 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.594 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 1.4 m -53.38 -29.35 34.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.397 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.7 t -78.81 -32.61 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.601 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.685 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 26.7 mm -70.59 -46.99 67.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.306 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 8.1 ptmt -62.29 -44.46 96.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.922 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.5 p -67.48 -35.39 73.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.703 -176.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -69.34 -34.63 74.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.624 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.415 HD12 HD11 ' A' ' 54' ' ' LEU . 82.6 mt -74.57 -42.75 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.361 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -57.41 -32.38 66.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.561 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 14.1 mm-40 -87.7 -29.13 21.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.45 -44.94 18.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 7.2 p -99.58 -45.04 5.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.649 -177.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.79 -17.17 6.85 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.681 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.601 ' HG3' ' HB2' ' A' ' 52' ' ' GLN . 16.5 ptm -82.86 116.17 62.63 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.541 0.686 . . . . 0.0 111.451 -175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 30.7 Cg_endo -68.07 162.9 38.04 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.522 2.148 . . . . 0.0 111.992 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -68.96 -8.46 44.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.847 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.39 66.64 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.399 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HA ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -128.07 -24.25 3.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 109.92 -179.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.714 ' OE1' ' HA ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -73.44 113.53 10.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.082 176.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 6.7 mmpt? -107.34 140.6 40.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 41' ' ' ILE . 1.9 mm? -112.27 123.98 51.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.829 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.0 tt0 -115.57 115.59 26.72 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.019 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD12 ' A' ' 78' ' ' ILE . 10.8 t80 -101.6 107.82 19.19 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.258 0.552 . . . . 0.0 110.108 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 57' ' ' GLU . 5.2 mm-40 56.74 29.44 15.9 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.053 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.0 14.95 37.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.026 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 25.7 mt -117.51 116.0 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -72.36 95.65 1.77 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.587 . . . . 0.0 110.007 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -84.52 154.09 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 64' ' ' SER . 0.0 OUTLIER -132.51 174.84 9.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.984 0.421 . . . . 0.0 111.839 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.36 -28.79 20.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.568 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.441 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 4.6 m -86.16 10.52 14.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.043 0.449 . . . . 0.0 111.174 -169.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 87.9 m-20 -114.71 172.66 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.4 p -130.08 166.58 19.88 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.05 -44.12 85.5 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -58.65 -38.88 79.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.628 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.14 -40.8 77.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.302 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -95.57 6.4 49.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 111.452 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.1 m120 59.54 38.89 22.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.967 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.1 mtt -67.48 87.13 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.206 0.526 . . . . 0.0 111.044 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.55 -168.64 2.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.302 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.51 115.12 2.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.121 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.4 36.7 3.25 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.648 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -82.66 114.65 21.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.029 0.415 . . . . 0.0 109.978 177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.85 102.2 13.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.57 -177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.9 mm -94.24 150.52 4.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -116.16 116.47 27.88 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.539 HD11 ' HG3' ' A' ' 52' ' ' GLN . 38.0 tp -82.53 131.68 35.21 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -149.24 145.59 27.17 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.293 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.7 tp -76.0 144.63 40.79 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 11.2 ptpt -58.1 -179.75 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -47.85 -48.37 31.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.046 -173.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 -96.64 130.6 43.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.286 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.627 -1.096 . . . . 0.0 111.891 -178.516 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.51 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.5 Cg_endo . . . . . 0 N--CA 1.479 0.643 0 N-CA-C 110.159 -0.747 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 74' ' ' ASN . 16.1 m -122.49 156.21 27.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.875 0.369 . . . . 0.0 110.813 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -82.52 127.24 33.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.021 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 76' ' ' ALA . 6.5 pt -130.71 136.64 57.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.129 0.49 . . . . 0.0 110.826 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' LEU . 17.5 mttt -123.35 145.47 48.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.764 -173.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.8 108.44 24.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.527 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -74.03 104.01 4.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.649 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.539 HG13 HD22 ' A' ' 19' ' ' LEU . 62.1 t -76.71 131.19 74.38 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.455 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.825 ' HG2' HD13 ' A' ' 19' ' ' LEU . 36.1 Cg_endo -66.62 155.68 69.24 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.14 1.894 . . . . 0.0 112.214 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.58 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.0 m120 -82.54 84.2 7.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.735 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.599 ' HB3' HG22 ' A' ' 15' ' ' THR . 48.6 mtm -137.45 75.09 1.51 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.261 0.553 . . . . 0.0 109.925 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.605 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 9.3 mp0 -79.91 -47.47 15.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.689 -171.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -120.89 10.78 10.94 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp -93.27 -2.18 55.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.834 -175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 11' ' ' MET . 15.3 t -167.77 -176.73 3.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.679 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -88.86 -12.52 41.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.808 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.67 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 4.2 m0 -84.99 164.34 18.34 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.563 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -82.85 29.94 0.45 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.672 0.748 . . . . 0.0 110.86 -178.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.825 HD13 ' HG2' ' A' ' 9' ' ' PRO . 19.4 mt -78.94 127.25 31.76 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.556 -0.715 . . . . 0.0 109.269 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.605 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 17.2 m-80 -137.82 20.57 2.86 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.766 -0.584 . . . . 0.0 111.364 -175.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 75.14 1.39 63.47 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.085 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -76.58 176.51 8.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.26 0.552 . . . . 0.0 110.526 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 7' ' ' GLN . 58.2 t -125.31 123.48 65.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.904 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 51.4 mt -88.05 136.92 32.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.35 110.38 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 120.971 0.415 . . . . 0.0 110.0 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.44 166.33 16.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.593 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 1' ' ' PRO . 6.6 m -126.49 122.59 35.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 4' ' ' ILE . 73.4 mt -136.09 154.04 77.2 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.72 152.52 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.87 1.713 . . . . 0.0 110.982 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.65 -8.7 10.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.3 p -79.61 -18.38 51.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.44 -175.13 2.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 110.648 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.1 172.83 12.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.342 -173.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.627 HG11 HG13 ' A' ' 61' ' ' ILE . 40.4 t -62.82 -26.81 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.564 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -54.16 -33.16 57.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.316 176.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.1 t -74.03 -32.05 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.231 0.539 . . . . 0.0 110.16 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 mm -72.61 -48.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.751 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 8.7 ptmt -59.86 -40.95 90.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.744 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -72.97 -39.23 57.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.041 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 16.4 ptpt -63.5 -35.6 81.01 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.259 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.9 mt -72.35 -43.58 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.264 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -59.84 -34.71 73.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.36 -36.41 39.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.748 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.14 -52.74 8.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.729 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 3.8 p -91.66 -43.49 9.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.11 -15.22 9.44 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.949 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.434 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 17.5 ptm -81.36 119.96 77.05 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.458 0.647 . . . . 0.0 111.565 -175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HG2' ' HD2' ' A' ' 51' ' ' LYS . 30.0 Cg_endo -67.85 156.7 64.9 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.77 2.313 . . . . 0.0 112.056 176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.97 -12.54 51.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.483 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.64 -32.58 58.56 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.557 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HD2' ' HG2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.68 -3.92 4.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.148 0.499 . . . . 0.0 110.495 -177.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -92.68 116.33 28.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.31 0.576 . . . . 0.0 109.547 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.76 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -104.92 140.92 37.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -178.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.74 118.69 32.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.146 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 25.9 tt0 -111.48 116.0 30.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.593 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.637 ' HB2' HD12 ' A' ' 78' ' ' ILE . 12.7 t80 -103.85 108.97 20.53 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HG2' ' CE1' ' A' ' 56' ' ' TYR . 61.6 mm-40 57.35 30.23 18.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.741 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.46 10.36 53.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.316 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 15.8 mt -114.49 118.67 59.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 10.1 m-30 -74.11 89.41 1.97 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.627 HG13 HG11 ' A' ' 34' ' ' VAL . 0.4 OUTLIER -74.44 154.4 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.75 -175.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 11.9 pttp -117.14 160.02 21.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.945 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -72.19 -5.28 34.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.46 ' OG ' ' HG3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -88.71 0.42 56.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.884 0.373 . . . . 0.0 110.748 177.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -112.47 176.89 4.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 85.3 p -130.43 170.03 14.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.318 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.52 -43.6 80.42 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.861 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.97 76.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.282 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -57.59 -44.73 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.958 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -88.9 3.38 51.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.264 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 71' ' ' ASN . 0.9 OUTLIER 59.26 41.0 20.72 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.021 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 58.7 mtt -62.8 94.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.446 0.641 . . . . 0.0 111.279 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.75 -177.9 2.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 33.3 t30 -61.83 116.76 5.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.22 39.29 3.79 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.364 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -77.53 114.91 16.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.345 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.28 105.11 16.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.139 0.495 . . . . 0.0 110.783 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -93.87 148.82 4.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -117.0 116.9 28.27 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.05 133.31 34.66 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.0 148.91 31.24 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.392 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 51' ' ' LYS . 26.1 tp -83.21 126.8 33.03 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.564 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -58.6 -64.98 0.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.293 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -134.46 142.89 47.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.42 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.43 -31.87 0.73 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.672 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.099 -1.39 . . . . 0.0 111.089 -177.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 27' ' ' THR . 11.4 Cg_endo . . . . . 0 C--O 1.231 0.145 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.2 m -122.96 154.66 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.385 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 m -85.55 124.85 32.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 76' ' ' ALA . 4.6 pt -128.38 148.0 32.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.967 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 77' ' ' VAL . 10.1 mttm -128.13 147.53 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 105.81 16.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.4 104.72 5.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.979 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 19' ' ' LEU . 57.6 t -73.67 133.02 80.13 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.367 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.835 ' HG2' HD13 ' A' ' 19' ' ' LEU . 38.0 Cg_endo -68.66 151.23 74.97 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.995 1.797 . . . . 0.0 111.772 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.607 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.2 m120 -79.89 88.45 5.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.517 ' HB3' HG22 ' A' ' 15' ' ' THR . 51.0 mtm -138.84 75.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.291 0.567 . . . . 0.0 109.797 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HG3' ' HA ' ' A' ' 20' ' ' ASN . 12.9 mp0 -78.84 -45.95 19.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.86 -168.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -120.21 2.8 10.9 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.133 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -86.33 -4.83 59.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.157 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 11' ' ' MET . 13.6 t -161.47 -176.46 5.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.826 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.99 -0.33 47.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.106 0.479 . . . . 0.0 111.627 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.662 ' HB2' ' HG ' ' A' ' 19' ' ' LEU . 5.2 m0 -89.84 174.56 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.081 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.15 28.51 1.4 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.193 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD13 ' HG2' ' A' ' 9' ' ' PRO . 15.7 mt -79.56 122.71 26.83 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.634 ' HA ' ' HG3' ' A' ' 12' ' ' GLN . 13.8 m-80 -136.49 20.13 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.255 0.55 . . . . 0.0 110.452 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.607 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 81.18 -7.85 59.34 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.976 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.576 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -65.79 176.02 1.73 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.522 0.677 . . . . 0.0 111.15 -178.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -122.91 126.69 74.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.919 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 mt -87.51 132.17 34.12 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.34 107.39 18.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -125.08 167.35 14.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.396 -177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 1' ' ' PRO . 2.1 m -126.51 119.89 28.29 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 4' ' ' ILE . 67.4 mt -134.38 149.89 72.41 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 42.6 Cg_endo -70.01 149.23 65.02 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.387 2.058 . . . . 0.0 111.62 176.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.8 tp -62.6 -12.16 21.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.872 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -72.65 -25.26 61.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 29' ' ' PRO . 1.2 m-20 -75.01 -173.62 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.136 0.493 . . . . 0.0 110.731 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -145.55 173.42 12.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.819 0.342 . . . . 0.0 111.714 -172.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 61' ' ' ILE . 25.6 t -57.28 -31.35 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.74 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 38' ' ' LYS . 15.3 m -50.64 -36.07 33.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.126 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' LYS . 39.0 t -72.04 -33.97 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.615 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.7 -52.6 22.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.816 0.341 . . . . 0.0 110.479 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 10.7 ptmt -57.97 -44.59 87.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.513 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.63 -32.72 56.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.291 0.567 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -65.65 -46.52 78.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.856 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.7 mt -69.47 -38.14 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.159 0.504 . . . . 0.0 110.264 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 47' ' ' MET . 7.6 t-80 -56.9 -34.57 68.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.481 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -90.91 -29.93 17.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.978 0.418 . . . . 0.0 111.024 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.62 -44.92 32.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.431 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 5.8 p -102.03 -40.5 6.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.958 0.409 . . . . 0.0 110.43 -176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.57 -8.77 10.91 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.962 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.546 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 15.0 ptm -90.99 117.89 68.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.332 0.587 . . . . 0.0 111.811 -176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 20.2 Cg_endo -66.92 157.25 62.46 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.7 2.266 . . . . 0.0 111.873 175.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -62.65 -14.2 40.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.682 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.07 -34.12 52.12 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.44 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HE2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -126.9 -7.82 6.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 110.252 -177.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 47' ' ' MET . 0.0 OUTLIER -93.93 116.57 29.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.59 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.726 ' HA ' ' NZ ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -107.13 142.81 36.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.782 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.05 124.56 46.16 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -116.39 119.52 35.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.038 0.447 . . . . 0.0 111.44 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HB2' HD12 ' A' ' 78' ' ' ILE . 8.8 t80 -103.65 104.78 14.86 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.078 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 57.24 29.69 17.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.849 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.44 14.51 37.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.916 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -120.69 114.35 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -76.67 92.74 3.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.678 0.752 . . . . 0.0 110.855 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.506 HG13 ' CG1' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -74.89 150.75 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.42 -177.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -125.71 171.26 10.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.125 0.488 . . . . 0.0 111.869 179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -18.88 45.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.188 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.432 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 3.9 m -86.97 10.12 17.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.065 0.459 . . . . 0.0 110.773 -175.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -122.4 171.19 9.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 79.4 p -129.56 169.93 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.94 -44.13 85.98 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.11 75.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.54 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.19 -39.96 84.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.723 0.297 . . . . 0.0 111.134 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CZ ' HG22 ' A' ' 61' ' ' ILE . 49.1 m-85 -91.09 -2.33 57.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.285 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.71 46.47 20.04 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.638 0.586 . . . . 0.0 110.124 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.6 mtt -62.04 87.79 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.272 0.558 . . . . 0.0 110.747 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.58 179.58 3.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.712 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -61.18 115.8 4.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.344 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.97 33.61 3.7 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.135 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -79.22 114.79 18.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.118 0.485 . . . . 0.0 110.031 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HD2' ' A' ' 5' ' ' LYS . 26.5 t -99.1 106.06 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.931 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.3 mm -94.44 149.03 4.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -116.57 119.35 35.29 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 tp -85.74 133.3 34.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.63 34.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.649 HD23 ' HD3' ' A' ' 85' ' ' ARG . 37.4 tp -89.78 124.29 34.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.109 0.48 . . . . 0.0 110.97 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -65.07 -65.3 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.051 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -132.48 141.7 48.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.93 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.649 ' HD3' HD23 ' A' ' 82' ' ' LEU . 12.2 ptt180 -148.78 29.72 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.336 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.489 -1.173 . . . . 0.0 111.355 -177.182 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.513 ' HB2' HG22 ' A' ' 27' ' ' THR . 6.9 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 N-CA-C 110.307 -0.69 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.56 158.63 36.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 m -90.51 122.13 33.07 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.12 0.486 . . . . 0.0 110.595 -176.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.736 HG22 ' HB3' ' A' ' 76' ' ' ALA . 1.8 pt -125.46 138.57 53.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.956 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -120.58 146.38 46.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.14 105.76 17.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.236 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 101.43 3.76 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.872 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 22' ' ' GLN . 22.3 t -72.24 129.33 87.72 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.7 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.672 ' HG2' HD13 ' A' ' 19' ' ' LEU . 43.1 Cg_endo -66.15 149.19 85.72 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.517 2.145 . . . . 0.0 111.677 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.643 ' ND2' ' HA3' ' A' ' 21' ' ' GLY . 15.6 m120 -73.78 85.43 1.68 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.459 ' HB3' HG22 ' A' ' 15' ' ' THR . 47.8 mtm -136.09 74.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.678 -0.409 . . . . 0.0 109.965 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 12' ' ' GLN . 3.6 mp0 -78.99 -44.96 21.22 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.727 0.775 . . . . 0.0 109.557 -173.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -119.79 3.59 11.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.212 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -88.87 -5.06 58.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.028 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 11' ' ' MET . 14.7 t -162.68 -175.74 4.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.675 -177.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -105.19 3.26 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.408 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 45' ' ' THR . 4.5 m0 -90.43 169.52 10.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.126 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HE2' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -81.96 31.43 0.37 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.154 0.502 . . . . 0.0 111.631 -178.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' HG2' ' A' ' 9' ' ' PRO . 20.8 mt -83.74 132.97 34.81 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.69 ' HB2' ' OE1' ' A' ' 22' ' ' GLN . 13.6 m-80 -147.29 19.27 1.21 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 110.14 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.643 ' HA3' ' ND2' ' A' ' 10' ' ' ASN . . . 85.23 -3.26 87.49 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.69 ' OE1' ' HB2' ' A' ' 20' ' ' ASN . 3.5 pm0 -70.88 172.11 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.577 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.24 130.57 74.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD21 ' NZ ' ' A' ' 18' ' ' LYS . 88.8 mt -91.01 147.34 23.15 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.53 109.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.68 160.68 19.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.241 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 1' ' ' PRO . 7.1 m -127.1 115.9 19.87 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 4' ' ' ILE . 96.1 mt -134.19 151.88 77.28 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.557 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.27 151.89 80.18 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.207 1.938 . . . . 0.0 111.439 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' HG ' ' HB2' ' A' ' 68' ' ' ALA . 21.3 tp -64.72 -4.53 4.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -83.65 -20.68 33.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.444 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 36' ' ' VAL . 1.6 m-20 -77.41 -174.72 3.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.268 0.556 . . . . 0.0 110.622 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -144.81 174.01 11.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.52 -172.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.796 HG11 HG13 ' A' ' 61' ' ' ILE . 39.5 t -61.91 -27.52 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.693 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 29.2 t -51.78 -33.31 34.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.44 175.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.469 HG21 ' OD2' ' A' ' 32' ' ' ASP . 19.8 t -77.44 -30.75 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.93 0.395 . . . . 0.0 110.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.2 mm -71.84 -49.28 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.368 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 49' ' ' ALA . 2.9 ptmt -59.07 -40.6 85.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.48 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 14.6 p -71.24 -41.09 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.083 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -65.72 -35.58 81.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.893 -177.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.9 -41.57 79.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.281 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -57.84 -34.75 70.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.088 177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 39' ' ' VAL . 52.9 mt-10 -82.84 -33.02 27.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.952 0.406 . . . . 0.0 110.419 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.8 -44.14 23.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.769 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 17' ' ' TRP . 4.1 p -102.18 -44.94 5.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.763 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.84 -5.84 10.49 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.116 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.457 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 16.9 ptm -89.57 116.88 67.45 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.345 0.593 . . . . 0.0 111.366 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 51' ' ' LYS . 27.3 Cg_endo -68.12 159.36 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.518 2.145 . . . . 0.0 111.848 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.661 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . . . -64.16 -14.85 57.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.822 -176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.16 -30.7 55.26 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.081 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -128.66 -3.96 5.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.167 0.508 . . . . 0.0 109.995 -177.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.23 115.52 28.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.734 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 9.7 mmpt? -108.14 141.61 39.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.655 -177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.0 mt -117.51 121.49 41.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.819 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 27.6 tt0 -113.54 117.36 31.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.238 -176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.623 ' HB2' HD12 ' A' ' 78' ' ' ILE . 9.9 t80 -103.54 109.45 21.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.027 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 56.4 29.59 15.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.747 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.67 13.05 45.37 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 19.6 mt -116.97 118.99 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -74.04 93.15 2.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.31 0.576 . . . . 0.0 110.056 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HG11 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -79.28 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.552 -178.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.22 166.83 12.12 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.59 -12.35 61.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.337 . . . . 0.0 111.387 -175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 m -78.22 -10.3 59.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 72.7 m-20 -99.47 164.26 12.17 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 33' ' ' GLN . 95.6 p -125.09 167.5 14.69 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.04 -43.41 87.63 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.911 0.386 . . . . 0.0 110.028 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . . . -61.96 -34.85 76.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 66' ' ' SER . 67.3 t80 -55.64 -45.08 77.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.194 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.422 ' HE2' ' ND2' ' A' ' 65' ' ' ASN . 29.7 m-85 -97.53 9.48 42.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.631 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.25 45.84 19.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.248 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.3 mtt -69.08 90.09 0.45 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.085 0.469 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.81 -172.34 2.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.823 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -61.08 115.53 3.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.257 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 31.58 5.46 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.62 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -75.02 114.56 13.64 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.03 104.53 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 0.0 110.913 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 56' ' ' TYR . 5.5 mm -94.23 148.27 5.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -112.88 118.33 34.6 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -82.77 132.74 35.16 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -148.03 147.01 29.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.126 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 51' ' ' LYS . 27.3 tp -78.6 148.7 33.18 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -61.05 -13.1 14.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.562 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 65.3 17.77 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.138 0.575 . . . . 0.0 111.976 176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 6.3 tpm_? -81.81 -42.49 19.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.993 0.425 . . . . 0.0 110.071 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.032 -1.427 . . . . 0.0 110.993 179.939 . . . . . . . . 0 0 . 1 stop_ save_